data_2n47_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n47 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.747 0.308 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -155.02 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.961 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -159.87 159.95 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.24 133.46 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.51 144.93 51.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -167.77 165.03 14.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -159.53 169.95 22.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.839 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.0 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -158.98 168.14 27.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.27 162.31 25.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -149.98 125.09 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.7 t -120.6 110.88 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -163.97 139.87 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.35 171.15 43.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -129.46 170.47 13.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -124.63 147.84 57.1 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.658 0.742 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.44 154.51 71.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -147.53 178.43 8.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -164.29 161.79 22.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.2 143.88 56.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.88 -47.68 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -169.281 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.656 0.741 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.98 146.93 88.68 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.65 2.233 . . . . 0.0 112.373 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 pm0 -74.49 3.15 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -148.83 7.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.6 mttt -74.99 129.99 38.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.683 0.278 . . . . 0.0 110.968 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.61 129.07 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.101 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.06 120.56 40.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.32 124.44 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.0 mt -109.93 139.41 45.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -170.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 55.01 50.52 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 171.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -89.9 -21.43 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.1 -65.53 4.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -114.8 -27.92 7.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.92 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.26 31.37 55.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.548 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -65.68 -45.18 83.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -71.86 -27.41 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.98 87.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.8 m -67.82 -34.62 77.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.02 -45.56 90.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.78 -38.39 90.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.62 79.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.19 -15.62 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -83.97 -1.45 54.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.868 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.87 2.51 62.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.6 m-30 -78.68 145.34 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.32 106.65 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.23 125.61 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.4 m -109.47 126.64 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.85 127.33 56.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 81' ' ' VAL . 69.2 t -121.38 131.91 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.98 159.31 40.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -81.7 -21.44 38.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -93.8 114.08 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -67.16 -34.56 77.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.97 -31.66 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.194 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.66 97.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.17 -35.98 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.756 0.313 . . . . 0.0 110.915 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 -38.75 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.21 -43.72 90.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -62.33 -44.81 95.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.15 -42.24 94.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.76 96.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.39 -40.02 96.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.955 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.96 -30.08 70.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.89 -6.55 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.93 33.71 59.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.478 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.72 162.23 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.096 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -96.57 137.17 36.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.92 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 tt -137.25 150.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -111.7 135.24 52.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.3 p -123.2 135.19 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.119 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 57' ' ' VAL . 90.0 t -130.83 123.79 55.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -85.39 116.08 23.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -171.33 142.22 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -65.59 131.49 46.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 169.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HB3' HD22 ' A' ' 113' ' ' LEU . 87.1 mt -59.52 -28.83 67.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.81 68.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -103.35 -11.24 18.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.18 131.02 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -96.74 112.71 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.824 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.1 mt -94.19 119.86 42.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.48 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.144 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.38 93.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.81 -28.5 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.66 83.06 3.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.63 95.78 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -135.15 129.72 34.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.1 159.26 28.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.772 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.8 mm -109.93 117.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.49 127.42 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 64.1 m -115.4 115.87 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.49 120.94 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.16 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 41.33 54.82 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 71.3 m -101.57 95.4 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.902 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -75.24 110.44 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -156.38 151.98 22.2 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.558 0.694 . . . . 0.0 110.952 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 145.1 81.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.609 2.206 . . . . 0.0 112.385 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -58.08 -29.21 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.1 p -60.43 -30.85 69.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.7 tp -70.14 -40.84 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -58.49 -40.31 82.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.29 -31.45 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -81.2 -36.07 30.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 85' ' ' LEU . 81.8 mt -70.42 -32.78 70.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.6 m-30 -50.76 -55.15 29.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.683 0.754 . . . . 0.0 110.891 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 36.0 Cg_endo -63.86 -32.78 66.21 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.09 -51.29 59.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.772 ' HB ' HG13 ' A' ' 98' ' ' ILE . 34.1 m -75.43 -31.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.11 -53.04 51.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.42 -33.38 75.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.51 -47.8 60.59 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.45 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 48.9 tp -89.59 138.98 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -62.07 151.82 79.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.898 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.95 138.94 51.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.24 3.22 82.37 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.505 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -73.0 172.88 49.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.513 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.64 140.09 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 111.154 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -111.1 136.46 50.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.426 ' CD1' HD12 ' A' ' 191' ' ' LEU . 35.3 mm -120.66 128.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt -129.98 125.73 36.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -146.68 130.36 16.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 144.84 -172.2 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 177.3 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.798 0.333 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.36 -31.18 71.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.13 -37.14 86.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 84.5 m -65.99 -45.23 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.53 -46.32 83.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -70.14 -26.83 64.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 94.5 p -83.87 -27.64 28.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.88 -9.39 58.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.68 105.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.624 0.726 . . . . 0.0 110.866 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.46 -21.88 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.331 -170.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 94.8 p -65.23 -23.52 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.943 -159.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.598 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.5 pp -141.18 163.1 33.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.07 145.9 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.52 131.55 40.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.62 -33.99 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.586 ' CG1' ' HB3' ' A' ' 191' ' ' LEU . 46.1 pt -139.51 143.32 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.207 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 121.71 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -138.14 139.71 39.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -100.65 121.92 42.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 165.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 53.5 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.5 mp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.799 0.333 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.03 127.94 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.94 123.98 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 171.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.524 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.5 pt? -153.78 151.62 29.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.68 ' O ' HD21 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.91 130.77 24.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 -173.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.48 169.34 50.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.527 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 -173.406 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.6 p-90 -155.03 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.99 160.0 32.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -153.21 133.82 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.834 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -106.88 144.86 32.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.94 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.76 165.01 14.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -157.85 169.99 23.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.05 160.0 40.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.84 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -156.9 165.34 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -163.12 160.08 23.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -150.08 124.97 9.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.93 112.77 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.089 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.74 135.11 5.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.41 -165.29 36.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -125.03 174.42 8.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.108 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -125.48 152.21 71.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.8 148.46 90.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.448 ' HA ' HD23 ' A' ' 50' ' ' LEU . 29.5 p30 -126.79 -170.14 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -162.64 158.84 23.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -75.3 144.98 42.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.1 mt -73.87 -43.2 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.136 -167.185 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 121.648 0.737 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 147.47 74.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.398 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 18.7 pm0 -76.31 13.87 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.32 -135.59 2.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.3 mttt -96.23 131.44 42.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.842 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 52' ' ' TYR . 4.8 mp -123.42 131.67 72.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 tp -102.42 122.26 43.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.943 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -111.67 122.96 49.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.0 mt -107.22 131.95 53.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -168.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.95 52.53 11.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.03 -19.75 24.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.88 -64.89 4.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.542 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.64 -33.08 5.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.87 44.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.516 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.07 -43.14 88.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.69 -29.39 66.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB2' HG11 ' A' ' 54' ' ' VAL . . . -63.29 -46.24 87.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.2 m -64.33 -35.47 80.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.98 -43.79 98.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.836 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.52 -42.96 93.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.86 -35.08 74.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.6 p -68.72 -15.64 63.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 18' ' ' ASN . 56.0 mt -85.58 0.05 53.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.72 63.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.553 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.463 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 2.5 m-30 -77.79 147.51 35.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.946 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -92.82 104.44 16.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.975 171.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG11 ' HB2' ' A' ' 44' ' ' ALA . 97.2 t -105.85 124.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.132 -167.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -109.6 128.03 54.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.7 127.37 56.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' ' 81' ' ' VAL . 87.7 t -122.78 134.12 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.03 160.98 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -77.38 -27.97 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -90.99 116.64 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.469 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 95.0 p -68.01 -35.13 77.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.85 -31.89 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.083 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.21 -40.36 97.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.511 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.78 -36.67 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.21 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.108 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.09 -36.98 83.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.66 95.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.047 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.07 -45.47 93.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.72 -38.84 84.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.34 -39.55 93.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.22 98.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.113 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.86 -38.43 90.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -32.37 73.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.6 -9.17 48.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.78 33.82 54.63 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.86 165.02 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.178 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.36 141.25 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -138.28 153.0 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -122.62 122.08 37.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.1 p -119.99 141.05 50.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HB ' HG23 ' A' ' 57' ' ' VAL . 73.6 t -133.17 121.78 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.469 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -82.18 114.73 20.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.984 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -170.67 140.06 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -61.75 131.2 49.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HB3' HD22 ' A' ' 113' ' ' LEU . 82.7 mt -59.02 -28.73 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -28.68 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.07 -11.33 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.69 130.87 45.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.92 113.3 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.52 119.65 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.4 t -86.59 140.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.165 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -46.05 81.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.12 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -58.11 -24.01 57.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.17 88.74 6.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . 37.7 m0 -83.86 104.76 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -172.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.2 mt-10 -140.98 140.91 34.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.82 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.4 173.39 43.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.1 mm -121.8 120.5 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.1 127.59 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.122 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -121.31 114.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.78 123.5 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.75 53.7 7.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.47 99.42 9.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -86.28 114.03 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 172.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.49 153.69 28.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.656 0.741 . . . . 0.0 110.974 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.12 141.58 76.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.676 2.251 . . . . 0.0 112.291 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.1 p -58.57 -29.94 66.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.7 p -62.17 -29.85 70.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.1 tp -68.84 -39.61 79.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -60.1 -39.51 86.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -61.65 -34.19 75.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -76.78 -38.13 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.008 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 85' ' ' LEU . 75.1 mt -69.91 -33.71 72.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.554 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m-30 -50.01 -56.37 18.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.559 0.695 . . . . 0.0 110.945 -167.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 27.1 Cg_endo -60.81 -33.73 92.44 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.747 2.298 . . . . 0.0 112.311 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.28 -52.74 44.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.93 -29.02 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -64.91 -50.09 67.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.75 -32.3 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.864 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.46 -14.74 73.02 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.495 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.33 133.21 46.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.946 0.403 . . . . 0.0 110.932 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 95' ' ' TRP . 86.4 tttt -70.53 139.12 86.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 167.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.1 123.2 10.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.05 5.07 86.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.69 176.1 46.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -135.5 148.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.057 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -104.01 129.42 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.782 167.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.499 ' CD1' HD12 ' A' ' 191' ' ' LEU . 31.3 mm -117.3 123.82 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.12 125.88 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -152.26 138.01 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.5 34.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.788 175.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 77.9 tttt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.792 0.329 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.802 ' O ' HD21 ' A' ' 153' ' ' LEU . 4.4 tt -55.17 -45.36 75.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.08 -36.72 82.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.7 m -60.76 -39.59 89.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.12 -49.91 65.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -72.43 -26.24 61.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.5 p -79.63 -24.08 42.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.12 -10.62 43.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.47 97.06 50.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.884 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -91.8 -17.15 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -172.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.5 p -64.53 -22.19 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -159.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.965 HD12 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -137.93 154.85 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -74.87 139.24 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.94 119.79 36.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.87 -28.97 17.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.836 -169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 191' ' ' LEU . 41.4 pt -140.11 149.41 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.04 115.47 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 165.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -137.28 142.59 41.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -102.25 124.84 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -175.739 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.736 0.303 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.11 129.74 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -130.6 127.29 38.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.553 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.4 pt? -153.56 146.48 24.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.936 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.508 ' O ' HD21 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -140.04 129.98 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -171.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.71 ' HA3' HD23 ' A' ' 163' ' ' LEU . . . -77.58 171.56 55.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.535 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 -174.51 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mmm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -154.63 175.93 13.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.13 160.02 32.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.23 135.43 14.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -121.93 144.91 48.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.39 165.06 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.1 p -158.5 169.95 23.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.96 159.98 40.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -157.8 166.03 33.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -162.65 160.01 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -129.93 142.55 50.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.57 106.43 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.094 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -155.96 163.02 40.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.89 -174.41 43.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -119.94 166.77 12.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.71 0.29 . . . . 0.0 111.162 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.8 149.93 70.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.68 156.43 60.94 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 0.0 112.367 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -139.99 -170.38 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.47 160.82 20.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -74.27 148.29 41.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 21' ' ' LEU . 2.8 tt -73.32 -46.25 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' A' ' 130' ' ' GLU . 60.4 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.128 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.604 0.716 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 145.05 86.29 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.242 . . . . 0.0 112.379 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -73.5 1.82 9.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.36 -147.71 5.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.8 mttt -77.33 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -122.02 129.62 75.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 tp -102.21 121.47 42.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -105.81 129.2 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.28 126.49 55.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.99 54.25 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.162 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -89.99 -15.72 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 63' ' ' GLY . . . 88.92 -63.25 3.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.06 -9.19 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 74.23 23.28 76.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.87 -39.54 90.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -73.89 -28.51 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.88 92.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 70' ' ' LEU . 87.3 m -68.19 -35.13 77.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.4 -47.3 84.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.03 -36.22 83.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.56 83.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.428 ' HA ' HG11 ' A' ' 76' ' ' VAL . 60.5 p -68.64 -16.57 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.85 -0.27 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 3.62 63.98 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -81.08 145.77 30.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 -174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -85.24 104.97 15.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.947 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -109.64 126.84 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 -167.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -109.06 126.27 52.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 166.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.98 128.24 56.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 HG23 ' HB ' ' A' ' 81' ' ' VAL . 83.8 t -119.56 130.07 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.49 156.9 32.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -80.55 -20.12 44.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -90.49 115.2 27.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.6 p -66.9 -36.08 81.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.62 -31.91 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 39' ' ' GLY . . . -64.09 -40.93 98.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.552 171.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.12 -35.96 78.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.25 80.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.112 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.07 -38.51 91.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.423 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -62.65 -41.6 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.61 -44.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -62.64 -45.47 92.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 79.8 mt -62.62 -42.03 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -44.91 96.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.36 -40.17 96.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.19 -29.89 70.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -89.95 -5.15 57.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.43 56.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.9 m -128.76 163.88 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.174 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.12 144.83 27.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.03 149.9 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.2 m -110.88 133.0 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -124.22 136.75 54.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' HG23 ' A' ' 57' ' ' VAL . 90.9 t -129.58 122.08 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.48 116.25 23.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -172.38 143.25 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -57.53 125.77 24.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -55.22 -35.09 64.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.0 -29.63 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -100.61 -9.36 22.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.932 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.19 132.67 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -97.85 115.23 27.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.75 120.39 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.87 138.11 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.5 87.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.48 -25.99 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.22 86.48 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.143 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.49 95.36 5.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -132.24 135.29 46.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.23 162.33 53.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.7 mm -109.83 118.16 56.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -174.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.7 124.47 70.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 m -121.65 117.73 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.91 121.83 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.189 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 42.69 55.02 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.5 m -99.64 87.59 3.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -74.98 114.36 13.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -157.52 151.13 19.14 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.633 0.73 . . . . 0.0 110.927 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.43 142.51 80.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.619 2.213 . . . . 0.0 112.384 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -58.89 -31.41 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.9 p -61.73 -29.15 69.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.9 tp -69.21 -40.63 77.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -60.77 -38.87 86.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.457 ' HA ' ' CD2' ' A' ' 114' ' ' TYR . 89.0 mt-30 -64.81 -32.49 74.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -74.15 -39.45 63.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.71 -29.78 66.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 m-30 -49.9 -56.12 19.48 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.64 0.733 . . . . 0.0 110.882 -168.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 30.3 Cg_endo -62.41 -34.31 76.92 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.762 2.308 . . . . 0.0 112.314 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.97 -49.83 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 98' ' ' ILE . 28.0 m -74.74 -30.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -65.43 -51.73 58.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.08 -34.49 78.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.12 -49.07 63.92 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 47.9 tp -95.01 135.83 36.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.995 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.53 153.11 84.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.859 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.8 141.75 53.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.41 2.33 79.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.481 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -70.45 170.83 44.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.18 139.79 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.159 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.91 139.57 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.89 124.88 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.52 124.96 29.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.772 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.457 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -157.89 139.86 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.42 -172.66 32.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.894 179.686 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.767 ' O ' HD21 ' A' ' 153' ' ' LEU . 3.0 tt -54.92 -45.26 74.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.43 -36.71 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.5 m -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.1 -50.33 61.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -70.07 -25.61 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.7 p -79.21 -23.99 43.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.7 -15.39 37.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.2 107.31 60.07 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.583 0.706 . . . . 0.0 110.849 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -88.55 -21.45 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.748 2.299 . . . . 0.0 112.403 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.8 p -70.22 -27.14 64.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -157.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -139.31 161.48 37.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.942 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.34 140.28 30.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -95.7 128.07 42.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.11 -29.3 16.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 190' ' ' LEU . 36.3 pt -139.8 148.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.24 114.77 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.006 166.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -140.06 144.62 36.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -99.92 126.01 45.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 165.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -175.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.34 134.31 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -131.56 128.51 39.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.58 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.1 pt? -152.09 146.56 25.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.439 ' O ' HD21 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -139.96 130.02 24.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -173.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.58 170.88 48.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.568 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.926 178.684 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -155.05 175.33 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -159.75 160.0 33.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.842 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.0 136.02 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -120.49 144.87 47.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -168.86 164.98 11.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -157.58 169.98 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.03 160.01 40.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.6 p -157.15 166.73 32.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.15 161.08 24.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -150.02 126.24 10.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.37 113.16 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -163.88 139.95 6.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.19 -177.76 48.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.489 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 p -122.77 161.5 23.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.331 . . . . 0.0 111.114 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.85 150.57 76.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.854 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.81 155.3 69.96 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -139.44 -176.53 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -167.17 167.92 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -69.41 145.6 52.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.497 HD21 ' O ' ' A' ' 21' ' ' LEU . 3.0 tt -73.98 -50.69 18.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 130' ' ' GLU . 61.8 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.639 0.733 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.95 147.96 89.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.617 2.212 . . . . 0.0 112.426 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -74.38 1.21 12.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -142.48 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.55 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.1 mttt -85.0 132.74 34.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.928 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.13 130.29 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.1 tp -101.19 121.61 42.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.81 131.94 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 mt -114.05 123.06 48.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.9 54.51 8.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -87.87 -17.2 31.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.56 -59.53 2.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.543 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -125.01 -3.92 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.905 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.625 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 71.9 20.95 79.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.585 176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm105 -67.61 -40.39 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -73.02 -28.14 62.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -45.64 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.073 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.6 m -67.52 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.888 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -58.62 -48.26 81.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.2 -36.3 83.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.07 81.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.34 -0.48 52.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.41 62.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -82.57 147.27 28.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.74 106.88 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.94 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -110.4 125.96 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.165 -166.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 m -110.76 127.1 55.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.48 129.58 55.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.69 131.81 71.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -156.69 158.74 37.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -77.81 -28.5 50.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -90.86 112.09 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.8 p -67.82 -33.28 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.67 -31.14 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.38 -39.2 96.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.462 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.74 -36.43 80.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.875 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.73 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.128 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.77 -39.45 94.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.625 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -61.32 -40.73 95.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.67 -47.28 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.09 -41.23 90.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.99 -39.21 91.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.475 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -61.98 -41.63 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.83 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.83 -32.63 73.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -91.15 -10.67 41.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.92 34.7 55.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.44 161.7 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.09 130.12 48.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pp -134.76 160.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -114.11 137.94 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.9 p -120.05 135.41 54.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.144 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.7 t -129.41 118.63 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.03 114.58 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -171.93 144.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -57.95 124.39 19.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -55.48 -37.01 67.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.13 79.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.08 -5.44 27.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.05 133.83 55.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -91.24 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.409 HG22 ' HA3' ' A' ' 120' ' ' GLY . 91.2 mt -95.22 119.43 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.52 137.3 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.36 -45.64 79.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.36 -27.62 68.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.98 76.44 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -76.04 100.3 4.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 91.2 mt-10 -131.7 138.2 48.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.22 162.89 39.36 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.517 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.31 117.76 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.54 122.71 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -125.43 115.89 20.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.9 124.85 65.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.141 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 43.93 55.08 5.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 73.7 m -107.08 90.94 3.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.948 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -73.99 119.97 18.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 109' ' ' LEU . 4.3 pp -148.5 152.27 38.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 150.21 53.99 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.616 2.21 . . . . 0.0 112.36 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -56.62 -34.7 67.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.788 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.2 p -62.11 -30.05 70.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 105' ' ' LEU . 55.2 tp -69.97 -37.84 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.953 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -57.22 -39.3 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.82 -31.63 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.98 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -80.37 -40.83 25.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.934 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.42 -36.74 66.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.966 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.6 m-30 -52.9 -56.56 22.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.63 0.728 . . . . 0.0 110.957 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 17.8 Cg_endo -55.66 -34.81 91.63 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.4 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.75 -47.05 56.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.19 -30.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.76 -51.61 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.986 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.26 -32.91 72.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.898 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.409 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -71.6 -42.56 54.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.1 tp -84.0 133.2 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.948 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -69.24 152.0 96.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.23 136.32 54.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.0 77.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.494 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.09 175.21 35.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.0 p -127.09 139.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -109.71 135.14 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mm -115.26 122.33 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.95 124.71 31.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.839 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.479 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -154.92 138.42 15.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 153.95 -173.52 32.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.443 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 58.7 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.806 ' O ' HD21 ' A' ' 153' ' ' LEU . 4.0 tt -57.26 -41.27 79.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.963 169.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.21 -34.18 75.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.2 m -63.23 -41.75 99.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.75 -49.62 72.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.37 -24.59 62.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.9 p -81.66 -24.67 36.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -82.76 -17.06 45.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tt -113.89 102.71 55.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.635 0.731 . . . . 0.0 110.869 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.28 -20.23 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.736 2.291 . . . . 0.0 112.356 -170.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.4 p -65.86 -23.81 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 -156.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 163' ' ' LEU . 2.8 pp -134.02 167.96 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.008 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -93.33 136.99 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 172.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -92.05 126.31 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.1 mt -91.39 -31.51 16.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.674 ' CG2' ' HB3' ' A' ' 191' ' ' LEU . 15.8 tt -143.41 137.38 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -166.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.05 116.66 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -140.06 144.27 36.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -98.65 125.54 43.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 42.7 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 132' ' ' PHE . 5.7 mp . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.736 0.303 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -109.52 132.14 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -132.99 129.07 37.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 168.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.547 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.4 pt? -153.47 146.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.934 171.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.674 ' HB3' ' CG2' ' A' ' 167' ' ' ILE . 0.3 OUTLIER -143.64 131.06 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -170.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.92 170.62 36.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.526 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 178.121 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -164.83 142.2 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.97 169.94 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.922 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -156.98 139.24 14.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -136.34 175.09 9.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.907 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.92 165.03 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.5 p -155.65 169.97 23.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.03 159.95 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -164.56 131.76 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.01 149.97 47.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -151.97 129.67 11.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.8 t -119.27 125.41 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -159.43 134.52 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.947 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.76 176.69 29.12 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.521 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.635 HG23 ' HD3' ' A' ' 17' ' ' PRO . 89.9 m -126.0 137.63 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.153 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -122.47 78.08 45.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.694 0.759 . . . . 0.0 110.943 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.635 ' HD3' HG23 ' A' ' 15' ' ' THR . 65.1 Cg_endo -76.77 155.58 34.93 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.712 2.274 . . . . 0.0 112.401 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -130.07 68.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -95.9 -160.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -48.92 145.59 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.18 -60.35 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.162 -168.412 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 121.565 0.697 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.44 137.28 25.41 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.83 3.12 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -169.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.44 -151.99 8.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.08 148.95 41.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.15 135.07 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.6 tp -105.96 121.24 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -109.17 126.89 53.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.91 138.32 42.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 60.45 53.3 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.34 99.74 11.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.858 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.36 88.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.518 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.1 7.46 6.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.811 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 74.63 25.08 70.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -67.35 -42.21 83.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.78 -28.39 55.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.937 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.441 ' HA ' HG11 ' A' ' 54' ' ' VAL . . . -63.2 -43.97 96.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.8 m -68.28 -35.81 78.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -65.35 -45.57 83.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.538 ' HB2' HG22 ' A' ' 54' ' ' VAL . 80.2 mt -64.85 -38.84 92.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.01 76.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -68.45 -22.05 64.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.02 -4.42 59.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.37 56.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.454 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -80.55 140.34 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -89.79 109.52 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 167.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 47' ' ' LEU . 62.7 t -112.96 134.16 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.8 m -107.71 125.07 50.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.168 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.74 130.95 55.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.88 136.04 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.171 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -157.46 159.35 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -78.6 -25.07 45.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -102.93 128.38 49.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.6 p -69.82 -30.44 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.45 -33.95 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.9 95.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.521 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 -34.83 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.07 86.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.94 -35.46 81.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.811 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -61.65 -42.01 98.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.092 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.63 -42.35 98.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.83 -41.5 97.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.6 -40.8 98.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.67 94.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.033 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.16 -39.1 93.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -33.97 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.93 -11.97 34.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.01 35.3 57.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.38 160.55 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 0.0 111.14 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.38 131.1 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -134.65 163.28 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.4 m -115.74 135.88 53.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.2 p -121.56 134.97 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.9 t -132.01 123.94 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.73 120.04 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 t -173.66 144.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -62.16 127.44 31.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 37' ' ' ALA . 96.3 mt -57.67 -33.52 68.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.5 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.41 -7.0 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -63.26 130.96 46.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -94.07 113.11 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.585 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.3 mt -91.81 115.41 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.9 t -86.58 137.93 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.03 52.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.102 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.76 -27.18 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.817 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.77 86.18 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.107 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -76.55 100.09 5.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.22 109.88 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.58 127.96 35.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.483 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -100.6 125.1 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.397 . . . . 0.0 111.104 -161.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.6 129.01 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.3 m -101.95 117.98 35.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.54 114.75 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.596 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 53.6 m-85 50.2 56.19 8.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.2 m -107.92 88.77 2.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.848 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -86.62 111.72 20.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.417 ' HB2' HD21 ' A' ' 109' ' ' LEU . 3.2 pp -145.49 153.02 51.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.924 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.46 152.32 70.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.647 2.231 . . . . 0.0 112.295 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -58.69 -29.81 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.8 m -57.89 -36.11 71.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 105' ' ' LEU . 47.0 tp -71.65 -36.03 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -54.02 -44.02 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -62.92 -28.65 70.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 -37.16 28.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.76 -39.19 73.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.5 m-85 -52.01 -52.49 61.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.722 0.772 . . . . 0.0 110.961 -165.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.1 Cg_endo -68.37 -32.1 26.67 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.637 2.225 . . . . 0.0 112.329 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -71.72 -44.12 64.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.0 -34.33 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -71.16 -52.77 17.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.53 -31.57 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.585 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -63.35 -31.04 79.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.64 135.42 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.19 157.55 78.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.561 0.696 . . . . 0.0 110.887 165.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.41 125.1 11.67 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.77 2.313 . . . . 0.0 112.332 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.17 67.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.496 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.14 176.91 46.38 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.386 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.32 139.05 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 0.0 111.155 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -120.64 128.92 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.465 HG12 HD12 ' A' ' 191' ' ' LEU . 86.9 mt -124.67 136.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.434 HD21 HD22 ' A' ' 190' ' ' LEU . 39.3 tp -123.99 125.66 44.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -153.04 136.13 15.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 148.62 -164.54 29.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.541 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -173.729 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.789 0.328 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.883 ' O ' HD21 ' A' ' 153' ' ' LEU . 5.3 tt -49.76 -37.16 28.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 170.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.21 -27.23 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 92.2 m -63.34 -59.75 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 1.059 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.09 -15.07 61.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.81 ' N ' HD23 ' A' ' 156' ' ' LEU . 62.9 tt0 -68.98 -40.07 79.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.2 p -79.68 -20.78 45.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.01 -19.5 58.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 103.07 55.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.719 . . . . 0.0 110.842 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.83 -21.85 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.0 p -73.14 -23.35 60.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -158.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.492 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -135.59 158.33 44.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.935 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.64 143.07 28.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.528 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 99.2 m95 -98.91 128.74 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.9 mt -94.3 -30.21 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.937 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.564 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.0 pt -135.31 147.55 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 115.71 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -133.7 140.13 46.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.04 129.77 55.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 175.477 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 39.6 pt -125.46 143.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.71 129.55 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.69 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.1 pt? -153.01 149.7 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.564 ' HB3' HG12 ' A' ' 167' ' ' ILE . 0.1 OUTLIER -140.08 132.23 28.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.26 173.24 54.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.549 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -171.877 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 ttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.758 0.313 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.1 m0 59.12 44.87 15.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -114.92 159.98 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -126.87 150.0 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.75 145.03 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.845 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.09 165.07 37.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -154.33 169.98 22.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.64 170.03 8.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.2 t -159.92 139.95 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.91 129.9 14.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.99 172.52 12.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -143.5 140.04 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -149.74 164.95 33.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.93 124.6 3.89 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.569 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.75 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 84.9 m -131.17 130.13 42.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.652 0.263 . . . . 0.0 111.258 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -134.61 115.97 12.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.813 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.27 146.3 50.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.596 2.197 . . . . 0.0 112.328 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -127.63 156.75 41.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -117.62 152.44 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 62.72 35.38 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.62 HD21 ' O ' ' A' ' 21' ' ' LEU . 2.6 tt -61.0 -36.29 79.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.127 176.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.508 ' CD1' HD12 ' A' ' 128' ' ' ILE . 81.7 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.648 0.737 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.23 111.46 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -79.44 16.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -168.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -99.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -101.44 133.22 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.65 127.78 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.85 125.95 50.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -106.2 122.85 47.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.69 43.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 178.67 105.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' A' ' 67' ' ' ALA . 8.4 tm-20 -60.36 -59.85 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.15 33.22 82.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 65.49 15.88 10.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.49 16.87 70.07 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.43 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -64.43 -46.68 82.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -79.33 -28.24 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.77 63.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.19 -30.02 68.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.13 -48.94 74.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.3 mt -65.54 -37.13 85.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.09 85.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -67.86 -19.95 65.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -89.21 0.83 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.75 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 93.35 4.21 64.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -85.19 142.12 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.946 0.403 . . . . 0.0 110.819 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -89.73 104.43 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.92 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 47' ' ' LEU . 96.1 t -107.35 125.76 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.054 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.6 m -112.53 125.04 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 167.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.06 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.13 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.78 134.07 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.9 t70 -155.17 158.85 39.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.7 -26.58 37.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.9 p -97.01 144.96 26.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.874 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.2 m -76.99 -37.78 54.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.68 -35.03 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 -170.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.6 -44.87 94.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.66 -36.17 80.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.56 -39.12 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.09 -36.67 83.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.457 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -60.6 -42.85 97.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.03 -43.69 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -63.72 -45.41 90.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -61.85 -41.51 97.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.98 92.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.45 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.01 -29.95 70.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.53 -5.56 55.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 31.87 60.94 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.05 161.39 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.159 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.23 131.34 54.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.37 169.45 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.093 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -122.88 131.95 53.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 p -120.8 133.95 55.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.7 123.34 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.174 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 66.1 tt0 -86.65 113.37 22.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.981 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -172.19 141.6 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.75 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.31 133.79 55.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.82 -31.54 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -72.3 -27.12 62.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -101.87 -13.75 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -69.44 134.62 49.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.27 109.91 20.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.698 HG22 ' HA3' ' A' ' 120' ' ' GLY . 94.9 mt -87.64 124.63 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.66 138.19 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.97 -53.45 12.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.4 -27.81 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.18 86.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.109 -164.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -132.6 161.88 32.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.35 -44.17 4.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.06 157.55 15.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.4 mt -129.37 129.7 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.71 128.89 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -171.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 t -112.35 118.59 35.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.02 113.87 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.4 t80 42.72 52.2 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -105.53 96.42 6.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -82.16 121.0 26.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.515 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.7 pt? -134.64 150.76 74.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.582 0.706 . . . . 0.0 110.905 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.61 151.68 69.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.8 p -53.94 -34.93 61.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.6 p -62.68 -35.98 81.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 105' ' ' LEU . 16.5 tp -75.45 -34.05 60.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -58.5 -43.82 89.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.18 -28.19 68.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.6 -42.99 12.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.85 -43.58 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -170.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.7 m-30 -54.05 -53.45 58.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 -170.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 38.0 Cg_endo -65.61 -29.8 51.83 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.59 -39.7 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.12 -43.41 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -63.87 -51.1 66.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.66 -31.45 72.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -81.15 -16.97 73.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.478 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.34 138.29 33.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.931 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.85 152.58 93.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.831 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.28 125.94 16.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.23 -2.7 88.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.562 -167.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.82 49.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.487 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 28' ' ' ILE . 80.8 t -131.19 146.87 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 0.0 111.107 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -121.72 137.41 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 28' ' ' ILE . 60.9 mt -116.92 135.89 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.411 HD21 HD22 ' A' ' 190' ' ' LEU . 44.6 tp -126.5 124.57 40.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.958 162.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 23.5 pt-20 -154.11 145.63 23.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.928 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.68 -172.64 33.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.749 0.309 . . . . 0.0 110.903 178.586 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.815 0.34 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -65.82 -36.61 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 81.6 m -63.97 -40.8 97.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.64 -37.69 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -64.12 -36.07 82.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.4 p -83.76 -28.18 28.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -80.5 -13.93 58.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.428 ' C ' HD21 ' A' ' 160' ' ' LEU . 3.3 tt -115.49 97.89 49.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.739 . . . . 0.0 110.981 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -91.08 -25.13 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 -170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 82.7 p -66.09 -20.47 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -161.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 163' ' ' LEU . 1.8 pp -128.18 154.21 46.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -94.83 140.58 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.67 121.49 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.08 -32.7 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.4 pt -139.93 147.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.165 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.04 117.11 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.62 137.1 46.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -112.09 123.04 49.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.4 pp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.76 143.18 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.486 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 67.8 mt-30 -139.72 132.81 29.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.698 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -154.82 150.12 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.69 ' C ' HD21 ' A' ' 191' ' ' LEU . 4.9 tt -139.92 127.5 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.622 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -108.49 140.28 15.48 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.402 . . . . 0.0 110.91 178.64 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.793 0.33 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.4 m0 58.96 44.98 15.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.51 159.93 17.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.16 149.95 49.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.96 145.02 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.98 164.94 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -154.94 169.99 22.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.67 170.0 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.96 139.98 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.04 129.56 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -161.57 163.81 29.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -121.78 131.03 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.114 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -143.76 163.09 34.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.14 155.13 8.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.53 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.634 HG23 ' HD3' ' A' ' 17' ' ' PRO . 87.6 m -135.39 130.09 34.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 111.274 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -139.96 83.67 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 0.0 110.829 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.634 ' HD3' HG23 ' A' ' 15' ' ' THR . 25.2 Cg_endo -69.3 136.47 34.31 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.702 2.268 . . . . 0.0 112.305 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -122.7 172.12 8.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -144.86 -179.96 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 56.32 50.36 13.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -60.84 -49.71 76.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.404 HG13 ' HB ' ' A' ' 126' ' ' VAL . 12.3 tt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.654 0.74 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.55 112.43 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.314 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -78.68 3.27 16.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.939 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.38 -87.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.463 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 99.3 mttt -119.13 133.02 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.54 136.86 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD23 ' CZ2' ' A' ' 95' ' ' TRP . 30.1 tp -94.74 121.01 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -103.11 110.5 22.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 90.5 mt -85.19 51.62 2.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 174.88 104.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.118 -171.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.5 tm-20 -56.18 -59.78 4.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.93 33.72 86.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.53 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 61.72 18.92 10.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.829 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.48 17.69 68.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -64.74 -51.74 60.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.325 . . . . 0.0 110.814 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -80.39 -29.27 37.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.74 82.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.039 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.21 -35.52 76.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.85 -51.13 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.0 mt -66.88 -35.17 79.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.01 76.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.183 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -70.67 -15.97 62.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -86.46 -5.26 59.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.25 2.46 59.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.442 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -82.82 142.56 31.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -91.11 108.66 20.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.892 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 47' ' ' LEU . 90.9 t -108.76 131.0 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -109.66 124.12 50.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.95 130.88 55.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.53 134.43 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.2 t70 -154.3 159.45 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -80.77 -21.83 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -108.78 127.84 54.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.7 p -69.62 -29.81 67.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.77 -33.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.054 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.68 90.81 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.494 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.01 -34.83 78.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.32 94.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.17 -36.84 85.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.75 95.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.88 -41.13 97.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.29 -45.69 93.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.9 -40.44 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.36 97.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.98 -38.29 90.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.65 -31.81 71.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.32 -6.98 49.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.87 33.07 60.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.462 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.15 160.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 111.193 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -104.31 131.96 51.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.23 161.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.5 m -114.2 133.62 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.3 p -123.15 133.93 54.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.189 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.34 124.96 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.2 116.5 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 173.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -174.99 143.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.8 t30 -60.47 131.02 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.06 -36.96 73.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.46 -30.32 65.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -100.7 -7.06 24.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 84' ' ' ASN . 4.8 t80 -57.69 129.0 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -94.69 108.05 20.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.75 143.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.145 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.82 131.81 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.28 -48.99 60.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.139 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -66.82 -22.62 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.45 -22.26 66.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.041 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.482 ' CZ2' HD23 ' A' ' 34' ' ' LEU . 30.7 p90 -147.95 167.08 25.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -118.58 -31.35 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.45 154.74 16.75 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.67 128.08 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 111.121 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.84 132.59 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -111.02 120.45 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -110.4 115.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.185 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.699 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 68.0 m-85 46.37 43.01 11.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -104.02 68.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -172.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -74.34 117.49 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.41 153.16 81.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.629 0.728 . . . . 0.0 110.905 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -63.52 148.86 92.23 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.643 2.229 . . . . 0.0 112.369 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -54.15 -30.38 48.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -60.07 -42.75 95.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -73.02 -32.58 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -57.34 -45.08 84.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -32.3 73.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -43.06 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.44 -30.41 67.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.522 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -50.07 -57.99 10.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.67 0.747 . . . . 0.0 110.917 -172.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 33.8 Cg_endo -63.43 -29.57 71.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 2.243 . . . . 0.0 112.309 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -68.52 -40.08 80.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.69 -42.97 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -63.18 -53.03 59.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.62 -33.34 74.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.54 -31.76 53.19 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.427 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.3 tp -75.9 134.42 40.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.998 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.67 139.84 80.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.668 0.747 . . . . 0.0 110.86 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.94 126.69 17.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.776 2.317 . . . . 0.0 112.304 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.82 1.5 87.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.514 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.15 173.31 54.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.45 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.5 t -124.79 139.49 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -115.42 131.39 56.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.51 131.28 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.078 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.409 HD21 HD22 ' A' ' 190' ' ' LEU . 48.5 tp -124.61 126.38 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 170.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -152.12 131.75 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 147.7 -155.76 26.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.446 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.409 ' HA ' HD21 ' A' ' 187' ' ' LEU . 62.4 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 155' ' ' THR . 98.7 mttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.734 ' O ' HD21 ' A' ' 153' ' ' LEU . 5.7 tt -53.66 -41.77 67.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.22 -33.95 76.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 152' ' ' LYS . 87.4 m -61.49 -43.22 99.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.36 -39.12 92.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.35 -36.27 83.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.1 p -83.29 -29.71 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.787 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -83.3 -19.56 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.4 tp -107.44 106.41 58.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.868 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -88.53 -22.98 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.421 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.2 p -69.18 -23.65 63.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 -159.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.677 HD13 ' HA3' ' A' ' 192' ' ' GLY . 4.3 pp -139.22 160.42 39.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -105.56 136.12 45.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.412 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 98.2 m95 -88.17 127.77 35.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -170.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.03 -33.83 12.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.709 HG12 ' HB3' ' A' ' 191' ' ' LEU . 49.8 pt -139.12 145.77 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.09 120.6 2.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -132.12 140.96 48.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.761 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -110.84 132.01 54.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 132' ' ' PHE . 47.1 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.71 0.291 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 30.9 pt -122.27 147.52 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.56 122.72 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.69 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -151.13 149.31 29.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.736 ' C ' HD21 ' A' ' 191' ' ' LEU . 2.4 tt -140.04 128.39 22.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -116.41 148.72 18.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.453 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 177.35 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.745 0.307 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.95 44.94 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -111.4 159.94 17.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.64 150.02 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.6 145.0 46.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.97 164.94 38.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -153.51 169.94 21.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.58 169.98 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.94 140.01 11.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -145.36 121.98 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -159.52 165.04 33.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -101.16 131.11 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -149.73 166.09 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 154.52 21.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.547 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.2 m -126.18 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.75 0.309 . . . . 0.0 111.159 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -140.0 89.96 10.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.62 125.16 18.19 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -121.24 169.99 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -140.38 -177.89 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.16 58.9 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.58 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.176 -175.773 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG13 ' HB ' ' A' ' 126' ' ' VAL . 11.4 tt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.615 0.722 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.09 112.26 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.339 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -77.65 10.99 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 -170.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.26 -96.79 0.35 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -109.63 131.39 55.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.25 130.04 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.7 tp -101.48 122.66 44.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -114.8 114.97 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.923 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 85.0 mt -91.91 58.9 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.991 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -54.31 -60.07 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.78 35.58 92.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 60.11 19.54 8.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.832 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 16.07 63.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.557 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -65.09 -48.9 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -81.17 -30.15 34.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.97 -51.14 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -65.28 -35.77 82.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.53 -51.65 68.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.4 mt -64.66 -37.11 86.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.82 78.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.2 p -68.11 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.7 mt -86.13 -3.28 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.97 3.64 61.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.519 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.3 m-30 -80.13 146.34 31.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -89.99 103.43 16.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.941 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 47' ' ' LEU . 80.6 t -104.57 126.19 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 -170.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 m -112.78 128.93 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.163 166.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.2 126.67 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.155 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.27 129.97 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -157.89 163.43 37.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -78.19 -26.38 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -99.12 111.67 24.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.9 p -68.84 -27.99 66.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.91 -47.48 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.87 99.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.543 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.75 -36.48 84.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.4 89.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.26 -35.05 77.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.09 98.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.064 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.47 -40.87 98.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.17 -40.79 90.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.06 -40.59 96.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.66 92.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.83 -38.61 91.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.53 -32.74 73.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.43 -9.32 45.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.69 33.05 58.57 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.448 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.63 161.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 111.131 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -104.87 131.6 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.1 pt -135.03 165.99 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -123.21 131.87 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -120.72 134.71 55.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.125 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.41 124.86 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -85.09 119.54 25.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.1 t -172.06 140.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -57.34 130.6 46.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.78 -32.69 67.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -71.93 -29.74 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.042 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.04 -13.32 19.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.29 135.87 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.35 110.01 21.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.679 HG22 ' HA3' ' A' ' 120' ' ' GLY . 93.6 mt -84.07 125.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.2 t -100.76 139.17 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.96 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 99.1 m-20 -65.27 -28.3 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB1' ' CE3' ' A' ' 95' ' ' TRP . . . -70.21 -44.61 68.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 -163.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.402 ' CE3' ' HB1' ' A' ' 94' ' ' ALA . 13.5 m-90 -130.05 162.38 28.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -171.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 48.0 mp0 -114.66 -37.86 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.47 151.51 18.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.532 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.5 mt -129.19 127.99 66.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.345 . . . . 0.0 111.138 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.86 131.86 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -115.66 116.17 27.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.01 118.77 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.176 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 41.05 48.26 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.79 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.2 t -113.73 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -73.48 119.61 17.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.97 148.42 69.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.941 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.33 146.63 75.94 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.3 p -56.51 -35.33 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.3 m -60.48 -40.24 90.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 86' ' ' ALA . 45.3 tp -70.88 -39.94 72.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.932 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -55.46 -42.83 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.17 -28.56 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -82.19 -37.01 26.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.3 mt -71.79 -37.31 70.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.3 m-30 -50.07 -54.4 33.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.604 0.716 . . . . 0.0 110.92 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 31.8 Cg_endo -62.73 -32.53 78.32 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.765 2.31 . . . . 0.0 112.357 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -71.66 -39.7 70.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.51 -42.7 90.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -64.68 -53.85 40.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.74 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.977 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.679 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.84 -22.43 63.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.59 135.89 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.931 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.5 mttt -78.25 152.68 79.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.617 0.723 . . . . 0.0 110.815 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.14 125.64 19.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.43 3.58 86.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.65 171.18 50.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 28' ' ' ILE . 76.9 t -131.1 142.09 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 111.117 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -119.64 136.0 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -120.15 132.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 190' ' ' LEU . 50.5 tp -125.6 129.11 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 168.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.53 129.42 13.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.0 -171.25 37.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.7 p90 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.904 179.107 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 54.4 tp -55.4 -39.87 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.09 -30.12 71.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 64.1 m -62.27 -59.66 4.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 1.016 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.27 -16.08 62.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -173.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.679 ' N ' HD23 ' A' ' 156' ' ' LEU . 88.0 mt-30 -69.35 -42.65 74.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.958 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.0 p -77.58 -21.84 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.18 -11.53 59.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 tp -114.13 100.99 53.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.935 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.78 -23.53 1.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.715 2.276 . . . . 0.0 112.425 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 74.6 m -76.12 -25.33 55.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -165.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -96.84 136.32 37.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -88.42 123.55 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -167.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.05 -32.23 16.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.656 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.2 pt -138.13 145.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.63 113.46 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 167.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -133.25 141.87 48.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.13 130.48 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 167.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.72 0.295 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 46.3 pt -120.23 143.47 31.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -144.54 127.1 16.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.719 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -152.85 149.44 28.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.669 ' C ' HD21 ' A' ' 191' ' ' LEU . 4.4 tt -139.98 128.28 22.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.91 140.05 15.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.896 174.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.8 44.98 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.69 158.56 18.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.18 149.95 49.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.62 144.97 46.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -157.37 165.06 36.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -152.89 169.01 23.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.65 169.87 8.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.884 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -159.97 140.02 11.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.21 126.64 11.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -160.06 165.02 32.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.57 133.34 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -150.05 166.83 28.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.75 147.83 9.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -134.89 135.49 41.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.6 84.4 22.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.746 0.784 . . . . 0.0 110.87 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -59.91 129.89 32.41 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 0.0 112.296 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -133.53 158.95 41.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 172.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -123.32 -170.13 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 59.17 53.67 5.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.62 -34.26 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.215 -178.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.497 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.7 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.653 0.74 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 34.7 Cg_exo -54.97 108.15 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.73 2.287 . . . . 0.0 112.298 168.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -80.03 18.35 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -166.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.23 -94.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.17 133.38 52.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.823 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.95 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.4 tp -101.3 122.38 43.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.7 t -106.07 112.6 25.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 85' ' ' LEU . 45.5 mt -87.45 52.04 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.06 105.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.042 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 8.6 tm-20 -63.2 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -173.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.05 35.49 92.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 60.0 20.02 9.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.817 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.3 68.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -64.87 -46.06 83.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.925 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.92 -33.0 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.26 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.1 m -69.18 -34.9 75.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.62 -49.43 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 3.1 mp -64.39 -38.19 90.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.68 79.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -68.96 -19.71 64.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 65.1 mt -93.3 2.99 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.29 6.03 64.98 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 73.1 m-85 -82.32 136.23 35.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.938 0.399 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -89.29 104.4 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.904 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -104.57 127.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.6 m -108.61 125.17 51.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.151 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.85 129.08 55.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.61 133.32 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 7.0 t70 -155.61 157.6 37.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -77.99 -22.38 49.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.0 p -114.53 132.19 56.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.1 p -67.07 -25.19 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.19 -44.63 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.028 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.43 93.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 ' HB ' ' A' ' 80' ' ' THR . 91.8 mt -65.08 -30.8 71.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.918 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.88 -34.97 72.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.068 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.39 -38.42 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.72 95.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.22 -47.57 76.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.969 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.34 -42.95 78.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.24 -39.48 82.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.941 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -64.35 -39.98 94.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.06 -37.89 89.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.25 -33.1 74.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.47 -7.34 47.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.46 30.62 62.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.04 165.03 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.63 131.88 54.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.5 pp -135.1 165.5 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -123.3 131.28 53.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.409 ' HB ' HD23 ' A' ' 64' ' ' LEU . 46.5 p -119.62 132.98 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.0 t -126.51 123.63 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -86.36 114.15 22.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -173.26 140.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -51.69 125.95 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 36' ' ' LEU . 47.7 tp -58.33 -35.93 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.01 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.25 -7.71 31.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -64.44 135.16 55.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.6 111.02 22.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.712 HG22 ' HA3' ' A' ' 120' ' ' GLY . 90.6 mt -84.68 121.05 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.19 140.62 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.16 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.027 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.86 -29.19 66.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.93 79.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.062 -164.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -129.91 158.72 38.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.72 -42.37 5.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.96 157.06 15.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.18 126.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.82 132.34 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -112.83 118.17 34.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -111.4 114.11 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.194 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 42.89 46.43 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' HD21 ' A' ' 105' ' ' LEU . 32.4 t -103.25 91.75 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -80.98 121.06 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.552 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.4 pp -152.75 153.1 29.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.563 0.697 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.48 154.81 55.53 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.671 2.247 . . . . 0.0 112.371 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.0 p -57.32 -32.97 67.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.821 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -60.01 -39.34 85.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 105' ' ' LEU . 38.2 tp -71.68 -35.41 70.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.425 ' HG3' HD12 ' A' ' 105' ' ' LEU . 27.7 mtt180 -56.76 -40.2 75.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.998 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.36 -27.73 69.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.896 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.37 -39.81 16.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.14 -39.03 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.577 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.6 m-30 -52.23 -54.67 39.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.658 0.742 . . . . 0.0 110.873 -171.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.6 Cg_endo -61.93 -30.1 83.16 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.708 2.272 . . . . 0.0 112.341 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -72.5 -39.66 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.44 -40.93 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -64.21 -54.65 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.33 -30.2 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.989 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.712 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -78.59 -24.35 62.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.455 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.2 tp -82.16 136.81 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 110.911 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.1 154.67 86.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 0.0 110.847 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.91 125.78 16.67 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.705 2.27 . . . . 0.0 112.353 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.47 88.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.49 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.27 169.95 45.78 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 28' ' ' ILE . 79.7 t -129.02 142.58 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -119.27 136.52 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.1 mt -120.11 131.45 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 190' ' ' LEU . 4.1 tt -127.93 130.5 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 167.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -150.15 140.87 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -164.47 -168.3 26.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -178.635 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.729 0.3 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.45 -45.19 80.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.879 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.05 -35.04 78.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 m -62.43 -41.19 98.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.2 mt -60.61 -42.14 96.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.81 -37.11 81.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.8 p -81.46 -28.12 34.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.03 -11.32 55.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.13 98.87 52.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.736 0.779 . . . . 0.0 110.962 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.99 -22.26 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.4 p -68.53 -21.48 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.876 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.0 pp -130.17 153.98 47.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.78 138.99 35.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -88.13 121.79 30.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.78 -30.43 19.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.6 pt -138.46 147.09 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 111.91 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 164.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -136.62 143.08 43.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.51 119.81 39.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 165.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.136 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.7 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.1 pt -121.46 141.59 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -138.47 137.49 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.62 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.1 pt? -155.64 147.69 23.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.833 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.66 ' C ' HD21 ' A' ' 191' ' ' LEU . 3.1 tt -140.1 128.37 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.84 139.42 15.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 174.469 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.87 44.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.63 160.0 17.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.69 150.01 49.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.48 145.04 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.97 164.98 37.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.848 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -154.96 169.97 22.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -169.64 169.97 8.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -156.2 133.78 10.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -154.26 135.07 13.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.562 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.7 p90 -155.95 157.31 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.987 176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -122.26 132.97 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.091 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -137.13 126.69 25.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.52 166.81 23.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.65 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 86.9 m -119.85 132.31 55.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.727 0.298 . . . . 0.0 111.206 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -127.36 114.51 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 110.817 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.32 144.97 42.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.35 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -130.05 168.06 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -130.65 169.1 16.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 51.25 41.49 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.877 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.38 -43.1 86.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 172.898 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 126' ' ' VAL . 8.7 tt . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.665 0.745 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.3 114.35 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 0.0 112.324 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -74.93 -0.58 19.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.61 -96.13 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -170.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -99.05 125.6 44.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.4 127.68 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.11 121.54 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.868 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -108.09 112.67 25.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt -87.73 58.13 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.993 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.97 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 8.0 tm-20 -60.65 -60.0 4.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.64 32.24 83.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 62.08 18.52 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.9 16.16 72.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.539 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -63.54 -45.52 90.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.906 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -79.46 -29.97 41.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.77 -51.98 59.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 p -70.9 -29.62 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.03 -52.06 58.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.541 ' HB2' HG22 ' A' ' 54' ' ' VAL . 98.5 mt -67.41 -35.45 79.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.24 82.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.173 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -68.98 -17.39 63.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.26 0.61 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.937 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.71 2.68 61.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -87.1 144.86 26.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -90.17 109.02 20.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 47' ' ' LEU . 94.6 t -109.27 126.56 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.8 m -110.54 124.9 52.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 167.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.52 130.54 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.69 132.62 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 33.2 t0 -154.62 163.91 39.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -83.41 -21.22 33.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -104.52 117.88 35.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.0 p -67.12 -27.8 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.84 -46.1 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.77 -40.64 98.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.607 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.09 -35.62 81.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.33 . . . . 0.0 110.889 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.54 84.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.42 -36.86 85.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.34 99.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.35 -42.21 93.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -62.24 -46.98 86.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mp -61.49 -37.22 82.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -65.03 -45.98 83.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.69 -37.68 87.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -65.44 -29.82 70.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -92.88 -4.4 52.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.81 32.82 58.61 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.428 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.14 161.8 26.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.398 . . . . 0.0 111.104 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.58 131.13 54.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pp -133.54 163.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.7 m -119.56 135.48 54.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.0 p -120.23 134.58 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.195 -177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.8 t -128.56 123.5 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.177 170.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.88 114.88 23.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -173.49 141.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.834 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -54.99 130.79 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.96 -35.03 74.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.36 69.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -98.73 -9.51 24.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.05 136.74 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -92.89 108.76 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.713 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.3 mt -83.32 119.45 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.78 140.32 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -172.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.49 -54.69 7.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -71.21 -29.4 65.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.51 81.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -129.36 164.45 23.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.7 -40.62 4.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.56 155.59 16.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.76 127.0 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 0.0 111.19 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.78 130.44 72.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.8 m -114.96 115.95 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.801 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.42 115.95 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 49.8 43.75 24.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -101.0 73.12 1.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -80.49 124.03 28.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -144.83 150.98 48.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.658 0.742 . . . . 0.0 110.878 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.37 154.86 71.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.762 2.308 . . . . 0.0 112.339 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.2 p -54.26 -30.82 51.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.1 m -58.17 -40.7 82.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.38 -34.22 65.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.888 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -55.87 -44.73 78.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.25 -30.38 71.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -85.85 -46.4 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.19 -42.16 80.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 6.5 m-30 -53.02 -54.98 38.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -168.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.5 Cg_endo -62.0 -28.74 80.87 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.349 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.46 -36.85 65.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.97 -41.13 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.151 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.55 -53.55 50.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.65 -31.49 72.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.937 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.713 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -76.56 -26.98 62.03 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.476 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.93 136.6 36.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.918 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.45 154.55 85.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 126.98 19.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.39 88.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.475 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.26 169.98 50.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.532 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.523 ' HB ' HG13 ' A' ' 28' ' ' ILE . 60.4 t -129.56 143.82 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -119.77 136.93 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.88 128.71 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.434 HD21 HD22 ' A' ' 190' ' ' LEU . 51.8 tp -123.41 129.77 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -153.46 134.72 14.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.952 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.01 -178.1 40.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.963 175.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.728 0.299 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 190' ' ' LEU . 64.2 tp -55.03 -38.12 67.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.878 161.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.78 -33.76 72.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 73.8 m -63.22 -41.89 99.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.98 -40.75 94.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.972 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.08 -36.53 84.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -83.98 -27.64 28.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -169.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -80.31 -13.28 59.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -111.75 100.55 48.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.938 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.35 -21.66 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.4 p -68.53 -20.81 64.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -163.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.2 pp -132.55 155.35 48.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -99.43 137.53 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.08 125.08 32.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -93.0 -30.75 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.647 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.6 pt -139.73 146.16 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.09 116.41 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -131.47 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -123.24 129.98 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 171.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.78 0.324 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.7 pt -124.27 142.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -145.0 129.15 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.735 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -154.67 150.84 28.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.867 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.693 ' C ' HD21 ' A' ' 191' ' ' LEU . 2.7 tt -139.95 129.93 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -175.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.03 140.19 15.92 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.935 174.125 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.703 0.287 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.3 m95 59.22 43.0 17.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.65 160.0 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.29 149.99 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.42 145.03 46.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.99 165.01 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.5 p -151.15 169.85 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.51 170.08 8.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -159.66 140.0 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.35 134.94 16.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.97 167.59 29.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.13 128.23 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.191 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.06 164.87 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.97 147.77 22.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.758 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 85.3 m -113.04 124.78 53.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 0.0 111.167 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.98 129.81 24.84 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.0 110.793 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 131.17 23.13 Favored 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.676 2.251 . . . . 0.0 112.343 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -135.01 167.12 21.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -141.98 179.33 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 56.56 37.86 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.732 HD21 ' O ' ' A' ' 21' ' ' LEU . 2.9 tt -64.49 -40.46 95.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 170.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.213 174.117 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.503 HG12 ' HB ' ' A' ' 126' ' ' VAL . 84.6 mt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.664 0.745 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.51 119.22 5.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 0.0 112.31 166.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -74.38 5.53 4.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.41 -96.11 0.51 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -167.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -100.81 125.08 47.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -120.43 129.34 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.6 tp -101.42 125.75 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.4 t -115.92 114.84 25.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.59 57.68 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.93 104.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.065 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.9 tm-20 -59.64 -60.05 4.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -176.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.83 35.93 92.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 173.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 60.41 19.75 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.25 20.53 60.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.476 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -65.29 -48.47 73.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.07 -31.1 50.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.79 -50.96 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.987 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.09 -35.71 81.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.28 -51.23 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.0 mt -67.73 -35.34 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.8 81.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.128 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -67.28 -17.58 64.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.73 -1.81 58.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.28 4.16 61.21 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.534 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.9 m-30 -85.43 142.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.861 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -89.97 105.86 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.926 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 47' ' ' LEU . 99.3 t -106.76 127.68 62.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -109.64 125.24 52.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.174 168.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.44 128.55 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 133.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.082 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.7 t70 -154.15 161.31 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -82.3 -21.13 36.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.9 p -108.54 131.32 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.6 p -71.73 -26.2 62.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.96 -47.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.01 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.34 98.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.56 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.34 -36.48 84.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.22 81.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.17 -35.57 79.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -62.36 -43.39 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.58 -41.25 96.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -62.19 -46.82 87.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.7 tp -60.07 -41.04 91.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -63.33 -43.73 96.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.53 -36.5 83.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -69.45 -31.17 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.42 -7.5 50.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 32.1 58.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.427 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.31 163.59 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.867 0.365 . . . . 0.0 111.194 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.97 131.33 53.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pp -135.39 166.41 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -122.88 134.17 54.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.159 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 p -120.01 134.04 55.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.113 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -127.55 123.97 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 170.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 63.8 tt0 -88.46 117.24 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.1 t -174.61 142.58 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -61.29 132.14 52.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.85 -25.02 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.92 60.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -104.42 -13.74 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.23 132.73 46.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.96 112.32 24.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.623 HG22 ' HA3' ' A' ' 120' ' ' GLY . 82.1 mt -81.39 122.11 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.85 139.92 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.134 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -59.41 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.18 -28.27 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.07 78.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -132.89 161.07 35.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -105.34 -44.99 4.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.97 153.87 17.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.466 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.1 mt -124.09 125.44 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.107 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.1 131.88 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.7 m -111.92 117.08 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mm -106.58 111.29 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 43.87 45.08 6.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 43.4 t -106.26 94.89 5.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -94.01 120.68 34.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt -128.29 150.16 73.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 39.2 Cg_endo -63.83 145.64 90.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.358 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.2 p -54.98 -34.35 63.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.1 p -62.34 -35.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.727 ' O ' HD21 ' A' ' 109' ' ' LEU . 1.3 tt -76.27 -34.46 59.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.912 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -57.16 -42.62 81.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.97 -27.35 68.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.82 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -86.27 -36.01 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.27 -41.2 66.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -52.25 -55.06 34.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.69 0.757 . . . . 0.0 110.905 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 20.0 Cg_endo -59.74 -29.74 90.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.333 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.05 -41.02 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.98 92.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -63.69 -55.23 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.44 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.97 -23.93 60.76 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.62 137.52 34.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.78 154.1 87.14 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.1 126.93 18.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.778 2.318 . . . . 0.0 112.261 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.85 89.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.526 -167.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.13 173.82 47.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.503 ' HB ' HG12 ' A' ' 28' ' ' ILE . 56.5 t -132.9 146.55 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.17 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -122.43 138.78 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.484 HD12 HD12 ' A' ' 28' ' ' ILE . 69.2 mt -118.66 132.18 69.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.448 HD23 HD22 ' A' ' 190' ' ' LEU . 5.0 tt -126.28 130.1 50.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 167.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -147.64 135.58 21.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.81 -167.86 23.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.418 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 -178.21 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.5 -40.11 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 172.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.85 -30.97 68.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 90.7 m -60.6 -44.86 95.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.23 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.58 -39.35 94.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.36 -36.59 84.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -85.99 -26.35 25.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.05 -8.67 59.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.34 99.34 49.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 0.0 110.902 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -89.24 -20.74 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.699 2.266 . . . . 0.0 112.412 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -68.08 -22.12 64.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.4 pp -131.76 154.8 48.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.57 140.86 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -86.98 123.09 31.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 92.5 mt -89.63 -33.4 16.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.8 pt -141.57 148.41 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.067 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.99 114.21 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.036 167.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -131.39 140.58 49.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -117.6 129.03 55.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 168.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.58 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 29.9 pt -124.08 141.42 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -139.05 138.39 37.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.573 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.2 pt? -156.25 152.51 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.626 ' C ' HD21 ' A' ' 191' ' ' LEU . 6.8 tt -139.9 129.79 24.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.13 138.59 14.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.511 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.93 175.186 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 45.02 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -110.56 159.34 17.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.78 149.94 49.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.16 145.01 47.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.84 165.03 37.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.839 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.5 p -152.52 169.87 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.74 170.05 8.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.36 139.93 12.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.83 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.35 130.03 14.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -164.01 168.72 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.85 139.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.156 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.39 165.01 32.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.65 167.53 14.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.553 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.691 HG23 ' HD3' ' A' ' 17' ' ' PRO . 96.6 m -93.8 120.04 33.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.281 . . . . 0.0 111.229 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.66 80.32 22.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.771 0.795 . . . . 0.0 110.863 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.691 ' HD3' HG23 ' A' ' 15' ' ' THR . 55.9 Cg_endo -74.18 146.16 35.91 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 0.0 112.288 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -137.9 157.73 45.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -150.64 -171.2 3.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 54.99 46.27 24.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.0 -43.01 93.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.144 -177.088 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.507 HG13 ' HB ' ' A' ' 126' ' ' VAL . 10.7 tt . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.654 0.74 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.08 112.79 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.616 2.211 . . . . 0.0 112.311 167.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -75.03 10.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.59 -100.4 0.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.98 133.36 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 88.9 mt -123.72 136.05 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 tp -95.19 121.77 37.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.899 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.42 113.97 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 83.0 mt -94.66 57.12 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 174.96 104.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -67.08 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 38.19 94.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 61.87 18.91 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.918 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.97 10.73 81.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.531 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -63.48 -45.58 90.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.945 0.402 . . . . 0.0 110.944 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.26 -33.6 37.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.09 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.3 m -66.23 -36.57 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.6 -49.29 75.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.3 mt -60.83 -39.09 87.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.26 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.5 p -69.04 -18.32 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -83.34 0.24 46.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.77 64.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.512 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -80.11 143.68 33.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -86.97 103.57 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 47' ' ' LEU . 67.5 t -105.38 127.77 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -168.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.8 m -112.49 125.17 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.6 129.26 56.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.63 133.91 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -154.63 163.62 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -83.79 -20.77 32.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.974 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.7 t -101.75 117.26 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.808 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -65.0 -28.15 69.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.53 -47.97 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.01 99.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.52 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.28 -35.55 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.945 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.0 99.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.36 -42.84 99.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -66.64 -41.16 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.3 -39.78 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -40.99 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.43 -38.19 90.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.5 -33.72 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.38 -8.23 45.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.84 33.06 60.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.32 160.97 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.38 . . . . 0.0 111.113 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.57 131.01 53.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.814 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -134.73 166.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -124.85 131.2 53.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 p -120.32 135.17 55.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.132 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -130.26 125.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -84.89 116.6 23.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 t -173.76 142.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.5 HD22 ' HB1' ' A' ' 86' ' ' ALA . 26.8 t30 -58.73 130.06 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.38 -30.58 65.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 84' ' ' ASN . . . -76.12 -23.53 54.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -104.92 -13.45 15.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.884 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 84' ' ' ASN . 72.1 t80 -70.38 137.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -94.01 107.42 19.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.2 mt -88.2 125.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.34 138.88 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.74 -44.58 61.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.17 -26.62 66.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.69 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -164.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -130.1 156.73 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.796 -172.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.95 -40.04 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.76 159.92 15.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 88.3 mt -129.99 125.65 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.107 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.64 130.78 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -129.02 118.27 22.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.62 128.91 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.132 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.1 t80 43.73 52.64 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 51.0 t -115.53 88.32 2.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -80.84 117.55 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.8 mt -121.17 145.3 41.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.585 0.707 . . . . 0.0 110.899 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.9 Cg_endo -67.78 148.81 77.93 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.757 2.305 . . . . 0.0 112.303 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.7 m -54.17 -42.97 70.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.0 m -60.38 -39.77 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.79 ' O ' HD21 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.54 -38.97 74.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 178.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.32 -41.65 89.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -83.56 -42.88 16.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.26 -42.22 60.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 -172.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.58 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.2 m-30 -54.51 -52.32 70.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.722 0.772 . . . . 0.0 110.923 -169.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 86.8 Cg_exo -45.1 -37.6 13.13 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 0.0 112.379 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -76.34 -37.07 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.51 -45.02 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.179 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 118' ' ' TYR . 2.7 m-30 -66.29 -54.45 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -176.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.07 -30.2 71.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.87 -29.56 67.04 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.512 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.18 133.6 38.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.344 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.48 153.12 78.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.701 0.762 . . . . 0.0 110.863 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.08 124.81 16.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.766 2.311 . . . . 0.0 112.31 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.56 87.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.524 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.54 170.91 47.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.441 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.507 ' HB ' HG13 ' A' ' 28' ' ' ILE . 77.5 t -129.18 140.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.116 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.97 132.54 56.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.8 129.88 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.069 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 190' ' ' LEU . 56.7 tp -126.01 123.54 38.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -148.98 132.85 17.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.71 -169.35 35.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 178.823 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.844 0.354 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.15 -42.64 91.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.903 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.49 -31.77 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.4 m -68.48 -56.17 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 1.118 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.31 -17.87 62.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.642 ' N ' HD23 ' A' ' 156' ' ' LEU . 66.5 mt-30 -73.84 -42.35 60.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 170.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -74.44 -20.71 59.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -83.59 -11.94 56.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.961 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.467 HD23 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -118.03 93.84 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 0.0 110.905 -174.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -89.2 -22.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.721 2.281 . . . . 0.0 112.397 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.2 p -69.9 -20.49 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -161.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.6 pp -131.49 154.96 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.09 142.14 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -89.35 119.35 29.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -169.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.64 -31.47 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.692 HG12 ' HB3' ' A' ' 191' ' ' LEU . 47.8 pt -139.99 145.58 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.57 114.49 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -128.6 138.82 52.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -122.86 132.67 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.5 pp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.743 0.306 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.05 148.46 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.93 132.81 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.697 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -154.86 149.84 26.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.692 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.2 tt -140.85 127.7 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -176.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.667 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.89 142.09 16.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 178.156 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 44.97 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.62 157.97 19.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.61 149.79 49.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.5 145.03 46.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -157.89 165.07 36.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.787 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -155.38 169.96 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.62 170.02 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.918 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 t -159.99 139.84 11.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.18 128.54 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 54.2 p90 -156.96 159.04 37.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.947 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.6 t -122.95 132.98 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -138.13 125.15 21.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.57 158.73 15.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.709 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 94.2 m -112.66 131.78 55.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.49 105.12 21.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.727 0.775 . . . . 0.0 110.813 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -71.9 142.78 39.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.599 2.199 . . . . 0.0 112.323 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -127.25 170.34 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -126.88 149.29 49.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 60.25 49.5 7.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 177.486 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.4 tt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 121.706 0.765 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 52.8 Cg_exo -53.7 119.26 5.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.274 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -78.93 2.29 20.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -90.32 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.478 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.74 134.02 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 0.0 110.858 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -124.31 132.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.9 tp -101.62 122.66 44.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.82 117.36 33.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 85' ' ' LEU . 47.8 mt -88.01 54.88 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.95 105.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -168.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -60.12 -60.34 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.86 78.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.45 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 63.2 16.12 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.89 22.08 71.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.67 -51.59 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.76 -28.8 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -69.5 -34.6 74.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.901 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 54' ' ' VAL . 97.9 mt -69.6 -35.05 74.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.76 85.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.4 p -68.72 -18.38 64.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.853 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.83 -0.87 57.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.709 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 96.27 4.81 59.58 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.408 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.18 145.23 26.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -91.53 108.06 19.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 47' ' ' LEU . 93.9 t -108.65 131.24 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -110.4 128.9 55.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.21 132.51 56.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.3 137.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.122 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -155.01 162.46 41.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.821 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.45 -24.18 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.8 t -102.87 119.63 39.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.9 p -68.03 -26.67 65.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 170.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.19 -46.22 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.035 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -41.96 99.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.41 -35.94 82.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.95 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.87 92.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.94 -37.54 88.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.867 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.98 96.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.068 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.11 -42.64 99.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -64.72 -41.32 96.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.94 -40.18 92.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.85 95.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.103 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.11 -37.84 88.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.03 -33.09 75.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.21 -9.68 41.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 72.02 34.68 61.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.419 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.02 161.31 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -104.41 130.15 52.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -133.06 162.01 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -115.37 132.0 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.9 p -123.77 134.74 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.84 125.14 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -85.24 117.7 24.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.926 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -175.17 145.1 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.3 t30 -55.25 128.24 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 170.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 36' ' ' LEU . 43.8 tp -57.93 -36.36 72.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.14 70.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -100.0 -6.12 27.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 84' ' ' ASN . 53.7 t80 -62.07 133.23 55.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -84.94 103.35 13.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.4 mt -87.49 123.14 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.133 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.2 t -102.02 134.21 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.54 -59.45 2.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.53 -22.76 64.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.97 68.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 -172.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.483 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 64.6 p-90 -147.46 160.77 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.44 -36.9 4.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.19 16.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.488 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.483 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 3.1 tp -132.83 123.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 111.199 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.83 129.7 71.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -113.21 116.37 29.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.59 113.75 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.143 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 40.22 50.48 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.1 t -98.99 90.02 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -76.32 119.46 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.435 ' O ' HD12 ' A' ' 105' ' ' LEU . 2.3 pp -145.51 149.28 40.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.39 155.22 71.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.691 2.26 . . . . 0.0 112.331 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.6 p -54.16 -29.37 45.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -58.73 -40.43 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.798 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.9 -34.02 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -55.3 -44.42 75.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.08 -31.28 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -87.29 -50.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.86 -43.17 84.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -55.82 -54.26 53.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.698 0.761 . . . . 0.0 110.964 -167.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.0 Cg_endo -66.75 -29.33 42.79 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -67.51 -40.24 85.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -39.77 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.57 -49.7 75.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -64.74 -32.02 73.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.957 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.46 -31.3 54.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.3 tp -73.59 132.04 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -75.49 155.06 85.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -54.29 127.46 25.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.688 2.258 . . . . 0.0 112.294 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.58 4.1 87.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.457 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.0 168.83 51.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.0 t -127.0 139.18 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.404 ' HA ' HG23 ' A' ' 98' ' ' ILE . 59.4 t80 -111.8 132.66 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.94 131.23 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.41 HD21 HD22 ' A' ' 190' ' ' LEU . 60.3 tp -123.21 123.94 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 168.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -150.28 128.98 12.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.04 -175.24 43.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.475 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.849 0.356 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.764 ' O ' HD21 ' A' ' 153' ' ' LEU . 5.4 tt -53.59 -44.0 69.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.99 -35.38 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.5 m -64.62 -41.74 95.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.24 -35.53 80.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.93 -33.77 70.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.0 p -78.27 -21.53 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -175.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.62 -22.4 56.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.453 HD12 ' CZ2' ' A' ' 165' ' ' TRP . 18.4 mt -105.36 102.85 39.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.679 0.752 . . . . 0.0 110.912 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.58 -27.76 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.788 2.325 . . . . 0.0 112.343 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.6 m -78.77 -17.07 56.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -165.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.657 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.9 pp -130.82 154.76 47.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.13 140.4 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.453 ' CZ2' HD12 ' A' ' 160' ' ' LEU . 99.1 m95 -85.08 126.24 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -172.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.86 -32.65 13.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.698 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.6 pt -140.1 146.73 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.532 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -159.18 119.24 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 168.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -132.3 140.26 48.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.809 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -113.9 120.42 40.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.3 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -176.475 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.728 0.299 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.82 142.52 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.36 124.45 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.723 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -153.82 148.55 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.76 ' C ' HD21 ' A' ' 191' ' ' LEU . 3.3 tt -140.03 129.73 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 -172.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -119.98 152.36 17.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.515 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.921 178.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.2 m0 59.1 45.04 15.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -115.01 160.05 20.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -127.47 149.96 49.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.09 144.98 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.776 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -157.02 165.06 37.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -155.04 169.93 22.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.52 169.95 8.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -159.94 140.06 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.85 128.7 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.9 p90 -163.64 162.67 24.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -130.22 136.76 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -138.34 149.25 45.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.93 172.41 42.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.659 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 88.7 m -124.3 129.56 50.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -119.76 96.23 49.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.702 0.763 . . . . 0.0 110.823 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HB3' ' HG3' ' A' ' 30' ' ' GLN . 74.8 Cg_exo -54.02 139.6 70.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.658 2.238 . . . . 0.0 112.355 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -129.5 170.22 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -129.96 165.15 22.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 52.55 39.44 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.7 -40.51 92.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 174.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.488 ' CD1' HD12 ' A' ' 128' ' ' ILE . 79.1 mt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.69 0.757 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.66 117.54 3.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.296 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.405 ' HG3' ' HB3' ' A' ' 17' ' ' PRO . 66.1 mm-40 -77.87 9.18 3.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -171.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.29 -101.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 51.4 mttm -99.95 133.6 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.703 0.287 . . . . 0.0 110.87 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.5 131.7 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.19 125.89 51.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.958 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.4 t -114.94 115.28 26.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 74.7 mt -88.37 58.11 4.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 175.05 105.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.088 -172.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 67' ' ' ALA . 10.1 tm-20 -57.77 -59.74 4.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.09 34.85 90.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.469 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 62.06 18.34 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.946 0.403 . . . . 0.0 110.889 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.38 15.16 67.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.477 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -64.66 -49.63 70.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -79.36 -29.91 42.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.29 67.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.88 -33.97 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -61.15 -50.89 71.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HB2' HG22 ' A' ' 54' ' ' VAL . 95.4 mt -67.6 -36.82 81.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.47 82.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.159 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -70.59 -16.72 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -91.3 0.15 57.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.969 172.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.95 4.65 60.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.584 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -89.85 145.91 24.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -90.23 109.15 20.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.953 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 47' ' ' LEU . 99.2 t -109.21 128.75 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -110.05 125.71 53.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.127 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.26 129.79 55.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 -172.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 134.68 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 7.1 t70 -154.83 160.55 41.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.836 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -80.6 -24.0 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -106.07 140.74 38.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -77.19 -28.01 53.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.88 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.04 -46.76 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.82 99.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.13 -37.08 84.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.0 110.882 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.57 90.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.39 -37.48 87.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -61.16 -43.2 99.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.085 175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -61.36 -46.45 90.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.59 -40.67 92.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.47 94.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.3 -38.17 90.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.84 -31.89 72.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.44 -8.22 45.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.923 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.8 34.18 56.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.437 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.8 160.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -104.38 130.81 52.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.86 165.33 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.3 m -119.43 133.82 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.4 p -120.73 132.75 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.12 122.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 65.0 tt0 -88.51 116.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.3 t -173.35 141.49 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 88' ' ' PHE . 49.1 t30 -57.45 129.41 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.05 -35.08 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.916 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.32 68.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.079 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -99.83 -8.31 24.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ASN . 79.4 t80 -66.45 134.55 52.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.45 108.9 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.779 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.9 mt -81.4 122.16 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.7 t -94.31 138.74 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.15 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 120' ' ' GLY . . . -72.7 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -24.39 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.05 70.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -165.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.493 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 67.7 p-90 -149.55 161.28 42.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 45.8 mp0 -116.42 -35.46 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.73 147.89 16.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 15.9 tt -133.0 129.73 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.8 134.88 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -169.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -109.55 117.67 34.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.51 113.05 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.096 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 48.3 44.48 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.1 t -114.46 72.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -73.03 122.38 21.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.814 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.0 mt -131.59 151.76 79.24 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.565 0.698 . . . . 0.0 110.962 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.76 146.25 91.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.374 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -57.91 -33.33 68.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.0 m -61.28 -40.9 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.0 tp -72.31 -36.47 68.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -54.15 -46.61 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -65.86 -26.09 67.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.11 -38.2 32.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.19 -31.87 66.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.4 m-30 -53.09 -53.6 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.671 0.748 . . . . 0.0 110.956 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.7 Cg_endo -65.55 -31.28 50.94 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.698 2.265 . . . . 0.0 112.378 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.49 -42.67 82.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.94 -39.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.84 -53.66 52.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.54 -30.02 70.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 92' ' ' ALA . . . -80.16 -28.15 50.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.9 tp -78.84 131.75 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.515 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.2 mttt -78.92 153.08 77.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.634 0.73 . . . . 0.0 110.839 172.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.45 128.14 28.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.335 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.12 -3.59 86.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.457 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -71.62 171.89 46.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.431 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.23 142.52 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.471 ' HB3' HD23 ' A' ' 163' ' ' LEU . 68.1 t80 -115.74 135.21 54.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.488 HD12 ' CD1' ' A' ' 28' ' ' ILE . 84.5 mt -120.04 131.86 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.422 HD21 HD22 ' A' ' 190' ' ' LEU . 54.4 tp -128.82 126.59 40.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.961 169.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 24.5 pt-20 -151.91 142.65 22.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.33 -166.9 34.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.866 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.789 0.328 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.689 ' O ' HD21 ' A' ' 153' ' ' LEU . 4.8 tt -55.26 -46.78 76.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.58 -37.12 85.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.5 m -62.56 -42.02 99.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.84 -39.56 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.958 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -62.99 -37.75 88.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.2 p -82.98 -28.13 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -81.74 -14.36 56.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 160' ' ' LEU . 4.9 tt -107.71 102.19 43.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 0.0 110.899 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -89.12 -24.2 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.386 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.2 m -68.96 -25.28 64.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -164.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 127' ' ' PHE . 4.2 mp -123.06 145.89 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -95.31 136.75 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.73 124.88 35.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -165.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.1 mt -92.01 -35.93 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.5 pt -141.78 146.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.05 119.38 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -135.05 141.05 46.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -176.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -116.17 130.91 57.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 166.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.6 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.8 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 42.4 pt -120.81 142.73 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 169.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 68.9 mt-30 -142.21 126.96 18.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.673 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.1 pt? -146.72 148.57 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.728 ' C ' HD21 ' A' ' 191' ' ' LEU . 4.8 tt -143.07 128.16 18.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.468 ' N ' HD21 ' A' ' 191' ' ' LEU . . . -122.2 154.7 16.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 176.074 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.722 0.296 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.05 44.99 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.86 140.23 37.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.11 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -133.93 145.02 49.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.1 165.06 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -150.9 169.79 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.65 170.02 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -159.42 140.04 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.81 134.94 18.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -153.71 169.29 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.74 132.73 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -145.19 165.04 29.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 147.25 21.27 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.795 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 92.0 m -116.48 129.02 55.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.633 0.254 . . . . 0.0 111.173 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -139.14 125.05 12.19 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.56 149.18 49.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -125.27 149.88 47.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.92 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -113.5 149.51 34.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 62.57 25.21 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.941 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 21' ' ' LEU . 7.9 tt -64.52 -39.94 94.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.97 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.843 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 128' ' ' ILE . 89.7 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.637 0.732 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.96 108.37 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.315 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -78.27 18.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -167.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' HA3' ' OE1' ' A' ' 96' ' ' GLU . . . -84.59 -97.7 0.66 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -102.94 128.69 49.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.811 -171.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.2 127.99 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.089 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . 63.8 tp -106.66 123.36 48.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 t -111.44 116.79 31.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.16 60.21 5.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.99 105.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' OE2' ' HB3' ' A' ' 67' ' ' ALA . 9.0 tm-20 -67.07 -60.52 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -170.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.65 35.0 91.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 59.03 20.73 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.74 61.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.521 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -65.68 -46.4 79.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -77.57 -27.89 51.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.59 59.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.3 p -69.43 -29.18 66.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -64.83 -50.76 65.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.472 ' HB2' HG22 ' A' ' 54' ' ' VAL . 98.2 mt -65.27 -37.84 88.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.79 85.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -66.87 -20.17 65.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -89.63 0.44 56.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 94.92 5.0 61.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.474 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.88 143.88 27.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -90.02 106.85 18.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.896 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 47' ' ' LEU . 77.5 t -107.21 125.66 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.4 m -112.08 128.59 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 167.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.49 130.57 56.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.128 -174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 133.19 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 7.7 t70 -155.79 156.62 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -77.93 -27.78 49.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.039 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.0 p -96.03 149.62 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -168.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -80.11 -31.29 39.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.949 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.74 -48.19 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.51 98.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.574 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.407 HD23 ' HB ' ' A' ' 80' ' ' THR . 95.7 mt -67.62 -36.71 81.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.14 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.88 -37.3 81.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -61.68 -42.72 99.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.18 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -68.41 -41.21 80.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.36 -40.51 96.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.16 96.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.51 -37.72 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -32.7 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.98 -7.28 49.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.69 59.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.89 163.77 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 111.165 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.24 131.35 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.43 170.19 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -123.93 130.66 52.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 64' ' ' LEU . 41.5 p -121.92 134.35 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.87 123.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 66.3 tt0 -85.86 114.37 22.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -173.6 143.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -55.4 133.23 49.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -57.77 -35.61 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 109' ' ' LEU . . . -71.62 -27.22 62.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.078 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -99.92 -11.92 20.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.23 135.02 52.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -93.19 112.63 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.509 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.4 mt -87.66 125.12 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.412 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 92.9 t -102.95 138.05 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.192 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 -61.13 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -168.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.42 -35.04 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -54.05 -38.97 65.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -170.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CG ' ' HB2' ' A' ' 34' ' ' LEU . 17.8 m-90 -132.28 154.83 49.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG2' ' HD3' ' A' ' 122' ' ' LYS . 53.7 mt-10 -107.38 -43.56 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.52 149.87 18.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mm -113.91 123.93 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.28 129.47 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.5 m -115.51 118.23 32.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.6 mm -113.67 116.69 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.176 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 47.42 42.97 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.2 t -108.06 96.44 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -89.9 120.39 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.5 150.04 74.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.637 0.732 . . . . 0.0 110.926 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 144.32 88.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.285 . . . . 0.0 112.324 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -60.12 -40.3 89.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 37.1 tp -73.83 -33.38 64.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.937 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -56.38 -44.97 80.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -75.07 -30.23 60.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -69.98 -39.89 75.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.31 -34.83 68.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 115' ' ' PRO . 35.7 t80 -51.37 -48.92 84.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.917 -163.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 114' ' ' TYR . 98.0 Cg_exo -47.34 -46.09 20.78 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.386 176.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -76.81 -36.24 57.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.18 -47.13 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.23 -54.53 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.16 -30.45 71.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.509 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -84.91 -11.97 75.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.467 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.67 129.63 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HD3' ' HG2' ' A' ' 96' ' ' GLU . 83.8 tttt -67.91 139.9 93.52 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.857 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.5 127.61 18.71 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.722 2.282 . . . . 0.0 112.345 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.94 1.26 88.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.483 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -73.71 170.41 52.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.418 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.83 142.82 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.791 0.329 . . . . 0.0 111.206 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -109.59 128.27 55.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 28' ' ' ILE . 38.1 mm -118.5 131.67 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.139 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 190' ' ' LEU . 58.4 tp -129.84 123.77 31.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 165.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -143.93 130.77 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.22 -167.38 30.13 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 176.558 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.859 0.361 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.6 tp -55.45 -44.81 76.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.95 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.1 -38.39 90.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.0 m -60.4 -37.08 79.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.19 -42.58 93.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.949 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -65.91 -36.23 82.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.1 p -78.18 -25.89 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -84.58 -13.77 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 163' ' ' LEU . 2.2 tt -119.36 92.95 46.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.663 0.744 . . . . 0.0 110.946 -175.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -89.53 -24.65 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 0.0 112.347 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.7 p -81.18 -15.36 55.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -162.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 160' ' ' LEU . 3.0 mp -114.51 140.03 49.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -86.35 132.85 33.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -92.29 114.48 27.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.474 ' HB2' HD23 ' A' ' 191' ' ' LEU . 83.8 mt -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -175.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.743 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -138.61 145.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.37 113.73 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -129.11 139.19 52.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -118.41 128.76 54.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 175.273 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 44.2 pt -124.01 146.22 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.194 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -143.23 130.85 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.7 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -152.19 150.28 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.884 ' O ' HD21 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.73 129.77 23.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.0 141.59 16.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 174.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.756 0.312 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -164.79 142.75 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.05 159.99 40.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -123.89 119.42 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.83 148.11 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -126.39 154.93 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.7 p -153.52 169.96 21.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.07 40.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.8 p -156.79 164.42 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -126.06 146.86 49.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.61 164.98 23.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.0 134.96 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.059 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -149.29 164.96 33.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.46 163.09 11.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -121.06 102.13 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.95 69.88 35.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 0.0 110.902 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.14 155.14 42.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.743 2.295 . . . . 0.0 112.314 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.2 155.02 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.46 170.14 22.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -60.02 133.38 56.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.83 -32.34 20.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.009 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 179.695 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.422 HG12 ' HB ' ' A' ' 126' ' ' VAL . 68.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.62 0.724 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.88 153.06 79.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.741 2.294 . . . . 0.0 112.277 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.31 12.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 -173.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.58 -143.4 7.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.524 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.01 144.47 30.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.695 0.283 . . . . 0.0 110.948 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.49 135.05 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 55' ' ' THR . 51.0 tp -105.57 126.03 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -106.42 124.9 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.57 133.24 39.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.06 53.76 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.059 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 41' ' ' GLY . 54.0 tp10 -90.16 123.33 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.14 16.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.425 -166.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -129.99 10.02 5.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' H ' ' HG3' ' A' ' 38' ' ' GLU . . . 75.01 22.05 77.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.76 -42.11 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -75.12 -29.15 60.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.845 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.43 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.55 -37.27 76.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -63.06 -47.34 83.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.587 ' HB2' HG22 ' A' ' 54' ' ' VAL . 70.0 mt -63.54 -38.82 92.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.28 79.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -70.64 -20.51 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.844 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -87.58 0.12 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.74 7.66 58.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -83.96 145.0 28.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.17 112.61 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 165.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 47' ' ' LEU . 89.9 t -111.44 135.72 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.485 ' O ' HD12 ' A' ' 34' ' ' LEU . 97.5 m -107.75 125.34 51.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 165.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.98 133.92 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.079 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.33 129.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 59' ' ' GLN . 49.5 t0 -154.5 153.24 31.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.424 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 92.4 mt-30 -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 174.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.3 t -95.67 115.45 27.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.83 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.0 p -69.07 -33.71 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.02 -31.37 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.78 -41.64 97.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.54 169.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.78 -35.04 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.29 88.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -64.29 -38.79 92.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.972 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.63 91.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.01 -43.16 99.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.1 -40.14 92.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -33.91 77.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.9 -10.99 34.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.92 66.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.416 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.39 161.7 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.169 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -97.37 129.97 44.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 pt -137.08 163.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.143 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.0 m -121.65 134.08 54.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.5 p -119.17 133.05 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.91 122.38 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -85.12 118.79 24.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 t -174.53 143.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.29 128.16 35.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.31 -38.59 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.33 -32.56 74.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -97.78 -6.37 32.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.99 129.89 42.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.9 114.93 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.879 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.436 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -93.76 117.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.191 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -83.69 136.23 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.051 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.39 -49.51 54.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -56.92 -26.09 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.74 80.6 9.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -69.86 130.14 41.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -173.14 150.81 1.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.49 163.33 46.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.473 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.6 mm -114.84 117.89 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.45 124.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.7 m -112.6 115.03 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.46 123.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 102' ' ' PHE . 53.8 t80 43.19 49.83 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.1 m -97.27 79.02 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -75.46 114.8 14.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.482 ' HB2' HD21 ' A' ' 109' ' ' LEU . 3.8 pp -152.04 152.71 30.24 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.618 0.723 . . . . 0.0 110.821 -169.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.85 149.74 78.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -58.1 -29.77 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -59.2 -35.96 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 105' ' ' LEU . 49.7 tp -69.87 -36.9 75.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.85 -28.02 69.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -82.43 -39.93 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.55 -32.56 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 m-30 -54.73 -55.23 40.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.715 0.769 . . . . 0.0 110.94 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 29.4 Cg_endo -61.69 -34.01 84.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.314 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -68.63 -46.42 69.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.94 -31.61 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -69.2 -57.11 5.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.71 -34.04 69.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -68.26 -31.12 74.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.712 HD11 ' HA3' ' A' ' 125' ' ' GLY . 57.7 tp -86.2 128.84 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.892 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.87 159.56 68.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.524 0.678 . . . . 0.0 110.911 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.04 133.53 46.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.44 48.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.712 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -75.54 168.3 54.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' A' ' 28' ' ' ILE . 96.1 t -131.95 140.16 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -106.46 131.88 53.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.7 134.4 66.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.19 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 190' ' ' LEU . 59.6 tp -127.19 127.18 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 172.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.84 139.74 15.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.08 30.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.539 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.45 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 72.9 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.902 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.876 0.369 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 168' ' ' ALA . 3.3 pp -48.2 -30.78 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 96.6 mt-10 -65.1 -36.51 84.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.1 p -75.15 -31.84 61.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.462 ' C ' HD21 ' A' ' 156' ' ' LEU . 10.1 tt -64.2 -45.17 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 4.4 pt20 -66.46 -28.22 68.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.3 p -73.18 -16.09 61.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -78.97 -13.27 59.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.71 108.25 61.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.674 0.749 . . . . 0.0 110.947 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.4 -20.67 3.92 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.763 2.309 . . . . 0.0 112.309 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.5 p -71.66 -24.67 61.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -159.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.576 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.7 pp -143.2 168.1 20.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -104.94 144.61 31.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -96.56 128.66 43.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 193' ' ' GLN . 93.1 mt -88.72 -31.67 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -172.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 190' ' ' LEU . 43.3 pt -138.27 147.83 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.087 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -146.55 117.64 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 166.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -130.02 140.02 50.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -103.87 122.66 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 49.5 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -170.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.1 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.7 0.286 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 44.7 pt -114.11 142.48 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -135.25 123.06 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.717 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -152.72 147.65 26.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.43 ' C ' HD21 ' A' ' 191' ' ' LEU . 9.9 tt -139.74 129.89 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.25 147.6 18.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.461 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.405 ' HB2' HD11 ' A' ' 166' ' ' LEU . 41.6 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.882 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -155.03 166.8 32.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.937 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -162.0 160.07 27.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -129.9 149.97 51.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -159.22 129.01 5.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.99 168.11 28.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 t -151.66 139.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.1 160.0 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -165.79 137.26 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.884 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -161.7 164.61 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.75 163.45 39.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.63 80.51 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.17 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.35 172.38 7.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.32 176.48 22.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -153.8 154.95 34.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.694 0.283 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.92 149.16 62.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.79 154.39 48.71 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.33 156.13 43.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.65 105.61 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.39 110.82 22.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.0 tp -70.12 -51.18 33.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 189' ' ' GLN . 49.0 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.6 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.605 0.716 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.41 131.32 27.26 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 0.0 112.335 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 84.4 mt-30 -75.91 13.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.947 -176.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.17 155.05 26.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 61.86 68.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 110.859 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 52' ' ' TYR . 47.7 mm -115.01 126.51 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.42 120.71 43.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.5 t -108.49 125.94 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.6 mt -108.63 135.45 49.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.11 45.77 25.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 56' ' ' ALA . 19.8 pm0 -71.45 -18.33 62.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 -175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.18 -66.95 3.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -130.33 11.61 5.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 82.98 5.24 89.51 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.507 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -64.86 -36.94 85.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.938 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.51 88.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.6 m -68.46 -38.38 81.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.845 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -58.47 -51.95 67.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.1 mt -59.71 -40.06 86.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.29 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.073 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.1 p -69.75 -17.83 63.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.87 1.06 41.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.77 4.61 65.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 33' ' ' ILE . 10.1 m-30 -74.12 147.0 43.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 0.0 111.004 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -84.98 101.96 12.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.856 166.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.22 124.5 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -165.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.6 m -112.28 126.06 54.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 165.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.464 ' HB2' ' CD ' ' A' ' 38' ' ' GLU . . . -110.05 126.61 54.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.24 128.33 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -176.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.23 155.92 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -78.99 -20.02 50.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -93.67 110.96 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.419 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 94.3 p -67.81 -34.85 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.85 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.43 -30.92 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.92 97.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.42 -36.53 81.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.871 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.74 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.25 -38.62 91.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 173.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.707 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -59.65 -43.33 93.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.86 -44.72 96.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -66.82 -41.13 87.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.35 -41.07 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.35 93.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.158 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.81 -39.21 93.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.92 -32.87 73.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.948 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.82 -10.1 41.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.57 32.98 58.92 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.499 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.79 160.1 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.23 137.68 45.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.972 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.77 164.19 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -119.21 133.5 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.6 p -118.49 135.01 54.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.147 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.0 t -128.08 119.96 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -84.09 113.63 21.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -173.04 143.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -54.86 124.06 15.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.29 -37.35 67.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -32.08 72.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.75 -8.18 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.85 127.21 30.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.978 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.21 114.93 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 pt -126.58 141.82 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.089 168.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.91 -179.8 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.46 -34.11 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -173.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -29.23 70.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.0 94.54 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.074 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 122' ' ' LYS . 41.7 m0 -89.89 104.84 17.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.945 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.92 126.08 15.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.86 158.7 36.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -112.12 118.7 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.129 -171.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.1 t -121.37 124.34 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 103' ' ' CYS . 58.8 m -130.1 108.44 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.9 mm -114.53 125.67 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.159 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 48.61 40.26 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -171.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 100' ' ' SER . 87.1 m -118.67 82.13 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.892 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.1 130.98 34.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.9 mt -121.1 146.96 45.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.2 Cg_endo -67.67 147.6 76.26 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.604 2.203 . . . . 0.0 112.389 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -54.23 -40.25 67.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.913 -172.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.3 m -60.49 -38.91 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.85 ' O ' HD21 ' A' ' 109' ' ' LEU . 3.6 tt -71.91 -39.98 69.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -59.71 -40.24 87.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.59 -29.42 70.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -83.62 -39.82 19.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.9 tp -72.15 -41.62 66.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 3.2 m-30 -55.37 -49.51 92.07 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.667 0.746 . . . . 0.0 110.951 -165.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 96.4 Cg_exo -47.32 -39.36 27.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.98 -47.89 19.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.38 -25.21 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -64.95 -47.67 76.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 175.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.9 -24.91 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.9 59.94 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.486 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -81.93 153.07 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 63.9 pttt -75.43 155.84 85.54 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.524 0.678 . . . . 0.0 110.895 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -56.22 122.7 12.25 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.64 -1.69 81.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.491 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.92 177.01 48.55 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.7 t -129.31 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.141 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -107.22 129.0 54.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.92 123.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 190' ' ' LEU . 63.2 tp -131.63 127.08 36.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 166.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -157.14 140.06 15.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.97 -178.59 35.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 175.707 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.9 tp -52.89 -46.81 68.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.63 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.4 m -63.37 -40.47 97.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.8 mt -59.81 -39.95 86.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -64.0 -34.25 77.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -81.88 -25.01 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -77.58 -15.47 59.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.88 98.28 28.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.51 -28.33 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.278 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 92.0 p -73.55 -20.69 60.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.785 -163.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.4 pp -134.12 159.11 41.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -103.42 139.72 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -88.16 124.9 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.26 -31.74 14.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.676 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -140.17 146.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.29 117.42 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -139.11 146.75 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -113.72 129.98 56.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.499 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.792 0.33 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.71 142.68 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.448 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.6 pt20 -143.19 128.13 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.717 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -152.61 147.57 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.676 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.7 tt -139.75 127.19 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -174.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.567 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -112.06 141.83 16.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.441 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.872 177.619 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mmm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.05 165.02 38.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -160.93 160.01 30.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.954 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -158.78 128.42 5.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.974 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.96 168.73 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -149.69 139.08 21.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.0 160.0 38.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.9 t -161.95 139.96 8.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.827 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -160.86 160.88 31.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -153.71 129.97 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.921 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -120.5 125.05 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -159.99 134.95 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.19 -175.91 40.96 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 t -153.9 155.04 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.99 148.08 58.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.752 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 155.04 47.92 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -129.9 160.02 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.806 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -141.76 99.85 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.39 132.57 44.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.56 -44.09 75.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 189' ' ' GLN . 67.9 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.579 0.705 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -39.31 125.05 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.347 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 88.4 mt-30 -60.06 -5.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.903 -169.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.28 -174.56 17.62 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 95' ' ' TRP . 72.0 mmtt 64.98 65.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.58 131.8 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 58.9 tp -104.35 119.85 39.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 174.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 44.1 t -105.89 122.5 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.04 127.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -171.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 62.73 50.09 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 20.0 pm0 -75.61 -19.19 59.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.29 -70.06 3.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.493 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.54 -4.03 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.785 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 88.4 12.77 64.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.455 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.71 -37.41 84.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -67.29 -41.06 86.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.14 90.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.4 m -72.37 -34.2 67.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.62 -51.73 68.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.952 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HB2' HG22 ' A' ' 54' ' ' VAL . 89.3 mt -67.01 -35.82 80.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.18 86.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -71.07 -20.67 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.02 2.77 51.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.81 4.86 61.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 87.5 m-85 -82.92 137.84 34.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 111.006 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -87.81 110.11 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 47' ' ' LEU . 79.7 t -110.99 130.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.6 m -102.9 125.01 49.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 163.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.29 124.41 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 -170.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.85 126.79 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.111 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -157.17 154.68 29.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -79.26 -19.99 49.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.961 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -93.67 111.61 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.828 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 96.1 p -67.36 -33.95 76.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.1 -31.29 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.042 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.68 -39.73 97.83 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 170.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.37 -34.64 76.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.14 82.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -62.5 -39.88 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.785 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -61.28 -41.66 97.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.061 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.93 -44.53 95.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -40.78 90.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 81.8 mt -61.71 -40.52 95.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.83 96.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.41 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.26 -34.09 76.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.84 -9.5 43.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.44 33.97 63.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.412 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.23 160.72 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.158 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -105.37 132.31 51.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.965 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.78 160.88 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.07 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -116.7 134.01 55.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.2 p -123.51 140.99 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 80.1 t -132.7 122.76 47.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.6 tm0? -83.37 116.91 22.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -174.83 145.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -55.18 123.17 12.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.901 172.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HG ' HD22 ' A' ' 113' ' ' LEU . 50.0 tp -55.78 -36.88 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.909 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -34.4 77.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.84 -7.22 27.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.29 134.8 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.948 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.37 111.29 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.8 mt -94.87 120.44 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.6 131.59 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.04 -43.59 33.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.12 -20.59 59.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.848 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.33 125.18 30.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.469 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 82.7 m95 -75.18 94.95 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 98.6 mt-10 -149.95 123.71 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 170.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.64 53.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.53 115.99 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 -172.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.96 129.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -135.04 112.67 10.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 HG22 ' CD2' ' A' ' 102' ' ' PHE . 25.6 mm -115.81 130.95 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CD2' HG22 ' A' ' 101' ' ' ILE . 71.3 m-85 53.51 44.87 29.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -173.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -117.07 85.67 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -80.79 121.6 26.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.3 pp -142.92 153.58 60.95 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.588 0.709 . . . . 0.0 110.966 -174.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.15 153.95 46.58 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 0.0 112.333 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -59.52 -33.24 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -60.13 -32.32 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 105' ' ' LEU . 52.8 tp -74.13 -39.31 63.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -56.4 -42.68 78.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.02 -32.23 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -78.9 -40.49 32.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.43 HD22 ' HG ' ' A' ' 85' ' ' LEU . 63.4 mt -73.73 -40.1 63.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.894 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.8 m-30 -53.55 -51.17 78.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.691 0.758 . . . . 0.0 110.877 -164.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 89.9 Cg_exo -46.94 -43.39 24.42 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 174.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.88 -45.99 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.6 -30.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -170.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -63.88 -51.18 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -71.68 -25.99 62.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.947 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.31 -52.61 51.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.404 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -81.31 153.97 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -88.88 155.87 49.88 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 110.923 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.01 130.17 26.88 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.772 2.315 . . . . 0.0 112.334 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.08 77.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.451 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.68 175.46 47.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.518 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.64 139.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -109.69 127.87 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.9 mt -122.44 128.37 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.035 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tt -134.34 128.3 33.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -155.55 139.97 16.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.54 -174.48 34.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 176.04 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.25 -45.39 87.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -34.98 79.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.8 m -64.84 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.158 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.95 -51.11 71.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.13 -31.82 69.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.7 p -75.56 -24.2 56.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 161' ' ' PRO . 97.3 mt-10 -83.82 -2.08 55.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.9 mt -104.47 95.11 7.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.597 0.713 . . . . 0.0 110.986 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 66.2 Cg_endo -83.14 -31.52 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.655 2.237 . . . . 0.0 112.277 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.7 p -75.81 -17.05 59.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.786 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.5 pp -132.01 162.06 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 -176.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -107.63 130.56 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.862 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.409 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.7 p90 -87.27 134.8 33.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.42 -30.09 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.753 HD13 ' HB3' ' A' ' 191' ' ' LEU . 59.8 mt -129.91 138.47 53.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -170.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.06 111.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.078 162.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -138.31 145.91 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.16 129.93 56.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 170.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.421 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.96 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.752 0.311 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.2 pt -120.03 143.72 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.435 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.5 pt20 -138.16 134.36 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.918 174.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.4 pt? -152.11 150.54 30.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.753 ' HB3' HD13 ' A' ' 167' ' ' ILE . 3.5 tt -139.93 129.68 24.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -112.75 146.64 18.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.497 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.836 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -154.94 165.03 37.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -144.97 -175.79 4.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.825 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -162.15 163.57 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -137.05 166.88 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -150.59 126.0 10.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -107.79 168.14 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -125.03 154.94 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -159.94 170.0 22.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -160.79 160.48 31.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.0 168.59 26.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.22 160.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.565 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 53.4 p90 -163.45 149.95 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.89 172.07 42.14 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.403 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -156.65 -174.93 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.77 151.49 42.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.674 0.749 . . . . 0.0 110.937 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.57 123.07 11.17 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.58 2.187 . . . . 0.0 112.309 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -143.03 -164.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -84.95 -170.07 2.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.72 142.93 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.35 -49.33 64.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -179.41 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.608 0.718 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.8 133.13 55.99 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.613 2.209 . . . . 0.0 112.375 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.16 -2.65 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA3' ' HZ3' ' A' ' 95' ' ' TRP . . . -78.06 -145.81 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.407 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.03 141.0 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.827 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.32 134.02 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 tp -102.38 121.89 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.33 113.99 25.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 64.3 mt -90.95 59.25 4.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -172.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.01 -60.26 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.53 39.06 95.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 171.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 60.98 19.73 10.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.82 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.85 15.62 67.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.437 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.95 -46.1 82.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 -172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.23 -40.09 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.02 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.041 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.7 m -65.51 -38.38 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.58 -51.64 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.71 -35.07 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.23 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.062 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 p -63.13 -13.99 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.24 -5.91 55.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 97.38 -6.39 63.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -102.41 148.19 25.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.04 117.71 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.37 147.5 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -114.39 130.56 56.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.91 129.95 56.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.1 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG23 ' HB ' ' A' ' 81' ' ' VAL . 49.3 t -117.29 132.47 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -159.74 162.52 34.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.07 -28.8 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -86.52 109.56 19.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -171.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 91.3 p -69.2 -36.25 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.85 -33.37 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.77 96.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.4 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.07 -34.89 79.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.55 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.95 -36.18 82.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.17 96.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.17 -42.48 98.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.0 -40.76 95.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.9 -41.35 97.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.73 95.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -64.2 -38.54 91.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.8 -33.55 75.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.4 -9.08 42.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.75 59.38 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.438 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.98 159.99 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.125 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -101.74 130.72 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.43 159.95 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.1 m -117.99 133.3 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -121.73 137.09 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.469 ' HB ' HG23 ' A' ' 57' ' ' VAL . 96.1 t -127.84 119.88 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.13 173.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.509 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.0 tm0? -85.09 114.42 22.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.866 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -173.41 145.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -58.41 125.22 22.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.93 -33.29 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.04 77.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -97.14 -8.54 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.49 132.4 49.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.75 111.91 23.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.513 HG22 ' HA3' ' A' ' 120' ' ' GLY . 89.9 mt -85.12 114.76 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.3 134.34 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -170.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.6 40.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.57 -22.56 56.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.835 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.37 92.54 7.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.439 ' HZ3' ' HA3' ' A' ' 31' ' ' GLY . 87.9 t90 -69.8 117.64 11.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -172.96 159.74 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.25 167.86 49.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.414 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.22 125.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.118 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.49 125.81 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.2 t -116.52 113.63 23.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.68 117.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 45.1 54.97 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 74.3 m -105.03 92.07 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -82.71 120.09 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.0 pp -156.14 150.88 20.46 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.991 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.1 149.48 89.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.76 2.307 . . . . 0.0 112.43 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -57.7 -29.71 64.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 -38.11 71.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 105' ' ' LEU . 25.7 tp -77.19 -35.96 55.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -54.59 -43.66 72.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.97 -24.64 67.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -85.09 -37.61 20.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.49 -35.84 68.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.931 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.0 m-85 -55.02 -52.66 69.19 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 0.0 110.926 -171.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.2 Cg_endo -65.23 -27.74 56.07 Favored 'Trans proline' 0 N--CA 1.466 -0.129 0 C-N-CA 122.739 2.293 . . . . 0.0 112.361 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -70.43 -39.11 74.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.791 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.7 -40.65 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.05 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.67 -57.25 10.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.47 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.513 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -72.18 -40.7 55.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.528 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.567 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.3 tp -79.78 121.06 24.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.394 . . . . 0.0 110.876 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -80.01 153.76 74.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 110.888 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.91 129.9 35.16 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.342 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.32 -1.4 64.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.416 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.567 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -81.75 170.28 51.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 164.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.5 t -125.16 141.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -106.65 129.36 54.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 169.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.43 129.61 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt -126.8 130.07 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.99 132.58 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.49 -168.6 32.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.453 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.975 178.277 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.53 -49.48 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.912 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.56 -33.11 74.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 53.5 m -71.57 -56.99 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 1.085 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.57 -20.65 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.608 ' N ' HD13 ' A' ' 156' ' ' LEU . 10.4 pt20 -75.72 -33.34 60.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -78.53 -19.26 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -84.43 -14.57 48.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.25 109.87 63.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.81 -20.28 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.356 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.3 p -61.63 -29.04 69.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -158.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.717 HD11 ' HA3' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -148.14 164.14 34.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -174.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLN . 96.6 m-20 -92.58 148.02 22.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -89.65 128.43 36.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.55 -33.8 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.574 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.9 pt -139.3 146.99 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.06 116.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -145.01 148.53 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -109.91 133.11 53.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -174.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.792 0.329 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.58 143.45 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -149.01 136.2 20.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.658 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.8 pt? -155.72 150.02 25.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.574 ' HB3' HG12 ' A' ' 167' ' ' ILE . 6.4 tt -140.66 131.37 25.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.934 -169.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.717 ' HA3' HD11 ' A' ' 163' ' ' LEU . . . -84.96 173.77 49.09 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 -172.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 164' ' ' ASN . 66.5 tt0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -124.9 -74.99 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -162.0 160.82 28.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -126.01 154.67 42.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -151.76 130.07 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -160.47 165.04 31.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -157.42 169.94 23.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -159.94 132.77 6.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.4 p -156.9 168.02 28.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.81 134.96 15.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.866 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -155.86 167.26 30.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.0 160.71 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -162.27 165.24 26.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.06 176.75 24.24 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.579 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.686 HG23 ' HD3' ' A' ' 17' ' ' PRO . 85.7 m -125.08 119.51 28.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -125.42 77.76 68.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.654 0.74 . . . . 0.0 110.932 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.686 ' HD3' HG23 ' A' ' 15' ' ' THR . 73.5 Cg_endo -76.62 153.54 34.34 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.651 2.234 . . . . 0.0 112.429 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -77.35 157.19 30.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.12 -35.98 70.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -113.81 152.51 30.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.82 -55.2 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -169.571 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.64 0.733 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.18 144.77 82.51 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -75.51 11.22 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -170.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.18 -130.37 3.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.53 139.31 32.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -174.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 52' ' ' TYR . 81.8 mt -124.22 131.79 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 173.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 tp -106.91 120.28 41.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -105.63 127.04 52.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.7 120.8 40.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.47 ' HB1' ' SG ' ' A' ' 103' ' ' CYS . . . 55.48 54.61 8.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 pm0 -70.23 -17.71 63.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 -172.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 -111.54 4.26 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.66 -41.5 70.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 110.904 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 88.59 13.88 62.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.447 176.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -65.83 -35.06 79.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.81 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.51 -33.07 72.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.92 97.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.8 m -65.82 -35.89 81.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -62.61 -44.51 96.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.56 -43.0 99.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.906 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.81 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.5 p -71.02 -20.26 62.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.878 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.2 mt -85.68 -1.59 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.41 8.59 59.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.51 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.4 ' HB3' HD13 ' A' ' 33' ' ' ILE . 50.8 m-85 -77.78 147.69 35.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.33 105.05 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.82 120.73 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -165.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.8 m -117.44 124.95 50.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.26 131.87 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.157 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.02 134.83 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -155.31 157.21 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.28 -20.09 41.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.0 t -93.13 111.38 23.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.7 p -67.8 -34.41 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.29 -31.35 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.105 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.26 98.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.92 -38.09 89.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.74 86.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.132 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.81 -39.98 94.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -63.16 -41.88 99.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.33 -43.28 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.7 -45.5 93.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.06 -41.3 98.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.87 93.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -64.56 -38.92 92.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.79 -31.79 69.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.21 -8.3 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.19 56.05 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.469 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.66 160.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.348 . . . . 0.0 111.195 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.85 135.5 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.866 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.4 pt -137.32 160.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -108.55 135.4 49.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.3 p -117.65 135.62 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.97 122.78 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -87.45 111.44 21.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.954 172.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -172.93 143.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -59.51 125.67 24.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 171.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.46 -36.38 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.5 -31.48 68.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -100.06 -9.23 22.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -89.79 112.22 23.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.531 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -98.59 115.75 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 93.3 t -88.29 139.36 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.25 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.76 -23.79 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.922 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -75.73 -52.38 10.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -170.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.79 139.82 32.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -164.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -126.72 166.47 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 42.73 71.05 0.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.482 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -92.73 130.47 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.08 130.39 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -173.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.4 t -103.71 118.09 35.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.01 115.03 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -169.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.44 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 61.6 m-85 47.38 48.81 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.47 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 88.8 m -99.61 74.04 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.874 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -76.7 114.96 16.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -153.48 153.38 29.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.517 0.675 . . . . 0.0 110.952 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 149.56 89.14 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.7 p -57.79 -30.57 65.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.812 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.6 p -62.77 -31.28 72.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.1 -35.53 66.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -55.16 -39.93 70.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.764 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -63.18 -30.86 71.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -82.77 -35.68 26.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -73.51 -41.55 62.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 8.3 m-30 -55.01 -48.06 96.96 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.71 0.767 . . . . 0.0 110.907 -164.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 84.8 Cg_exo -49.82 -41.75 45.99 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.254 . . . . 0.0 112.353 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -78.67 -46.03 20.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 77.9 t -73.31 -54.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.035 -165.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -80.04 -38.66 31.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 -168.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -69.15 -30.13 68.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.531 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -70.92 -14.85 73.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.27 124.33 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.07 139.78 97.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 0.0 110.9 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.27 130.37 32.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.92 -1.52 85.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.425 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.82 178.65 51.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.462 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.06 147.04 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -112.98 133.45 54.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mp -121.97 135.52 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 190' ' ' LEU . 47.3 tp -121.17 129.35 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 171.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -157.54 134.18 9.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 172.81 -171.67 44.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.513 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -177.458 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.821 0.343 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 156' ' ' LEU . 45.6 tp -49.48 -40.45 37.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 171.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.95 -30.74 71.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.7 m -66.5 -60.24 2.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -171.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 1.083 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.43 -16.5 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -177.032 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.61 ' N ' HD23 ' A' ' 156' ' ' LEU . 65.0 tt0 -66.18 -40.91 90.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 170.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.9 p -79.25 -17.81 54.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.792 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.84 -13.3 60.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 163' ' ' LEU . 65.9 tp -104.58 107.46 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.624 0.726 . . . . 0.0 110.946 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.13 -29.64 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.705 2.27 . . . . 0.0 112.293 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -80.45 -22.53 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -160.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 160' ' ' LEU . 98.4 mt -123.43 150.73 43.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -174.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -94.54 139.61 30.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.493 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 98.5 m95 -93.49 126.94 38.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.3 mt -93.47 -31.05 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.666 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.7 pt -138.06 148.47 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.4 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -155.19 122.59 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 166.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -128.92 134.88 48.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -117.08 119.95 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.7 pp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.767 0.318 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.65 144.66 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.94 134.19 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.755 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.1 pt? -154.51 152.55 30.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.666 ' HB3' HG12 ' A' ' 167' ' ' ILE . 1.5 tt -138.17 130.59 29.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.6 171.21 52.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.538 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -169.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.747 0.308 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -155.02 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.961 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -159.87 159.95 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.24 133.46 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.51 144.93 51.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -167.77 165.03 14.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -159.53 169.95 22.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.839 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.0 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -158.98 168.14 27.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.27 162.31 25.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -149.98 125.09 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.7 t -120.6 110.88 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -163.97 139.87 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.35 171.15 43.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -129.46 170.47 13.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -124.63 147.84 57.1 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.658 0.742 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.44 154.51 71.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -147.53 178.43 8.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -164.29 161.79 22.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.2 143.88 56.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.832 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 95.7 mt -81.88 -47.68 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.23 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -125.77 -46.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 162.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.18 19.43 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.832 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -65.14 -6.71 9.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.094 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -61.89 -5.82 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.43 -2.43 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 25' ' ' ALA . 96.7 mt -68.3 132.97 91.4 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 111.105 172.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.98 146.93 88.68 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.65 2.233 . . . . 0.0 112.373 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 pm0 -74.49 3.15 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -148.83 7.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.6 mttt -74.99 129.99 38.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.683 0.278 . . . . 0.0 110.968 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.61 129.07 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.101 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.06 120.56 40.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.32 124.44 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.0 mt -109.93 139.41 45.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -170.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 55.01 50.52 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 171.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -89.9 -21.43 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.1 -65.53 4.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -114.8 -27.92 7.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.92 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.26 31.37 55.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.548 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -65.68 -45.18 83.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -71.86 -27.41 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.98 87.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.8 m -67.82 -34.62 77.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.02 -45.56 90.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.78 -38.39 90.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.62 79.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.19 -15.62 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -83.97 -1.45 54.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.868 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.87 2.51 62.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.6 m-30 -78.68 145.34 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.32 106.65 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.23 125.61 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.4 m -109.47 126.64 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.85 127.33 56.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 81' ' ' VAL . 69.2 t -121.38 131.91 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.98 159.31 40.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -81.7 -21.44 38.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -93.8 114.08 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -67.16 -34.56 77.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.97 -31.66 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.194 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.66 97.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.17 -35.98 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.756 0.313 . . . . 0.0 110.915 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 -38.75 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.21 -43.72 90.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -62.33 -44.81 95.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.15 -42.24 94.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.76 96.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.39 -40.02 96.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.955 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.96 -30.08 70.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.89 -6.55 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.93 33.71 59.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.478 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.72 162.23 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.096 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -96.57 137.17 36.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.92 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 tt -137.25 150.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -111.7 135.24 52.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.3 p -123.2 135.19 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.119 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 57' ' ' VAL . 90.0 t -130.83 123.79 55.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -85.39 116.08 23.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -171.33 142.22 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -65.59 131.49 46.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 169.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HB3' HD22 ' A' ' 113' ' ' LEU . 87.1 mt -59.52 -28.83 67.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.81 68.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -103.35 -11.24 18.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.18 131.02 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -96.74 112.71 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.824 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.1 mt -94.19 119.86 42.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.48 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.144 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.38 93.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.81 -28.5 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.66 83.06 3.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.63 95.78 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -135.15 129.72 34.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.1 159.26 28.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.772 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.8 mm -109.93 117.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.49 127.42 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 64.1 m -115.4 115.87 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.49 120.94 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.16 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 41.33 54.82 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 71.3 m -101.57 95.4 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.902 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -75.24 110.44 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -156.38 151.98 22.2 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.558 0.694 . . . . 0.0 110.952 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 145.1 81.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.609 2.206 . . . . 0.0 112.385 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -58.08 -29.21 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.1 p -60.43 -30.85 69.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.7 tp -70.14 -40.84 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -58.49 -40.31 82.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.29 -31.45 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -81.2 -36.07 30.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 85' ' ' LEU . 81.8 mt -70.42 -32.78 70.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.6 m-30 -50.76 -55.15 29.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.683 0.754 . . . . 0.0 110.891 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 36.0 Cg_endo -63.86 -32.78 66.21 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.09 -51.29 59.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.772 ' HB ' HG13 ' A' ' 98' ' ' ILE . 34.1 m -75.43 -31.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.11 -53.04 51.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.42 -33.38 75.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.51 -47.8 60.59 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.45 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 48.9 tp -89.59 138.98 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -62.07 151.82 79.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.898 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.95 138.94 51.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.24 3.22 82.37 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.505 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -73.0 172.88 49.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.513 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 194' ' ' LYS . 2.7 p -127.64 140.09 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 111.154 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -111.1 136.46 50.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.426 ' CD1' HD12 ' A' ' 191' ' ' LEU . 35.3 mm -120.66 128.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt -129.98 125.73 36.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -146.68 130.36 16.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 144.84 -172.2 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -63.32 157.4 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB3' HG13 ' A' ' 188' ' ' ILE . . . -96.7 153.99 38.55 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.516 0.675 . . . . 0.0 111.175 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.56 -28.89 23.2 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.658 2.239 . . . . 0.0 112.318 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -54.68 -17.88 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -57.39 -17.99 15.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.964 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.854 HD13 ' HD3' ' A' ' 144' ' ' PRO . 44.2 mt -60.63 -25.53 66.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -63.24 -15.88 58.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.445 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 90.0 t80 -62.43 -50.32 71.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.33 -45.53 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -162.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.5 p -118.01 -22.78 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -162.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.29 -3.07 68.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.39 172.18 14.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.47 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.854 ' HD3' HD13 ' A' ' 137' ' ' LEU . 60.9 Cg_endo -73.29 -43.11 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.723 2.282 . . . . 0.0 112.312 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.55 -20.03 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 150.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -168.54 136.18 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.806 ' O ' HD21 ' A' ' 147' ' ' LEU . 1.7 tt -53.07 -27.65 21.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -65.48 -20.5 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -81.39 -9.95 59.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.52 132.48 38.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.35 130.99 7.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.305 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -78.24 161.21 27.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 163.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.36 -31.18 71.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.13 -37.14 86.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 84.5 m -65.99 -45.23 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.53 -46.32 83.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -70.14 -26.83 64.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 94.5 p -83.87 -27.64 28.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.88 -9.39 58.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.68 105.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.624 0.726 . . . . 0.0 110.866 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.46 -21.88 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.331 -170.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 94.8 p -65.23 -23.52 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.943 -159.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.598 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.5 pp -141.18 163.1 33.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.07 145.9 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.52 131.55 40.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.62 -33.99 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.586 ' CG1' ' HB3' ' A' ' 191' ' ' LEU . 46.1 pt -139.51 143.32 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.207 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 121.71 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -138.14 139.71 39.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -100.65 121.92 42.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 165.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 53.5 mt -109.37 145.91 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -172.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -106.8 123.5 48.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -157.06 152.09 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.95 138.25 58.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.3 125.79 27.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -74.16 149.41 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.26 39.4 28.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.68 -164.27 32.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.42 172.98 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 111.105 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -51.9 -45.26 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -64.44 136.83 57.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -60.2 170.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' A' ' 139' ' ' TYR . . . 175.02 115.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.432 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -74.12 158.01 34.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.882 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.7 152.28 36.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.88 138.6 32.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.5 mp -117.81 143.27 46.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.436 HG13 ' HB3' ' A' ' 133' ' ' ALA . 92.3 mt -113.03 127.94 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.94 123.98 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 171.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.524 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.5 pt? -153.78 151.62 29.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.68 ' O ' HD21 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.91 130.77 24.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 -173.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.48 169.34 50.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.527 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -90.87 126.86 36.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 126' ' ' VAL . 53.9 tttm -106.25 113.39 26.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 171.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.1 mt -99.81 137.61 38.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.945 162.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -41.66 129.98 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.488 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 85.3 t60 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.6 p-90 -155.03 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.99 160.0 32.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -153.21 133.82 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.834 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -106.88 144.86 32.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.94 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.76 165.01 14.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -157.85 169.99 23.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.05 160.0 40.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.84 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -156.9 165.34 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -163.12 160.08 23.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -150.08 124.97 9.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.93 112.77 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.089 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.74 135.11 5.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.41 -165.29 36.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -125.03 174.42 8.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.108 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -125.48 152.21 71.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.8 148.46 90.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.448 ' HA ' HD23 ' A' ' 50' ' ' LEU . 29.5 p30 -126.79 -170.14 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -162.64 158.84 23.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -75.3 144.98 42.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.856 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 93.1 mt -73.87 -43.2 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 170.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -116.39 -82.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.136 -167.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.3 p -129.45 -36.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 161.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.75 HG21 HD13 ' A' ' 191' ' ' LEU . 23.3 m -124.67 6.6 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.856 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -66.18 -5.73 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -66.56 -0.01 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 168.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 24' ' ' VAL . 89.0 mm-40 -88.58 -0.33 57.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 171.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.63 130.2 82.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 111.139 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 147.47 74.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.398 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 18.7 pm0 -76.31 13.87 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.32 -135.59 2.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.3 mttt -96.23 131.44 42.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.842 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 52' ' ' TYR . 4.8 mp -123.42 131.67 72.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 tp -102.42 122.26 43.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.943 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -111.67 122.96 49.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.0 mt -107.22 131.95 53.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -168.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.95 52.53 11.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.03 -19.75 24.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.88 -64.89 4.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.542 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.64 -33.08 5.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.87 44.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.516 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.07 -43.14 88.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.69 -29.39 66.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB2' HG11 ' A' ' 54' ' ' VAL . . . -63.29 -46.24 87.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.2 m -64.33 -35.47 80.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.98 -43.79 98.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.836 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.52 -42.96 93.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.86 -35.08 74.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.6 p -68.72 -15.64 63.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 18' ' ' ASN . 56.0 mt -85.58 0.05 53.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.72 63.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.553 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.463 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 2.5 m-30 -77.79 147.51 35.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.946 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -92.82 104.44 16.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.975 171.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG11 ' HB2' ' A' ' 44' ' ' ALA . 97.2 t -105.85 124.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.132 -167.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -109.6 128.03 54.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.7 127.37 56.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 HG23 ' HB ' ' A' ' 81' ' ' VAL . 87.7 t -122.78 134.12 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.03 160.98 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -77.38 -27.97 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -90.99 116.64 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.469 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 95.0 p -68.01 -35.13 77.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.85 -31.89 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.083 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.21 -40.36 97.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.511 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.78 -36.67 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.21 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.108 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.09 -36.98 83.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.66 95.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.047 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.07 -45.47 93.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.72 -38.84 84.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.34 -39.55 93.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.22 98.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.113 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.86 -38.43 90.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -32.37 73.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.6 -9.17 48.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.78 33.82 54.63 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.86 165.02 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.178 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.36 141.25 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -138.28 153.0 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -122.62 122.08 37.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.1 p -119.99 141.05 50.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HB ' HG23 ' A' ' 57' ' ' VAL . 73.6 t -133.17 121.78 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.469 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -82.18 114.73 20.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.984 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -170.67 140.06 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -61.75 131.2 49.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HB3' HD22 ' A' ' 113' ' ' LEU . 82.7 mt -59.02 -28.73 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -28.68 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.07 -11.33 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.69 130.87 45.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.92 113.3 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.52 119.65 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.4 t -86.59 140.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.165 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -46.05 81.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.12 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -58.11 -24.01 57.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.17 88.74 6.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . 37.7 m0 -83.86 104.76 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -172.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.2 mt-10 -140.98 140.91 34.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.82 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.4 173.39 43.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.1 mm -121.8 120.5 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.1 127.59 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.122 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -121.31 114.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.78 123.5 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.75 53.7 7.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.47 99.42 9.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -86.28 114.03 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 172.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.49 153.69 28.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.656 0.741 . . . . 0.0 110.974 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.12 141.58 76.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.676 2.251 . . . . 0.0 112.291 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.1 p -58.57 -29.94 66.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.7 p -62.17 -29.85 70.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.1 tp -68.84 -39.61 79.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -60.1 -39.51 86.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -61.65 -34.19 75.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -76.78 -38.13 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.008 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 85' ' ' LEU . 75.1 mt -69.91 -33.71 72.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.554 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m-30 -50.01 -56.37 18.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.559 0.695 . . . . 0.0 110.945 -167.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 27.1 Cg_endo -60.81 -33.73 92.44 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.747 2.298 . . . . 0.0 112.311 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.28 -52.74 44.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.93 -29.02 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -64.91 -50.09 67.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.75 -32.3 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.864 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.46 -14.74 73.02 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.495 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.33 133.21 46.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.946 0.403 . . . . 0.0 110.932 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 95' ' ' TRP . 86.4 tttt -70.53 139.12 86.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 167.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.1 123.2 10.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.05 5.07 86.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.69 176.1 46.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -135.5 148.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.057 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -104.01 129.42 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.782 167.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.499 ' CD1' HD12 ' A' ' 191' ' ' LEU . 31.3 mm -117.3 123.82 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.12 125.88 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -152.26 138.01 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.5 34.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.47 153.79 42.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.788 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -85.81 129.32 54.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.495 0.664 . . . . 0.0 111.176 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.44 ' HB3' HD23 ' A' ' 150' ' ' LEU . 57.9 Cg_exo -52.07 -33.37 52.96 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.641 2.227 . . . . 0.0 112.35 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 99.2 mt-10 -51.28 -20.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -51.85 -25.54 8.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.844 HD13 ' HD3' ' A' ' 144' ' ' PRO . 20.9 mt -66.04 -28.3 68.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 20.9 pt20 -63.31 -15.26 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -169.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -89.08 -35.48 16.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -97.83 -52.84 3.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 -165.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 59.5 p -131.59 -13.8 3.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.194 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.07 -28.26 8.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.47 -172.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.64 173.41 34.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.844 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.2 Cg_endo -74.56 -41.77 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.693 2.262 . . . . 0.0 112.299 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -129.79 -27.09 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.817 154.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -160.25 142.32 12.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.915 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.442 ' O ' HD21 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -52.35 -25.0 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 170.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.48 -23.41 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -78.07 -14.71 59.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.526 HD22 ' HD3' ' A' ' 144' ' ' PRO . 22.2 mt -90.27 120.0 69.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 110.864 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.74 127.93 5.07 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.798 2.332 . . . . 0.0 112.371 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.02 148.21 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.802 ' O ' HD21 ' A' ' 153' ' ' LEU . 4.4 tt -55.17 -45.36 75.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.08 -36.72 82.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.7 m -60.76 -39.59 89.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.12 -49.91 65.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -72.43 -26.24 61.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.5 p -79.63 -24.08 42.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.12 -10.62 43.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.47 97.06 50.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.884 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -91.8 -17.15 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -172.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.5 p -64.53 -22.19 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -159.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.965 HD12 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -137.93 154.85 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -74.87 139.24 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.94 119.79 36.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.87 -28.97 17.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.836 -169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 191' ' ' LEU . 41.4 pt -140.11 149.41 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.04 115.47 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 165.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -137.28 142.59 41.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -102.25 124.84 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.4 mt -107.09 149.07 28.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -109.27 125.71 52.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -158.51 147.89 19.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -54.82 134.11 47.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.54 122.17 15.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -79.6 151.52 30.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.778 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 53.77 34.98 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.01 -134.92 4.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.51 144.94 55.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.114 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -64.25 -48.11 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -65.85 152.6 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -49.98 157.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.6 117.01 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -72.8 149.93 43.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -153.19 147.72 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.83 139.21 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.72 146.4 44.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.915 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.11 129.74 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -130.6 127.29 38.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.553 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.4 pt? -153.56 146.48 24.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.936 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.75 HD13 HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -140.04 129.98 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -171.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.71 ' HA3' HD23 ' A' ' 163' ' ' LEU . . . -77.58 171.56 55.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.535 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -85.39 119.56 25.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 194' ' ' LYS . 14.8 tmtt? -108.99 110.02 21.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.34 137.51 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -54.89 123.78 14.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.508 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 85.0 t60 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mmm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -154.63 175.93 13.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.13 160.02 32.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.23 135.43 14.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -121.93 144.91 48.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.39 165.06 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.1 p -158.5 169.95 23.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.96 159.98 40.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -157.8 166.03 33.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -162.65 160.01 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -129.93 142.55 50.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.57 106.43 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.094 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -155.96 163.02 40.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.89 -174.41 43.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -119.94 166.77 12.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.71 0.29 . . . . 0.0 111.162 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.8 149.93 70.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.68 156.43 60.94 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 0.0 112.367 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -139.99 -170.38 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.47 160.82 20.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -74.27 148.29 41.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.789 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 2.8 tt -73.32 -46.25 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' A' ' 130' ' ' GLU . 60.4 t -114.97 -81.9 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.128 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.2 p -128.74 -37.72 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.788 HG21 HD13 ' A' ' 191' ' ' LEU . 23.8 m -123.09 5.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.184 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.789 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -66.91 -3.04 6.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.055 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -66.85 -0.38 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.865 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.572 ' HB2' HD11 ' A' ' 191' ' ' LEU . 90.1 mm-40 -88.75 -4.31 58.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 170.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 25' ' ' ALA . 97.1 mt -70.55 130.77 88.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 0.0 111.091 171.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 145.05 86.29 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.242 . . . . 0.0 112.379 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -73.5 1.82 9.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.36 -147.71 5.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.8 mttt -77.33 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -122.02 129.62 75.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 tp -102.21 121.47 42.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -105.81 129.2 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.28 126.49 55.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.99 54.25 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.162 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -89.99 -15.72 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 63' ' ' GLY . . . 88.92 -63.25 3.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.06 -9.19 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 74.23 23.28 76.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.87 -39.54 90.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -73.89 -28.51 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.88 92.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 70' ' ' LEU . 87.3 m -68.19 -35.13 77.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.4 -47.3 84.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.03 -36.22 83.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.56 83.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.428 ' HA ' HG11 ' A' ' 76' ' ' VAL . 60.5 p -68.64 -16.57 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.85 -0.27 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 3.62 63.98 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -81.08 145.77 30.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 -174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -85.24 104.97 15.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.947 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -109.64 126.84 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 -167.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -109.06 126.27 52.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 166.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.98 128.24 56.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 HG23 ' HB ' ' A' ' 81' ' ' VAL . 83.8 t -119.56 130.07 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.49 156.9 32.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -80.55 -20.12 44.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -90.49 115.2 27.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.6 p -66.9 -36.08 81.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.62 -31.91 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 39' ' ' GLY . . . -64.09 -40.93 98.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.552 171.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.12 -35.96 78.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.25 80.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.112 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.07 -38.51 91.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.423 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -62.65 -41.6 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.61 -44.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -62.64 -45.47 92.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 79.8 mt -62.62 -42.03 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -44.91 96.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.36 -40.17 96.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.19 -29.89 70.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -89.95 -5.15 57.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.43 56.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.9 m -128.76 163.88 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.174 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.12 144.83 27.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.03 149.9 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.2 m -110.88 133.0 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -124.22 136.75 54.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' HG23 ' A' ' 57' ' ' VAL . 90.9 t -129.58 122.08 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 173.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.48 116.25 23.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -172.38 143.25 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -57.53 125.77 24.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -55.22 -35.09 64.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.0 -29.63 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -100.61 -9.36 22.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.932 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.19 132.67 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -97.85 115.23 27.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.75 120.39 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.87 138.11 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.5 87.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.48 -25.99 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.22 86.48 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.143 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.49 95.36 5.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -132.24 135.29 46.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.23 162.33 53.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.7 mm -109.83 118.16 56.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -174.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.7 124.47 70.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 m -121.65 117.73 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.91 121.83 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.189 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 42.69 55.02 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.5 m -99.64 87.59 3.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -74.98 114.36 13.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -157.52 151.13 19.14 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.633 0.73 . . . . 0.0 110.927 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.43 142.51 80.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.619 2.213 . . . . 0.0 112.384 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -58.89 -31.41 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.9 p -61.73 -29.15 69.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.9 tp -69.21 -40.63 77.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -60.77 -38.87 86.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.457 ' HA ' ' CD2' ' A' ' 114' ' ' TYR . 89.0 mt-30 -64.81 -32.49 74.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -74.15 -39.45 63.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.71 -29.78 66.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 m-30 -49.9 -56.12 19.48 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.64 0.733 . . . . 0.0 110.882 -168.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 30.3 Cg_endo -62.41 -34.31 76.92 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.762 2.308 . . . . 0.0 112.314 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.97 -49.83 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 98' ' ' ILE . 28.0 m -74.74 -30.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -65.43 -51.73 58.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.08 -34.49 78.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.12 -49.07 63.92 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 47.9 tp -95.01 135.83 36.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.995 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.53 153.11 84.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.859 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.8 141.75 53.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.41 2.33 79.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.481 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -70.45 170.83 44.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.18 139.79 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.159 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.91 139.57 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.89 124.88 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.52 124.96 29.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.772 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.457 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -157.89 139.86 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.42 -172.66 32.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -67.18 149.56 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.894 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.31 162.73 23.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.125 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.46 ' HB3' HD23 ' A' ' 150' ' ' LEU . 52.6 Cg_exo -51.34 -24.93 16.95 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -53.97 -27.32 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -64.17 -19.85 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.472 ' CD2' ' HD3' ' A' ' 144' ' ' PRO . 37.8 mt -58.46 -30.13 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.8 -16.24 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -63.44 -54.67 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -107.24 -55.88 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 -158.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.7 p -124.97 -16.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.131 -170.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.08 75.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.465 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.0 157.51 8.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.475 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.472 ' HD3' ' CD2' ' A' ' 137' ' ' LEU . 40.2 Cg_endo -72.47 -53.95 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.678 2.252 . . . . 0.0 112.293 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.61 -34.52 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.83 161.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -157.25 133.71 9.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.894 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 150' ' ' LEU . 96.0 mt -59.74 -24.21 63.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.21 -24.12 67.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.17 -10.97 59.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -176.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 134' ' ' PRO . 54.1 mt -83.02 130.16 58.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.578 0.704 . . . . 0.0 110.916 -166.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.86 121.29 4.5 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.752 2.301 . . . . 0.0 112.286 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -71.04 145.63 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.767 ' O ' HD21 ' A' ' 153' ' ' LEU . 3.0 tt -54.92 -45.26 74.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.43 -36.71 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.5 m -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.1 -50.33 61.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -70.07 -25.61 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.7 p -79.21 -23.99 43.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.7 -15.39 37.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.2 107.31 60.07 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.583 0.706 . . . . 0.0 110.849 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -88.55 -21.45 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.748 2.299 . . . . 0.0 112.403 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.8 p -70.22 -27.14 64.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -157.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -139.31 161.48 37.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.942 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.34 140.28 30.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -95.7 128.07 42.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.11 -29.3 16.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 190' ' ' LEU . 36.3 pt -139.8 148.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.24 114.77 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.006 166.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -140.06 144.62 36.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -99.92 126.01 45.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 165.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -107.76 146.92 31.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.1 123.78 49.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -157.46 151.56 24.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.66 138.12 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.87 126.11 26.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.977 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.51 149.51 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.21 38.24 28.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.42 -163.89 33.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.512 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.33 171.32 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.108 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -55.42 -43.49 75.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 136.22 57.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -53.83 169.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.02 115.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.538 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.07 157.44 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -149.86 150.93 32.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.1 141.05 28.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.16 148.45 44.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.34 134.31 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -131.56 128.51 39.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.58 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.1 pt? -152.09 146.56 25.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.788 HD13 HG21 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -139.96 130.02 24.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -173.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.58 170.88 48.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.568 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -105.98 126.55 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.926 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.57 112.91 24.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.93 139.93 30.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.958 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -44.79 128.23 6.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 84.3 t60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -155.05 175.33 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -159.75 160.0 33.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.842 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.0 136.02 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -120.49 144.87 47.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -168.86 164.98 11.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -157.58 169.98 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.03 160.01 40.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.6 p -157.15 166.73 32.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.15 161.08 24.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -150.02 126.24 10.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.37 113.16 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -163.88 139.95 6.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.19 -177.76 48.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.489 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 p -122.77 161.5 23.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.331 . . . . 0.0 111.114 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.85 150.57 76.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.854 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.81 155.3 69.96 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -139.44 -176.53 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -167.17 167.92 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -69.41 145.6 52.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.815 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 3.0 tt -73.98 -50.69 18.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 130' ' ' GLU . 61.8 t -111.84 -79.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -130.17 -38.16 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.815 164.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.707 HG21 HD13 ' A' ' 191' ' ' LEU . 31.3 m -121.47 4.49 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 -169.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.815 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -66.48 -4.23 7.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.014 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -66.89 -0.23 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.736 ' HB2' HD11 ' A' ' 191' ' ' LEU . 91.2 mm-40 -88.12 -4.28 58.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 170.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 129.7 88.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.101 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.95 147.96 89.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.617 2.212 . . . . 0.0 112.426 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -74.38 1.21 12.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -142.48 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.55 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.1 mttt -85.0 132.74 34.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.928 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.13 130.29 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.1 tp -101.19 121.61 42.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.81 131.94 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 mt -114.05 123.06 48.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.9 54.51 8.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -87.87 -17.2 31.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.56 -59.53 2.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.543 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -125.01 -3.92 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.905 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.625 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 71.9 20.95 79.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.585 176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm105 -67.61 -40.39 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -73.02 -28.14 62.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -45.64 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.073 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.6 m -67.52 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.888 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -58.62 -48.26 81.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.2 -36.3 83.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.07 81.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.34 -0.48 52.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.41 62.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -82.57 147.27 28.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.74 106.88 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.94 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -110.4 125.96 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.165 -166.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 m -110.76 127.1 55.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.48 129.58 55.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.69 131.81 71.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -156.69 158.74 37.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -77.81 -28.5 50.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -90.86 112.09 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.8 p -67.82 -33.28 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.67 -31.14 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.38 -39.2 96.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.462 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.74 -36.43 80.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.875 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.73 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.128 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.77 -39.45 94.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.625 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -61.32 -40.73 95.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.67 -47.28 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.09 -41.23 90.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.99 -39.21 91.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.475 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -61.98 -41.63 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.83 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.83 -32.63 73.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -91.15 -10.67 41.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.92 34.7 55.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.44 161.7 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.09 130.12 48.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pp -134.76 160.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -114.11 137.94 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.9 p -120.05 135.41 54.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.144 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.7 t -129.41 118.63 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.03 114.58 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -171.93 144.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -57.95 124.39 19.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -55.48 -37.01 67.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.13 79.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.08 -5.44 27.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.05 133.83 55.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -91.24 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.409 HG22 ' HA3' ' A' ' 120' ' ' GLY . 91.2 mt -95.22 119.43 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.52 137.3 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.36 -45.64 79.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.36 -27.62 68.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.98 76.44 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -76.04 100.3 4.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 91.2 mt-10 -131.7 138.2 48.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.22 162.89 39.36 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.517 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.31 117.76 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.54 122.71 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -125.43 115.89 20.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.9 124.85 65.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.141 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 43.93 55.08 5.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 73.7 m -107.08 90.94 3.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.948 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -73.99 119.97 18.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 109' ' ' LEU . 4.3 pp -148.5 152.27 38.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 150.21 53.99 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.616 2.21 . . . . 0.0 112.36 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -56.62 -34.7 67.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.788 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.2 p -62.11 -30.05 70.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 105' ' ' LEU . 55.2 tp -69.97 -37.84 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.953 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -57.22 -39.3 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.82 -31.63 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.98 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -80.37 -40.83 25.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.934 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.42 -36.74 66.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.966 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.6 m-30 -52.9 -56.56 22.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.63 0.728 . . . . 0.0 110.957 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 17.8 Cg_endo -55.66 -34.81 91.63 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.4 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.75 -47.05 56.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.19 -30.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.76 -51.61 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.986 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.26 -32.91 72.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.898 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.409 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -71.6 -42.56 54.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.1 tp -84.0 133.2 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.948 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -69.24 152.0 96.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.23 136.32 54.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 194' ' ' LYS . . . 88.3 4.0 77.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.494 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.09 175.21 35.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 194' ' ' LYS . 7.0 p -127.09 139.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -109.71 135.14 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mm -115.26 122.33 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.95 124.71 31.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.839 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.479 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -154.92 138.42 15.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 153.95 -173.52 32.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.443 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 58.7 m-85 -66.03 149.98 49.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.82 156.06 39.77 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.554 0.692 . . . . 0.0 111.077 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.52 -27.16 24.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.718 2.279 . . . . 0.0 112.308 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.08 -20.8 18.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -58.8 -20.26 48.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.829 HD13 ' HD3' ' A' ' 144' ' ' PRO . 41.4 mt -59.19 -26.63 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.08 -17.17 56.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.07 -50.87 52.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -108.52 -51.48 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.834 -159.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 p -120.0 -15.09 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -166.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . 75.4 5.14 76.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 139.58 173.04 12.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.829 ' HD3' HD13 ' A' ' 137' ' ' LEU . 64.5 Cg_endo -71.44 -48.21 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.615 2.21 . . . . 0.0 112.296 171.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.45 -19.64 3.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.769 151.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -169.07 142.61 2.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.947 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 142' ' ' GLY . 94.8 mt -56.21 -26.08 49.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.39 -19.86 63.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.98 -8.21 59.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.428 HD22 ' HD3' ' A' ' 144' ' ' PRO . 77.2 mt -83.99 141.07 40.31 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 0.0 110.883 -166.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.36 136.04 17.3 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.729 2.286 . . . . 0.0 112.303 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.06 155.76 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 168.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.806 ' O ' HD21 ' A' ' 153' ' ' LEU . 4.0 tt -57.26 -41.27 79.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.963 169.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.21 -34.18 75.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.2 m -63.23 -41.75 99.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.75 -49.62 72.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.37 -24.59 62.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.9 p -81.66 -24.67 36.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -82.76 -17.06 45.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tt -113.89 102.71 55.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.635 0.731 . . . . 0.0 110.869 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.28 -20.23 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.736 2.291 . . . . 0.0 112.356 -170.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.4 p -65.86 -23.81 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 -156.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 163' ' ' LEU . 2.8 pp -134.02 167.96 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.008 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -93.33 136.99 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 172.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -92.05 126.31 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.1 mt -91.39 -31.51 16.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.674 ' CG2' ' HB3' ' A' ' 191' ' ' LEU . 15.8 tt -143.41 137.38 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -166.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.05 116.66 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -140.06 144.27 36.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -98.65 125.54 43.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 42.7 mt -110.67 149.92 29.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -173.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.97 126.6 53.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -156.9 147.47 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.66 134.78 56.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 185' ' ' ALA . 45.8 tp -68.44 126.53 29.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.31 150.03 42.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 59.81 35.8 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -104.09 -151.92 22.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.521 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.87 163.12 28.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.679 0.276 . . . . 0.0 111.136 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -54.62 -46.14 73.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -64.4 141.92 58.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.817 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -60.01 171.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.06 114.99 0.41 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.28 153.04 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 175' ' ' LEU . . . -150.8 150.91 31.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.07 34.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.129 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 132' ' ' PHE . 5.7 mp -120.09 146.65 45.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -109.52 132.14 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -132.99 129.07 37.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 168.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.547 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.4 pt? -153.47 146.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.934 171.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -143.64 131.06 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -170.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.92 170.62 36.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.526 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -102.85 126.34 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 124' ' ' GLY . 85.9 tttt -89.62 115.18 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 169.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.7 137.37 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.886 165.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -46.61 125.15 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 86.1 t60 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -164.83 142.2 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.97 169.94 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.922 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -156.98 139.24 14.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -136.34 175.09 9.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.907 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.92 165.03 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.5 p -155.65 169.97 23.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.03 159.95 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -164.56 131.76 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.01 149.97 47.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -151.97 129.67 11.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.8 t -119.27 125.41 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -159.43 134.52 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.947 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.76 176.69 29.12 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.521 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.635 HG23 ' HD3' ' A' ' 17' ' ' PRO . 89.9 m -126.0 137.63 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.153 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -122.47 78.08 45.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.694 0.759 . . . . 0.0 110.943 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.635 ' HD3' HG23 ' A' ' 15' ' ' THR . 65.1 Cg_endo -76.77 155.58 34.93 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.712 2.274 . . . . 0.0 112.401 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -130.07 68.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -95.9 -160.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -48.92 145.59 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.614 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 30.1 tp -69.18 -60.35 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -173.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.79 -83.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.162 -168.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -127.85 -47.22 1.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.809 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.775 HG21 HD13 ' A' ' 191' ' ' LEU . 28.6 m -122.92 21.03 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.064 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.614 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -57.54 -19.11 22.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -69.4 -4.21 17.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -90.31 -2.79 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt -77.24 129.25 78.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.565 0.697 . . . . 0.0 111.173 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.44 137.28 25.41 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.83 3.12 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -169.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.44 -151.99 8.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.08 148.95 41.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.15 135.07 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.6 tp -105.96 121.24 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -109.17 126.89 53.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.91 138.32 42.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 60.45 53.3 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.34 99.74 11.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.858 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.36 88.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.518 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.1 7.46 6.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.811 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 74.63 25.08 70.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -67.35 -42.21 83.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.78 -28.39 55.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.937 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.441 ' HA ' HG11 ' A' ' 54' ' ' VAL . . . -63.2 -43.97 96.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.8 m -68.28 -35.81 78.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -65.35 -45.57 83.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' HB2' HG22 ' A' ' 54' ' ' VAL . 80.2 mt -64.85 -38.84 92.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.01 76.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -68.45 -22.05 64.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.02 -4.42 59.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.37 56.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.454 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -80.55 140.34 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -89.79 109.52 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 167.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 47' ' ' LEU . 62.7 t -112.96 134.16 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.8 m -107.71 125.07 50.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.168 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.74 130.95 55.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.88 136.04 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.171 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -157.46 159.35 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -78.6 -25.07 45.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -102.93 128.38 49.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.6 p -69.82 -30.44 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.45 -33.95 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.9 95.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.521 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 -34.83 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.07 86.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.94 -35.46 81.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.811 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -61.65 -42.01 98.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.092 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.63 -42.35 98.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.83 -41.5 97.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.6 -40.8 98.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.67 94.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.033 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.16 -39.1 93.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -33.97 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.93 -11.97 34.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.01 35.3 57.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.38 160.55 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 0.0 111.14 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.38 131.1 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -134.65 163.28 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.4 m -115.74 135.88 53.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.2 p -121.56 134.97 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.9 t -132.01 123.94 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.73 120.04 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 t -173.66 144.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -62.16 127.44 31.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 37' ' ' ALA . 96.3 mt -57.67 -33.52 68.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.5 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.41 -7.0 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -63.26 130.96 46.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -94.07 113.11 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.585 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.3 mt -91.81 115.41 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.9 t -86.58 137.93 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.03 52.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.102 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.76 -27.18 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.817 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.77 86.18 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.107 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -76.55 100.09 5.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.22 109.88 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.58 127.96 35.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.483 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -100.6 125.1 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.397 . . . . 0.0 111.104 -161.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.6 129.01 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.3 m -101.95 117.98 35.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.54 114.75 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.596 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 53.6 m-85 50.2 56.19 8.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.2 m -107.92 88.77 2.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.848 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -86.62 111.72 20.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.417 ' HB2' HD21 ' A' ' 109' ' ' LEU . 3.2 pp -145.49 153.02 51.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.924 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.46 152.32 70.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.647 2.231 . . . . 0.0 112.295 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -58.69 -29.81 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.8 m -57.89 -36.11 71.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 105' ' ' LEU . 47.0 tp -71.65 -36.03 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -54.02 -44.02 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -62.92 -28.65 70.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 -37.16 28.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.76 -39.19 73.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.5 m-85 -52.01 -52.49 61.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.722 0.772 . . . . 0.0 110.961 -165.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.1 Cg_endo -68.37 -32.1 26.67 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.637 2.225 . . . . 0.0 112.329 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -71.72 -44.12 64.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.0 -34.33 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -71.16 -52.77 17.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.53 -31.57 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.585 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -63.35 -31.04 79.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.64 135.42 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.19 157.55 78.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.561 0.696 . . . . 0.0 110.887 165.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.41 125.1 11.67 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.77 2.313 . . . . 0.0 112.332 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.17 67.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.496 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.14 176.91 46.38 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.386 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 194' ' ' LYS . 14.6 p -131.32 139.05 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 0.0 111.155 -174.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -120.64 128.92 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.465 HG12 HD12 ' A' ' 191' ' ' LEU . 86.9 mt -124.67 136.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.434 HD21 HD22 ' A' ' 190' ' ' LEU . 39.3 tp -123.99 125.66 44.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -153.04 136.13 15.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 148.62 -164.54 29.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.541 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.557 ' HB3' ' HG2' ' A' ' 136' ' ' GLN . 68.8 m-85 -65.09 140.25 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -97.09 163.7 19.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 0.0 111.104 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 84.5 Cg_exo -47.23 -34.44 18.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 147' ' ' LEU . 98.4 mt-10 -58.2 -29.55 65.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -174.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.557 ' HG2' ' HB3' ' A' ' 132' ' ' PHE . 3.7 pp0? -64.86 -24.99 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -168.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.604 ' C ' HD12 ' A' ' 137' ' ' LEU . 3.8 pp -68.55 -23.84 64.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -165.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.532 ' HG3' ' HA3' ' A' ' 142' ' ' GLY . 36.2 tt0 -60.17 -28.71 68.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.49 ' C ' ' O ' ' A' ' 138' ' ' GLN . 86.8 t80 -25.06 -65.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 171.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -116.5 -24.01 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.7 p -117.93 17.02 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.05 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' A' ' 138' ' ' GLN . . . -64.81 126.04 31.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.52 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.0 -115.05 0.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.428 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.1 -25.96 31.15 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.393 170.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.63 32.99 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.26 161.97 8.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.572 ' C ' HD12 ' A' ' 147' ' ' LEU . 2.8 pp -65.86 -15.07 62.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 -160.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -79.74 -18.72 50.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.17 -1.5 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 -171.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 147' ' ' LEU . 82.9 mt -99.49 159.62 29.56 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 110.95 -160.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.67 142.2 82.8 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.324 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.6 167.78 10.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.883 ' O ' HD21 ' A' ' 153' ' ' LEU . 5.3 tt -49.76 -37.16 28.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 170.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.21 -27.23 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 92.2 m -63.34 -59.75 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 1.059 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.09 -15.07 61.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.81 ' N ' HD23 ' A' ' 156' ' ' LEU . 62.9 tt0 -68.98 -40.07 79.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.2 p -79.68 -20.78 45.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.01 -19.5 58.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 103.07 55.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.719 . . . . 0.0 110.842 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.83 -21.85 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.0 p -73.14 -23.35 60.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -158.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.492 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -135.59 158.33 44.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.935 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.64 143.07 28.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.528 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 99.2 m95 -98.91 128.74 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.9 mt -94.3 -30.21 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.937 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.564 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.0 pt -135.31 147.55 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 115.71 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -133.7 140.13 46.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.04 129.77 55.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 mt -107.99 132.55 53.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -116.26 128.75 55.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -130.38 144.52 51.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -67.59 119.61 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 127.81 32.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.925 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.607 ' OD2' ' HB1' ' A' ' 179' ' ' ALA . 59.5 t0 -77.85 132.2 37.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -117.06 -27.57 6.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.25 -55.05 2.56 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.411 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.607 ' HB1' ' OD2' ' A' ' 176' ' ' ASP . . . -87.65 168.14 13.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.21 13.47 14.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -125.98 62.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.8 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.92 162.44 35.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.939 169.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.81 22.98 5.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.66 144.56 32.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -155.36 157.05 36.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.14 130.93 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.74 151.8 44.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.541 HG23 ' HB3' ' A' ' 133' ' ' ALA . 39.6 pt -125.46 143.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.71 129.55 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.69 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.1 pt? -153.01 149.7 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.775 HD13 HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -140.08 132.23 28.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.26 173.24 54.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.549 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -91.34 108.25 19.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.659 ' C ' ' HD2' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -95.24 108.03 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 169.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.93 131.41 37.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 173.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -109.41 115.66 30.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' A' ' 197' ' ' HIS . 65.7 t-80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 ttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.758 0.313 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.1 m0 59.12 44.87 15.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -114.92 159.98 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -126.87 150.0 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.75 145.03 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.845 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.09 165.07 37.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -154.33 169.98 22.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.64 170.03 8.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.2 t -159.92 139.95 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.91 129.9 14.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.99 172.52 12.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -143.5 140.04 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -149.74 164.95 33.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.93 124.6 3.89 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.569 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.75 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 84.9 m -131.17 130.13 42.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.652 0.263 . . . . 0.0 111.258 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -134.61 115.97 12.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.813 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.27 146.3 50.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.596 2.197 . . . . 0.0 112.328 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -127.63 156.75 41.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -117.62 152.44 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 62.72 35.38 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.62 HD21 ' O ' ' A' ' 21' ' ' LEU . 2.6 tt -61.0 -36.29 79.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.95 -82.6 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.127 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m -127.06 -35.24 2.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 152.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 24' ' ' VAL . 8.3 p -128.64 16.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -60.55 -10.37 4.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -64.49 -4.51 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -95.51 -11.56 27.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.508 ' CD1' HD12 ' A' ' 128' ' ' ILE . 81.7 mt -79.99 132.99 58.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 111.132 -172.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.23 111.46 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -79.44 16.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -168.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -99.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -101.44 133.22 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.65 127.78 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.85 125.95 50.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -106.2 122.85 47.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.69 43.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 178.67 105.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' A' ' 67' ' ' ALA . 8.4 tm-20 -60.36 -59.85 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.15 33.22 82.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 65.49 15.88 10.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.49 16.87 70.07 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.43 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -64.43 -46.68 82.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -79.33 -28.24 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.77 63.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.19 -30.02 68.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.13 -48.94 74.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.3 mt -65.54 -37.13 85.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.09 85.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -67.86 -19.95 65.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -89.21 0.83 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.75 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 93.35 4.21 64.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -85.19 142.12 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.946 0.403 . . . . 0.0 110.819 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -89.73 104.43 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.92 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 47' ' ' LEU . 96.1 t -107.35 125.76 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.054 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.6 m -112.53 125.04 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 167.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.06 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.13 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.78 134.07 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.9 t70 -155.17 158.85 39.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.7 -26.58 37.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.9 p -97.01 144.96 26.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.874 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.2 m -76.99 -37.78 54.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.68 -35.03 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 -170.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.6 -44.87 94.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.66 -36.17 80.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.56 -39.12 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.09 -36.67 83.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.457 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -60.6 -42.85 97.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.03 -43.69 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -63.72 -45.41 90.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -61.85 -41.51 97.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.98 92.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.45 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.01 -29.95 70.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.53 -5.56 55.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 31.87 60.94 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.05 161.39 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.159 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.23 131.34 54.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.37 169.45 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.093 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -122.88 131.95 53.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 p -120.8 133.95 55.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.7 123.34 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.174 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 66.1 tt0 -86.65 113.37 22.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.981 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -172.19 141.6 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.75 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.31 133.79 55.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.82 -31.54 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -72.3 -27.12 62.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -101.87 -13.75 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -69.44 134.62 49.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.27 109.91 20.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.698 HG22 ' HA3' ' A' ' 120' ' ' GLY . 94.9 mt -87.64 124.63 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.66 138.19 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.97 -53.45 12.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.4 -27.81 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.18 86.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.109 -164.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -132.6 161.88 32.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.35 -44.17 4.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.06 157.55 15.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.4 mt -129.37 129.7 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.71 128.89 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -171.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 t -112.35 118.59 35.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.02 113.87 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.4 t80 42.72 52.2 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -105.53 96.42 6.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -82.16 121.0 26.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.515 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.7 pt? -134.64 150.76 74.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.582 0.706 . . . . 0.0 110.905 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.61 151.68 69.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.8 p -53.94 -34.93 61.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.6 p -62.68 -35.98 81.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 105' ' ' LEU . 16.5 tp -75.45 -34.05 60.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -58.5 -43.82 89.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.18 -28.19 68.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.6 -42.99 12.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.85 -43.58 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -170.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.7 m-30 -54.05 -53.45 58.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 -170.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 38.0 Cg_endo -65.61 -29.8 51.83 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.59 -39.7 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.12 -43.41 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -63.87 -51.1 66.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.66 -31.45 72.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -81.15 -16.97 73.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.478 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.34 138.29 33.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.931 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.85 152.58 93.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.831 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.28 125.94 16.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.23 -2.7 88.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.562 -167.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.82 49.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.487 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 28' ' ' ILE . 80.8 t -131.19 146.87 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 0.0 111.107 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -121.72 137.41 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 174.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 28' ' ' ILE . 60.9 mt -116.92 135.89 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.411 HD21 HD22 ' A' ' 190' ' ' LEU . 44.6 tp -126.5 124.57 40.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.958 162.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 23.5 pt-20 -154.11 145.63 23.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.928 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.68 -172.64 33.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -61.75 148.26 43.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.749 0.309 . . . . 0.0 110.903 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.15 34.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.52 0.676 . . . . 0.0 111.139 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.34 -31.07 45.58 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.659 2.239 . . . . 0.0 112.416 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' HD11 ' A' ' 147' ' ' LEU . 67.1 mt-10 -61.51 -33.12 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.806 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.693 ' HG3' ' HB2' ' A' ' 185' ' ' ALA . 24.8 tm0? -67.3 -21.96 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 1.012 ' O ' HD21 ' A' ' 137' ' ' LEU . 5.8 tt -56.9 -25.36 57.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 139' ' ' TYR . 15.2 pt20 -59.92 -21.84 61.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.848 -171.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.1 t80 -28.32 -65.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -96.18 -36.62 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.833 -156.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.1 p -130.73 -7.7 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.087 -169.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.43 0.29 71.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.413 ' HA2' HD23 ' A' ' 137' ' ' LEU . . . 146.79 155.77 6.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.447 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.608 ' HD3' HD13 ' A' ' 137' ' ' LEU . 51.8 Cg_endo -72.34 -42.19 1.49 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 0.0 112.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 97.6 mttt -127.53 -20.99 3.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.893 153.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.569 ' HB3' HD13 ' A' ' 149' ' ' LEU . 67.8 t0 179.55 129.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 135' ' ' GLU . 18.3 tp -56.33 -24.85 46.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -76.62 -21.76 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -170.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 146' ' ' ASP . 6.4 mp -84.58 -2.76 57.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -169.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 147' ' ' LEU . 82.5 mt -97.09 154.03 38.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.611 0.719 . . . . 0.0 110.916 -160.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -58.12 107.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -68.3 149.95 48.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 166.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -65.82 -36.61 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 81.6 m -63.97 -40.8 97.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.64 -37.69 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -64.12 -36.07 82.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.4 p -83.76 -28.18 28.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -80.5 -13.93 58.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.428 ' C ' HD21 ' A' ' 160' ' ' LEU . 3.3 tt -115.49 97.89 49.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.739 . . . . 0.0 110.981 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -91.08 -25.13 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 -170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 82.7 p -66.09 -20.47 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -161.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 163' ' ' LEU . 1.8 pp -128.18 154.21 46.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -94.83 140.58 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.67 121.49 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.08 -32.7 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.4 pt -139.93 147.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.165 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.04 117.11 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.62 137.1 46.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -112.09 123.04 49.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.4 pp -124.1 143.59 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -125.61 136.16 52.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -128.97 151.54 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -56.82 114.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -165.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.71 130.32 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.05 146.57 49.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -93.32 -19.69 21.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.62 54.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.85 166.38 33.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 111.023 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -50.52 124.43 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -55.34 126.97 27.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.858 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.3 -3.32 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.36 -10.46 50.4 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.511 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.08 138.63 31.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 0.0 110.863 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 136' ' ' GLN . . . -148.89 157.01 43.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.65 130.99 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.121 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.4 152.6 40.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.952 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.76 143.18 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.486 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 67.8 mt-30 -139.72 132.81 29.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.698 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -154.82 150.12 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.69 ' C ' HD21 ' A' ' 191' ' ' LEU . 4.9 tt -139.92 127.5 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.622 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -108.49 140.28 15.48 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -106.0 130.48 53.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.402 . . . . 0.0 110.91 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -90.23 129.56 36.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.72 140.88 34.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 24.2 pm0 -77.96 -10.02 59.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 178.51 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.793 0.33 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.4 m0 58.96 44.98 15.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.51 159.93 17.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.16 149.95 49.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.96 145.02 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.98 164.94 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -154.94 169.99 22.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.67 170.0 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.96 139.98 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.04 129.56 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -161.57 163.81 29.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -121.78 131.03 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.114 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -143.76 163.09 34.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.14 155.13 8.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.53 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.634 HG23 ' HD3' ' A' ' 17' ' ' PRO . 87.6 m -135.39 130.09 34.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 111.274 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -139.96 83.67 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 0.0 110.829 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.634 ' HD3' HG23 ' A' ' 15' ' ' THR . 25.2 Cg_endo -69.3 136.47 34.31 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.702 2.268 . . . . 0.0 112.305 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -122.7 172.12 8.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -144.86 -179.96 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 56.32 50.36 13.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 66.4 tp -60.84 -49.71 76.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.65 -81.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -126.81 -47.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 158.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.435 HG21 HD13 ' A' ' 191' ' ' LEU . 34.2 m -119.49 15.22 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.165 -171.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -12.32 9.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -57.31 -13.12 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.36 -7.8 56.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 25' ' ' ALA . 12.3 tt -71.52 137.14 83.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.654 0.74 . . . . 0.0 111.034 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.55 112.43 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.314 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -78.68 3.27 16.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.939 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.38 -87.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.463 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 99.3 mttt -119.13 133.02 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.54 136.86 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD23 ' CZ2' ' A' ' 95' ' ' TRP . 30.1 tp -94.74 121.01 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -103.11 110.5 22.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 90.5 mt -85.19 51.62 2.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 174.88 104.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.118 -171.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.5 tm-20 -56.18 -59.78 4.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.93 33.72 86.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.53 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 61.72 18.92 10.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.829 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.48 17.69 68.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -64.74 -51.74 60.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.325 . . . . 0.0 110.814 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -80.39 -29.27 37.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.74 82.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.039 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.21 -35.52 76.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.85 -51.13 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.0 mt -66.88 -35.17 79.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.01 76.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.183 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -70.67 -15.97 62.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -86.46 -5.26 59.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.25 2.46 59.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.442 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -82.82 142.56 31.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -91.11 108.66 20.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.892 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 47' ' ' LEU . 90.9 t -108.76 131.0 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -109.66 124.12 50.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.95 130.88 55.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.53 134.43 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.2 t70 -154.3 159.45 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -80.77 -21.83 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -108.78 127.84 54.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.7 p -69.62 -29.81 67.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.77 -33.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.054 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.68 90.81 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.494 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.01 -34.83 78.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.32 94.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.17 -36.84 85.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.75 95.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.88 -41.13 97.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.29 -45.69 93.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.9 -40.44 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.36 97.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.98 -38.29 90.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.65 -31.81 71.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.32 -6.98 49.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.87 33.07 60.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.462 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.15 160.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 111.193 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -104.31 131.96 51.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.23 161.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.5 m -114.2 133.62 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.3 p -123.15 133.93 54.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.189 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.34 124.96 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.2 116.5 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 173.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -174.99 143.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.8 t30 -60.47 131.02 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.06 -36.96 73.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.46 -30.32 65.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -100.7 -7.06 24.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 84' ' ' ASN . 4.8 t80 -57.69 129.0 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -94.69 108.05 20.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.75 143.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.145 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.82 131.81 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.28 -48.99 60.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.139 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -66.82 -22.62 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.45 -22.26 66.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.041 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.482 ' CZ2' HD23 ' A' ' 34' ' ' LEU . 30.7 p90 -147.95 167.08 25.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -118.58 -31.35 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.45 154.74 16.75 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.67 128.08 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 111.121 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.84 132.59 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -111.02 120.45 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -110.4 115.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.185 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.699 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 68.0 m-85 46.37 43.01 11.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -104.02 68.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -172.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -74.34 117.49 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.41 153.16 81.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.629 0.728 . . . . 0.0 110.905 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -63.52 148.86 92.23 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.643 2.229 . . . . 0.0 112.369 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -54.15 -30.38 48.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -60.07 -42.75 95.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -73.02 -32.58 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -57.34 -45.08 84.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -32.3 73.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -43.06 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.44 -30.41 67.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.522 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -50.07 -57.99 10.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.67 0.747 . . . . 0.0 110.917 -172.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 33.8 Cg_endo -63.43 -29.57 71.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 2.243 . . . . 0.0 112.309 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -68.52 -40.08 80.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.69 -42.97 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -63.18 -53.03 59.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.62 -33.34 74.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.54 -31.76 53.19 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.427 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.3 tp -75.9 134.42 40.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.998 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.67 139.84 80.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.668 0.747 . . . . 0.0 110.86 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.94 126.69 17.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.776 2.317 . . . . 0.0 112.304 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.82 1.5 87.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.514 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.15 173.31 54.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.45 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.5 t -124.79 139.49 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -115.42 131.39 56.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.51 131.28 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.078 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.409 HD21 HD22 ' A' ' 190' ' ' LEU . 48.5 tp -124.61 126.38 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 170.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -152.12 131.75 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 147.7 -155.76 26.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.446 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.409 ' HA ' HD21 ' A' ' 187' ' ' LEU . 62.4 m-85 -64.02 140.54 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 -165.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.532 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -110.14 159.15 33.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.52 0.676 . . . . 0.0 111.165 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.12 -26.61 26.64 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.17 -28.59 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -57.63 -37.24 72.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.004 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.938 ' O ' HD21 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.88 -15.16 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 178.055 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' A' ' 139' ' ' TYR . 66.4 tt0 -67.11 -2.77 6.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.618 ' C ' ' O ' ' A' ' 138' ' ' GLN . 74.6 m-85 -17.63 -77.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -175.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -129.7 -41.41 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.866 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.9 p -91.84 -0.34 57.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.513 ' HA2' ' HG3' ' A' ' 138' ' ' GLN . . . 65.47 20.94 68.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.437 171.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.68 173.26 12.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.813 ' HD3' HD13 ' A' ' 137' ' ' LEU . 70.3 Cg_endo -71.5 -35.03 8.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.699 2.266 . . . . 0.0 112.315 173.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.11 -29.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 158.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -172.27 155.78 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.818 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 142' ' ' GLY . 35.5 tp -60.78 -18.48 55.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -73.54 -30.27 62.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -161.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.711 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -105.12 11.76 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.894 -173.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.407 HD12 HD12 ' A' ' 147' ' ' LEU . 72.6 mt -90.46 148.74 39.55 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.66 0.743 . . . . 0.0 110.901 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.69 129.47 34.11 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.736 2.291 . . . . 0.0 112.337 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 155' ' ' THR . 98.7 mttt -100.23 159.55 15.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.919 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.734 ' O ' HD21 ' A' ' 153' ' ' LEU . 5.7 tt -53.66 -41.77 67.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.22 -33.95 76.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 152' ' ' LYS . 87.4 m -61.49 -43.22 99.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.36 -39.12 92.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.35 -36.27 83.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.1 p -83.29 -29.71 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.787 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -83.3 -19.56 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.4 tp -107.44 106.41 58.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.868 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -88.53 -22.98 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.421 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.2 p -69.18 -23.65 63.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 -159.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.677 HD13 ' HA3' ' A' ' 192' ' ' GLY . 4.3 pp -139.22 160.42 39.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -105.56 136.12 45.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.412 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 98.2 m95 -88.17 127.77 35.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -170.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.03 -33.83 12.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.709 HG12 ' HB3' ' A' ' 191' ' ' LEU . 49.8 pt -139.12 145.77 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.09 120.6 2.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -132.12 140.96 48.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.761 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -110.84 132.01 54.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.8 pp -128.87 146.73 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -118.11 139.85 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -133.07 154.87 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 171.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -57.81 119.68 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -167.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.6 mt -93.75 139.84 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -73.55 147.03 44.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.59 -29.42 12.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.99 55.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.62 166.14 34.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -54.47 129.29 35.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.839 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -54.01 120.93 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -86.56 -11.03 52.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.28 -26.83 9.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.53 137.84 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -155.29 154.72 32.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -79.82 127.48 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 172.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 132' ' ' PHE . 47.1 mt -126.17 153.63 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.977 -168.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.532 HG23 ' HB3' ' A' ' 133' ' ' ALA . 30.9 pt -122.27 147.52 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.56 122.72 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.69 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -151.13 149.31 29.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.736 ' C ' HD21 ' A' ' 191' ' ' LEU . 2.4 tt -140.04 128.39 22.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -116.41 148.72 18.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.453 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -112.74 130.9 55.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -96.89 134.33 40.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.03 138.21 38.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.12 -41.11 74.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.505 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.745 0.307 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.95 44.94 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -111.4 159.94 17.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.64 150.02 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.6 145.0 46.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.97 164.94 38.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -153.51 169.94 21.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.58 169.98 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.94 140.01 11.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -145.36 121.98 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -159.52 165.04 33.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -101.16 131.11 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -149.73 166.09 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 154.52 21.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.547 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.2 m -126.18 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.75 0.309 . . . . 0.0 111.159 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -140.0 89.96 10.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.62 125.16 18.19 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -121.24 169.99 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -140.38 -177.89 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.16 58.9 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.601 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 64.2 tp -61.58 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.61 -84.19 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.176 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.1 m -126.52 -35.22 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 160.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' CG1' HD13 ' A' ' 191' ' ' LEU . 3.9 p -129.42 8.71 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.173 -168.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.601 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -63.2 -6.82 4.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.181 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -7.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -91.68 -8.4 47.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG13 ' HB ' ' A' ' 126' ' ' VAL . 11.4 tt -74.94 137.49 73.02 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.722 . . . . 0.0 111.151 -174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.09 112.26 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.339 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -77.65 10.99 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 -170.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.26 -96.79 0.35 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -109.63 131.39 55.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.25 130.04 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.7 tp -101.48 122.66 44.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -114.8 114.97 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.923 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 85.0 mt -91.91 58.9 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.991 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -54.31 -60.07 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.78 35.58 92.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 60.11 19.54 8.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.832 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 16.07 63.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.557 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -65.09 -48.9 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -81.17 -30.15 34.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.97 -51.14 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -65.28 -35.77 82.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.53 -51.65 68.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.4 mt -64.66 -37.11 86.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.82 78.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.2 p -68.11 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.7 mt -86.13 -3.28 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.97 3.64 61.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.519 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.3 m-30 -80.13 146.34 31.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -89.99 103.43 16.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.941 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 47' ' ' LEU . 80.6 t -104.57 126.19 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 -170.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 m -112.78 128.93 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.163 166.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.2 126.67 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.155 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.27 129.97 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -157.89 163.43 37.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -78.19 -26.38 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -99.12 111.67 24.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.9 p -68.84 -27.99 66.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.91 -47.48 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.87 99.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.543 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.75 -36.48 84.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.4 89.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.26 -35.05 77.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.09 98.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.064 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.47 -40.87 98.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.17 -40.79 90.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.06 -40.59 96.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.66 92.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.83 -38.61 91.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.53 -32.74 73.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.43 -9.32 45.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.69 33.05 58.57 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.448 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.63 161.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 111.131 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -104.87 131.6 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.1 pt -135.03 165.99 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -123.21 131.87 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -120.72 134.71 55.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.125 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.41 124.86 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -85.09 119.54 25.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.1 t -172.06 140.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -57.34 130.6 46.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.78 -32.69 67.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -71.93 -29.74 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.042 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.04 -13.32 19.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.29 135.87 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.35 110.01 21.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.679 HG22 ' HA3' ' A' ' 120' ' ' GLY . 93.6 mt -84.07 125.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.2 t -100.76 139.17 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.96 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 99.1 m-20 -65.27 -28.3 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB1' ' CE3' ' A' ' 95' ' ' TRP . . . -70.21 -44.61 68.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 -163.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.402 ' CE3' ' HB1' ' A' ' 94' ' ' ALA . 13.5 m-90 -130.05 162.38 28.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -171.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 48.0 mp0 -114.66 -37.86 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.47 151.51 18.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.532 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.5 mt -129.19 127.99 66.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.345 . . . . 0.0 111.138 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.86 131.86 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -115.66 116.17 27.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.01 118.77 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.176 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 41.05 48.26 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.79 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.2 t -113.73 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -73.48 119.61 17.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.97 148.42 69.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.941 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.33 146.63 75.94 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.3 p -56.51 -35.33 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.3 m -60.48 -40.24 90.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 86' ' ' ALA . 45.3 tp -70.88 -39.94 72.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.932 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -55.46 -42.83 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.17 -28.56 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -82.19 -37.01 26.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.3 mt -71.79 -37.31 70.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.3 m-30 -50.07 -54.4 33.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.604 0.716 . . . . 0.0 110.92 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 31.8 Cg_endo -62.73 -32.53 78.32 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.765 2.31 . . . . 0.0 112.357 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -71.66 -39.7 70.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.51 -42.7 90.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -64.68 -53.85 40.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.74 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.977 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.679 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.84 -22.43 63.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.59 135.89 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.931 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.5 mttt -78.25 152.68 79.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.617 0.723 . . . . 0.0 110.815 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.14 125.64 19.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.43 3.58 86.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.65 171.18 50.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 28' ' ' ILE . 76.9 t -131.1 142.09 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 111.117 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -119.64 136.0 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -120.15 132.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 190' ' ' LEU . 50.5 tp -125.6 129.11 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 168.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.53 129.42 13.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.0 -171.25 37.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -76.49 158.78 30.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.904 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.05 149.97 44.29 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.496 0.665 . . . . 0.0 111.169 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.29 -34.3 98.49 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.187 . . . . 0.0 112.349 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.96 -34.77 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.799 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' A' ' 185' ' ' ALA . 23.2 tm0? -66.36 -30.69 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.818 ' O ' HD21 ' A' ' 137' ' ' LEU . 4.9 tt -59.9 -29.46 68.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -174.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 139' ' ' TYR . 19.8 pt20 -61.03 -23.54 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -169.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 138' ' ' GLN . 83.3 t80 -28.23 -65.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -103.03 -33.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.846 -159.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.9 p -118.29 -20.65 8.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -170.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.08 -14.38 27.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.437 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 142.74 143.3 4.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.06 -43.16 1.71 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.624 2.216 . . . . 0.0 112.346 -175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -121.28 -27.89 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 157.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.565 ' HB3' HD13 ' A' ' 149' ' ' LEU . 5.4 t70 -170.7 150.62 3.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.438 HD12 HD12 ' A' ' 150' ' ' LEU . 17.7 tp -60.73 -25.95 66.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -80.03 -28.7 39.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.792 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 ' HB3' ' A' ' 146' ' ' ASP . 4.4 mp -78.64 -4.93 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -170.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 93.4 mt -85.46 143.83 39.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.662 0.744 . . . . 0.0 110.903 -164.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 71.9 Cg_exo -56.32 107.44 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -71.08 152.38 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 174.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 54.4 tp -55.4 -39.87 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.09 -30.12 71.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 64.1 m -62.27 -59.66 4.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 1.016 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.27 -16.08 62.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -173.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.679 ' N ' HD23 ' A' ' 156' ' ' LEU . 88.0 mt-30 -69.35 -42.65 74.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.958 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.0 p -77.58 -21.84 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.18 -11.53 59.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 tp -114.13 100.99 53.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.935 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.78 -23.53 1.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.715 2.276 . . . . 0.0 112.425 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 74.6 m -76.12 -25.33 55.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -165.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -96.84 136.32 37.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -88.42 123.55 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -167.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.05 -32.23 16.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.656 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.2 pt -138.13 145.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.63 113.46 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 167.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -133.25 141.87 48.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.13 130.48 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 167.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp -123.48 150.6 43.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.82 142.2 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.924 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -128.66 150.27 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 167.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -63.32 118.85 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -165.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.0 mt -93.44 138.34 31.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -72.0 146.32 47.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.16 -25.23 20.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.67 55.12 0.18 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -151.95 166.34 31.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 111.09 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -53.2 124.91 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -55.38 127.55 30.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -84.67 -4.77 59.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.66 13.33 57.0 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.5 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.7 147.98 22.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.799 0.333 . . . . 0.0 110.888 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 136' ' ' GLN . . . -152.26 146.1 25.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.9 130.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.73 152.42 40.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 -168.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 46.3 pt -120.23 143.47 31.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -144.54 127.1 16.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.719 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -152.85 149.44 28.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.669 ' C ' HD21 ' A' ' 191' ' ' LEU . 4.4 tt -139.98 128.28 22.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.91 140.05 15.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -111.04 134.59 52.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.896 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -97.89 136.28 38.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.01 142.95 39.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.17 -22.78 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 58.8 m170 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.825 178.278 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.8 44.98 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.69 158.56 18.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.18 149.95 49.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.62 144.97 46.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -157.37 165.06 36.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -152.89 169.01 23.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.65 169.87 8.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.884 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -159.97 140.02 11.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.21 126.64 11.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -160.06 165.02 32.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.57 133.34 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -150.05 166.83 28.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.75 147.83 9.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -134.89 135.49 41.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.6 84.4 22.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.746 0.784 . . . . 0.0 110.87 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -59.91 129.89 32.41 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 0.0 112.296 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -133.53 158.95 41.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 172.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -123.32 -170.13 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 59.17 53.67 5.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.658 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 94.8 mt -64.62 -34.26 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.49 -83.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.215 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.6 m -126.12 -39.6 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 157.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 191' ' ' LEU . 34.7 m -126.02 14.48 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 -170.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.658 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -59.97 -10.85 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.114 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -7.2 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 171.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -90.37 -11.06 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.497 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.7 tt -74.27 137.68 75.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 111.106 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 34.7 Cg_exo -54.97 108.15 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.73 2.287 . . . . 0.0 112.298 168.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -80.03 18.35 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -166.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.23 -94.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.17 133.38 52.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.823 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.95 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.4 tp -101.3 122.38 43.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.7 t -106.07 112.6 25.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 85' ' ' LEU . 45.5 mt -87.45 52.04 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.06 105.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.042 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 8.6 tm-20 -63.2 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -173.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.05 35.49 92.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 60.0 20.02 9.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.817 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.3 68.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -64.87 -46.06 83.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.925 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.92 -33.0 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.26 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.1 m -69.18 -34.9 75.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.62 -49.43 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 3.1 mp -64.39 -38.19 90.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.68 79.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -68.96 -19.71 64.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 65.1 mt -93.3 2.99 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.29 6.03 64.98 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 73.1 m-85 -82.32 136.23 35.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.938 0.399 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -89.29 104.4 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.904 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -104.57 127.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.6 m -108.61 125.17 51.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.151 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.85 129.08 55.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.61 133.32 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 7.0 t70 -155.61 157.6 37.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -77.99 -22.38 49.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.0 p -114.53 132.19 56.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.1 p -67.07 -25.19 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.19 -44.63 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.028 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.43 93.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 ' HB ' ' A' ' 80' ' ' THR . 91.8 mt -65.08 -30.8 71.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.918 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.88 -34.97 72.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.068 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.39 -38.42 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.72 95.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.22 -47.57 76.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.969 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.34 -42.95 78.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.24 -39.48 82.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.941 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -64.35 -39.98 94.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.06 -37.89 89.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.25 -33.1 74.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.47 -7.34 47.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.46 30.62 62.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.04 165.03 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.63 131.88 54.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.5 pp -135.1 165.5 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -123.3 131.28 53.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.409 ' HB ' HD23 ' A' ' 64' ' ' LEU . 46.5 p -119.62 132.98 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.0 t -126.51 123.63 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -86.36 114.15 22.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -173.26 140.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -51.69 125.95 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 36' ' ' LEU . 47.7 tp -58.33 -35.93 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.01 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.25 -7.71 31.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -64.44 135.16 55.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.6 111.02 22.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.712 HG22 ' HA3' ' A' ' 120' ' ' GLY . 90.6 mt -84.68 121.05 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.19 140.62 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.16 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.027 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.86 -29.19 66.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.93 79.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.062 -164.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -129.91 158.72 38.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.72 -42.37 5.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.96 157.06 15.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.18 126.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.82 132.34 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -112.83 118.17 34.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -111.4 114.11 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.194 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 42.89 46.43 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' HD21 ' A' ' 105' ' ' LEU . 32.4 t -103.25 91.75 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -80.98 121.06 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.552 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.4 pp -152.75 153.1 29.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.563 0.697 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.48 154.81 55.53 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.671 2.247 . . . . 0.0 112.371 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.0 p -57.32 -32.97 67.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.821 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -60.01 -39.34 85.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 105' ' ' LEU . 38.2 tp -71.68 -35.41 70.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' HG3' HD12 ' A' ' 105' ' ' LEU . 27.7 mtt180 -56.76 -40.2 75.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.998 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.36 -27.73 69.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.896 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.37 -39.81 16.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.14 -39.03 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.577 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.6 m-30 -52.23 -54.67 39.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.658 0.742 . . . . 0.0 110.873 -171.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.6 Cg_endo -61.93 -30.1 83.16 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.708 2.272 . . . . 0.0 112.341 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -72.5 -39.66 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.44 -40.93 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -64.21 -54.65 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.33 -30.2 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.989 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.712 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -78.59 -24.35 62.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.455 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.2 tp -82.16 136.81 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 110.911 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.1 154.67 86.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 0.0 110.847 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.91 125.78 16.67 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.705 2.27 . . . . 0.0 112.353 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.47 88.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.49 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.27 169.95 45.78 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 28' ' ' ILE . 79.7 t -129.02 142.58 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -119.27 136.52 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.1 mt -120.11 131.45 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 190' ' ' LEU . 4.1 tt -127.93 130.5 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 167.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -150.15 140.87 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -164.47 -168.3 26.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.18 165.85 19.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.21 156.05 39.97 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 173.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -52.52 -36.34 70.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.624 2.216 . . . . 0.0 112.418 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 97.8 mt-10 -60.56 -34.85 74.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.809 -169.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.7 tm0? -64.33 -29.99 71.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.533 HD13 ' HD3' ' A' ' 144' ' ' PRO . 31.9 mt -66.55 -20.85 66.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.625 ' O ' ' C ' ' A' ' 139' ' ' TYR . 16.8 pt20 -66.89 -13.74 62.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.625 ' C ' ' O ' ' A' ' 138' ' ' GLN . 33.9 t80 -18.57 -78.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -132.18 0.25 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 -167.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -124.52 -14.13 6.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.87 -14.42 31.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.436 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.53 171.43 18.09 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.438 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.533 ' HD3' HD13 ' A' ' 137' ' ' LEU . 49.4 Cg_endo -70.47 -50.19 0.41 Allowed 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.679 2.253 . . . . 0.0 112.378 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 99.6 mttt -131.99 -28.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.967 161.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.519 ' HB3' HD11 ' A' ' 149' ' ' LEU . 49.1 t0 171.24 124.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 -177.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.47 HD22 ' HB2' ' A' ' 137' ' ' LEU . 53.6 mt -68.37 -20.07 64.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 -167.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -75.49 -36.65 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 -161.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.86 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -103.53 25.95 9.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.837 -171.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.12 162.33 46.72 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.643 0.735 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.97 116.83 2.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -79.16 137.9 37.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.995 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.45 -45.19 80.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.879 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.05 -35.04 78.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 m -62.43 -41.19 98.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.2 mt -60.61 -42.14 96.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.81 -37.11 81.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.8 p -81.46 -28.12 34.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.03 -11.32 55.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.13 98.87 52.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.736 0.779 . . . . 0.0 110.962 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.99 -22.26 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.4 p -68.53 -21.48 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.876 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.0 pp -130.17 153.98 47.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.78 138.99 35.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -88.13 121.79 30.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.78 -30.43 19.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.6 pt -138.46 147.09 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 111.91 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 164.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -136.62 143.08 43.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.51 119.81 39.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 165.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 mt -102.68 140.3 37.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -120.01 133.88 55.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -172.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -128.41 153.3 47.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 165.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -58.48 116.18 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.836 -166.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.2 mt -97.1 138.25 34.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -77.34 143.42 38.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -101.23 -22.44 14.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.72 55.08 0.19 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.441 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.68 166.25 34.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -54.87 130.01 39.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -55.07 119.24 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.82 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.25 -10.95 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -173.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 112.59 3.78 25.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -91.29 142.38 27.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -145.54 145.1 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.15 130.62 35.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 170.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.7 mt -124.0 157.12 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.004 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.1 pt -121.46 141.59 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -138.47 137.49 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.62 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.1 pt? -155.64 147.69 23.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.833 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.66 ' C ' HD21 ' A' ' 191' ' ' LEU . 3.1 tt -140.1 128.37 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.84 139.42 15.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -107.14 133.04 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -98.13 132.66 43.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.68 144.84 30.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.42 -32.91 68.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.835 179.326 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.87 44.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.63 160.0 17.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.69 150.01 49.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.48 145.04 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.97 164.98 37.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.848 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -154.96 169.97 22.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -169.64 169.97 8.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -156.2 133.78 10.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -154.26 135.07 13.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.562 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.7 p90 -155.95 157.31 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.987 176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -122.26 132.97 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.091 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -137.13 126.69 25.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.52 166.81 23.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.65 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 86.9 m -119.85 132.31 55.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.727 0.298 . . . . 0.0 111.206 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -127.36 114.51 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 110.817 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.32 144.97 42.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.35 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -130.05 168.06 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 26' ' ' ASN . 52.4 p30 -130.65 169.1 16.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 51.25 41.49 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.877 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.63 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 62.5 tp -66.38 -43.1 86.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.96 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -124.95 -51.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 152.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 191' ' ' LEU . 35.9 m -118.05 13.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -59.32 -12.19 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 19' ' ' ASP . 53.1 p30 -62.01 -5.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 173.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -90.57 -12.15 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 126' ' ' VAL . 8.7 tt -75.47 138.46 71.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.665 0.745 . . . . 0.0 111.059 -176.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.3 114.35 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 0.0 112.324 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -74.93 -0.58 19.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.61 -96.13 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -170.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -99.05 125.6 44.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.4 127.68 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.11 121.54 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.868 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -108.09 112.67 25.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt -87.73 58.13 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.993 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.97 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 8.0 tm-20 -60.65 -60.0 4.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.64 32.24 83.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 62.08 18.52 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.9 16.16 72.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.539 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -63.54 -45.52 90.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.906 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -79.46 -29.97 41.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.77 -51.98 59.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 p -70.9 -29.62 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.03 -52.06 58.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.541 ' HB2' HG22 ' A' ' 54' ' ' VAL . 98.5 mt -67.41 -35.45 79.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.24 82.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.173 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -68.98 -17.39 63.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.26 0.61 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.937 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.71 2.68 61.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -87.1 144.86 26.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -90.17 109.02 20.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 47' ' ' LEU . 94.6 t -109.27 126.56 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.8 m -110.54 124.9 52.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 167.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.52 130.54 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.69 132.62 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 33.2 t0 -154.62 163.91 39.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -83.41 -21.22 33.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -104.52 117.88 35.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.0 p -67.12 -27.8 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.84 -46.1 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.77 -40.64 98.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.607 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.09 -35.62 81.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.33 . . . . 0.0 110.889 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.54 84.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.42 -36.86 85.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.34 99.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.35 -42.21 93.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -62.24 -46.98 86.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mp -61.49 -37.22 82.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -65.03 -45.98 83.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.69 -37.68 87.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -65.44 -29.82 70.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -92.88 -4.4 52.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.81 32.82 58.61 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.428 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.14 161.8 26.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.398 . . . . 0.0 111.104 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.58 131.13 54.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pp -133.54 163.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.7 m -119.56 135.48 54.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.0 p -120.23 134.58 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.195 -177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.8 t -128.56 123.5 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.177 170.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.88 114.88 23.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -173.49 141.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.834 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -54.99 130.79 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.96 -35.03 74.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.36 69.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -98.73 -9.51 24.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.05 136.74 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -92.89 108.76 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.713 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.3 mt -83.32 119.45 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.78 140.32 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -172.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.49 -54.69 7.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -71.21 -29.4 65.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.51 81.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -129.36 164.45 23.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.7 -40.62 4.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.56 155.59 16.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.76 127.0 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 0.0 111.19 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.78 130.44 72.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.8 m -114.96 115.95 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.801 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.42 115.95 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 49.8 43.75 24.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -101.0 73.12 1.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -80.49 124.03 28.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -144.83 150.98 48.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.658 0.742 . . . . 0.0 110.878 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.37 154.86 71.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.762 2.308 . . . . 0.0 112.339 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.2 p -54.26 -30.82 51.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.1 m -58.17 -40.7 82.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.38 -34.22 65.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.888 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -55.87 -44.73 78.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.25 -30.38 71.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -85.85 -46.4 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.19 -42.16 80.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 6.5 m-30 -53.02 -54.98 38.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -168.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.5 Cg_endo -62.0 -28.74 80.87 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.349 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.46 -36.85 65.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.97 -41.13 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.151 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.55 -53.55 50.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.65 -31.49 72.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.937 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.713 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -76.56 -26.98 62.03 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.476 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.93 136.6 36.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.918 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.45 154.55 85.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 126.98 19.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.39 88.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.475 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.26 169.98 50.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.532 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.523 ' HB ' HG13 ' A' ' 28' ' ' ILE . 60.4 t -129.56 143.82 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -119.77 136.93 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.88 128.71 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.434 HD21 HD22 ' A' ' 190' ' ' LEU . 51.8 tp -123.41 129.77 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -153.46 134.72 14.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.952 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.01 -178.1 40.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -72.28 150.1 43.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.963 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -94.84 154.77 39.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.504 0.668 . . . . 0.0 111.174 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.74 -25.1 78.13 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 174.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 59.4 mt-10 -58.84 -23.37 60.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -54.3 -27.7 37.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.968 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 1.088 ' O ' HD21 ' A' ' 137' ' ' LEU . 1.6 tt -57.88 -16.28 11.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 139' ' ' TYR . 20.1 pt20 -67.19 -4.89 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.611 ' C ' ' O ' ' A' ' 138' ' ' GLN . 77.6 m-85 -18.73 -77.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.96 -51.24 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.0 p -85.63 -1.95 57.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.24 35.13 87.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.35 170.59 13.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.842 ' HD3' HD13 ' A' ' 137' ' ' LEU . 93.7 Cg_endo -79.48 -31.94 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.762 2.308 . . . . 0.0 112.308 173.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 -26.6 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 161.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -171.46 154.6 3.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.48 -9.78 37.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 168.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.7 -25.02 26.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.96 -7.56 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -171.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.99 154.7 91.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.634 0.731 . . . . 0.0 110.88 -158.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.62 150.3 22.09 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.641 2.227 . . . . 0.0 112.367 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -104.94 137.49 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 190' ' ' LEU . 64.2 tp -55.03 -38.12 67.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.878 161.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.78 -33.76 72.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 73.8 m -63.22 -41.89 99.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.98 -40.75 94.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.972 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.08 -36.53 84.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -83.98 -27.64 28.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -169.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -80.31 -13.28 59.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -111.75 100.55 48.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.938 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.35 -21.66 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.4 p -68.53 -20.81 64.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -163.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.2 pp -132.55 155.35 48.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -99.43 137.53 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.08 125.08 32.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -93.0 -30.75 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.647 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.6 pt -139.73 146.16 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.09 116.41 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -131.47 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -123.24 129.98 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 171.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp -130.49 152.9 49.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -119.49 138.05 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -130.77 154.9 47.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 173.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -69.1 133.74 48.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -166.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.433 HD12 ' HG3' ' A' ' 138' ' ' GLN . 85.2 mt -98.1 154.6 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.09 137.58 55.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 170.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.4 -38.68 78.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.822 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.18 55.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -164.38 -178.67 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 111.066 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -43.5 127.11 4.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -55.11 127.71 30.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.858 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -74.78 -23.0 58.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.89 -24.72 9.31 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.55 140.58 41.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -162.31 158.03 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.62 132.44 44.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 mt -122.16 149.97 42.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.47 HG23 ' HB3' ' A' ' 133' ' ' ALA . 20.7 pt -124.27 142.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -145.0 129.15 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.735 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -154.67 150.84 28.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.867 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.693 ' C ' HD21 ' A' ' 191' ' ' LEU . 2.7 tt -139.95 129.93 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -175.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.03 140.19 15.92 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -106.65 131.46 53.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.935 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -96.63 133.01 41.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.79 145.0 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.05 -33.92 70.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.506 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.703 0.287 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.3 m95 59.22 43.0 17.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.65 160.0 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.29 149.99 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.42 145.03 46.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.99 165.01 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.5 p -151.15 169.85 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.51 170.08 8.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -159.66 140.0 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.35 134.94 16.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.97 167.59 29.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.13 128.23 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.191 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.06 164.87 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.97 147.77 22.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.758 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 85.3 m -113.04 124.78 53.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 0.0 111.167 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.98 129.81 24.84 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.0 110.793 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 131.17 23.13 Favored 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.676 2.251 . . . . 0.0 112.343 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -135.01 167.12 21.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 56.1 p30 -141.98 179.33 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 56.56 37.86 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.732 HD21 ' O ' ' A' ' 21' ' ' LEU . 2.9 tt -64.49 -40.46 95.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 170.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.25 -83.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.213 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.409 ' HB2' HG21 ' A' ' 167' ' ' ILE . 73.4 m -128.72 -37.0 1.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 154.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.548 HG21 HD13 ' A' ' 191' ' ' LEU . 27.3 m -121.86 17.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 -167.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.612 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -56.99 -11.03 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 46.9 t30 -52.57 -17.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.816 171.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -86.99 -20.0 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.503 HG12 ' HB ' ' A' ' 126' ' ' VAL . 84.6 mt -79.47 129.84 70.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 0.0 111.097 -171.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.51 119.22 5.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 0.0 112.31 166.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -74.38 5.53 4.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.41 -96.11 0.51 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -167.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -100.81 125.08 47.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -120.43 129.34 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.6 tp -101.42 125.75 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.4 t -115.92 114.84 25.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.59 57.68 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.93 104.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.065 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.9 tm-20 -59.64 -60.05 4.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -176.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.83 35.93 92.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 173.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 60.41 19.75 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.25 20.53 60.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.476 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -65.29 -48.47 73.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.07 -31.1 50.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.79 -50.96 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.987 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.09 -35.71 81.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.28 -51.23 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.0 mt -67.73 -35.34 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.8 81.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.128 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -67.28 -17.58 64.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.73 -1.81 58.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.28 4.16 61.21 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.534 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.9 m-30 -85.43 142.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.861 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -89.97 105.86 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.926 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 47' ' ' LEU . 99.3 t -106.76 127.68 62.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -109.64 125.24 52.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.174 168.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.44 128.55 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 133.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.082 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.7 t70 -154.15 161.31 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -82.3 -21.13 36.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.9 p -108.54 131.32 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.6 p -71.73 -26.2 62.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.96 -47.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.01 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.34 98.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.56 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.34 -36.48 84.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.22 81.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.17 -35.57 79.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -62.36 -43.39 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.58 -41.25 96.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -62.19 -46.82 87.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.7 tp -60.07 -41.04 91.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -63.33 -43.73 96.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.53 -36.5 83.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -69.45 -31.17 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.42 -7.5 50.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 32.1 58.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.427 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.31 163.59 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.867 0.365 . . . . 0.0 111.194 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.97 131.33 53.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pp -135.39 166.41 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -122.88 134.17 54.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.159 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 p -120.01 134.04 55.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.113 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -127.55 123.97 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 170.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 63.8 tt0 -88.46 117.24 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.1 t -174.61 142.58 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -61.29 132.14 52.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.85 -25.02 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.92 60.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -104.42 -13.74 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.23 132.73 46.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.96 112.32 24.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.623 HG22 ' HA3' ' A' ' 120' ' ' GLY . 82.1 mt -81.39 122.11 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.85 139.92 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.134 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -59.41 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.18 -28.27 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.07 78.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -132.89 161.07 35.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -105.34 -44.99 4.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.97 153.87 17.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.466 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.1 mt -124.09 125.44 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.107 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.1 131.88 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.7 m -111.92 117.08 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mm -106.58 111.29 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 43.87 45.08 6.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 43.4 t -106.26 94.89 5.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -94.01 120.68 34.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt -128.29 150.16 73.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 39.2 Cg_endo -63.83 145.64 90.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.358 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.2 p -54.98 -34.35 63.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.1 p -62.34 -35.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.727 ' O ' HD21 ' A' ' 109' ' ' LEU . 1.3 tt -76.27 -34.46 59.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.912 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -57.16 -42.62 81.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.97 -27.35 68.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.82 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -86.27 -36.01 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.27 -41.2 66.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -52.25 -55.06 34.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.69 0.757 . . . . 0.0 110.905 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 20.0 Cg_endo -59.74 -29.74 90.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.333 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.05 -41.02 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.98 92.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -63.69 -55.23 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.44 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.97 -23.93 60.76 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.62 137.52 34.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.78 154.1 87.14 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.1 126.93 18.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.778 2.318 . . . . 0.0 112.261 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.85 89.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.526 -167.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.13 173.82 47.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.503 ' HB ' HG12 ' A' ' 28' ' ' ILE . 56.5 t -132.9 146.55 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.17 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -122.43 138.78 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.484 HD12 HD12 ' A' ' 28' ' ' ILE . 69.2 mt -118.66 132.18 69.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.448 HD23 HD22 ' A' ' 190' ' ' LEU . 5.0 tt -126.28 130.1 50.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 167.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -147.64 135.58 21.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.81 -167.86 23.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.418 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.579 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -99.78 149.29 35.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.499 0.666 . . . . 0.0 111.213 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' A' ' 150' ' ' LEU . 71.7 Cg_exo -50.13 -36.7 46.43 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.248 . . . . 0.0 112.44 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -58.01 -30.64 66.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -64.24 -25.45 68.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 -173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.485 ' CD1' ' HD3' ' A' ' 144' ' ' PRO . 1.6 mm? -62.73 -15.69 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -168.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.625 ' O ' ' C ' ' A' ' 139' ' ' TYR . 64.7 tt0 -63.4 -17.71 62.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.899 -174.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.625 ' C ' ' O ' ' A' ' 138' ' ' GLN . 60.5 m-85 -19.19 -81.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -169.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -144.19 0.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.3 p -125.12 -13.43 6.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 -173.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 147' ' ' LEU . . . 84.64 -18.5 24.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.432 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 137' ' ' LEU . . . 138.7 -172.88 22.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.485 ' HD3' ' CD1' ' A' ' 137' ' ' LEU . 57.8 Cg_endo -73.03 -43.35 0.77 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.718 2.279 . . . . 0.0 112.336 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.87 -32.28 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 160.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.754 ' HB3' HD12 ' A' ' 149' ' ' LEU . 16.7 t0 -176.03 153.86 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 142' ' ' GLY . 26.5 tp -59.0 -35.38 73.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -79.84 -35.07 38.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -155.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 1.011 HD23 ' C ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -98.95 9.89 42.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -158.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 134' ' ' PRO . 75.8 mt -79.98 159.55 70.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 110.964 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -55.17 137.79 77.58 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.664 2.242 . . . . 0.0 112.407 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -92.81 139.21 30.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.5 -40.11 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 172.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.85 -30.97 68.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 90.7 m -60.6 -44.86 95.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.23 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.58 -39.35 94.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.36 -36.59 84.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -85.99 -26.35 25.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.05 -8.67 59.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.34 99.34 49.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 0.0 110.902 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -89.24 -20.74 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.699 2.266 . . . . 0.0 112.412 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -68.08 -22.12 64.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.4 pp -131.76 154.8 48.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.57 140.86 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -86.98 123.09 31.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 92.5 mt -89.63 -33.4 16.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.8 pt -141.57 148.41 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.067 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.99 114.21 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.036 167.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -131.39 140.58 49.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -117.6 129.03 55.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 168.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.58 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp -122.95 151.69 41.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.83 142.59 48.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.62 154.11 47.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 168.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -58.93 123.11 15.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 64.1 mt -87.54 134.94 33.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.4 140.43 39.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.56 -22.48 8.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.875 -175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.0 55.01 0.19 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -160.1 168.38 25.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -52.36 122.68 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.825 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -55.06 121.53 8.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -83.92 -17.23 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.97 -0.0 41.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.5 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.09 140.36 33.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.736 0.303 . . . . 0.0 110.899 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -152.99 152.93 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.081 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.38 129.76 34.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 167.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.11 151.55 43.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.961 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 133' ' ' ALA . 29.9 pt -124.08 141.42 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 174.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -139.05 138.39 37.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.573 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.2 pt? -156.25 152.51 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.626 ' C ' HD21 ' A' ' 191' ' ' LEU . 6.8 tt -139.9 129.79 24.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.13 138.59 14.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.511 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -107.07 131.84 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.93 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -97.52 133.27 42.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 139.5 42.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.21 -42.5 93.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.461 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 45.02 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -110.56 159.34 17.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.78 149.94 49.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.16 145.01 47.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.84 165.03 37.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.839 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.5 p -152.52 169.87 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.74 170.05 8.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.36 139.93 12.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.83 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.35 130.03 14.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -164.01 168.72 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.85 139.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.156 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.39 165.01 32.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.65 167.53 14.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.553 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.691 HG23 ' HD3' ' A' ' 17' ' ' PRO . 96.6 m -93.8 120.04 33.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.281 . . . . 0.0 111.229 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.66 80.32 22.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.771 0.795 . . . . 0.0 110.863 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.691 ' HD3' HG23 ' A' ' 15' ' ' THR . 55.9 Cg_endo -74.18 146.16 35.91 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 0.0 112.288 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -137.9 157.73 45.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -150.64 -171.2 3.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 54.99 46.27 24.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.575 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 59.1 tp -65.0 -43.01 93.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.19 -86.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.144 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.5 t -125.74 -48.79 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 158.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 191' ' ' LEU . 33.4 m -115.35 17.73 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.177 -170.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -60.18 -9.24 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -61.57 -3.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.72 -12.31 25.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.507 HG13 ' HB ' ' A' ' 126' ' ' VAL . 10.7 tt -74.27 137.52 75.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.654 0.74 . . . . 0.0 111.049 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.08 112.79 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.616 2.211 . . . . 0.0 112.311 167.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -75.03 10.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.59 -100.4 0.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.98 133.36 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 88.9 mt -123.72 136.05 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 tp -95.19 121.77 37.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.899 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.42 113.97 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 83.0 mt -94.66 57.12 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 174.96 104.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -67.08 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 38.19 94.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 61.87 18.91 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.918 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.97 10.73 81.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.531 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -63.48 -45.58 90.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.945 0.402 . . . . 0.0 110.944 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.26 -33.6 37.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.09 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.3 m -66.23 -36.57 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.6 -49.29 75.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 54' ' ' VAL . 96.3 mt -60.83 -39.09 87.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.26 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.5 p -69.04 -18.32 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -83.34 0.24 46.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.77 64.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.512 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -80.11 143.68 33.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -86.97 103.57 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 47' ' ' LEU . 67.5 t -105.38 127.77 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -168.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.8 m -112.49 125.17 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.6 129.26 56.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.63 133.91 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -154.63 163.62 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -83.79 -20.77 32.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.974 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.7 t -101.75 117.26 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.808 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -65.0 -28.15 69.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.53 -47.97 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.01 99.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.52 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.28 -35.55 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.945 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.0 99.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.36 -42.84 99.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -66.64 -41.16 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.3 -39.78 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -40.99 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.43 -38.19 90.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.5 -33.72 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.38 -8.23 45.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.84 33.06 60.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.32 160.97 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.38 . . . . 0.0 111.113 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.57 131.01 53.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.814 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -134.73 166.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -124.85 131.2 53.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 p -120.32 135.17 55.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.132 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -130.26 125.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -84.89 116.6 23.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 t -173.76 142.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.5 HD22 ' HB1' ' A' ' 86' ' ' ALA . 26.8 t30 -58.73 130.06 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.38 -30.58 65.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 84' ' ' ASN . . . -76.12 -23.53 54.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -104.92 -13.45 15.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.884 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 84' ' ' ASN . 72.1 t80 -70.38 137.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -94.01 107.42 19.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.2 mt -88.2 125.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.34 138.88 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.74 -44.58 61.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.17 -26.62 66.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.69 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -164.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -130.1 156.73 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.796 -172.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.95 -40.04 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.76 159.92 15.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 88.3 mt -129.99 125.65 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.107 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.64 130.78 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -129.02 118.27 22.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.62 128.91 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.132 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.1 t80 43.73 52.64 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 51.0 t -115.53 88.32 2.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -80.84 117.55 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.8 mt -121.17 145.3 41.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.585 0.707 . . . . 0.0 110.899 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.9 Cg_endo -67.78 148.81 77.93 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.757 2.305 . . . . 0.0 112.303 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.7 m -54.17 -42.97 70.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.0 m -60.38 -39.77 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.79 ' O ' HD21 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.54 -38.97 74.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 178.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.32 -41.65 89.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -83.56 -42.88 16.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.26 -42.22 60.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 -172.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.58 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.2 m-30 -54.51 -52.32 70.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.722 0.772 . . . . 0.0 110.923 -169.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 86.8 Cg_exo -45.1 -37.6 13.13 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 0.0 112.379 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -76.34 -37.07 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.51 -45.02 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.179 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 118' ' ' TYR . 2.7 m-30 -66.29 -54.45 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -176.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.07 -30.2 71.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.87 -29.56 67.04 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.512 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.18 133.6 38.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.344 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.48 153.12 78.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.701 0.762 . . . . 0.0 110.863 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.08 124.81 16.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.766 2.311 . . . . 0.0 112.31 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.56 87.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.524 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.54 170.91 47.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.441 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.507 ' HB ' HG13 ' A' ' 28' ' ' ILE . 77.5 t -129.18 140.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.116 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.97 132.54 56.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.8 129.88 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.069 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 190' ' ' LEU . 56.7 tp -126.01 123.54 38.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -148.98 132.85 17.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.71 -169.35 35.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -68.13 157.32 35.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 136' ' ' GLN . . . -86.09 129.41 54.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.221 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.79 -36.28 72.89 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.624 2.216 . . . . 0.0 112.427 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -47.95 -35.13 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.814 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 133' ' ' ALA . 8.1 pt20 -58.63 -33.1 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 1.24 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.8 tt -59.73 -19.23 48.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -164.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 139' ' ' TYR . 22.4 pt20 -63.25 -13.26 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.945 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.588 ' C ' ' O ' ' A' ' 138' ' ' GLN . 33.2 m-85 -20.37 -74.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -120.74 -19.85 7.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -161.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.0 p -123.51 -16.81 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -164.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.62 -19.98 13.25 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.44 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.57 178.36 36.36 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.443 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.735 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.0 Cg_endo -73.51 -42.5 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.388 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.02 -28.04 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 155.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -165.69 159.78 16.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.473 HD21 HD12 ' A' ' 150' ' ' LEU . 90.2 mt -51.17 -26.31 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 170.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.84 -30.25 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.4 mp -78.8 -18.2 54.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.88 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.532 HD22 ' HD3' ' A' ' 144' ' ' PRO . 93.0 mt -87.84 113.67 55.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.914 -172.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 23.9 Cg_exo -70.66 124.11 10.42 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.66 2.24 . . . . 0.0 112.366 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.01 154.09 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.15 -42.64 91.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.903 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.49 -31.77 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.4 m -68.48 -56.17 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 1.118 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.31 -17.87 62.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.642 ' N ' HD23 ' A' ' 156' ' ' LEU . 66.5 mt-30 -73.84 -42.35 60.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 170.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -74.44 -20.71 59.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -83.59 -11.94 56.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.961 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.467 HD23 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -118.03 93.84 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 0.0 110.905 -174.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -89.2 -22.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.721 2.281 . . . . 0.0 112.397 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.2 p -69.9 -20.49 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -161.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.6 pp -131.49 154.96 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.09 142.14 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -89.35 119.35 29.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -169.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.64 -31.47 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.692 HG12 ' HB3' ' A' ' 191' ' ' LEU . 47.8 pt -139.99 145.58 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.57 114.49 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -128.6 138.82 52.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -122.86 132.67 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.5 pp -124.68 141.92 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 175.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -118.79 135.01 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.856 -165.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -131.46 158.19 41.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -51.89 119.02 3.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -166.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.79 139.77 34.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.978 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -79.38 143.86 34.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -98.45 -21.68 16.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.62 54.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.456 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -158.35 169.09 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -61.72 135.02 57.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' A' ' 183' ' ' GLY . 18.7 t-160 -57.64 121.01 9.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -90.15 -5.02 56.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.4 ' H ' ' CD2' ' A' ' 181' ' ' HIS . . . 116.19 -27.73 7.98 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.453 175.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.23 141.14 40.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.422 ' HB2' ' OE1' ' A' ' 136' ' ' GLN . . . -149.56 148.58 29.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.53 137.05 39.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.74 146.03 49.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 133' ' ' ALA . 43.9 pt -126.05 148.46 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.93 132.81 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.697 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -154.86 149.84 26.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.692 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.2 tt -140.85 127.7 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -176.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.667 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.89 142.09 16.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -111.27 129.93 55.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -90.17 133.66 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.01 140.57 40.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.76 -22.63 63.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 59.3 m170 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.81 178.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 44.97 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.62 157.97 19.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.61 149.79 49.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.5 145.03 46.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -157.89 165.07 36.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.787 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -155.38 169.96 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.62 170.02 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.918 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 t -159.99 139.84 11.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.18 128.54 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 54.2 p90 -156.96 159.04 37.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.947 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.6 t -122.95 132.98 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -138.13 125.15 21.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.57 158.73 15.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.709 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 94.2 m -112.66 131.78 55.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.49 105.12 21.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.727 0.775 . . . . 0.0 110.813 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -71.9 142.78 39.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.599 2.199 . . . . 0.0 112.323 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -127.25 170.34 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -126.88 149.29 49.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 60.25 49.5 7.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 66.4 tp -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.96 -79.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -126.55 -37.31 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 154.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 24' ' ' VAL . 5.4 p -130.07 16.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -169.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -64.7 -2.12 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -174.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -54.74 -13.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.97 -16.4 31.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 25' ' ' ALA . 9.4 tt -76.53 138.26 67.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.706 0.765 . . . . 0.0 111.074 -173.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 52.8 Cg_exo -53.7 119.26 5.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.274 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -78.93 2.29 20.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -90.32 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.478 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.74 134.02 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 0.0 110.858 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -124.31 132.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.9 tp -101.62 122.66 44.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.82 117.36 33.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 85' ' ' LEU . 47.8 mt -88.01 54.88 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.95 105.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -168.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -60.12 -60.34 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.86 78.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.45 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 63.2 16.12 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.89 22.08 71.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.67 -51.59 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.76 -28.8 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -69.5 -34.6 74.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.901 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 54' ' ' VAL . 97.9 mt -69.6 -35.05 74.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.76 85.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.4 p -68.72 -18.38 64.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.853 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.83 -0.87 57.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.709 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 96.27 4.81 59.58 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.408 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.18 145.23 26.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -91.53 108.06 19.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 47' ' ' LEU . 93.9 t -108.65 131.24 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -110.4 128.9 55.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.21 132.51 56.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.3 137.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.122 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -155.01 162.46 41.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.821 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.45 -24.18 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.8 t -102.87 119.63 39.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.9 p -68.03 -26.67 65.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 170.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.19 -46.22 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.035 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -41.96 99.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.41 -35.94 82.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.95 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.87 92.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.94 -37.54 88.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.867 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.98 96.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.068 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.11 -42.64 99.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -64.72 -41.32 96.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.94 -40.18 92.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.85 95.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.103 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.11 -37.84 88.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.03 -33.09 75.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.21 -9.68 41.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.688 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 72.02 34.68 61.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.419 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.02 161.31 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -104.41 130.15 52.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -133.06 162.01 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -115.37 132.0 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.9 p -123.77 134.74 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.84 125.14 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -85.24 117.7 24.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.926 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -175.17 145.1 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.3 t30 -55.25 128.24 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 170.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 36' ' ' LEU . 43.8 tp -57.93 -36.36 72.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.14 70.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -100.0 -6.12 27.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 84' ' ' ASN . 53.7 t80 -62.07 133.23 55.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -84.94 103.35 13.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.4 mt -87.49 123.14 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.133 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.2 t -102.02 134.21 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.54 -59.45 2.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.53 -22.76 64.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.97 68.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 -172.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.483 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 64.6 p-90 -147.46 160.77 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.44 -36.9 4.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.19 16.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.488 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.483 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 3.1 tp -132.83 123.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 111.199 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.83 129.7 71.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -113.21 116.37 29.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.59 113.75 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.143 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 40.22 50.48 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.1 t -98.99 90.02 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -76.32 119.46 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.435 ' O ' HD12 ' A' ' 105' ' ' LEU . 2.3 pp -145.51 149.28 40.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.39 155.22 71.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.691 2.26 . . . . 0.0 112.331 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.6 p -54.16 -29.37 45.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -58.73 -40.43 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.798 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.9 -34.02 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -55.3 -44.42 75.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.08 -31.28 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -87.29 -50.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.86 -43.17 84.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -55.82 -54.26 53.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.698 0.761 . . . . 0.0 110.964 -167.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.0 Cg_endo -66.75 -29.33 42.79 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -67.51 -40.24 85.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -39.77 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.57 -49.7 75.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -64.74 -32.02 73.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.957 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.46 -31.3 54.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.3 tp -73.59 132.04 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -75.49 155.06 85.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -54.29 127.46 25.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.688 2.258 . . . . 0.0 112.294 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.58 4.1 87.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.457 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.0 168.83 51.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.0 t -127.0 139.18 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.404 ' HA ' HG23 ' A' ' 98' ' ' ILE . 59.4 t80 -111.8 132.66 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.94 131.23 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.41 HD21 HD22 ' A' ' 190' ' ' LEU . 60.3 tp -123.21 123.94 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 168.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -150.28 128.98 12.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.04 -175.24 43.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.475 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -70.06 159.38 33.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.608 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -105.58 150.53 39.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.523 0.678 . . . . 0.0 111.146 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.404 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . 38.1 Cg_endo -62.35 -21.43 72.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.313 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -57.63 -29.05 64.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.768 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.81 -26.63 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.003 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 1.098 ' O ' HD21 ' A' ' 137' ' ' LEU . 5.2 tt -58.29 -22.05 51.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -165.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.578 ' O ' ' C ' ' A' ' 139' ' ' TYR . 21.5 pt20 -61.37 -13.84 22.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -170.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.578 ' C ' ' O ' ' A' ' 138' ' ' GLN . 48.1 m-85 -20.54 -78.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -119.97 -19.26 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 -157.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 p -121.25 -13.3 8.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -166.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . 65.81 16.88 64.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.49 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.18 165.85 10.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.877 ' HD3' HD13 ' A' ' 137' ' ' LEU . 87.7 Cg_endo -76.69 -42.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.64 -25.36 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 151.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -169.23 145.9 3.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 142' ' ' GLY . 90.4 mt -61.0 -21.0 63.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 172.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -77.89 -21.81 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.35 -7.74 59.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 134' ' ' PRO . 96.0 mt -85.06 142.94 39.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.686 0.755 . . . . 0.0 110.879 -170.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 142.11 27.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.785 2.323 . . . . 0.0 112.308 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -98.55 156.59 16.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.764 ' O ' HD21 ' A' ' 153' ' ' LEU . 5.4 tt -53.59 -44.0 69.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.99 -35.38 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.5 m -64.62 -41.74 95.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.24 -35.53 80.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.93 -33.77 70.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.0 p -78.27 -21.53 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -175.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.62 -22.4 56.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.453 HD12 ' CZ2' ' A' ' 165' ' ' TRP . 18.4 mt -105.36 102.85 39.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.679 0.752 . . . . 0.0 110.912 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.58 -27.76 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.788 2.325 . . . . 0.0 112.343 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.6 m -78.77 -17.07 56.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -165.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.657 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.9 pp -130.82 154.76 47.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.13 140.4 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.453 ' CZ2' HD12 ' A' ' 160' ' ' LEU . 99.1 m95 -85.08 126.24 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -172.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.86 -32.65 13.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.698 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.6 pt -140.1 146.73 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.532 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -159.18 119.24 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 168.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -132.3 140.26 48.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.809 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -113.9 120.42 40.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.94 145.68 36.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -119.2 136.72 54.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -132.06 154.75 49.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 168.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -59.26 120.07 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.1 141.86 28.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -73.73 145.38 45.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -93.56 -39.05 11.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.26 54.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.461 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -153.37 174.73 13.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.773 0.32 . . . . 0.0 111.103 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.88 130.18 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.69 119.54 7.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -85.29 -12.92 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -172.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 118.82 -21.32 9.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.541 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.19 139.47 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 0.0 110.925 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -154.9 155.26 33.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.056 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.59 129.11 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 167.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.0 mt -120.15 149.51 42.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.93 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 133' ' ' ALA . 31.7 pt -124.82 142.52 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 172.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.36 124.45 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.723 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -153.82 148.55 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.76 ' C ' HD21 ' A' ' 191' ' ' LEU . 3.3 tt -140.03 129.73 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 -172.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -119.98 152.36 17.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.515 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -118.75 135.84 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.921 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -92.49 130.1 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.94 144.55 30.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.84 -32.91 70.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 179.221 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.2 m0 59.1 45.04 15.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -115.01 160.05 20.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -127.47 149.96 49.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.09 144.98 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.776 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -157.02 165.06 37.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -155.04 169.93 22.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.52 169.95 8.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -159.94 140.06 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.85 128.7 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.9 p90 -163.64 162.67 24.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -130.22 136.76 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -138.34 149.25 45.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.93 172.41 42.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.659 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 88.7 m -124.3 129.56 50.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -119.76 96.23 49.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.702 0.763 . . . . 0.0 110.823 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HB3' ' HG3' ' A' ' 30' ' ' GLN . 74.8 Cg_exo -54.02 139.6 70.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.658 2.238 . . . . 0.0 112.355 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -129.5 170.22 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 56.0 p30 -129.96 165.15 22.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 52.55 39.44 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 63.3 tp -65.7 -40.51 92.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.59 -80.85 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -130.95 -36.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 152.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.85 14.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.166 -168.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.488 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -58.64 -13.84 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 10.3 p-10 -62.69 -8.47 6.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.9 -14.83 27.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.978 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.488 ' CD1' HD12 ' A' ' 128' ' ' ILE . 79.1 mt -80.43 132.62 58.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.69 0.757 . . . . 0.0 111.13 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.66 117.54 3.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.296 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.405 ' HG3' ' HB3' ' A' ' 17' ' ' PRO . 66.1 mm-40 -77.87 9.18 3.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -171.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.29 -101.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 51.4 mttm -99.95 133.6 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.703 0.287 . . . . 0.0 110.87 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.5 131.7 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.19 125.89 51.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.958 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.4 t -114.94 115.28 26.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 74.7 mt -88.37 58.11 4.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 175.05 105.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.088 -172.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 67' ' ' ALA . 10.1 tm-20 -57.77 -59.74 4.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.09 34.85 90.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.469 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 62.06 18.34 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.946 0.403 . . . . 0.0 110.889 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.38 15.16 67.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.477 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -64.66 -49.63 70.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -79.36 -29.91 42.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.29 67.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.88 -33.97 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -61.15 -50.89 71.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HB2' HG22 ' A' ' 54' ' ' VAL . 95.4 mt -67.6 -36.82 81.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.47 82.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.159 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -70.59 -16.72 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -91.3 0.15 57.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.969 172.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.95 4.65 60.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.584 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -89.85 145.91 24.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -90.23 109.15 20.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.953 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 47' ' ' LEU . 99.2 t -109.21 128.75 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -110.05 125.71 53.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.127 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.26 129.79 55.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 -172.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 134.68 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 7.1 t70 -154.83 160.55 41.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.836 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -80.6 -24.0 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -106.07 140.74 38.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -77.19 -28.01 53.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.88 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.04 -46.76 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.82 99.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.13 -37.08 84.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.0 110.882 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.57 90.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.39 -37.48 87.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -61.16 -43.2 99.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.085 175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -61.36 -46.45 90.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.59 -40.67 92.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.47 94.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.3 -38.17 90.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.84 -31.89 72.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.44 -8.22 45.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.923 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.8 34.18 56.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.437 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.8 160.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -104.38 130.81 52.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.86 165.33 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.3 m -119.43 133.82 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.4 p -120.73 132.75 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.12 122.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 65.0 tt0 -88.51 116.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.3 t -173.35 141.49 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 88' ' ' PHE . 49.1 t30 -57.45 129.41 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.05 -35.08 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.916 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.32 68.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.079 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -99.83 -8.31 24.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ASN . 79.4 t80 -66.45 134.55 52.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.45 108.9 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.779 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.9 mt -81.4 122.16 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.7 t -94.31 138.74 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.15 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 120' ' ' GLY . . . -72.7 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -24.39 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.05 70.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -165.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.493 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 67.7 p-90 -149.55 161.28 42.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 45.8 mp0 -116.42 -35.46 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.73 147.89 16.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 15.9 tt -133.0 129.73 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.8 134.88 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -169.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -109.55 117.67 34.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.51 113.05 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.096 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 48.3 44.48 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.1 t -114.46 72.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -73.03 122.38 21.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.814 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.0 mt -131.59 151.76 79.24 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.565 0.698 . . . . 0.0 110.962 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.76 146.25 91.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.374 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -57.91 -33.33 68.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.0 m -61.28 -40.9 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.0 tp -72.31 -36.47 68.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -54.15 -46.61 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -65.86 -26.09 67.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.11 -38.2 32.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.19 -31.87 66.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.4 m-30 -53.09 -53.6 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.671 0.748 . . . . 0.0 110.956 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.7 Cg_endo -65.55 -31.28 50.94 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.698 2.265 . . . . 0.0 112.378 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.49 -42.67 82.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.94 -39.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.84 -53.66 52.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.54 -30.02 70.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 92' ' ' ALA . . . -80.16 -28.15 50.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.9 tp -78.84 131.75 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.515 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.2 mttt -78.92 153.08 77.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.634 0.73 . . . . 0.0 110.839 172.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.45 128.14 28.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.335 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.12 -3.59 86.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.457 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -71.62 171.89 46.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.431 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.23 142.52 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.471 ' HB3' HD23 ' A' ' 163' ' ' LEU . 68.1 t80 -115.74 135.21 54.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.488 HD12 ' CD1' ' A' ' 28' ' ' ILE . 84.5 mt -120.04 131.86 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.422 HD21 HD22 ' A' ' 190' ' ' LEU . 54.4 tp -128.82 126.59 40.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.961 169.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 24.5 pt-20 -151.91 142.65 22.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.33 -166.9 34.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -64.73 153.33 40.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.431 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -93.35 156.56 39.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.54 0.686 . . . . 0.0 111.153 174.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.53 -23.81 49.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.642 2.228 . . . . 0.0 112.397 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -54.94 -27.58 44.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.766 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -58.52 -29.68 66.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.52 -10.73 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -162.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.615 ' O ' ' C ' ' A' ' 139' ' ' TYR . 65.3 tt0 -67.44 -8.48 33.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -176.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 138' ' ' GLN . 75.7 m-85 -20.0 -79.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.011 -170.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -134.65 -1.32 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.866 -166.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.3 p -131.67 -6.77 3.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.35 60.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.79 170.83 11.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.448 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.78 -39.63 19.64 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.659 2.239 . . . . 0.0 112.32 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 98.4 mttt -129.34 -29.53 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 154.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' HB3' HD13 ' A' ' 149' ' ' LEU . 68.2 t0 179.24 126.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 147' ' ' LEU . 1.2 pp -56.3 -20.08 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -77.74 -20.17 53.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.907 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.8 mp -82.97 -6.52 59.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -163.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.19 154.96 40.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 110.918 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -52.98 114.4 1.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.784 2.322 . . . . 0.0 112.307 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.45 152.59 45.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.689 ' O ' HD21 ' A' ' 153' ' ' LEU . 4.8 tt -55.26 -46.78 76.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.58 -37.12 85.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.5 m -62.56 -42.02 99.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.84 -39.56 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.958 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -62.99 -37.75 88.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.2 p -82.98 -28.13 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -81.74 -14.36 56.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 160' ' ' LEU . 4.9 tt -107.71 102.19 43.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 0.0 110.899 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -89.12 -24.2 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.386 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.2 m -68.96 -25.28 64.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -164.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 127' ' ' PHE . 4.2 mp -123.06 145.89 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -95.31 136.75 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.73 124.88 35.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -165.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.1 mt -92.01 -35.93 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.5 pt -141.78 146.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.05 119.38 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -135.05 141.05 46.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -176.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -116.17 130.91 57.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 166.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.6 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.8 pp -127.01 149.96 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -114.14 136.8 52.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -133.55 155.86 48.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -55.16 117.06 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -170.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.79 133.0 36.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.49 140.78 55.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -100.01 -29.92 12.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.55 54.96 0.18 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -156.53 167.33 30.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.135 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -51.74 130.54 28.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.909 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -53.02 115.41 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -85.18 -12.72 52.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 120.9 -35.54 3.65 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.511 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.91 135.07 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.9 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -170.58 162.08 7.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.82 44.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt -118.58 149.85 40.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.431 HG23 ' HB3' ' A' ' 133' ' ' ALA . 42.4 pt -120.81 142.73 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 68.9 mt-30 -142.21 126.96 18.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.673 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.1 pt? -146.72 148.57 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.728 ' C ' HD21 ' A' ' 191' ' ' LEU . 4.8 tt -143.07 128.16 18.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.468 ' N ' HD21 ' A' ' 191' ' ' LEU . . . -122.2 154.7 16.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -125.32 144.36 50.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -95.59 136.39 36.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.5 mt -72.7 141.5 48.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.832 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.11 -23.16 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 178.485 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.722 0.296 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.05 44.99 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.86 140.23 37.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.11 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -133.93 145.02 49.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.1 165.06 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -150.9 169.79 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.65 170.02 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -159.42 140.04 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.81 134.94 18.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -153.71 169.29 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.74 132.73 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -145.19 165.04 29.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 147.25 21.27 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.795 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 92.0 m -116.48 129.02 55.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.633 0.254 . . . . 0.0 111.173 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -139.14 125.05 12.19 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.56 149.18 49.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -125.27 149.88 47.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.92 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -113.5 149.51 34.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 62.57 25.21 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.941 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 21' ' ' LEU . 7.9 tt -64.52 -39.94 94.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.97 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.02 -82.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.3 m -128.15 -37.56 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 143.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.477 ' CG2' HD13 ' A' ' 191' ' ' LEU . 27.0 m -124.96 29.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.202 -176.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.491 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -53.05 -15.08 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.121 -174.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -64.99 -2.01 2.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -100.59 -17.78 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 128' ' ' ILE . 89.7 mt -75.82 134.36 72.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.637 0.732 . . . . 0.0 111.177 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.96 108.37 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.315 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -78.27 18.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -167.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' HA3' ' OE1' ' A' ' 96' ' ' GLU . . . -84.59 -97.7 0.66 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -102.94 128.69 49.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.811 -171.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.2 127.99 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.089 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . 63.8 tp -106.66 123.36 48.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 t -111.44 116.79 31.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.16 60.21 5.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.99 105.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' OE2' ' HB3' ' A' ' 67' ' ' ALA . 9.0 tm-20 -67.07 -60.52 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -170.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.65 35.0 91.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 59.03 20.73 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.74 61.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.521 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -65.68 -46.4 79.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -77.57 -27.89 51.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.59 59.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.3 p -69.43 -29.18 66.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -64.83 -50.76 65.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.472 ' HB2' HG22 ' A' ' 54' ' ' VAL . 98.2 mt -65.27 -37.84 88.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.79 85.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -66.87 -20.17 65.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -89.63 0.44 56.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 94.92 5.0 61.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.474 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.88 143.88 27.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -90.02 106.85 18.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.896 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 47' ' ' LEU . 77.5 t -107.21 125.66 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.4 m -112.08 128.59 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 167.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.49 130.57 56.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.128 -174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 133.19 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 7.7 t70 -155.79 156.62 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -77.93 -27.78 49.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.039 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.0 p -96.03 149.62 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -168.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -80.11 -31.29 39.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.949 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.74 -48.19 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.51 98.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.574 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.407 HD23 ' HB ' ' A' ' 80' ' ' THR . 95.7 mt -67.62 -36.71 81.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.14 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.88 -37.3 81.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -61.68 -42.72 99.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.18 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -68.41 -41.21 80.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.36 -40.51 96.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.16 96.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.51 -37.72 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -32.7 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.98 -7.28 49.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.69 59.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.89 163.77 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 111.165 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.24 131.35 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.43 170.19 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -123.93 130.66 52.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 64' ' ' LEU . 41.5 p -121.92 134.35 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.87 123.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 66.3 tt0 -85.86 114.37 22.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -173.6 143.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -55.4 133.23 49.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -57.77 -35.61 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 109' ' ' LEU . . . -71.62 -27.22 62.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.078 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -99.92 -11.92 20.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.23 135.02 52.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -93.19 112.63 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.509 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.4 mt -87.66 125.12 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.412 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 92.9 t -102.95 138.05 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.192 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 -61.13 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -168.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.42 -35.04 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -54.05 -38.97 65.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -170.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CG ' ' HB2' ' A' ' 34' ' ' LEU . 17.8 m-90 -132.28 154.83 49.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG2' ' HD3' ' A' ' 122' ' ' LYS . 53.7 mt-10 -107.38 -43.56 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.52 149.87 18.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mm -113.91 123.93 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.28 129.47 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.5 m -115.51 118.23 32.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.6 mm -113.67 116.69 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.176 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 47.42 42.97 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.2 t -108.06 96.44 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -89.9 120.39 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.5 150.04 74.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.637 0.732 . . . . 0.0 110.926 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 144.32 88.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.285 . . . . 0.0 112.324 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -60.12 -40.3 89.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 37.1 tp -73.83 -33.38 64.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.937 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -56.38 -44.97 80.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -75.07 -30.23 60.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -69.98 -39.89 75.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.31 -34.83 68.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 115' ' ' PRO . 35.7 t80 -51.37 -48.92 84.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.917 -163.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 114' ' ' TYR . 98.0 Cg_exo -47.34 -46.09 20.78 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.386 176.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -76.81 -36.24 57.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.18 -47.13 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.23 -54.53 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.16 -30.45 71.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.509 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -84.91 -11.97 75.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.467 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.67 129.63 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HD3' ' HG2' ' A' ' 96' ' ' GLU . 83.8 tttt -67.91 139.9 93.52 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.857 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.5 127.61 18.71 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.722 2.282 . . . . 0.0 112.345 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.94 1.26 88.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.483 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -73.71 170.41 52.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.418 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.83 142.82 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.791 0.329 . . . . 0.0 111.206 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -109.59 128.27 55.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 28' ' ' ILE . 38.1 mm -118.5 131.67 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.139 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 190' ' ' LEU . 58.4 tp -129.84 123.77 31.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 165.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -143.93 130.77 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.22 -167.38 30.13 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.7 158.74 9.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.452 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -86.57 131.22 46.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 111.215 174.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.42 -38.42 63.38 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.564 2.176 . . . . 0.0 112.373 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -47.21 -35.41 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 133' ' ' ALA . 6.9 pt20 -56.71 -30.95 64.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 1.269 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.4 tt -59.04 -17.59 26.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 139' ' ' TYR . 15.8 pt20 -63.05 -16.45 59.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.566 ' C ' ' O ' ' A' ' 138' ' ' GLN . 37.9 m-85 -24.77 -66.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -120.13 -18.13 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.832 -161.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.6 p -126.37 -17.06 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -163.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.37 -22.88 7.88 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.424 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.63 175.76 37.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.544 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.786 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.8 Cg_endo -73.44 -41.1 1.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.754 2.303 . . . . 0.0 112.353 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -129.79 -27.96 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 156.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -161.92 155.87 21.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 169.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.434 HD12 HD12 ' A' ' 150' ' ' LEU . 53.5 tp -50.19 -23.86 2.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 169.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.15 -28.7 70.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 1.1 mp -78.49 -14.13 59.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.975 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.434 HD12 HD12 ' A' ' 147' ' ' LEU . 83.7 mt -95.81 112.13 58.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.931 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.76 132.27 6.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.379 -173.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.8 149.79 48.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 166.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.6 tp -55.45 -44.81 76.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.95 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.1 -38.39 90.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.0 m -60.4 -37.08 79.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.19 -42.58 93.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.949 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -65.91 -36.23 82.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.1 p -78.18 -25.89 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -84.58 -13.77 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 163' ' ' LEU . 2.2 tt -119.36 92.95 46.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.663 0.744 . . . . 0.0 110.946 -175.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -89.53 -24.65 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 0.0 112.347 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.7 p -81.18 -15.36 55.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -162.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 160' ' ' LEU . 3.0 mp -114.51 140.03 49.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -86.35 132.85 33.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -92.29 114.48 27.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' HB2' HD23 ' A' ' 191' ' ' LEU . 83.8 mt -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -175.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.743 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -138.61 145.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.37 113.73 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -129.11 139.19 52.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -118.41 128.76 54.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -110.05 123.27 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -106.83 128.17 54.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -163.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 184' ' ' LYS . 90.2 mtm180 -132.73 156.44 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 158.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -56.69 120.88 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -167.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.0 mt -97.1 142.09 29.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.81 150.92 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -98.3 -27.93 13.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.01 54.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.488 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.95 166.55 33.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -57.56 136.16 56.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' A' ' 183' ' ' GLY . 20.1 t-160 -57.06 120.1 7.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -91.05 -5.55 55.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -173.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.4 ' H ' ' CD2' ' A' ' 181' ' ' HIS . . . 118.14 -31.47 5.64 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 175.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 97.0 mttt -73.45 139.74 46.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.917 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -150.09 148.21 28.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.109 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -104.19 137.69 41.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.027 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.99 145.44 49.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 133' ' ' ALA . 44.2 pt -124.01 146.22 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.194 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -143.23 130.85 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.7 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.3 pt? -152.19 150.28 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.884 ' O ' HD21 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.73 129.77 23.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.0 141.59 16.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -107.65 132.87 52.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -98.39 131.6 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.33 145.18 31.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -73.52 -18.0 61.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.746 177.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.756 0.312 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -164.79 142.75 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.05 159.99 40.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -123.89 119.42 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.83 148.11 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -126.39 154.93 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.7 p -153.52 169.96 21.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.07 40.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.8 p -156.79 164.42 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -126.06 146.86 49.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.61 164.98 23.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.0 134.96 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.059 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -149.29 164.96 33.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.46 163.09 11.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -121.06 102.13 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.95 69.88 35.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 0.0 110.902 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.14 155.14 42.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.743 2.295 . . . . 0.0 112.314 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.2 155.02 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.46 170.14 22.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -60.02 133.38 56.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.83 -32.34 20.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.009 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.11 -93.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.2 t -124.97 -51.82 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.709 ' O ' HG12 ' A' ' 24' ' ' VAL . 40.1 t -126.82 26.11 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.092 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.72 -8.86 7.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -62.46 -7.69 4.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -89.27 -10.7 45.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.883 175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.422 HG12 ' HB ' ' A' ' 126' ' ' VAL . 68.8 mt -79.24 130.76 68.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 111.207 173.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.88 153.06 79.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.741 2.294 . . . . 0.0 112.277 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.31 12.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 -173.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.58 -143.4 7.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.524 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.01 144.47 30.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.695 0.283 . . . . 0.0 110.948 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.49 135.05 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 55' ' ' THR . 51.0 tp -105.57 126.03 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -106.42 124.9 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.57 133.24 39.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.06 53.76 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.059 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 41' ' ' GLY . 54.0 tp10 -90.16 123.33 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.14 16.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.425 -166.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -129.99 10.02 5.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' H ' ' HG3' ' A' ' 38' ' ' GLU . . . 75.01 22.05 77.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.76 -42.11 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -75.12 -29.15 60.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.845 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.43 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.55 -37.27 76.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -63.06 -47.34 83.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.587 ' HB2' HG22 ' A' ' 54' ' ' VAL . 70.0 mt -63.54 -38.82 92.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.28 79.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -70.64 -20.51 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.844 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -87.58 0.12 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.74 7.66 58.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -83.96 145.0 28.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.17 112.61 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 165.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 47' ' ' LEU . 89.9 t -111.44 135.72 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.485 ' O ' HD12 ' A' ' 34' ' ' LEU . 97.5 m -107.75 125.34 51.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 165.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.98 133.92 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.079 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.33 129.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 59' ' ' GLN . 49.5 t0 -154.5 153.24 31.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.424 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 92.4 mt-30 -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 174.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.3 t -95.67 115.45 27.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.83 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.0 p -69.07 -33.71 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.02 -31.37 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.78 -41.64 97.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.54 169.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.78 -35.04 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.29 88.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -64.29 -38.79 92.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.972 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.63 91.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.01 -43.16 99.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.1 -40.14 92.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -33.91 77.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.9 -10.99 34.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.92 66.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.416 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.39 161.7 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.169 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -97.37 129.97 44.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 pt -137.08 163.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.143 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.0 m -121.65 134.08 54.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.5 p -119.17 133.05 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.91 122.38 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -85.12 118.79 24.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 t -174.53 143.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.29 128.16 35.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.31 -38.59 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.33 -32.56 74.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -97.78 -6.37 32.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.99 129.89 42.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.9 114.93 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.879 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.436 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -93.76 117.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.191 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -83.69 136.23 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.051 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.39 -49.51 54.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -56.92 -26.09 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.74 80.6 9.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -69.86 130.14 41.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -173.14 150.81 1.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.49 163.33 46.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.473 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.6 mm -114.84 117.89 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.45 124.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.7 m -112.6 115.03 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.46 123.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 102' ' ' PHE . 53.8 t80 43.19 49.83 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.1 m -97.27 79.02 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -75.46 114.8 14.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.482 ' HB2' HD21 ' A' ' 109' ' ' LEU . 3.8 pp -152.04 152.71 30.24 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.618 0.723 . . . . 0.0 110.821 -169.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.85 149.74 78.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -58.1 -29.77 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -59.2 -35.96 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 105' ' ' LEU . 49.7 tp -69.87 -36.9 75.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.85 -28.02 69.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -82.43 -39.93 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.55 -32.56 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 m-30 -54.73 -55.23 40.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.715 0.769 . . . . 0.0 110.94 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 29.4 Cg_endo -61.69 -34.01 84.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.314 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -68.63 -46.42 69.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.94 -31.61 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -69.2 -57.11 5.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.71 -34.04 69.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -68.26 -31.12 74.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.712 HD11 ' HA3' ' A' ' 125' ' ' GLY . 57.7 tp -86.2 128.84 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.892 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.87 159.56 68.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.524 0.678 . . . . 0.0 110.911 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.04 133.53 46.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.44 48.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.712 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -75.54 168.3 54.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' A' ' 28' ' ' ILE . 96.1 t -131.95 140.16 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -106.46 131.88 53.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.7 134.4 66.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.19 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 190' ' ' LEU . 59.6 tp -127.19 127.18 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 172.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.84 139.74 15.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.08 30.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.539 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.45 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 72.9 m-85 -65.17 150.34 48.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.902 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.558 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -112.1 161.83 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 0.0 111.132 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -49.71 -30.02 21.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 0.0 112.309 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.1 -22.27 49.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 -175.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -59.78 -23.31 63.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.96 -20.03 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -172.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.483 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 58.7 tp60 -60.86 -24.5 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 -170.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.742 ' CZ ' ' HA3' ' A' ' 183' ' ' GLY . 43.3 t80 -47.42 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.012 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -117.61 -10.31 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 69.4 p -120.45 12.15 11.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -167.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 138' ' ' GLN . . . -82.38 81.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.464 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.41 -130.92 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.0 -31.67 35.49 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.706 2.271 . . . . 0.0 112.33 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -86.34 39.8 0.85 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.955 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.05 170.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.872 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.8 tp -53.96 -27.86 33.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -166.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -77.38 -22.48 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.8 mp -92.81 -9.6 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -170.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.92 150.48 42.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 0.0 110.926 -156.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.79 167.07 28.16 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.617 2.211 . . . . 0.0 112.393 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -129.94 154.33 47.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 168' ' ' ALA . 3.3 pp -48.2 -30.78 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 96.6 mt-10 -65.1 -36.51 84.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.1 p -75.15 -31.84 61.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.462 ' C ' HD21 ' A' ' 156' ' ' LEU . 10.1 tt -64.2 -45.17 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 4.4 pt20 -66.46 -28.22 68.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.3 p -73.18 -16.09 61.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -78.97 -13.27 59.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.71 108.25 61.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.674 0.749 . . . . 0.0 110.947 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.4 -20.67 3.92 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.763 2.309 . . . . 0.0 112.309 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.5 p -71.66 -24.67 61.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -159.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.576 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.7 pp -143.2 168.1 20.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -104.94 144.61 31.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -96.56 128.66 43.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 193' ' ' GLN . 93.1 mt -88.72 -31.67 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -172.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 190' ' ' LEU . 43.3 pt -138.27 147.83 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.087 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 153' ' ' LEU . . . -146.55 117.64 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 166.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -130.02 140.02 50.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -103.87 122.66 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 49.5 mt -111.08 143.22 42.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.98 124.29 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.418 ' HB2' HD11 ' A' ' 187' ' ' LEU . 88.5 mmt-85 -140.07 174.31 10.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -79.77 140.09 37.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.87 138.29 58.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.16 143.53 48.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.34 119.94 20.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.96 -88.17 0.12 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.58 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.25 170.17 9.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -84.65 -167.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.879 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -100.32 108.64 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.742 ' HA3' ' CZ ' ' A' ' 139' ' ' TYR . . . -179.31 -158.01 20.79 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.451 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -70.38 146.1 50.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 0.0 110.971 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.17 142.85 35.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.046 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -104.4 131.13 52.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.1 mp -126.94 153.02 46.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.928 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.558 HG23 ' HB3' ' A' ' 133' ' ' ALA . 44.7 pt -114.11 142.48 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -135.25 123.06 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.717 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -152.72 147.65 26.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.43 ' C ' HD21 ' A' ' 191' ' ' LEU . 9.9 tt -139.74 129.89 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.25 147.6 18.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.461 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.405 ' HB2' HD11 ' A' ' 166' ' ' LEU . 41.6 tt0 -119.58 130.14 54.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.882 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 1.245 ' HD2' ' O ' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -80.06 115.33 19.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 175.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.83 140.25 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.72 34.83 5.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -176.553 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -155.03 166.8 32.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.937 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -162.0 160.07 27.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -129.9 149.97 51.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -159.22 129.01 5.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.99 168.11 28.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 t -151.66 139.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.1 160.0 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -165.79 137.26 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.884 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -161.7 164.61 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.75 163.45 39.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.63 80.51 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.17 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.35 172.38 7.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.32 176.48 22.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -153.8 154.95 34.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.694 0.283 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.92 149.16 62.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.79 154.39 48.71 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.33 156.13 43.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.65 105.61 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.39 110.82 22.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.616 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 48.0 tp -70.12 -51.18 33.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 189' ' ' GLN . 49.0 t -101.85 -82.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 -174.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.4 m -128.34 -39.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.821 158.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.63 15.65 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.616 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -63.89 -19.03 64.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.115 -166.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -57.3 -16.7 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.818 173.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.32 1.24 51.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 25' ' ' ALA . 85.6 mt -67.48 133.84 92.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.716 . . . . 0.0 111.143 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.41 131.32 27.26 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 0.0 112.335 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 84.4 mt-30 -75.91 13.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.947 -176.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.17 155.05 26.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 61.86 68.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 110.859 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 52' ' ' TYR . 47.7 mm -115.01 126.51 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.42 120.71 43.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.5 t -108.49 125.94 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.6 mt -108.63 135.45 49.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.11 45.77 25.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 56' ' ' ALA . 19.8 pm0 -71.45 -18.33 62.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 -175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.18 -66.95 3.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -130.33 11.61 5.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 82.98 5.24 89.51 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.507 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -64.86 -36.94 85.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.938 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.51 88.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.6 m -68.46 -38.38 81.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.845 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -58.47 -51.95 67.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.1 mt -59.71 -40.06 86.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.29 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.073 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.1 p -69.75 -17.83 63.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.87 1.06 41.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.77 4.61 65.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 33' ' ' ILE . 10.1 m-30 -74.12 147.0 43.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 0.0 111.004 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -84.98 101.96 12.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.856 166.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.22 124.5 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -165.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.6 m -112.28 126.06 54.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 165.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' HB2' ' CD ' ' A' ' 38' ' ' GLU . . . -110.05 126.61 54.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.24 128.33 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -176.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.23 155.92 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -78.99 -20.02 50.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -93.67 110.96 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.419 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 94.3 p -67.81 -34.85 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.85 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.43 -30.92 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.92 97.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.42 -36.53 81.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.871 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.74 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.25 -38.62 91.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 173.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.707 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -59.65 -43.33 93.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.86 -44.72 96.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -66.82 -41.13 87.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.35 -41.07 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.35 93.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.158 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.81 -39.21 93.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.92 -32.87 73.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.948 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.82 -10.1 41.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.57 32.98 58.92 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.499 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.79 160.1 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.23 137.68 45.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.972 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.77 164.19 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -119.21 133.5 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.6 p -118.49 135.01 54.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.147 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.0 t -128.08 119.96 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -84.09 113.63 21.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -173.04 143.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -54.86 124.06 15.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.29 -37.35 67.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -32.08 72.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.75 -8.18 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.85 127.21 30.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.978 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.21 114.93 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 pt -126.58 141.82 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.089 168.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.91 -179.8 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.46 -34.11 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -173.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -29.23 70.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.0 94.54 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.074 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 122' ' ' LYS . 41.7 m0 -89.89 104.84 17.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.945 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.92 126.08 15.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.86 158.7 36.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -112.12 118.7 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.129 -171.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.1 t -121.37 124.34 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 103' ' ' CYS . 58.8 m -130.1 108.44 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.9 mm -114.53 125.67 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.159 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 48.61 40.26 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -171.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 100' ' ' SER . 87.1 m -118.67 82.13 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.892 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.1 130.98 34.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.9 mt -121.1 146.96 45.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.2 Cg_endo -67.67 147.6 76.26 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.604 2.203 . . . . 0.0 112.389 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -54.23 -40.25 67.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.913 -172.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.3 m -60.49 -38.91 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.85 ' O ' HD21 ' A' ' 109' ' ' LEU . 3.6 tt -71.91 -39.98 69.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -59.71 -40.24 87.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.59 -29.42 70.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -83.62 -39.82 19.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.9 tp -72.15 -41.62 66.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 3.2 m-30 -55.37 -49.51 92.07 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.667 0.746 . . . . 0.0 110.951 -165.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 96.4 Cg_exo -47.32 -39.36 27.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.98 -47.89 19.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.38 -25.21 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -64.95 -47.67 76.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 175.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.9 -24.91 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.9 59.94 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.486 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.452 HD22 ' HD2' ' A' ' 194' ' ' LYS . 1.9 pt? -81.93 153.07 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 63.9 pttt -75.43 155.84 85.54 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.524 0.678 . . . . 0.0 110.895 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -56.22 122.7 12.25 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.64 -1.69 81.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.491 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.92 177.01 48.55 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.7 t -129.31 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.141 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -107.22 129.0 54.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.92 123.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 190' ' ' LEU . 63.2 tp -131.63 127.08 36.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 166.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -157.14 140.06 15.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.97 -178.59 35.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -58.35 160.86 4.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.96 142.03 98.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 111.049 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.471 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . 80.9 Cg_exo -51.93 -48.78 19.83 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -45.72 -34.86 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.64 -22.72 66.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.783 HD21 ' N ' ' A' ' 138' ' ' GLN . 0.2 OUTLIER -78.76 -8.58 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -164.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.783 ' N ' HD21 ' A' ' 137' ' ' LEU . 77.4 mt-30 -72.54 -25.13 61.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -171.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.9 t80 -25.45 -65.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -110.84 -24.81 10.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.6 p -112.64 11.73 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.233 -167.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.02 104.21 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.576 ' H ' ' H ' ' A' ' 145' ' ' LYS . . . -174.98 -74.97 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -66.76 -3.27 9.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.645 2.23 . . . . 0.0 112.265 154.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.576 ' H ' ' H ' ' A' ' 143' ' ' GLY . 75.3 mmtt -114.29 38.22 3.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -69.76 147.85 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.802 -169.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 150' ' ' LEU . 19.2 tp -54.3 -26.25 28.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.21 -31.72 72.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 149' ' ' LEU . 5.4 mp -82.89 -13.53 55.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 147' ' ' LEU . 86.4 mt -93.33 123.19 61.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.692 0.758 . . . . 0.0 110.901 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 77.5 Cg_endo -84.57 135.05 5.81 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.363 -169.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.28 145.07 56.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 164.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.9 tp -52.89 -46.81 68.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.63 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.4 m -63.37 -40.47 97.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 54.8 mt -59.81 -39.95 86.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -64.0 -34.25 77.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -81.88 -25.01 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -77.58 -15.47 59.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.88 98.28 28.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.51 -28.33 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.278 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 92.0 p -73.55 -20.69 60.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.785 -163.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.4 pp -134.12 159.11 41.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -103.42 139.72 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -88.16 124.9 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.26 -31.74 14.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.676 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -140.17 146.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.29 117.42 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -139.11 146.75 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.409 HD22 ' HB2' ' A' ' 186' ' ' ALA . 18.7 t-20 -113.72 129.98 56.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.499 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp -135.27 154.15 51.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -106.37 130.64 54.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -174.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -143.78 169.18 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.78 137.42 55.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.9 tp -67.45 129.09 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -69.72 131.37 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -169.85 157.04 6.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.93 -81.19 1.08 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.14 70.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 111.104 -175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.94 151.96 23.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -130.11 -34.93 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -74.79 129.99 38.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.62 125.74 1.21 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.557 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.856 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.16 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.098 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.409 ' HB2' HD22 ' A' ' 170' ' ' ASN . . . -99.09 136.74 38.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.061 173.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.89 144.94 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.71 142.68 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.448 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.6 pt20 -143.19 128.13 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.717 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.2 pt? -152.61 147.57 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.676 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.7 tt -139.75 127.19 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -174.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.567 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -112.06 141.83 16.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.441 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -108.9 129.37 55.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.872 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.452 ' HD2' HD22 ' A' ' 121' ' ' LEU . 83.5 tttt -89.29 130.05 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 177.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.75 145.05 28.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.945 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.49 149.93 36.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.803 177.646 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mmm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.05 165.02 38.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -160.93 160.01 30.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.954 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -158.78 128.42 5.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.974 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.96 168.73 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -149.69 139.08 21.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.0 160.0 38.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.9 t -161.95 139.96 8.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.827 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -160.86 160.88 31.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -153.71 129.97 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.921 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -120.5 125.05 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -159.99 134.95 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.19 -175.91 40.96 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 t -153.9 155.04 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.99 148.08 58.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.752 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 155.04 47.92 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -129.9 160.02 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.806 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -141.76 99.85 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.39 132.57 44.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 47.4 tp -68.56 -44.09 75.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 189' ' ' GLN . 67.9 t -111.35 -83.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 t -130.61 -37.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 163.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.17 2.96 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -63.36 -24.24 67.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -162.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -63.3 -14.7 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -78.25 -4.09 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.32 139.69 96.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.579 0.705 . . . . 0.0 111.168 169.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -39.31 125.05 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.347 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 88.4 mt-30 -60.06 -5.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.903 -169.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.28 -174.56 17.62 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 95' ' ' TRP . 72.0 mmtt 64.98 65.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.58 131.8 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 58.9 tp -104.35 119.85 39.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 174.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 44.1 t -105.89 122.5 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.04 127.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -171.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 62.73 50.09 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 20.0 pm0 -75.61 -19.19 59.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.29 -70.06 3.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.493 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.54 -4.03 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.785 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 88.4 12.77 64.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.455 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.71 -37.41 84.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -67.29 -41.06 86.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.14 90.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.4 m -72.37 -34.2 67.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.62 -51.73 68.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.952 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HB2' HG22 ' A' ' 54' ' ' VAL . 89.3 mt -67.01 -35.82 80.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.18 86.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -71.07 -20.67 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.02 2.77 51.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.81 4.86 61.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 87.5 m-85 -82.92 137.84 34.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 111.006 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -87.81 110.11 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 47' ' ' LEU . 79.7 t -110.99 130.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 -170.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.6 m -102.9 125.01 49.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 163.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.29 124.41 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 -170.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.85 126.79 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.111 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -157.17 154.68 29.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -79.26 -19.99 49.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.961 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -93.67 111.61 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.828 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 96.1 p -67.36 -33.95 76.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.1 -31.29 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.042 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.68 -39.73 97.83 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 170.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.37 -34.64 76.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.14 82.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -62.5 -39.88 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.785 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -61.28 -41.66 97.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.061 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.93 -44.53 95.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -40.78 90.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 81.8 mt -61.71 -40.52 95.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.83 96.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.41 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.26 -34.09 76.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.84 -9.5 43.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.44 33.97 63.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.412 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.23 160.72 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.158 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -105.37 132.31 51.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.965 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.78 160.88 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.07 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -116.7 134.01 55.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.2 p -123.51 140.99 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 80.1 t -132.7 122.76 47.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.6 tm0? -83.37 116.91 22.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -174.83 145.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -55.18 123.17 12.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.901 172.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HG ' HD22 ' A' ' 113' ' ' LEU . 50.0 tp -55.78 -36.88 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.909 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -34.4 77.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.84 -7.22 27.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.29 134.8 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.948 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.37 111.29 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.8 mt -94.87 120.44 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.6 131.59 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.04 -43.59 33.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.12 -20.59 59.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.848 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.33 125.18 30.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.469 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 82.7 m95 -75.18 94.95 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 98.6 mt-10 -149.95 123.71 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 170.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.64 53.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.53 115.99 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 -172.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.96 129.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -135.04 112.67 10.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 HG22 ' CD2' ' A' ' 102' ' ' PHE . 25.6 mm -115.81 130.95 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CD2' HG22 ' A' ' 101' ' ' ILE . 71.3 m-85 53.51 44.87 29.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -173.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -117.07 85.67 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -80.79 121.6 26.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.3 pp -142.92 153.58 60.95 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.588 0.709 . . . . 0.0 110.966 -174.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.15 153.95 46.58 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 0.0 112.333 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -59.52 -33.24 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -60.13 -32.32 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 105' ' ' LEU . 52.8 tp -74.13 -39.31 63.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -56.4 -42.68 78.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.02 -32.23 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -78.9 -40.49 32.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.43 HD22 ' HG ' ' A' ' 85' ' ' LEU . 63.4 mt -73.73 -40.1 63.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.894 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.8 m-30 -53.55 -51.17 78.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.691 0.758 . . . . 0.0 110.877 -164.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 89.9 Cg_exo -46.94 -43.39 24.42 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 174.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.88 -45.99 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.6 -30.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -170.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -63.88 -51.18 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -71.68 -25.99 62.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.947 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.31 -52.61 51.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.404 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.421 HD22 ' HD2' ' A' ' 194' ' ' LYS . 1.6 pt? -81.31 153.97 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -88.88 155.87 49.88 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 110.923 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.01 130.17 26.88 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.772 2.315 . . . . 0.0 112.334 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.08 77.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.451 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.68 175.46 47.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.518 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.64 139.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -109.69 127.87 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.9 mt -122.44 128.37 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.035 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tt -134.34 128.3 33.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -155.55 139.97 16.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.54 -174.48 34.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -56.01 160.8 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -59.9 136.97 90.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.5 0.667 . . . . 0.0 111.107 171.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . 96.5 Cg_exo -52.04 -40.32 68.14 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -47.51 -30.34 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -57.6 -28.0 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -171.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.635 HD21 ' N ' ' A' ' 138' ' ' GLN . 0.2 OUTLIER -74.24 -16.63 60.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -165.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.635 ' N ' HD21 ' A' ' 137' ' ' LEU . 70.9 mt-30 -68.93 -21.3 64.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 -170.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.568 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.4 t80 -25.1 -65.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -114.12 -22.3 10.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.1 p -113.85 6.52 16.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.6 114.66 7.0 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.42 ' H ' ' H ' ' A' ' 145' ' ' LYS . . . -175.04 -75.28 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.451 169.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.06 -11.07 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.625 2.217 . . . . 0.0 112.363 155.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HB3' HD11 ' A' ' 137' ' ' LEU . 73.8 mmtt -96.18 34.28 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' HB3' HD13 ' A' ' 149' ' ' LEU . 10.9 t70 -66.27 146.5 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -169.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 150' ' ' LEU . 19.4 tp -56.45 -24.74 47.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.66 -31.03 71.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.5 mp -85.78 -16.46 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 175.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 147' ' ' LEU . 89.5 mt -86.66 134.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.609 0.719 . . . . 0.0 110.982 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.35 135.72 6.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 -171.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.8 155.69 37.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.25 -45.39 87.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -34.98 79.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.8 m -64.84 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.158 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.95 -51.11 71.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.13 -31.82 69.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.7 p -75.56 -24.2 56.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 161' ' ' PRO . 97.3 mt-10 -83.82 -2.08 55.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.9 mt -104.47 95.11 7.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.597 0.713 . . . . 0.0 110.986 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 66.2 Cg_endo -83.14 -31.52 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.655 2.237 . . . . 0.0 112.277 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.7 p -75.81 -17.05 59.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.786 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.5 pp -132.01 162.06 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 -176.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -107.63 130.56 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.862 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.409 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 29.7 p90 -87.27 134.8 33.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -170.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.42 -30.09 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.753 HD13 ' HB3' ' A' ' 191' ' ' LEU . 59.8 mt -129.91 138.47 53.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -170.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.06 111.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.078 162.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -138.31 145.91 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.16 129.93 56.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 170.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.421 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp -132.13 154.33 49.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.99 134.63 50.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.85 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -140.19 173.66 11.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.51 135.59 56.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.78 127.2 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.985 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.55 139.54 45.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -169.94 156.29 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.98 -73.02 1.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.518 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.62 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 111.023 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.82 166.76 10.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.96 -34.96 1.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -88.29 156.09 19.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 136.45 148.43 5.52 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.56 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.96 151.87 25.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.16 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.11 133.92 43.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.71 145.54 49.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.2 pt -120.03 143.72 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.435 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.5 pt20 -138.16 134.36 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.918 174.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 190' ' ' LEU . 2.4 pt? -152.11 150.54 30.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.753 ' HB3' HD13 ' A' ' 167' ' ' ILE . 3.5 tt -139.93 129.68 24.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -112.75 146.64 18.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.497 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -114.18 128.97 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.836 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.421 ' HD2' HD22 ' A' ' 121' ' ' LEU . 82.5 tttt -83.3 125.23 31.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 145.1 26.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 -175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.83 154.5 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 178.038 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -154.94 165.03 37.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -144.97 -175.79 4.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.825 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -162.15 163.57 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -137.05 166.88 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -150.59 126.0 10.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -107.79 168.14 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -125.03 154.94 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -159.94 170.0 22.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -160.79 160.48 31.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.0 168.59 26.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.22 160.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.565 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 53.4 p90 -163.45 149.95 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.89 172.07 42.14 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.403 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -156.65 -174.93 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.77 151.49 42.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.674 0.749 . . . . 0.0 110.937 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.57 123.07 11.17 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.58 2.187 . . . . 0.0 112.309 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -143.03 -164.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -84.95 -170.07 2.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.72 142.93 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.566 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 58.1 tp -67.35 -49.33 64.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.61 -81.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.2 t -122.45 -54.38 1.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 165.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.433 ' CG2' HD23 ' A' ' 191' ' ' LEU . 34.6 m -125.87 20.53 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -57.92 -19.99 34.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -160.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -65.38 -7.56 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.05 0.07 54.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 25' ' ' ALA . 23.2 pt -81.0 152.0 71.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.608 0.718 . . . . 0.0 111.115 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.8 133.13 55.99 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.613 2.209 . . . . 0.0 112.375 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.16 -2.65 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA3' ' HZ3' ' A' ' 95' ' ' TRP . . . -78.06 -145.81 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.407 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.03 141.0 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.827 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.32 134.02 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 tp -102.38 121.89 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.33 113.99 25.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 64.3 mt -90.95 59.25 4.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -172.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.01 -60.26 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.53 39.06 95.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 171.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 60.98 19.73 10.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.82 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.85 15.62 67.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.437 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.95 -46.1 82.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 -172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.23 -40.09 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.02 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.041 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.7 m -65.51 -38.38 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.58 -51.64 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.71 -35.07 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.23 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.062 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 p -63.13 -13.99 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.24 -5.91 55.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 97.38 -6.39 63.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -102.41 148.19 25.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.04 117.71 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.37 147.5 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -114.39 130.56 56.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.91 129.95 56.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.1 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG23 ' HB ' ' A' ' 81' ' ' VAL . 49.3 t -117.29 132.47 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -159.74 162.52 34.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.07 -28.8 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -86.52 109.56 19.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -171.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 91.3 p -69.2 -36.25 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.85 -33.37 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.77 96.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.4 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.07 -34.89 79.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.55 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.95 -36.18 82.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.17 96.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.17 -42.48 98.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.0 -40.76 95.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.9 -41.35 97.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.73 95.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -64.2 -38.54 91.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.8 -33.55 75.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.4 -9.08 42.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.75 59.38 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.438 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.98 159.99 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.125 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -101.74 130.72 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.43 159.95 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.1 m -117.99 133.3 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -121.73 137.09 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.469 ' HB ' HG23 ' A' ' 57' ' ' VAL . 96.1 t -127.84 119.88 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.13 173.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.509 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.0 tm0? -85.09 114.42 22.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.866 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -173.41 145.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -58.41 125.22 22.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.93 -33.29 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.04 77.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -97.14 -8.54 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.49 132.4 49.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.75 111.91 23.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.513 HG22 ' HA3' ' A' ' 120' ' ' GLY . 89.9 mt -85.12 114.76 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.3 134.34 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -170.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.6 40.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.57 -22.56 56.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.835 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.37 92.54 7.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.439 ' HZ3' ' HA3' ' A' ' 31' ' ' GLY . 87.9 t90 -69.8 117.64 11.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -172.96 159.74 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.25 167.86 49.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.414 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.22 125.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.118 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.49 125.81 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.2 t -116.52 113.63 23.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.68 117.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 45.1 54.97 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 74.3 m -105.03 92.07 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -82.71 120.09 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.0 pp -156.14 150.88 20.46 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.991 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.1 149.48 89.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.76 2.307 . . . . 0.0 112.43 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -57.7 -29.71 64.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 -38.11 71.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 105' ' ' LEU . 25.7 tp -77.19 -35.96 55.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -54.59 -43.66 72.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.97 -24.64 67.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -85.09 -37.61 20.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.49 -35.84 68.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.931 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.0 m-85 -55.02 -52.66 69.19 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 0.0 110.926 -171.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.2 Cg_endo -65.23 -27.74 56.07 Favored 'Trans proline' 0 N--CA 1.466 -0.129 0 C-N-CA 122.739 2.293 . . . . 0.0 112.361 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -70.43 -39.11 74.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.791 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.7 -40.65 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.05 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.67 -57.25 10.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.47 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.513 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -72.18 -40.7 55.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.528 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.567 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.3 tp -79.78 121.06 24.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.394 . . . . 0.0 110.876 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -80.01 153.76 74.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 110.888 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.91 129.9 35.16 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.342 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.32 -1.4 64.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.416 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.567 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -81.75 170.28 51.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 164.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 194' ' ' LYS . 72.5 t -125.16 141.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -106.65 129.36 54.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 169.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.43 129.61 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt -126.8 130.07 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.99 132.58 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.49 -168.6 32.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.453 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -91.52 159.4 15.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.975 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.401 ' HB1' ' HB1' ' A' ' 186' ' ' ALA . . . -89.08 145.89 35.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 0.0 111.112 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.449 ' HB2' HD21 ' A' ' 147' ' ' LEU . 33.4 Cg_endo -62.52 -33.25 79.11 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.279 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.82 -29.96 70.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -63.0 -41.06 99.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.771 HD21 HD23 ' A' ' 150' ' ' LEU . 2.5 mm? -93.67 -5.02 49.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -69.16 -3.1 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -169.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -74.74 -165.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -74.39 -6.76 50.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -162.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.3 p -94.95 -2.37 50.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.23 34.48 90.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.72 ' CA ' ' HB3' ' A' ' 137' ' ' LEU . . . 56.17 -160.56 7.29 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.573 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.497 ' HD3' ' HG ' ' A' ' 137' ' ' LEU . 43.3 Cg_endo -69.96 -47.99 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.347 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.68 -41.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 162.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -164.36 119.76 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.834 HD23 ' C ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.77 -10.12 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.933 -177.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.71 ' N ' HD23 ' A' ' 147' ' ' LEU . 95.4 m-20 -64.29 -23.92 67.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 176.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.6 mp -70.7 -12.09 61.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.771 HD23 HD21 ' A' ' 137' ' ' LEU . 7.9 mp -103.58 128.03 28.28 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.887 -176.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.477 ' HB2' ' HB3' ' A' ' 156' ' ' LEU . 87.0 Cg_endo -80.3 143.03 15.36 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.698 2.265 . . . . 0.0 112.416 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -76.98 139.98 40.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.53 -49.48 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.912 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.56 -33.11 74.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 53.5 m -71.57 -56.99 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 1.085 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.57 -20.65 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.608 ' N ' HD13 ' A' ' 156' ' ' LEU . 10.4 pt20 -75.72 -33.34 60.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -78.53 -19.26 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -84.43 -14.57 48.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.25 109.87 63.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.81 -20.28 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.356 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.3 p -61.63 -29.04 69.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -158.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.717 HD11 ' HA3' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -148.14 164.14 34.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -174.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLN . 96.6 m-20 -92.58 148.02 22.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -89.65 128.43 36.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.55 -33.8 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.574 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.9 pt -139.3 146.99 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.06 116.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -145.01 148.53 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -109.91 133.11 53.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -120.9 152.76 38.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -111.69 137.68 49.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.9 mmt-85 -142.92 165.55 27.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.866 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -78.95 130.84 36.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 172.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 185' ' ' ALA . 59.4 tp -90.15 126.45 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -77.91 122.84 26.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 171.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -175.78 160.03 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -104.11 4.99 45.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.509 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -75.57 168.84 19.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.726 0.298 . . . . 0.0 111.085 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -106.6 1.18 25.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -77.68 170.04 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -50.64 125.02 12.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.39 21.01 40.32 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.47 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.53 143.78 55.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 110.883 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 175' ' ' LEU . . . -129.31 152.03 49.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.401 ' HB1' ' HB1' ' A' ' 133' ' ' ALA . . . -139.09 128.19 23.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -173.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.22 147.48 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.58 143.45 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -149.01 136.2 20.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.658 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.8 pt? -155.72 150.02 25.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.574 ' HB3' HG12 ' A' ' 167' ' ' ILE . 6.4 tt -140.66 131.37 25.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.934 -169.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.717 ' HA3' HD11 ' A' ' 163' ' ' LEU . . . -84.96 173.77 49.09 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 -172.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 164' ' ' ASN . 66.5 tt0 -105.92 129.33 54.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.903 ' HD2' ' O ' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -92.42 99.99 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 170.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.0 mt -99.1 133.63 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 157.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -87.66 -35.85 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -177.575 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -124.9 -74.99 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -162.0 160.82 28.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -126.01 154.67 42.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -151.76 130.07 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -160.47 165.04 31.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -157.42 169.94 23.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -159.94 132.77 6.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.4 p -156.9 168.02 28.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.81 134.96 15.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.866 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -155.86 167.26 30.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.0 160.71 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -162.27 165.24 26.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.06 176.75 24.24 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.579 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.686 HG23 ' HD3' ' A' ' 17' ' ' PRO . 85.7 m -125.08 119.51 28.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -125.42 77.76 68.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.654 0.74 . . . . 0.0 110.932 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.686 ' HD3' HG23 ' A' ' 15' ' ' THR . 73.5 Cg_endo -76.62 153.54 34.34 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.651 2.234 . . . . 0.0 112.429 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -77.35 157.19 30.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.12 -35.98 70.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -113.81 152.51 30.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.796 ' H ' ' HB1' ' A' ' 25' ' ' ALA . 49.1 tp -76.82 -55.2 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.79 -81.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -125.08 -46.05 1.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 163.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.805 ' O ' HG12 ' A' ' 24' ' ' VAL . 94.7 t -124.84 17.27 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -170.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.796 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -65.41 -11.21 40.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -65.9 -6.19 11.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -90.66 0.25 57.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 25' ' ' ALA . 96.8 mt -70.05 132.7 88.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.64 0.733 . . . . 0.0 111.124 174.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.18 144.77 82.51 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -75.51 11.22 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -170.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.18 -130.37 3.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.53 139.31 32.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -174.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 52' ' ' TYR . 81.8 mt -124.22 131.79 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 173.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 tp -106.91 120.28 41.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -105.63 127.04 52.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.7 120.8 40.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.47 ' HB1' ' SG ' ' A' ' 103' ' ' CYS . . . 55.48 54.61 8.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 pm0 -70.23 -17.71 63.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 -172.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 -111.54 4.26 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.66 -41.5 70.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 110.904 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . 88.59 13.88 62.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.447 176.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -65.83 -35.06 79.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.81 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.51 -33.07 72.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.92 97.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.8 m -65.82 -35.89 81.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -62.61 -44.51 96.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.56 -43.0 99.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.906 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.81 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.5 p -71.02 -20.26 62.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.878 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.2 mt -85.68 -1.59 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.41 8.59 59.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.51 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.4 ' HB3' HD13 ' A' ' 33' ' ' ILE . 50.8 m-85 -77.78 147.69 35.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.33 105.05 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.82 120.73 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -165.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.8 m -117.44 124.95 50.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.26 131.87 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.157 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.02 134.83 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -155.31 157.21 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.28 -20.09 41.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.0 t -93.13 111.38 23.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.7 p -67.8 -34.41 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.29 -31.35 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.105 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.26 98.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.92 -38.09 89.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.74 86.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.132 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.81 -39.98 94.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -63.16 -41.88 99.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.33 -43.28 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.7 -45.5 93.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.06 -41.3 98.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.87 93.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -64.56 -38.92 92.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.79 -31.79 69.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.21 -8.3 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.19 56.05 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.469 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.66 160.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.348 . . . . 0.0 111.195 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.85 135.5 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.866 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.4 pt -137.32 160.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -108.55 135.4 49.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.3 p -117.65 135.62 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.97 122.78 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -87.45 111.44 21.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.954 172.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -172.93 143.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -59.51 125.67 24.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 171.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.46 -36.38 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.5 -31.48 68.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -100.06 -9.23 22.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -89.79 112.22 23.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.531 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -98.59 115.75 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 93.3 t -88.29 139.36 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.25 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.76 -23.79 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.922 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -75.73 -52.38 10.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -170.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.79 139.82 32.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -164.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -126.72 166.47 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 42.73 71.05 0.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.482 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -92.73 130.47 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.08 130.39 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -173.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.4 t -103.71 118.09 35.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.01 115.03 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -169.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.44 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 61.6 m-85 47.38 48.81 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.47 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 88.8 m -99.61 74.04 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.874 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -76.7 114.96 16.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -153.48 153.38 29.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.517 0.675 . . . . 0.0 110.952 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 149.56 89.14 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.7 p -57.79 -30.57 65.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.812 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.6 p -62.77 -31.28 72.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.1 -35.53 66.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -55.16 -39.93 70.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.764 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -63.18 -30.86 71.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -82.77 -35.68 26.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -73.51 -41.55 62.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 8.3 m-30 -55.01 -48.06 96.96 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.71 0.767 . . . . 0.0 110.907 -164.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 84.8 Cg_exo -49.82 -41.75 45.99 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.254 . . . . 0.0 112.353 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -78.67 -46.03 20.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 77.9 t -73.31 -54.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.035 -165.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -80.04 -38.66 31.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 -168.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -69.15 -30.13 68.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.531 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -70.92 -14.85 73.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.27 124.33 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.07 139.78 97.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 0.0 110.9 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.27 130.37 32.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.92 -1.52 85.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.425 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.82 178.65 51.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.462 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.06 147.04 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -112.98 133.45 54.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mp -121.97 135.52 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 190' ' ' LEU . 47.3 tp -121.17 129.35 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 171.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -157.54 134.18 9.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 172.81 -171.67 44.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.513 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -65.51 140.89 58.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.566 ' HB3' HG23 ' A' ' 188' ' ' ILE . . . -90.94 144.9 30.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.582 0.706 . . . . 0.0 111.077 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.38 -26.49 21.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HA ' HD11 ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.3 -25.05 31.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -57.17 -24.8 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.435 HD12 ' HG ' ' A' ' 150' ' ' LEU . 92.5 mt -62.64 -13.03 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.002 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 139' ' ' TYR . 21.5 tm0? -56.73 -12.16 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.588 ' C ' ' O ' ' A' ' 138' ' ' GLN . 63.2 m-85 -21.16 -69.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.96 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -135.11 -57.05 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.944 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.1 p -102.32 0.9 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 138' ' ' GLN . . . 84.88 -5.69 81.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.48 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 142.59 -171.45 24.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.01 -32.8 16.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.569 2.179 . . . . 0.0 112.367 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.63 -45.03 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.502 ' HB3' HD13 ' A' ' 149' ' ' LEU . 22.3 t0 -173.56 151.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.898 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 135' ' ' GLU . 16.3 tp -62.97 -22.97 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 170.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -74.67 -20.59 59.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 -168.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.4 mp -81.07 -9.58 59.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -174.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.48 ' HA ' HD13 ' A' ' 150' ' ' LEU . 3.2 mm? -89.02 142.29 30.1 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.546 0.689 . . . . 0.0 110.978 -165.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.48 145.75 38.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -94.77 165.82 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 156' ' ' LEU . 45.6 tp -49.48 -40.45 37.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 171.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.95 -30.74 71.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.7 m -66.5 -60.24 2.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -171.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 1.083 HD23 ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.43 -16.5 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -177.032 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.61 ' N ' HD23 ' A' ' 156' ' ' LEU . 65.0 tt0 -66.18 -40.91 90.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 170.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.9 p -79.25 -17.81 54.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.792 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.84 -13.3 60.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 163' ' ' LEU . 65.9 tp -104.58 107.46 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.624 0.726 . . . . 0.0 110.946 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.13 -29.64 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.705 2.27 . . . . 0.0 112.293 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -80.45 -22.53 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -160.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 160' ' ' LEU . 98.4 mt -123.43 150.73 43.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -174.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -94.54 139.61 30.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.493 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 98.5 m95 -93.49 126.94 38.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.3 mt -93.47 -31.05 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.666 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.7 pt -138.06 148.47 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.4 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -155.19 122.59 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 166.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -128.92 134.88 48.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -117.08 119.95 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.7 pp -127.57 147.91 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -172.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.58 138.09 52.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -132.47 152.39 51.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -56.43 119.83 6.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.74 125.73 27.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.988 -166.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -123.46 28.99 6.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -94.3 -143.92 14.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.509 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 181' ' ' HIS . . . -77.63 -178.39 5.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.057 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -73.24 75.0 1.32 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.4 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 26.7 p80 -144.95 -178.47 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.8 151.54 31.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.57 -168.37 35.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.521 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -76.84 142.2 40.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -164.13 159.51 20.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.26 130.66 41.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.9 mt -124.43 150.83 45.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.973 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 133' ' ' ALA . 33.2 pt -125.65 144.66 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.94 134.19 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.755 ' N ' HD21 ' A' ' 190' ' ' LEU . 1.1 pt? -154.51 152.55 30.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.666 ' HB3' HG12 ' A' ' 167' ' ' ILE . 1.5 tt -138.17 130.59 29.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.6 171.21 52.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.538 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -84.92 123.36 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -115.33 109.96 18.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.26 134.16 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.906 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.34 -40.14 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.842 -179.775 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.747 0.308 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -155.02 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.961 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -159.87 159.95 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.24 133.46 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.51 144.93 51.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -167.77 165.03 14.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -159.53 169.95 22.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.839 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.0 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -158.98 168.14 27.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.27 162.31 25.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -149.98 125.09 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.7 t -120.6 110.88 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -163.97 139.87 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.35 171.15 43.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -129.46 170.47 13.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -124.63 147.84 57.1 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.658 0.742 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.44 154.51 71.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -147.53 178.43 8.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -164.29 161.79 22.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.2 143.88 56.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.88 -47.68 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -169.281 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.656 0.741 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.98 146.93 88.68 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.65 2.233 . . . . 0.0 112.373 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 pm0 -74.49 3.15 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -148.83 7.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.6 mttt -74.99 129.99 38.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.683 0.278 . . . . 0.0 110.968 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.61 129.07 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.101 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.06 120.56 40.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.32 124.44 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.0 mt -109.93 139.41 45.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -170.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.01 50.52 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 171.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -89.9 -21.43 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.1 -65.53 4.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -114.8 -27.92 7.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.92 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.26 31.37 55.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.548 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -65.68 -45.18 83.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -71.86 -27.41 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.98 87.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.8 m -67.82 -34.62 77.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.02 -45.56 90.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.78 -38.39 90.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.62 79.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.19 -15.62 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -83.97 -1.45 54.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.868 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.87 2.51 62.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.6 m-30 -78.68 145.34 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.32 106.65 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.23 125.61 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.4 m -109.47 126.64 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.85 127.33 56.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 81' ' ' VAL . 69.2 t -121.38 131.91 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.98 159.31 40.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -81.7 -21.44 38.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -93.8 114.08 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -67.16 -34.56 77.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.97 -31.66 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.194 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.66 97.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.17 -35.98 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.756 0.313 . . . . 0.0 110.915 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 -38.75 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.21 -43.72 90.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -62.33 -44.81 95.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.15 -42.24 94.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.76 96.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.39 -40.02 96.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.955 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.96 -30.08 70.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.89 -6.55 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.93 33.71 59.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.478 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.72 162.23 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.096 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -96.57 137.17 36.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.92 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 tt -137.25 150.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -111.7 135.24 52.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.3 p -123.2 135.19 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.119 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 57' ' ' VAL . 90.0 t -130.83 123.79 55.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -85.39 116.08 23.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -171.33 142.22 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -65.59 131.49 46.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 169.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 113' ' ' LEU . 87.1 mt -59.52 -28.83 67.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.81 68.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -103.35 -11.24 18.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.18 131.02 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -96.74 112.71 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.824 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.1 mt -94.19 119.86 42.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.48 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.144 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.38 93.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.81 -28.5 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.66 83.06 3.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.63 95.78 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -135.15 129.72 34.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.1 159.26 28.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.757 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.8 mm -109.93 117.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.49 127.42 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.406 ' CB ' HH22 ' A' ' 110' ' ' ARG . 64.1 m -115.4 115.87 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.49 120.94 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.16 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 41.33 54.82 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 71.3 m -101.57 95.4 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.902 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -75.24 110.44 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -156.38 151.98 22.2 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.558 0.694 . . . . 0.0 110.952 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 145.1 81.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.609 2.206 . . . . 0.0 112.385 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -58.08 -29.21 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.1 p -60.43 -30.85 69.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.7 tp -70.14 -40.84 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.406 HH22 ' CB ' ' A' ' 100' ' ' SER . 41.4 mmt180 -58.49 -40.31 82.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.29 -31.45 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -81.2 -36.07 30.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 85' ' ' LEU . 81.8 mt -70.42 -32.78 70.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.559 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.6 m-30 -50.76 -55.15 29.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.683 0.754 . . . . 0.0 110.891 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 36.0 Cg_endo -63.86 -32.78 66.21 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.09 -51.29 59.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.757 ' HB ' HG13 ' A' ' 98' ' ' ILE . 34.1 m -75.43 -31.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.11 -53.04 51.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.42 -33.38 75.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.51 -47.8 60.59 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.442 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 48.9 tp -89.59 138.98 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -62.07 151.82 79.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.898 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.95 138.94 51.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.24 3.22 82.37 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.505 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.442 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -73.0 172.88 49.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.513 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.64 140.09 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 111.154 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -111.1 136.46 50.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 191' ' ' LEU . 35.3 mm -120.66 128.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt -129.98 125.73 36.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -146.68 130.36 16.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 144.84 -172.2 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 177.3 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.798 0.333 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.36 -31.18 71.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.13 -37.14 86.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 84.5 m -65.99 -45.23 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.53 -46.32 83.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -70.14 -26.83 64.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 94.5 p -83.87 -27.64 28.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.88 -9.39 58.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.68 105.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.624 0.726 . . . . 0.0 110.866 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.46 -21.88 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.331 -170.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 94.8 p -65.23 -23.52 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.943 -159.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.591 HD12 ' C ' ' A' ' 163' ' ' LEU . 3.5 pp -141.18 163.1 33.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.07 145.9 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.52 131.55 40.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.62 -33.99 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 191' ' ' LEU . 46.1 pt -139.51 143.32 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.207 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 121.71 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -138.14 139.71 39.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -100.65 121.92 42.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 165.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -172.376 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.799 0.333 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.03 127.94 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.94 123.98 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 171.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.5 pt? -153.78 151.62 29.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.671 ' O ' HD23 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.91 130.77 24.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 -173.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.48 169.34 50.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.527 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 -173.406 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.6 p-90 -155.03 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.99 160.0 32.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -153.21 133.82 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.834 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -106.88 144.86 32.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.94 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.76 165.01 14.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -157.85 169.99 23.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.05 160.0 40.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.84 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -156.9 165.34 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -163.12 160.08 23.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -150.08 124.97 9.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.93 112.77 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.089 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.74 135.11 5.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.41 -165.29 36.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -125.03 174.42 8.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.108 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -125.48 152.21 71.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.8 148.46 90.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' HD22 ' A' ' 50' ' ' LEU . 29.5 p30 -126.79 -170.14 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -162.64 158.84 23.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -75.3 144.98 42.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.1 mt -73.87 -43.2 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.136 -167.185 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 121.648 0.737 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 147.47 74.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.398 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 18.7 pm0 -76.31 13.87 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.32 -135.59 2.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.3 mttt -96.23 131.44 42.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.842 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 52' ' ' TYR . 4.8 mp -123.42 131.67 72.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 tp -102.42 122.26 43.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.943 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -111.67 122.96 49.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.0 mt -107.22 131.95 53.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -168.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.95 52.53 11.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.03 -19.75 24.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.88 -64.89 4.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.542 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.64 -33.08 5.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.87 44.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.516 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.07 -43.14 88.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.69 -29.39 66.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -63.29 -46.24 87.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.2 m -64.33 -35.47 80.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.98 -43.79 98.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.836 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.52 -42.96 93.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.86 -35.08 74.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.6 p -68.72 -15.64 63.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 18' ' ' ASN . 56.0 mt -85.58 0.05 53.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.72 63.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.553 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.45 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 2.5 m-30 -77.79 147.51 35.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.946 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -92.82 104.44 16.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.975 171.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 44' ' ' ALA . 97.2 t -105.85 124.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.132 -167.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -109.6 128.03 54.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.7 127.37 56.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.7 t -122.78 134.12 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.03 160.98 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -77.38 -27.97 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -90.99 116.64 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 95.0 p -68.01 -35.13 77.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.85 -31.89 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.083 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.21 -40.36 97.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.511 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.78 -36.67 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.21 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.108 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.09 -36.98 83.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.66 95.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.047 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.07 -45.47 93.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.72 -38.84 84.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.34 -39.55 93.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.22 98.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.113 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.86 -38.43 90.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -32.37 73.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.6 -9.17 48.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.78 33.82 54.63 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.86 165.02 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.178 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.36 141.25 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -138.28 153.0 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -122.62 122.08 37.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.1 p -119.99 141.05 50.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -133.17 121.78 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -82.18 114.73 20.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.984 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -170.67 140.06 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -61.75 131.2 49.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 113' ' ' LEU . 82.7 mt -59.02 -28.73 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -28.68 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.07 -11.33 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.69 130.87 45.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.92 113.3 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.52 119.65 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.4 t -86.59 140.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.165 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -46.05 81.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.12 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -58.11 -24.01 57.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.17 88.74 6.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . 37.7 m0 -83.86 104.76 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -172.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.2 mt-10 -140.98 140.91 34.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.82 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.4 173.39 43.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.1 mm -121.8 120.5 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.1 127.59 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.122 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -121.31 114.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.78 123.5 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.75 53.7 7.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.47 99.42 9.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -86.28 114.03 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 172.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.49 153.69 28.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.656 0.741 . . . . 0.0 110.974 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.12 141.58 76.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.676 2.251 . . . . 0.0 112.291 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.1 p -58.57 -29.94 66.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.7 p -62.17 -29.85 70.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.1 tp -68.84 -39.61 79.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -60.1 -39.51 86.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -61.65 -34.19 75.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -76.78 -38.13 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.008 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 85' ' ' LEU . 75.1 mt -69.91 -33.71 72.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.55 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m-30 -50.01 -56.37 18.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.559 0.695 . . . . 0.0 110.945 -167.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 27.1 Cg_endo -60.81 -33.73 92.44 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.747 2.298 . . . . 0.0 112.311 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.28 -52.74 44.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.93 -29.02 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -64.91 -50.09 67.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.75 -32.3 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.864 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.46 -14.74 73.02 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.495 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.33 133.21 46.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.946 0.403 . . . . 0.0 110.932 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 95' ' ' TRP . 86.4 tttt -70.53 139.12 86.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 167.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.1 123.2 10.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.05 5.07 86.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.69 176.1 46.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -135.5 148.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.057 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -104.01 129.42 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.782 167.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.49 ' CD1' HD12 ' A' ' 191' ' ' LEU . 31.3 mm -117.3 123.82 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.12 125.88 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -152.26 138.01 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.5 34.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.788 175.852 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 77.9 tttt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.792 0.329 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 153' ' ' LEU . 4.4 tt -55.17 -45.36 75.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.08 -36.72 82.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.7 m -60.76 -39.59 89.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.12 -49.91 65.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -72.43 -26.24 61.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.5 p -79.63 -24.08 42.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.12 -10.62 43.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.47 97.06 50.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.884 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -91.8 -17.15 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -172.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.5 p -64.53 -22.19 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -159.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.958 HD12 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -137.93 154.85 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -74.87 139.24 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.94 119.79 36.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.87 -28.97 17.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.836 -169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 191' ' ' LEU . 41.4 pt -140.11 149.41 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.04 115.47 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 165.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -137.28 142.59 41.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -102.25 124.84 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -175.739 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.736 0.303 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.11 129.74 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -130.6 127.29 38.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -153.56 146.48 24.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.936 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 191' ' ' LEU . 0.1 OUTLIER -140.04 129.98 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -171.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.702 ' HA3' HD22 ' A' ' 163' ' ' LEU . . . -77.58 171.56 55.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.535 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 -174.51 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mmm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -154.63 175.93 13.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.13 160.02 32.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.23 135.43 14.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -121.93 144.91 48.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.39 165.06 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.1 p -158.5 169.95 23.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.96 159.98 40.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -157.8 166.03 33.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -162.65 160.01 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -129.93 142.55 50.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.57 106.43 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.094 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -155.96 163.02 40.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.89 -174.41 43.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -119.94 166.77 12.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.71 0.29 . . . . 0.0 111.162 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.8 149.93 70.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.68 156.43 60.94 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 0.0 112.367 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -139.99 -170.38 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.47 160.82 20.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -74.27 148.29 41.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.482 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.8 tt -73.32 -46.25 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG11 ' HG3' ' A' ' 130' ' ' GLU . 60.4 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.128 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.604 0.716 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 145.05 86.29 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.242 . . . . 0.0 112.379 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -73.5 1.82 9.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.36 -147.71 5.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.8 mttt -77.33 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -122.02 129.62 75.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 tp -102.21 121.47 42.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -105.81 129.2 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.28 126.49 55.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.99 54.25 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.162 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -89.99 -15.72 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 63' ' ' GLY . . . 88.92 -63.25 3.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.06 -9.19 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.23 23.28 76.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.87 -39.54 90.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -73.89 -28.51 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.88 92.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 70' ' ' LEU . 87.3 m -68.19 -35.13 77.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.4 -47.3 84.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.03 -36.22 83.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.56 83.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.413 ' HA ' HG11 ' A' ' 76' ' ' VAL . 60.5 p -68.64 -16.57 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.85 -0.27 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 3.62 63.98 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -81.08 145.77 30.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 -174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -85.24 104.97 15.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.947 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -109.64 126.84 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 -167.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -109.06 126.27 52.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 166.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.98 128.24 56.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -119.56 130.07 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.49 156.9 32.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -80.55 -20.12 44.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -90.49 115.2 27.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.6 p -66.9 -36.08 81.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.62 -31.91 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 39' ' ' GLY . . . -64.09 -40.93 98.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.552 171.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.12 -35.96 78.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.25 80.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.112 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.07 -38.51 91.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -62.65 -41.6 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.61 -44.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -62.64 -45.47 92.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 79.8 mt -62.62 -42.03 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -44.91 96.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.36 -40.17 96.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.19 -29.89 70.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -89.95 -5.15 57.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.43 56.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.9 m -128.76 163.88 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.174 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.12 144.83 27.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.03 149.9 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.2 m -110.88 133.0 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -124.22 136.75 54.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.9 t -129.58 122.08 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.48 116.25 23.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -172.38 143.25 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -57.53 125.77 24.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -55.22 -35.09 64.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.0 -29.63 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -100.61 -9.36 22.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.932 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.19 132.67 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -97.85 115.23 27.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.75 120.39 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.87 138.11 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.5 87.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.48 -25.99 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.22 86.48 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.143 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.49 95.36 5.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -132.24 135.29 46.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.23 162.33 53.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.7 mm -109.83 118.16 56.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -174.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.7 124.47 70.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 m -121.65 117.73 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.91 121.83 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.189 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 42.69 55.02 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.5 m -99.64 87.59 3.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -74.98 114.36 13.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -157.52 151.13 19.14 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.633 0.73 . . . . 0.0 110.927 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.43 142.51 80.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.619 2.213 . . . . 0.0 112.384 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -58.89 -31.41 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.9 p -61.73 -29.15 69.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.9 tp -69.21 -40.63 77.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -60.77 -38.87 86.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 114' ' ' TYR . 89.0 mt-30 -64.81 -32.49 74.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -74.15 -39.45 63.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.71 -29.78 66.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 m-30 -49.9 -56.12 19.48 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.64 0.733 . . . . 0.0 110.882 -168.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 30.3 Cg_endo -62.41 -34.31 76.92 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.762 2.308 . . . . 0.0 112.314 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.97 -49.83 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 98' ' ' ILE . 28.0 m -74.74 -30.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -65.43 -51.73 58.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.08 -34.49 78.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.12 -49.07 63.92 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.473 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 47.9 tp -95.01 135.83 36.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.995 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.53 153.11 84.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.859 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.8 141.75 53.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.41 2.33 79.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.473 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -70.45 170.83 44.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.18 139.79 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.159 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.91 139.57 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.89 124.88 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.52 124.96 29.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.772 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.439 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -157.89 139.86 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.42 -172.66 32.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.894 179.686 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 153' ' ' LEU . 3.0 tt -54.92 -45.26 74.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.43 -36.71 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.5 m -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.1 -50.33 61.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -70.07 -25.61 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.7 p -79.21 -23.99 43.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.7 -15.39 37.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.2 107.31 60.07 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.583 0.706 . . . . 0.0 110.849 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -88.55 -21.45 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.748 2.299 . . . . 0.0 112.403 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.8 p -70.22 -27.14 64.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -157.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -139.31 161.48 37.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.942 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.34 140.28 30.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -95.7 128.07 42.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.11 -29.3 16.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' A' ' 190' ' ' LEU . 36.3 pt -139.8 148.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.24 114.77 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.006 166.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -140.06 144.62 36.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -99.92 126.01 45.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 165.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -175.341 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.34 134.31 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -131.56 128.51 39.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -152.09 146.56 25.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -139.96 130.02 24.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -173.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.58 170.88 48.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.568 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.926 178.684 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -155.05 175.33 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -159.75 160.0 33.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.842 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.0 136.02 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -120.49 144.87 47.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -168.86 164.98 11.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -157.58 169.98 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.03 160.01 40.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.6 p -157.15 166.73 32.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.15 161.08 24.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -150.02 126.24 10.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.37 113.16 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -163.88 139.95 6.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.19 -177.76 48.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.489 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 p -122.77 161.5 23.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.331 . . . . 0.0 111.114 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.85 150.57 76.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.854 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.81 155.3 69.96 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -139.44 -176.53 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -167.17 167.92 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -69.41 145.6 52.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.489 ' O ' HD23 ' A' ' 21' ' ' LEU . 3.0 tt -73.98 -50.69 18.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 130' ' ' GLU . 61.8 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.639 0.733 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.95 147.96 89.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.617 2.212 . . . . 0.0 112.426 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -74.38 1.21 12.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -142.48 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.55 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.1 mttt -85.0 132.74 34.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.928 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.13 130.29 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.1 tp -101.19 121.61 42.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.81 131.94 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 mt -114.05 123.06 48.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.9 54.51 8.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -87.87 -17.2 31.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.56 -59.53 2.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.543 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -125.01 -3.92 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.905 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.607 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 71.9 20.95 79.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.585 176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm105 -67.61 -40.39 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -73.02 -28.14 62.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -45.64 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.073 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.6 m -67.52 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.888 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -58.62 -48.26 81.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.2 -36.3 83.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.07 81.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.34 -0.48 52.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.41 62.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -82.57 147.27 28.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.74 106.88 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.94 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -110.4 125.96 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.165 -166.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 m -110.76 127.1 55.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.48 129.58 55.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.69 131.81 71.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -156.69 158.74 37.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -77.81 -28.5 50.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -90.86 112.09 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.8 p -67.82 -33.28 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.67 -31.14 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.38 -39.2 96.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.462 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.74 -36.43 80.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.875 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.73 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.128 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.77 -39.45 94.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.32 -40.73 95.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.67 -47.28 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.09 -41.23 90.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.99 -39.21 91.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.98 -41.63 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.83 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.83 -32.63 73.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -91.15 -10.67 41.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.92 34.7 55.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.44 161.7 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.09 130.12 48.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -134.76 160.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -114.11 137.94 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.9 p -120.05 135.41 54.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.144 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.7 t -129.41 118.63 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.03 114.58 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -171.93 144.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -57.95 124.39 19.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -55.48 -37.01 67.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.13 79.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.08 -5.44 27.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.05 133.83 55.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -91.24 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.4 HG22 ' HA3' ' A' ' 120' ' ' GLY . 91.2 mt -95.22 119.43 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.52 137.3 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.36 -45.64 79.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.36 -27.62 68.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.98 76.44 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -76.04 100.3 4.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 91.2 mt-10 -131.7 138.2 48.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.22 162.89 39.36 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.517 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.31 117.76 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.54 122.71 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -125.43 115.89 20.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.9 124.85 65.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.141 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 43.93 55.08 5.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 73.7 m -107.08 90.94 3.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.948 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -73.99 119.97 18.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HB2' HD23 ' A' ' 109' ' ' LEU . 4.3 pp -148.5 152.27 38.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 150.21 53.99 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.616 2.21 . . . . 0.0 112.36 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -56.62 -34.7 67.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.788 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.2 p -62.11 -30.05 70.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 105' ' ' LEU . 55.2 tp -69.97 -37.84 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.953 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -57.22 -39.3 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.82 -31.63 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.98 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -80.37 -40.83 25.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.934 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.42 -36.74 66.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.966 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.6 m-30 -52.9 -56.56 22.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.63 0.728 . . . . 0.0 110.957 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 17.8 Cg_endo -55.66 -34.81 91.63 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.4 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.75 -47.05 56.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.19 -30.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.76 -51.61 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.986 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.26 -32.91 72.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.898 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -71.6 -42.56 54.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.1 tp -84.0 133.2 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.948 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -69.24 152.0 96.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.23 136.32 54.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.0 77.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.494 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.09 175.21 35.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.0 p -127.09 139.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -109.71 135.14 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mm -115.26 122.33 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.95 124.71 31.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.839 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -154.92 138.42 15.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 153.95 -173.52 32.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.427 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 58.7 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 153' ' ' LEU . 4.0 tt -57.26 -41.27 79.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.963 169.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.21 -34.18 75.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.2 m -63.23 -41.75 99.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.75 -49.62 72.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.37 -24.59 62.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.9 p -81.66 -24.67 36.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -82.76 -17.06 45.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tt -113.89 102.71 55.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.635 0.731 . . . . 0.0 110.869 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.28 -20.23 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.736 2.291 . . . . 0.0 112.356 -170.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.4 p -65.86 -23.81 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 -156.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 163' ' ' LEU . 2.8 pp -134.02 167.96 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.008 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -93.33 136.99 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 172.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -92.05 126.31 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.1 mt -91.39 -31.51 16.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.665 ' CG2' ' HB3' ' A' ' 191' ' ' LEU . 15.8 tt -143.41 137.38 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -166.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.05 116.66 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -140.06 144.27 36.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -98.65 125.54 43.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -173.977 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 132' ' ' PHE . 5.7 mp . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.736 0.303 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -109.52 132.14 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -132.99 129.07 37.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 168.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.542 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -153.47 146.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.934 171.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.665 ' HB3' ' CG2' ' A' ' 167' ' ' ILE . 0.3 OUTLIER -143.64 131.06 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -170.401 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.92 170.62 36.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.526 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 178.121 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -164.83 142.2 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.97 169.94 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.922 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -156.98 139.24 14.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -136.34 175.09 9.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.907 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.92 165.03 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.5 p -155.65 169.97 23.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.03 159.95 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -164.56 131.76 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.01 149.97 47.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -151.97 129.67 11.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.8 t -119.27 125.41 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -159.43 134.52 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.947 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.76 176.69 29.12 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.521 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.619 HG22 ' HD3' ' A' ' 17' ' ' PRO . 89.9 m -126.0 137.63 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.153 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -122.47 78.08 45.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.694 0.759 . . . . 0.0 110.943 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD3' HG22 ' A' ' 15' ' ' THR . 65.1 Cg_endo -76.77 155.58 34.93 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.712 2.274 . . . . 0.0 112.401 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -130.07 68.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -95.9 -160.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -48.92 145.59 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.18 -60.35 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.162 -168.412 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 121.565 0.697 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.44 137.28 25.41 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.83 3.12 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -169.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.44 -151.99 8.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.08 148.95 41.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.15 135.07 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.6 tp -105.96 121.24 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -109.17 126.89 53.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.91 138.32 42.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.45 53.3 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.34 99.74 11.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.858 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.36 88.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.518 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.1 7.46 6.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.8 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.63 25.08 70.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -67.35 -42.21 83.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.78 -28.39 55.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.937 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' HG11 ' A' ' 54' ' ' VAL . . . -63.2 -43.97 96.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.8 m -68.28 -35.81 78.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -65.35 -45.57 83.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 54' ' ' VAL . 80.2 mt -64.85 -38.84 92.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.01 76.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -68.45 -22.05 64.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.02 -4.42 59.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.37 56.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.454 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -80.55 140.34 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -89.79 109.52 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 167.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 47' ' ' LEU . 62.7 t -112.96 134.16 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.8 m -107.71 125.07 50.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.168 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.74 130.95 55.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.88 136.04 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.171 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -157.46 159.35 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -78.6 -25.07 45.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -102.93 128.38 49.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.6 p -69.82 -30.44 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.45 -33.95 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.9 95.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.521 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 -34.83 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.07 86.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.94 -35.46 81.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.8 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.65 -42.01 98.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.092 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.63 -42.35 98.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.83 -41.5 97.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.6 -40.8 98.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.67 94.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.033 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.16 -39.1 93.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -33.97 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.93 -11.97 34.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.01 35.3 57.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.38 160.55 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 0.0 111.14 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.38 131.1 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -134.65 163.28 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.4 m -115.74 135.88 53.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.2 p -121.56 134.97 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.9 t -132.01 123.94 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.73 120.04 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 t -173.66 144.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -62.16 127.44 31.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.67 -33.52 68.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.5 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.41 -7.0 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -63.26 130.96 46.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -94.07 113.11 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.576 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.3 mt -91.81 115.41 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.9 t -86.58 137.93 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.03 52.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.102 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.76 -27.18 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.817 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.77 86.18 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.107 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -76.55 100.09 5.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.22 109.88 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.58 127.96 35.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.483 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -100.6 125.1 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.397 . . . . 0.0 111.104 -161.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.6 129.01 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.3 m -101.95 117.98 35.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.54 114.75 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.582 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 53.6 m-85 50.2 56.19 8.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.2 m -107.92 88.77 2.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.848 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.62 111.72 20.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 171.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.2 pp -145.49 153.02 51.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.924 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.46 152.32 70.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.647 2.231 . . . . 0.0 112.295 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -58.69 -29.81 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.8 m -57.89 -36.11 71.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 105' ' ' LEU . 47.0 tp -71.65 -36.03 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -54.02 -44.02 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -62.92 -28.65 70.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 -37.16 28.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.76 -39.19 73.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.5 m-85 -52.01 -52.49 61.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.722 0.772 . . . . 0.0 110.961 -165.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.1 Cg_endo -68.37 -32.1 26.67 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.637 2.225 . . . . 0.0 112.329 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -71.72 -44.12 64.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.0 -34.33 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -71.16 -52.77 17.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.53 -31.57 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.576 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -63.35 -31.04 79.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.64 135.42 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.19 157.55 78.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.561 0.696 . . . . 0.0 110.887 165.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.41 125.1 11.67 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.77 2.313 . . . . 0.0 112.332 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.17 67.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.496 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.14 176.91 46.38 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.386 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.32 139.05 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 0.0 111.155 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -120.64 128.92 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 191' ' ' LEU . 86.9 mt -124.67 136.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 39.3 tp -123.99 125.66 44.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -153.04 136.13 15.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 148.62 -164.54 29.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.541 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -173.729 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.625 ' N ' ' HG1' ' A' ' 155' ' ' THR . 96.9 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.789 0.328 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.874 HD23 ' O ' ' A' ' 153' ' ' LEU . 5.3 tt -49.76 -37.16 28.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 170.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.21 -27.23 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.625 ' HG1' ' N ' ' A' ' 152' ' ' LYS . 92.2 m -63.34 -59.75 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -168.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.045 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.09 -15.07 61.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.801 ' N ' HD22 ' A' ' 156' ' ' LEU . 62.9 tt0 -68.98 -40.07 79.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.2 p -79.68 -20.78 45.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.01 -19.5 58.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 103.07 55.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.719 . . . . 0.0 110.842 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.83 -21.85 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.0 p -73.14 -23.35 60.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -158.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.485 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -135.59 158.33 44.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.935 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.64 143.07 28.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.519 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 99.2 m95 -98.91 128.74 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.9 mt -94.3 -30.21 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.937 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.55 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.0 pt -135.31 147.55 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 115.71 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -133.7 140.13 46.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.04 129.77 55.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 175.477 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 39.6 pt -125.46 143.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.71 129.55 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -153.01 149.7 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 167' ' ' ILE . 0.1 OUTLIER -140.08 132.23 28.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.26 173.24 54.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.549 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -171.877 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 ttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.758 0.313 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.1 m0 59.12 44.87 15.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -114.92 159.98 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -126.87 150.0 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.75 145.03 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.845 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.09 165.07 37.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -154.33 169.98 22.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.64 170.03 8.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.2 t -159.92 139.95 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.91 129.9 14.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.99 172.52 12.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -143.5 140.04 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -149.74 164.95 33.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.93 124.6 3.89 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.569 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.731 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 84.9 m -131.17 130.13 42.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.652 0.263 . . . . 0.0 111.258 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -134.61 115.97 12.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.813 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.27 146.3 50.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.596 2.197 . . . . 0.0 112.328 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -127.63 156.75 41.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -117.62 152.44 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 62.72 35.38 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.6 tt -61.0 -36.29 79.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.127 176.611 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HD11 ' A' ' 128' ' ' ILE . 81.7 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.648 0.737 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.23 111.46 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -79.44 16.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -168.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -99.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -101.44 133.22 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.65 127.78 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.85 125.95 50.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -106.2 122.85 47.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.69 43.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 178.67 105.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 8.4 tm-20 -60.36 -59.85 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.15 33.22 82.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 65.49 15.88 10.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.49 16.87 70.07 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.43 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -64.43 -46.68 82.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -79.33 -28.24 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.77 63.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.19 -30.02 68.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.13 -48.94 74.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -65.54 -37.13 85.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.09 85.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -67.86 -19.95 65.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -89.21 0.83 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 93.35 4.21 64.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -85.19 142.12 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.946 0.403 . . . . 0.0 110.819 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -89.73 104.43 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.92 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' A' ' 47' ' ' LEU . 96.1 t -107.35 125.76 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.054 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.6 m -112.53 125.04 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 167.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.06 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.13 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.78 134.07 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.9 t70 -155.17 158.85 39.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.7 -26.58 37.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.9 p -97.01 144.96 26.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.874 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.2 m -76.99 -37.78 54.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.68 -35.03 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 -170.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.6 -44.87 94.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.66 -36.17 80.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.56 -39.12 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.09 -36.67 83.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -60.6 -42.85 97.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.03 -43.69 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -63.72 -45.41 90.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -61.85 -41.51 97.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.98 92.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.45 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.01 -29.95 70.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.53 -5.56 55.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 31.87 60.94 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.05 161.39 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.159 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.23 131.34 54.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.37 169.45 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.093 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -122.88 131.95 53.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 p -120.8 133.95 55.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.7 123.34 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.174 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -86.65 113.37 22.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.981 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -172.19 141.6 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.75 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.31 133.79 55.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.82 -31.54 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -72.3 -27.12 62.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -101.87 -13.75 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -69.44 134.62 49.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.27 109.91 20.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.684 HG22 ' HA3' ' A' ' 120' ' ' GLY . 94.9 mt -87.64 124.63 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.66 138.19 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.97 -53.45 12.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.4 -27.81 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.18 86.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.109 -164.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -132.6 161.88 32.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.35 -44.17 4.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.06 157.55 15.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.4 mt -129.37 129.7 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.71 128.89 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -171.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 t -112.35 118.59 35.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.02 113.87 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.4 t80 42.72 52.2 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -105.53 96.42 6.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -82.16 121.0 26.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HD23 ' A' ' 109' ' ' LEU . 1.7 pt? -134.64 150.76 74.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.582 0.706 . . . . 0.0 110.905 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.61 151.68 69.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.8 p -53.94 -34.93 61.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.6 p -62.68 -35.98 81.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 105' ' ' LEU . 16.5 tp -75.45 -34.05 60.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -58.5 -43.82 89.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.18 -28.19 68.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.6 -42.99 12.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.85 -43.58 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -170.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.7 m-30 -54.05 -53.45 58.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 -170.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 38.0 Cg_endo -65.61 -29.8 51.83 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.59 -39.7 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.12 -43.41 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -63.87 -51.1 66.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.66 -31.45 72.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.684 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -81.15 -16.97 73.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.478 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.34 138.29 33.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.931 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.85 152.58 93.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.831 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.28 125.94 16.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.23 -2.7 88.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.562 -167.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.82 49.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.487 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.416 HG11 HG12 ' A' ' 28' ' ' ILE . 80.8 t -131.19 146.87 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 0.0 111.107 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -121.72 137.41 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 174.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' CD1' ' A' ' 28' ' ' ILE . 60.9 mt -116.92 135.89 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.5 124.57 40.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.958 162.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 23.5 pt-20 -154.11 145.63 23.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.928 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.68 -172.64 33.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.749 0.309 . . . . 0.0 110.903 178.586 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.815 0.34 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -65.82 -36.61 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 81.6 m -63.97 -40.8 97.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.64 -37.69 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -64.12 -36.07 82.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.4 p -83.76 -28.18 28.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -80.5 -13.93 58.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 160' ' ' LEU . 3.3 tt -115.49 97.89 49.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.739 . . . . 0.0 110.981 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -91.08 -25.13 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 -170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 82.7 p -66.09 -20.47 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -161.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 163' ' ' LEU . 1.8 pp -128.18 154.21 46.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -94.83 140.58 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.67 121.49 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.08 -32.7 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.4 pt -139.93 147.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.165 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.04 117.11 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.62 137.1 46.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -112.09 123.04 49.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.4 pp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.76 143.18 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 67.8 mt-30 -139.72 132.81 29.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.82 150.12 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.683 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.9 tt -139.92 127.5 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -108.49 140.28 15.48 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.402 . . . . 0.0 110.91 178.64 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.793 0.33 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.4 m0 58.96 44.98 15.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.51 159.93 17.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.16 149.95 49.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.96 145.02 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.98 164.94 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -154.94 169.99 22.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.67 170.0 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.96 139.98 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.04 129.56 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -161.57 163.81 29.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -121.78 131.03 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.114 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -143.76 163.09 34.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.14 155.13 8.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.53 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 17' ' ' PRO . 87.6 m -135.39 130.09 34.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 111.274 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -139.96 83.67 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 0.0 110.829 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD3' HG22 ' A' ' 15' ' ' THR . 25.2 Cg_endo -69.3 136.47 34.31 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.702 2.268 . . . . 0.0 112.305 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -122.7 172.12 8.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -144.86 -179.96 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 56.32 50.36 13.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -60.84 -49.71 76.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.913 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.654 0.74 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.55 112.43 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.314 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -78.68 3.27 16.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.939 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.38 -87.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.463 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 99.3 mttt -119.13 133.02 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.54 136.86 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 30.1 tp -94.74 121.01 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -103.11 110.5 22.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 90.5 mt -85.19 51.62 2.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.88 104.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.118 -171.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.5 tm-20 -56.18 -59.78 4.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.93 33.72 86.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.53 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 61.72 18.92 10.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.829 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.48 17.69 68.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -64.74 -51.74 60.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.325 . . . . 0.0 110.814 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -80.39 -29.27 37.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.74 82.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.039 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.21 -35.52 76.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.85 -51.13 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.509 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -66.88 -35.17 79.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.01 76.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.183 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -70.67 -15.97 62.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -86.46 -5.26 59.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.25 2.46 59.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.442 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -82.82 142.56 31.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -91.11 108.66 20.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.892 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 47' ' ' LEU . 90.9 t -108.76 131.0 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -109.66 124.12 50.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.95 130.88 55.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.53 134.43 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.2 t70 -154.3 159.45 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -80.77 -21.83 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -108.78 127.84 54.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.7 p -69.62 -29.81 67.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.77 -33.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.054 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.68 90.81 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.494 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.01 -34.83 78.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.32 94.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.17 -36.84 85.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.75 95.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.88 -41.13 97.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.29 -45.69 93.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.9 -40.44 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.36 97.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.98 -38.29 90.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.65 -31.81 71.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.32 -6.98 49.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.87 33.07 60.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.462 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.15 160.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 111.193 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -104.31 131.96 51.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.23 161.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.5 m -114.2 133.62 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.3 p -123.15 133.93 54.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.189 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.34 124.96 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.2 116.5 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 173.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -174.99 143.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.8 t30 -60.47 131.02 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.06 -36.96 73.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.46 -30.32 65.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -100.7 -7.06 24.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 84' ' ' ASN . 4.8 t80 -57.69 129.0 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -94.69 108.05 20.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.75 143.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.145 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.82 131.81 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.28 -48.99 60.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.139 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -66.82 -22.62 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.45 -22.26 66.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.041 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 34' ' ' LEU . 30.7 p90 -147.95 167.08 25.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -118.58 -31.35 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.45 154.74 16.75 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.67 128.08 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 111.121 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.84 132.59 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -111.02 120.45 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -110.4 115.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.185 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.686 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 68.0 m-85 46.37 43.01 11.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -104.02 68.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -172.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -74.34 117.49 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.41 153.16 81.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.629 0.728 . . . . 0.0 110.905 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -63.52 148.86 92.23 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.643 2.229 . . . . 0.0 112.369 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -54.15 -30.38 48.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -60.07 -42.75 95.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -73.02 -32.58 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -57.34 -45.08 84.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -32.3 73.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -43.06 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.44 -30.41 67.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.518 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -50.07 -57.99 10.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.67 0.747 . . . . 0.0 110.917 -172.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 33.8 Cg_endo -63.43 -29.57 71.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 2.243 . . . . 0.0 112.309 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -68.52 -40.08 80.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.69 -42.97 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -63.18 -53.03 59.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.62 -33.34 74.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.54 -31.76 53.19 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.427 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.3 tp -75.9 134.42 40.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.998 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.67 139.84 80.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.668 0.747 . . . . 0.0 110.86 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.94 126.69 17.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.776 2.317 . . . . 0.0 112.304 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.82 1.5 87.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.514 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.15 173.31 54.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.45 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.79 139.49 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -115.42 131.39 56.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.51 131.28 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.078 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -124.61 126.38 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -152.12 131.75 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 147.7 -155.76 26.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.446 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 -165.563 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 155' ' ' THR . 98.7 mttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 153' ' ' LEU . 5.7 tt -53.66 -41.77 67.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.22 -33.95 76.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 152' ' ' LYS . 87.4 m -61.49 -43.22 99.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.36 -39.12 92.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.35 -36.27 83.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.1 p -83.29 -29.71 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.787 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -83.3 -19.56 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.4 tp -107.44 106.41 58.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.868 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -88.53 -22.98 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.421 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.2 p -69.18 -23.65 63.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 -159.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.662 HD13 ' HA3' ' A' ' 192' ' ' GLY . 4.3 pp -139.22 160.42 39.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -105.56 136.12 45.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.17 127.77 35.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -170.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.03 -33.83 12.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.694 HG12 ' HB3' ' A' ' 191' ' ' LEU . 49.8 pt -139.12 145.77 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.09 120.6 2.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -132.12 140.96 48.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.761 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -110.84 132.01 54.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.71 0.291 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 30.9 pt -122.27 147.52 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.56 122.72 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.684 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -151.13 149.31 29.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.4 tt -140.04 128.39 22.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.662 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -116.41 148.72 18.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.453 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 177.35 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.745 0.307 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.95 44.94 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -111.4 159.94 17.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.64 150.02 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.6 145.0 46.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.97 164.94 38.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -153.51 169.94 21.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.58 169.98 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.94 140.01 11.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -145.36 121.98 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -159.52 165.04 33.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -101.16 131.11 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -149.73 166.09 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 154.52 21.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.547 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.2 m -126.18 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.75 0.309 . . . . 0.0 111.159 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -140.0 89.96 10.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.62 125.16 18.19 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -121.24 169.99 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -140.38 -177.89 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.16 58.9 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.58 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.176 -175.773 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' HB ' ' A' ' 126' ' ' VAL . 11.4 tt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.615 0.722 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.09 112.26 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.339 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -77.65 10.99 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 -170.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.26 -96.79 0.35 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -109.63 131.39 55.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.25 130.04 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.7 tp -101.48 122.66 44.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -114.8 114.97 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.923 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 85.0 mt -91.91 58.9 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.991 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -54.31 -60.07 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.78 35.58 92.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 60.11 19.54 8.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.832 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 16.07 63.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.557 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -65.09 -48.9 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -81.17 -30.15 34.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.97 -51.14 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -65.28 -35.77 82.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.53 -51.65 68.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.66 -37.11 86.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.82 78.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.2 p -68.11 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.7 mt -86.13 -3.28 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.97 3.64 61.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.519 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.3 m-30 -80.13 146.34 31.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -89.99 103.43 16.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.941 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -104.57 126.19 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 -170.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 m -112.78 128.93 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.163 166.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.2 126.67 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.155 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.27 129.97 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -157.89 163.43 37.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -78.19 -26.38 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -99.12 111.67 24.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.9 p -68.84 -27.99 66.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.91 -47.48 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.87 99.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.543 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.75 -36.48 84.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.4 89.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.26 -35.05 77.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.09 98.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.064 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.47 -40.87 98.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.17 -40.79 90.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.06 -40.59 96.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.66 92.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.83 -38.61 91.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.53 -32.74 73.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.43 -9.32 45.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.69 33.05 58.57 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.448 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.63 161.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 111.131 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -104.87 131.6 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.1 pt -135.03 165.99 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -123.21 131.87 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -120.72 134.71 55.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.125 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.41 124.86 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -85.09 119.54 25.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.1 t -172.06 140.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -57.34 130.6 46.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.78 -32.69 67.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -71.93 -29.74 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.042 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.04 -13.32 19.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.29 135.87 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.35 110.01 21.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.664 HG22 ' HA3' ' A' ' 120' ' ' GLY . 93.6 mt -84.07 125.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.2 t -100.76 139.17 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.96 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 99.1 m-20 -65.27 -28.3 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.61 68.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 -163.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -130.05 162.38 28.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.547 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 48.0 mp0 -114.66 -37.86 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.47 151.51 18.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.532 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.5 mt -129.19 127.99 66.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.345 . . . . 0.0 111.138 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.86 131.86 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -115.66 116.17 27.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.01 118.77 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.176 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 41.05 48.26 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.79 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.2 t -113.73 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -73.48 119.61 17.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.97 148.42 69.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.941 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.33 146.63 75.94 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.3 p -56.51 -35.33 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.3 m -60.48 -40.24 90.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 86' ' ' ALA . 45.3 tp -70.88 -39.94 72.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.932 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -55.46 -42.83 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.17 -28.56 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -82.19 -37.01 26.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.3 mt -71.79 -37.31 70.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.3 m-30 -50.07 -54.4 33.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.604 0.716 . . . . 0.0 110.92 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 31.8 Cg_endo -62.73 -32.53 78.32 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.765 2.31 . . . . 0.0 112.357 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -71.66 -39.7 70.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.51 -42.7 90.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -64.68 -53.85 40.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.74 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.977 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.84 -22.43 63.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.59 135.89 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.931 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.547 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.5 mttt -78.25 152.68 79.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.617 0.723 . . . . 0.0 110.815 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.14 125.64 19.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.43 3.58 86.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.65 171.18 50.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 28' ' ' ILE . 76.9 t -131.1 142.09 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 111.117 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -119.64 136.0 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -120.15 132.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 50.5 tp -125.6 129.11 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 168.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.53 129.42 13.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.0 -171.25 37.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.7 p90 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.904 179.107 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 54.4 tp -55.4 -39.87 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.09 -30.12 71.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 64.1 m -62.27 -59.66 4.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.008 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.27 -16.08 62.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -173.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.671 ' N ' HD22 ' A' ' 156' ' ' LEU . 88.0 mt-30 -69.35 -42.65 74.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.958 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.0 p -77.58 -21.84 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.18 -11.53 59.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 tp -114.13 100.99 53.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.935 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.78 -23.53 1.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.715 2.276 . . . . 0.0 112.425 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 74.6 m -76.12 -25.33 55.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -165.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -96.84 136.32 37.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -88.42 123.55 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -167.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.05 -32.23 16.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.643 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.2 pt -138.13 145.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.63 113.46 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 167.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -133.25 141.87 48.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.13 130.48 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 167.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.72 0.295 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 46.3 pt -120.23 143.47 31.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -144.54 127.1 16.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.85 149.44 28.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.4 tt -139.98 128.28 22.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.91 140.05 15.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.896 174.825 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.8 44.98 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.69 158.56 18.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.18 149.95 49.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.62 144.97 46.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -157.37 165.06 36.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -152.89 169.01 23.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.65 169.87 8.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.884 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -159.97 140.02 11.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.21 126.64 11.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -160.06 165.02 32.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.57 133.34 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -150.05 166.83 28.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.75 147.83 9.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -134.89 135.49 41.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.6 84.4 22.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.746 0.784 . . . . 0.0 110.87 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -59.91 129.89 32.41 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 0.0 112.296 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -133.53 158.95 41.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 172.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -123.32 -170.13 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 59.17 53.67 5.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.62 -34.26 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.215 -178.997 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.7 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.653 0.74 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.97 108.15 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.73 2.287 . . . . 0.0 112.298 168.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -80.03 18.35 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -166.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.23 -94.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.17 133.38 52.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.823 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.95 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.4 tp -101.3 122.38 43.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.7 t -106.07 112.6 25.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.45 52.04 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.06 105.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.042 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -63.2 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.05 35.49 92.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 60.0 20.02 9.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.817 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.3 68.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -64.87 -46.06 83.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.925 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.92 -33.0 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.26 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.1 m -69.18 -34.9 75.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.62 -49.43 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 3.1 mp -64.39 -38.19 90.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.68 79.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -68.96 -19.71 64.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 65.1 mt -93.3 2.99 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.29 6.03 64.98 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 73.1 m-85 -82.32 136.23 35.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.938 0.399 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -89.29 104.4 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.904 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -104.57 127.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.6 m -108.61 125.17 51.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.151 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.85 129.08 55.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.61 133.32 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.61 157.6 37.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -77.99 -22.38 49.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.0 p -114.53 132.19 56.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.1 p -67.07 -25.19 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.19 -44.63 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.028 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.43 93.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.08 -30.8 71.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.918 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.88 -34.97 72.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.068 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.39 -38.42 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.72 95.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.22 -47.57 76.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.969 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.34 -42.95 78.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.24 -39.48 82.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.941 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.98 94.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.06 -37.89 89.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.25 -33.1 74.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.47 -7.34 47.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.46 30.62 62.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.04 165.03 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.63 131.88 54.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.1 165.5 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -123.3 131.28 53.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.5 p -119.62 132.98 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.0 t -126.51 123.63 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -86.36 114.15 22.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -173.26 140.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -51.69 125.95 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.7 tp -58.33 -35.93 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.01 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.25 -7.71 31.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -64.44 135.16 55.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.6 111.02 22.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.702 HG22 ' HA3' ' A' ' 120' ' ' GLY . 90.6 mt -84.68 121.05 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.19 140.62 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.16 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.027 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.86 -29.19 66.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.93 79.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.062 -164.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -129.91 158.72 38.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.72 -42.37 5.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.96 157.06 15.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.18 126.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.82 132.34 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -112.83 118.17 34.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -111.4 114.11 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.194 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 42.89 46.43 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.413 ' SG ' HD23 ' A' ' 105' ' ' LEU . 32.4 t -103.25 91.75 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -80.98 121.06 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.4 pp -152.75 153.1 29.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.563 0.697 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.48 154.81 55.53 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.671 2.247 . . . . 0.0 112.371 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.0 p -57.32 -32.97 67.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.821 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -60.01 -39.34 85.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 105' ' ' LEU . 38.2 tp -71.68 -35.41 70.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.415 ' HG3' HD12 ' A' ' 105' ' ' LEU . 27.7 mtt180 -56.76 -40.2 75.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.998 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.36 -27.73 69.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.896 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.37 -39.81 16.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.14 -39.03 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.6 m-30 -52.23 -54.67 39.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.658 0.742 . . . . 0.0 110.873 -171.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.6 Cg_endo -61.93 -30.1 83.16 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.708 2.272 . . . . 0.0 112.341 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -72.5 -39.66 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.44 -40.93 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -64.21 -54.65 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.33 -30.2 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.989 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.702 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -78.59 -24.35 62.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.455 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.2 tp -82.16 136.81 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 110.911 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.1 154.67 86.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 0.0 110.847 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.91 125.78 16.67 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.705 2.27 . . . . 0.0 112.353 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.47 88.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.49 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.27 169.95 45.78 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 28' ' ' ILE . 79.7 t -129.02 142.58 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -119.27 136.52 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.1 mt -120.11 131.45 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.442 HD22 HD21 ' A' ' 190' ' ' LEU . 4.1 tt -127.93 130.5 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 167.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -150.15 140.87 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -164.47 -168.3 26.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -178.635 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.729 0.3 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.45 -45.19 80.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.879 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.05 -35.04 78.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 m -62.43 -41.19 98.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.2 mt -60.61 -42.14 96.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.81 -37.11 81.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.8 p -81.46 -28.12 34.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.03 -11.32 55.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.13 98.87 52.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.736 0.779 . . . . 0.0 110.962 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.99 -22.26 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.4 p -68.53 -21.48 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.0 pp -130.17 153.98 47.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.78 138.99 35.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -88.13 121.79 30.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.78 -30.43 19.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.6 pt -138.46 147.09 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 111.91 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 164.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -136.62 143.08 43.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.51 119.81 39.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 165.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.136 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.7 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.1 pt -121.46 141.59 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -138.47 137.49 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -155.64 147.69 23.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.833 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.654 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.1 tt -140.1 128.37 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.84 139.42 15.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 174.469 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.87 44.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.63 160.0 17.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.69 150.01 49.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.48 145.04 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.97 164.98 37.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.848 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -154.96 169.97 22.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -169.64 169.97 8.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -156.2 133.78 10.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -154.26 135.07 13.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.7 p90 -155.95 157.31 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.987 176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -122.26 132.97 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.091 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -137.13 126.69 25.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.52 166.81 23.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.631 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 86.9 m -119.85 132.31 55.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.727 0.298 . . . . 0.0 111.206 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -127.36 114.51 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 110.817 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.32 144.97 42.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.35 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.05 168.06 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -130.65 169.1 16.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 51.25 41.49 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.877 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.38 -43.1 86.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 172.898 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 126' ' ' VAL . 8.7 tt . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.665 0.745 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.3 114.35 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 0.0 112.324 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -74.93 -0.58 19.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.61 -96.13 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -170.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -99.05 125.6 44.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.4 127.68 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.11 121.54 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.868 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -108.09 112.67 25.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt -87.73 58.13 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.993 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.97 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.65 -60.0 4.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.64 32.24 83.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 62.08 18.52 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.9 16.16 72.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.539 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -63.54 -45.52 90.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.906 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -79.46 -29.97 41.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.77 -51.98 59.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 p -70.9 -29.62 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.03 -52.06 58.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.5 mt -67.41 -35.45 79.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.24 82.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.173 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -68.98 -17.39 63.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.26 0.61 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.937 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.71 2.68 61.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -87.1 144.86 26.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -90.17 109.02 20.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 47' ' ' LEU . 94.6 t -109.27 126.56 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.8 m -110.54 124.9 52.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 167.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.52 130.54 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.69 132.62 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.62 163.91 39.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -83.41 -21.22 33.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -104.52 117.88 35.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.0 p -67.12 -27.8 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.84 -46.1 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.77 -40.64 98.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.607 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.09 -35.62 81.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.33 . . . . 0.0 110.889 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.54 84.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.42 -36.86 85.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.34 99.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.35 -42.21 93.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -62.24 -46.98 86.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mp -61.49 -37.22 82.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.03 -45.98 83.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.69 -37.68 87.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -65.44 -29.82 70.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -92.88 -4.4 52.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.81 32.82 58.61 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.428 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.14 161.8 26.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.398 . . . . 0.0 111.104 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.58 131.13 54.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -133.54 163.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.7 m -119.56 135.48 54.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.0 p -120.23 134.58 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.195 -177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.8 t -128.56 123.5 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.177 170.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.88 114.88 23.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -173.49 141.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.834 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -54.99 130.79 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.96 -35.03 74.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.36 69.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -98.73 -9.51 24.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.05 136.74 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -92.89 108.76 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.698 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.3 mt -83.32 119.45 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.78 140.32 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -172.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.49 -54.69 7.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -71.21 -29.4 65.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.51 81.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -129.36 164.45 23.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.7 -40.62 4.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.56 155.59 16.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.76 127.0 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 0.0 111.19 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.78 130.44 72.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.8 m -114.96 115.95 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.801 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.42 115.95 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 49.8 43.75 24.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -101.0 73.12 1.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -80.49 124.03 28.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -144.83 150.98 48.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.658 0.742 . . . . 0.0 110.878 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.37 154.86 71.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.762 2.308 . . . . 0.0 112.339 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.2 p -54.26 -30.82 51.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.1 m -58.17 -40.7 82.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.38 -34.22 65.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.888 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -55.87 -44.73 78.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.25 -30.38 71.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -85.85 -46.4 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.19 -42.16 80.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 6.5 m-30 -53.02 -54.98 38.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -168.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.5 Cg_endo -62.0 -28.74 80.87 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.349 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.46 -36.85 65.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.97 -41.13 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.151 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.55 -53.55 50.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.65 -31.49 72.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.937 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -76.56 -26.98 62.03 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.476 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.93 136.6 36.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.918 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.45 154.55 85.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 126.98 19.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.39 88.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.475 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.26 169.98 50.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.532 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 28' ' ' ILE . 60.4 t -129.56 143.82 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -119.77 136.93 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.88 128.71 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 51.8 tp -123.41 129.77 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -153.46 134.72 14.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.952 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.01 -178.1 40.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.963 175.984 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.728 0.299 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.417 HD11 HD22 ' A' ' 190' ' ' LEU . 64.2 tp -55.03 -38.12 67.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.878 161.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.78 -33.76 72.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 73.8 m -63.22 -41.89 99.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.98 -40.75 94.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.972 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.08 -36.53 84.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -83.98 -27.64 28.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -169.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -80.31 -13.28 59.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -111.75 100.55 48.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.938 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.35 -21.66 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.4 p -68.53 -20.81 64.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -163.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.2 pp -132.55 155.35 48.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -99.43 137.53 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.08 125.08 32.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -93.0 -30.75 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.633 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.6 pt -139.73 146.16 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.09 116.41 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -131.47 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -123.24 129.98 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 171.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.78 0.324 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.7 pt -124.27 142.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -145.0 129.15 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.67 150.84 28.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.867 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.688 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.7 tt -139.95 129.93 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -175.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.03 140.19 15.92 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.935 174.125 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.703 0.287 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.3 m95 59.22 43.0 17.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.65 160.0 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.29 149.99 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.42 145.03 46.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.99 165.01 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.5 p -151.15 169.85 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.51 170.08 8.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -159.66 140.0 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.35 134.94 16.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.97 167.59 29.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.13 128.23 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.191 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.06 164.87 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.97 147.77 22.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.74 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 85.3 m -113.04 124.78 53.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 0.0 111.167 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.98 129.81 24.84 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.0 110.793 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 131.17 23.13 Favored 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.676 2.251 . . . . 0.0 112.343 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -135.01 167.12 21.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -141.98 179.33 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 56.56 37.86 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.724 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.9 tt -64.49 -40.46 95.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 170.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.213 174.117 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 126' ' ' VAL . 84.6 mt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.664 0.745 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.51 119.22 5.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 0.0 112.31 166.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -74.38 5.53 4.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.41 -96.11 0.51 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -167.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -100.81 125.08 47.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -120.43 129.34 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.6 tp -101.42 125.75 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.4 t -115.92 114.84 25.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.59 57.68 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.93 104.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.065 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.9 tm-20 -59.64 -60.05 4.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -176.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.83 35.93 92.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 173.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 60.41 19.75 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.25 20.53 60.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.476 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -65.29 -48.47 73.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.07 -31.1 50.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.79 -50.96 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.987 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.09 -35.71 81.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.28 -51.23 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -67.73 -35.34 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.8 81.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.128 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -67.28 -17.58 64.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.73 -1.81 58.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.74 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.28 4.16 61.21 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.534 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.9 m-30 -85.43 142.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.861 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -89.97 105.86 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.926 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.3 t -106.76 127.68 62.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -109.64 125.24 52.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.174 168.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.44 128.55 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 133.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.082 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.7 t70 -154.15 161.31 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -82.3 -21.13 36.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.9 p -108.54 131.32 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.6 p -71.73 -26.2 62.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.96 -47.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.01 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.34 98.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.56 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.34 -36.48 84.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.22 81.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.17 -35.57 79.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -62.36 -43.39 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.58 -41.25 96.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -62.19 -46.82 87.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.7 tp -60.07 -41.04 91.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.33 -43.73 96.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.53 -36.5 83.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -69.45 -31.17 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.42 -7.5 50.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 32.1 58.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.427 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.31 163.59 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.867 0.365 . . . . 0.0 111.194 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.97 131.33 53.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -135.39 166.41 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -122.88 134.17 54.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.159 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 p -120.01 134.04 55.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.113 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -127.55 123.97 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 170.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 63.8 tt0 -88.46 117.24 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.1 t -174.61 142.58 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -61.29 132.14 52.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.85 -25.02 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.92 60.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -104.42 -13.74 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.23 132.73 46.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.96 112.32 24.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' HA3' ' A' ' 120' ' ' GLY . 82.1 mt -81.39 122.11 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.85 139.92 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.134 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -59.41 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.18 -28.27 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.07 78.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -132.89 161.07 35.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -105.34 -44.99 4.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.97 153.87 17.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.466 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.1 mt -124.09 125.44 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.107 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.1 131.88 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.7 m -111.92 117.08 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mm -106.58 111.29 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 43.87 45.08 6.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 43.4 t -106.26 94.89 5.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -94.01 120.68 34.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt -128.29 150.16 73.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 39.2 Cg_endo -63.83 145.64 90.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.358 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.2 p -54.98 -34.35 63.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.1 p -62.34 -35.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.721 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.3 tt -76.27 -34.46 59.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.912 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -57.16 -42.62 81.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.97 -27.35 68.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.82 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -86.27 -36.01 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.27 -41.2 66.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -52.25 -55.06 34.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.69 0.757 . . . . 0.0 110.905 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 20.0 Cg_endo -59.74 -29.74 90.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.333 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.05 -41.02 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.98 92.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -63.69 -55.23 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.44 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.614 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.97 -23.93 60.76 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.62 137.52 34.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.78 154.1 87.14 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.1 126.93 18.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.778 2.318 . . . . 0.0 112.261 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.85 89.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.526 -167.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.13 173.82 47.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 28' ' ' ILE . 56.5 t -132.9 146.55 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.17 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -122.43 138.78 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' ILE . 69.2 mt -118.66 132.18 69.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.432 HD22 HD21 ' A' ' 190' ' ' LEU . 5.0 tt -126.28 130.1 50.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 167.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -147.64 135.58 21.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.81 -167.86 23.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.418 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 -178.21 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.5 -40.11 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 172.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.85 -30.97 68.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 90.7 m -60.6 -44.86 95.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.23 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.58 -39.35 94.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.36 -36.59 84.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -85.99 -26.35 25.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.05 -8.67 59.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.34 99.34 49.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 0.0 110.902 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -89.24 -20.74 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.699 2.266 . . . . 0.0 112.412 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -68.08 -22.12 64.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.4 pp -131.76 154.8 48.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.57 140.86 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -86.98 123.09 31.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 92.5 mt -89.63 -33.4 16.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.8 pt -141.57 148.41 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.067 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.99 114.21 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.036 167.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -131.39 140.58 49.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -117.6 129.03 55.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 168.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 29.9 pt -124.08 141.42 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -139.05 138.39 37.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.2 pt? -156.25 152.51 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 191' ' ' LEU . 6.8 tt -139.9 129.79 24.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.505 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.13 138.59 14.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.511 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.93 175.186 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 45.02 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -110.56 159.34 17.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.78 149.94 49.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.16 145.01 47.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.84 165.03 37.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.839 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.5 p -152.52 169.87 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.74 170.05 8.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.36 139.93 12.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.83 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.35 130.03 14.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -164.01 168.72 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.85 139.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.156 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.39 165.01 32.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.65 167.53 14.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.553 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.674 HG22 ' HD3' ' A' ' 17' ' ' PRO . 96.6 m -93.8 120.04 33.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.281 . . . . 0.0 111.229 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.66 80.32 22.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.771 0.795 . . . . 0.0 110.863 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HD3' HG22 ' A' ' 15' ' ' THR . 55.9 Cg_endo -74.18 146.16 35.91 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 0.0 112.288 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -137.9 157.73 45.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -150.64 -171.2 3.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 54.99 46.27 24.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.0 -43.01 93.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.144 -177.088 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' HB ' ' A' ' 126' ' ' VAL . 10.7 tt . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.654 0.74 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.08 112.79 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.616 2.211 . . . . 0.0 112.311 167.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -75.03 10.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.59 -100.4 0.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.98 133.36 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 88.9 mt -123.72 136.05 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 tp -95.19 121.77 37.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.899 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.42 113.97 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 83.0 mt -94.66 57.12 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.96 104.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -67.08 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 38.19 94.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 61.87 18.91 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.918 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.97 10.73 81.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.531 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -63.48 -45.58 90.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.945 0.402 . . . . 0.0 110.944 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.26 -33.6 37.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.09 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.3 m -66.23 -36.57 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.6 -49.29 75.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -60.83 -39.09 87.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.26 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.5 p -69.04 -18.32 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -83.34 0.24 46.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.77 64.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.512 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -80.11 143.68 33.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -86.97 103.57 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 47' ' ' LEU . 67.5 t -105.38 127.77 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -168.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.8 m -112.49 125.17 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.6 129.26 56.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.63 133.91 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -154.63 163.62 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -83.79 -20.77 32.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.974 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.7 t -101.75 117.26 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.808 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -65.0 -28.15 69.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.53 -47.97 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.01 99.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.52 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.28 -35.55 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.945 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.0 99.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.36 -42.84 99.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -66.64 -41.16 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.3 -39.78 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -40.99 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.43 -38.19 90.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.5 -33.72 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.38 -8.23 45.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.84 33.06 60.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.32 160.97 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.38 . . . . 0.0 111.113 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.57 131.01 53.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.814 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -134.73 166.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -124.85 131.2 53.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 p -120.32 135.17 55.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.132 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -130.26 125.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -84.89 116.6 23.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 t -173.76 142.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.501 HD21 ' HB3' ' A' ' 86' ' ' ALA . 26.8 t30 -58.73 130.06 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.38 -30.58 65.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 84' ' ' ASN . . . -76.12 -23.53 54.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -104.92 -13.45 15.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.884 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 84' ' ' ASN . 72.1 t80 -70.38 137.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -94.01 107.42 19.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.2 mt -88.2 125.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.34 138.88 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.74 -44.58 61.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.17 -26.62 66.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.69 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -164.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -130.1 156.73 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.796 -172.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.95 -40.04 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.76 159.92 15.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 88.3 mt -129.99 125.65 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.107 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.64 130.78 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -129.02 118.27 22.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.62 128.91 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.132 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.1 t80 43.73 52.64 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 51.0 t -115.53 88.32 2.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -80.84 117.55 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.8 mt -121.17 145.3 41.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.585 0.707 . . . . 0.0 110.899 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.9 Cg_endo -67.78 148.81 77.93 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.757 2.305 . . . . 0.0 112.303 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.7 m -54.17 -42.97 70.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.0 m -60.38 -39.77 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.54 -38.97 74.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 178.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.32 -41.65 89.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -83.56 -42.88 16.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.26 -42.22 60.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 -172.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.2 m-30 -54.51 -52.32 70.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.722 0.772 . . . . 0.0 110.923 -169.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 86.8 Cg_exo -45.1 -37.6 13.13 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 0.0 112.379 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -76.34 -37.07 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.51 -45.02 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.179 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 118' ' ' TYR . 2.7 m-30 -66.29 -54.45 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.07 -30.2 71.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.87 -29.56 67.04 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.512 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.18 133.6 38.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.344 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.48 153.12 78.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.701 0.762 . . . . 0.0 110.863 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.08 124.81 16.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.766 2.311 . . . . 0.0 112.31 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.56 87.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.524 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.54 170.91 47.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.441 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG13 ' A' ' 28' ' ' ILE . 77.5 t -129.18 140.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.116 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.97 132.54 56.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.8 129.88 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.069 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 190' ' ' LEU . 56.7 tp -126.01 123.54 38.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -148.98 132.85 17.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.71 -169.35 35.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 178.823 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.844 0.354 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.15 -42.64 91.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.903 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.49 -31.77 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.4 m -68.48 -56.17 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.111 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.31 -17.87 62.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 156' ' ' LEU . 66.5 mt-30 -73.84 -42.35 60.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 170.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -74.44 -20.71 59.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -83.59 -11.94 56.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.961 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -118.03 93.84 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 0.0 110.905 -174.096 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -89.2 -22.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.721 2.281 . . . . 0.0 112.397 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.2 p -69.9 -20.49 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -161.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.6 pp -131.49 154.96 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.09 142.14 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -89.35 119.35 29.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -169.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.64 -31.47 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 191' ' ' LEU . 47.8 pt -139.99 145.58 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.57 114.49 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -128.6 138.82 52.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -122.86 132.67 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.589 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.5 pp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.743 0.306 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.05 148.46 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.93 132.81 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.86 149.84 26.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.677 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.2 tt -140.85 127.7 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -176.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.89 142.09 16.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 178.156 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 44.97 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.62 157.97 19.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.61 149.79 49.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.5 145.03 46.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -157.89 165.07 36.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.787 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -155.38 169.96 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.62 170.02 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.918 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 t -159.99 139.84 11.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.18 128.54 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.672 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 54.2 p90 -156.96 159.04 37.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.947 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.6 t -122.95 132.98 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -138.13 125.15 21.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.57 158.73 15.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.69 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 94.2 m -112.66 131.78 55.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.49 105.12 21.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.727 0.775 . . . . 0.0 110.813 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -71.9 142.78 39.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.599 2.199 . . . . 0.0 112.323 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -127.25 170.34 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -126.88 149.29 49.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 60.25 49.5 7.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 177.486 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.4 tt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 121.706 0.765 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 52.8 Cg_exo -53.7 119.26 5.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.274 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -78.93 2.29 20.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -90.32 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.478 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.74 134.02 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 0.0 110.858 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -124.31 132.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.9 tp -101.62 122.66 44.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.82 117.36 33.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 85' ' ' LEU . 47.8 mt -88.01 54.88 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.95 105.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -168.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -60.12 -60.34 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.86 78.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.45 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 63.2 16.12 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.89 22.08 71.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.67 -51.59 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.76 -28.8 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -69.5 -34.6 74.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.901 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 97.9 mt -69.6 -35.05 74.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.76 85.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.4 p -68.72 -18.38 64.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.853 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.83 -0.87 57.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 96.27 4.81 59.58 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.408 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.18 145.23 26.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -91.53 108.06 19.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 93.9 t -108.65 131.24 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -110.4 128.9 55.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.21 132.51 56.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.3 137.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.122 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -155.01 162.46 41.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.821 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.45 -24.18 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.8 t -102.87 119.63 39.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.9 p -68.03 -26.67 65.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 170.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.19 -46.22 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.035 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -41.96 99.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.41 -35.94 82.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.95 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.87 92.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.94 -37.54 88.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.867 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.98 96.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.068 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.11 -42.64 99.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -64.72 -41.32 96.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.94 -40.18 92.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.85 95.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.103 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.11 -37.84 88.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.03 -33.09 75.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.21 -9.68 41.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 72.02 34.68 61.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.419 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.02 161.31 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -104.41 130.15 52.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -133.06 162.01 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -115.37 132.0 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.9 p -123.77 134.74 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.84 125.14 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -85.24 117.7 24.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.926 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -175.17 145.1 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.3 t30 -55.25 128.24 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 170.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.421 HD11 HD22 ' A' ' 36' ' ' LEU . 43.8 tp -57.93 -36.36 72.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.14 70.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -100.0 -6.12 27.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 84' ' ' ASN . 53.7 t80 -62.07 133.23 55.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -84.94 103.35 13.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.4 mt -87.49 123.14 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.133 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.2 t -102.02 134.21 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.54 -59.45 2.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.53 -22.76 64.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.97 68.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 -172.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.474 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 64.6 p-90 -147.46 160.77 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.44 -36.9 4.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.19 16.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.488 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 98' ' ' ILE . 3.1 tp -132.83 123.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 111.199 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.83 129.7 71.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -113.21 116.37 29.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.59 113.75 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.143 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 40.22 50.48 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.1 t -98.99 90.02 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -76.32 119.46 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 105' ' ' LEU . 2.3 pp -145.51 149.28 40.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.39 155.22 71.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.691 2.26 . . . . 0.0 112.331 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.6 p -54.16 -29.37 45.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -58.73 -40.43 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.798 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.9 -34.02 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -55.3 -44.42 75.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.08 -31.28 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -87.29 -50.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.86 -43.17 84.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -55.82 -54.26 53.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.698 0.761 . . . . 0.0 110.964 -167.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.0 Cg_endo -66.75 -29.33 42.79 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -67.51 -40.24 85.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -39.77 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.57 -49.7 75.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -64.74 -32.02 73.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.957 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.46 -31.3 54.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.3 tp -73.59 132.04 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -75.49 155.06 85.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -54.29 127.46 25.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.688 2.258 . . . . 0.0 112.294 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.58 4.1 87.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.457 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.0 168.83 51.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.0 t -127.0 139.18 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -111.8 132.66 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.94 131.23 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.21 123.94 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -150.28 128.98 12.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.04 -175.24 43.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.475 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.849 0.356 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 153' ' ' LEU . 5.4 tt -53.59 -44.0 69.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.99 -35.38 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.5 m -64.62 -41.74 95.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.24 -35.53 80.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.93 -33.77 70.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.0 p -78.27 -21.53 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -175.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.62 -22.4 56.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' CZ2' ' A' ' 165' ' ' TRP . 18.4 mt -105.36 102.85 39.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.679 0.752 . . . . 0.0 110.912 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.58 -27.76 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.788 2.325 . . . . 0.0 112.343 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.6 m -78.77 -17.07 56.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -165.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.639 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.9 pp -130.82 154.76 47.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.13 140.4 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.444 ' CZ2' HD12 ' A' ' 160' ' ' LEU . 99.1 m95 -85.08 126.24 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -172.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.86 -32.65 13.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.682 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.6 pt -140.1 146.73 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 153' ' ' LEU . . . -159.18 119.24 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 168.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -132.3 140.26 48.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.809 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -113.9 120.42 40.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.3 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -176.475 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.728 0.299 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.82 142.52 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.36 124.45 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -153.82 148.55 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -174.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.3 tt -140.03 129.73 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 -172.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -119.98 152.36 17.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.515 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.921 178.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.2 m0 59.1 45.04 15.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -115.01 160.05 20.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -127.47 149.96 49.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.09 144.98 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.776 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -157.02 165.06 37.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -155.04 169.93 22.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.52 169.95 8.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -159.94 140.06 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.85 128.7 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.65 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.9 p90 -163.64 162.67 24.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -130.22 136.76 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -138.34 149.25 45.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.93 172.41 42.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.64 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 88.7 m -124.3 129.56 50.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -119.76 96.23 49.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.702 0.763 . . . . 0.0 110.823 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.02 139.6 70.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.658 2.238 . . . . 0.0 112.355 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -129.5 170.22 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -129.96 165.15 22.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 52.55 39.44 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.7 -40.51 92.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 174.691 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.479 ' CD1' HD11 ' A' ' 128' ' ' ILE . 79.1 mt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.69 0.757 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.66 117.54 3.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.296 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -77.87 9.18 3.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.29 -101.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -99.95 133.6 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.703 0.287 . . . . 0.0 110.87 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.5 131.7 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.19 125.89 51.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.958 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.4 t -114.94 115.28 26.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 74.7 mt -88.37 58.11 4.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.05 105.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.088 -172.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 10.1 tm-20 -57.77 -59.74 4.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.09 34.85 90.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.469 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 62.06 18.34 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.946 0.403 . . . . 0.0 110.889 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.38 15.16 67.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.477 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -64.66 -49.63 70.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -79.36 -29.91 42.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.29 67.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.88 -33.97 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -61.15 -50.89 71.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 54' ' ' VAL . 95.4 mt -67.6 -36.82 81.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.47 82.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.159 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -70.59 -16.72 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -91.3 0.15 57.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.969 172.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.95 4.65 60.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.584 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -89.85 145.91 24.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -90.23 109.15 20.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.953 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.2 t -109.21 128.75 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -110.05 125.71 53.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.127 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.26 129.79 55.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 -172.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 134.68 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.83 160.55 41.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.836 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -80.6 -24.0 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -106.07 140.74 38.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -77.19 -28.01 53.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.88 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.04 -46.76 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.82 99.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.13 -37.08 84.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.0 110.882 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.57 90.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.39 -37.48 87.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -61.16 -43.2 99.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.085 175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -61.36 -46.45 90.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.59 -40.67 92.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.47 94.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.3 -38.17 90.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.84 -31.89 72.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.44 -8.22 45.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.923 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.8 34.18 56.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.437 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.8 160.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -104.38 130.81 52.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.86 165.33 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.3 m -119.43 133.82 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.4 p -120.73 132.75 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.12 122.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -88.51 116.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.3 t -173.35 141.49 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 88' ' ' PHE . 49.1 t30 -57.45 129.41 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.05 -35.08 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.916 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.32 68.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.079 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -99.83 -8.31 24.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ASN . 79.4 t80 -66.45 134.55 52.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.45 108.9 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.779 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.9 mt -81.4 122.16 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.7 t -94.31 138.74 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.15 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' GLY . . . -72.7 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -24.39 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.05 70.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -165.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.484 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 67.7 p-90 -149.55 161.28 42.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 45.8 mp0 -116.42 -35.46 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.73 147.89 16.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.484 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 15.9 tt -133.0 129.73 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.8 134.88 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -169.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -109.55 117.67 34.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.51 113.05 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.096 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 48.3 44.48 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.1 t -114.46 72.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -73.03 122.38 21.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.814 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.0 mt -131.59 151.76 79.24 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.565 0.698 . . . . 0.0 110.962 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.76 146.25 91.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.374 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -57.91 -33.33 68.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.0 m -61.28 -40.9 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.0 tp -72.31 -36.47 68.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -54.15 -46.61 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -65.86 -26.09 67.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.11 -38.2 32.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.19 -31.87 66.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.4 m-30 -53.09 -53.6 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.671 0.748 . . . . 0.0 110.956 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.7 Cg_endo -65.55 -31.28 50.94 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.698 2.265 . . . . 0.0 112.378 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.49 -42.67 82.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.94 -39.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.84 -53.66 52.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.54 -30.02 70.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' ALA . . . -80.16 -28.15 50.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.407 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.9 tp -78.84 131.75 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.2 mttt -78.92 153.08 77.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.634 0.73 . . . . 0.0 110.839 172.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.45 128.14 28.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.335 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.12 -3.59 86.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.457 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -71.62 171.89 46.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.431 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.23 142.52 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 163' ' ' LEU . 68.1 t80 -115.74 135.21 54.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 28' ' ' ILE . 84.5 mt -120.04 131.86 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.407 HD23 HD21 ' A' ' 190' ' ' LEU . 54.4 tp -128.82 126.59 40.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.961 169.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -151.91 142.65 22.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.33 -166.9 34.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.866 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.789 0.328 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 153' ' ' LEU . 4.8 tt -55.26 -46.78 76.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.58 -37.12 85.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.5 m -62.56 -42.02 99.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.84 -39.56 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.958 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -62.99 -37.75 88.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.2 p -82.98 -28.13 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -81.74 -14.36 56.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 160' ' ' LEU . 4.9 tt -107.71 102.19 43.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 0.0 110.899 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -89.12 -24.2 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.386 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.2 m -68.96 -25.28 64.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -164.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 127' ' ' PHE . 4.2 mp -123.06 145.89 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -95.31 136.75 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.73 124.88 35.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -165.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.1 mt -92.01 -35.93 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.5 pt -141.78 146.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.05 119.38 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -135.05 141.05 46.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -176.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -116.17 130.91 57.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 166.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.8 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 42.4 pt -120.81 142.73 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 169.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -142.21 126.96 18.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -146.72 148.57 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.721 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.8 tt -143.07 128.16 18.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.459 ' N ' HD23 ' A' ' 191' ' ' LEU . . . -122.2 154.7 16.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 176.074 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.722 0.296 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.05 44.99 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.86 140.23 37.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.11 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -133.93 145.02 49.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.1 165.06 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -150.9 169.79 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.65 170.02 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -159.42 140.04 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.81 134.94 18.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -153.71 169.29 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.74 132.73 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -145.19 165.04 29.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 147.25 21.27 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.777 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 92.0 m -116.48 129.02 55.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.633 0.254 . . . . 0.0 111.173 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -139.14 125.05 12.19 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.56 149.18 49.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -125.27 149.88 47.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.92 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -113.5 149.51 34.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 62.57 25.21 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.941 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.9 tt -64.52 -39.94 94.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.97 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.843 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 128' ' ' ILE . 89.7 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.637 0.732 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.96 108.37 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.315 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -78.27 18.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -167.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' HA3' ' OE1' ' A' ' 96' ' ' GLU . . . -84.59 -97.7 0.66 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -102.94 128.69 49.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.811 -171.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.2 127.99 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.089 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . 63.8 tp -106.66 123.36 48.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 t -111.44 116.79 31.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.16 60.21 5.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.99 105.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -67.07 -60.52 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -170.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.65 35.0 91.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 59.03 20.73 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.74 61.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.521 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -65.68 -46.4 79.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -77.57 -27.89 51.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.59 59.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.3 p -69.43 -29.18 66.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -64.83 -50.76 65.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.2 mt -65.27 -37.84 88.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.79 85.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -66.87 -20.17 65.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -89.63 0.44 56.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 94.92 5.0 61.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.474 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.88 143.88 27.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -90.02 106.85 18.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.896 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 47' ' ' LEU . 77.5 t -107.21 125.66 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.4 m -112.08 128.59 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 167.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.49 130.57 56.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.128 -174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 133.19 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -155.79 156.62 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -77.93 -27.78 49.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.039 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.0 p -96.03 149.62 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -168.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -80.11 -31.29 39.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.949 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.74 -48.19 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.51 98.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.574 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.62 -36.71 81.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.14 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.88 -37.3 81.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.72 99.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 174.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.18 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -68.41 -41.21 80.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.36 -40.51 96.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.16 96.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.51 -37.72 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -32.7 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.98 -7.28 49.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.69 59.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.89 163.77 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 111.165 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.24 131.35 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.43 170.19 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -123.93 130.66 52.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.5 p -121.92 134.35 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.87 123.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -85.86 114.37 22.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -173.6 143.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -55.4 133.23 49.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -57.77 -35.61 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 109' ' ' LEU . . . -71.62 -27.22 62.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.078 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -99.92 -11.92 20.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.23 135.02 52.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -93.19 112.63 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.501 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.4 mt -87.66 125.12 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.9 t -102.95 138.05 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.192 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 -61.13 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -168.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.42 -35.04 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.05 -38.97 65.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 34' ' ' LEU . 17.8 m-90 -132.28 154.83 49.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 122' ' ' LYS . 53.7 mt-10 -107.38 -43.56 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.52 149.87 18.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mm -113.91 123.93 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.28 129.47 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.5 m -115.51 118.23 32.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.6 mm -113.67 116.69 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.176 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 47.42 42.97 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.2 t -108.06 96.44 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -89.9 120.39 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.5 150.04 74.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.637 0.732 . . . . 0.0 110.926 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 144.32 88.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.285 . . . . 0.0 112.324 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -60.12 -40.3 89.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 37.1 tp -73.83 -33.38 64.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.937 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -56.38 -44.97 80.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -75.07 -30.23 60.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -69.98 -39.89 75.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.31 -34.83 68.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 115' ' ' PRO . 35.7 t80 -51.37 -48.92 84.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.917 -163.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 114' ' ' TYR . 98.0 Cg_exo -47.34 -46.09 20.78 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.386 176.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -76.81 -36.24 57.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.18 -47.13 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.23 -54.53 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.16 -30.45 71.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -84.91 -11.97 75.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.467 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.67 129.63 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 96' ' ' GLU . 83.8 tttt -67.91 139.9 93.52 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.857 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.5 127.61 18.71 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.722 2.282 . . . . 0.0 112.345 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.94 1.26 88.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.483 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -73.71 170.41 52.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.418 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.83 142.82 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.791 0.329 . . . . 0.0 111.206 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -109.59 128.27 55.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 28' ' ' ILE . 38.1 mm -118.5 131.67 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.139 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.526 HD23 HD21 ' A' ' 190' ' ' LEU . 58.4 tp -129.84 123.77 31.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 165.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -143.93 130.77 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.22 -167.38 30.13 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 176.558 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.859 0.361 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.6 tp -55.45 -44.81 76.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.95 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.1 -38.39 90.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.0 m -60.4 -37.08 79.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.19 -42.58 93.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.949 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -65.91 -36.23 82.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.1 p -78.18 -25.89 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -84.58 -13.77 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 tt -119.36 92.95 46.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.663 0.744 . . . . 0.0 110.946 -175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -89.53 -24.65 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 0.0 112.347 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.7 p -81.18 -15.36 55.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -162.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -114.51 140.03 49.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -86.35 132.85 33.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -92.29 114.48 27.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 191' ' ' LEU . 83.8 mt -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -175.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -138.61 145.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.37 113.73 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -129.11 139.19 52.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -118.41 128.76 54.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 175.273 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 44.2 pt -124.01 146.22 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.194 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -143.23 130.85 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -152.19 150.28 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.877 HD23 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.73 129.77 23.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.0 141.59 16.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 174.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.756 0.312 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -164.79 142.75 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.05 159.99 40.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -123.89 119.42 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.83 148.11 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -126.39 154.93 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.7 p -153.52 169.96 21.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.07 40.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.8 p -156.79 164.42 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -126.06 146.86 49.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.61 164.98 23.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.0 134.96 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.059 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -149.29 164.96 33.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.46 163.09 11.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -121.06 102.13 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.95 69.88 35.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 0.0 110.902 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.14 155.14 42.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.743 2.295 . . . . 0.0 112.314 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.2 155.02 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.46 170.14 22.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -60.02 133.38 56.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.83 -32.34 20.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.009 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 179.695 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 126' ' ' VAL . 68.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.62 0.724 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.88 153.06 79.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.741 2.294 . . . . 0.0 112.277 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.31 12.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 -173.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.58 -143.4 7.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.524 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.01 144.47 30.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.695 0.283 . . . . 0.0 110.948 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.49 135.05 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 55' ' ' THR . 51.0 tp -105.57 126.03 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -106.42 124.9 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.57 133.24 39.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.06 53.76 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.059 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' H ' ' A' ' 41' ' ' GLY . 54.0 tp10 -90.16 123.33 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.14 16.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.425 -166.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -129.99 10.02 5.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 38' ' ' GLU . . . 75.01 22.05 77.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.76 -42.11 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -75.12 -29.15 60.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.845 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.43 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.55 -37.27 76.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -63.06 -47.34 83.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 54' ' ' VAL . 70.0 mt -63.54 -38.82 92.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.28 79.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -70.64 -20.51 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.844 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -87.58 0.12 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.74 7.66 58.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -83.96 145.0 28.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.17 112.61 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 165.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 47' ' ' LEU . 89.9 t -111.44 135.72 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 34' ' ' LEU . 97.5 m -107.75 125.34 51.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 165.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.98 133.92 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.079 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.33 129.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 59' ' ' GLN . 49.5 t0 -154.5 153.24 31.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.424 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 92.4 mt-30 -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 174.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.3 t -95.67 115.45 27.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.83 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.0 p -69.07 -33.71 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.02 -31.37 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.78 -41.64 97.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.54 169.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.78 -35.04 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.29 88.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -64.29 -38.79 92.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.972 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.63 91.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.01 -43.16 99.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.1 -40.14 92.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -33.91 77.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.9 -10.99 34.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.92 66.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.416 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.39 161.7 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.169 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -97.37 129.97 44.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 pt -137.08 163.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.143 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.0 m -121.65 134.08 54.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.5 p -119.17 133.05 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.91 122.38 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -85.12 118.79 24.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 t -174.53 143.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.29 128.16 35.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.31 -38.59 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.33 -32.56 74.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -97.78 -6.37 32.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.99 129.89 42.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.9 114.93 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.879 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.426 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -93.76 117.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.191 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -83.69 136.23 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.051 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.39 -49.51 54.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -56.92 -26.09 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.74 80.6 9.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -69.86 130.14 41.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -173.14 150.81 1.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.49 163.33 46.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.473 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.6 mm -114.84 117.89 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.45 124.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.7 m -112.6 115.03 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.46 123.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 102' ' ' PHE . 53.8 t80 43.19 49.83 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.1 m -97.27 79.02 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -75.46 114.8 14.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.8 pp -152.04 152.71 30.24 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.618 0.723 . . . . 0.0 110.821 -169.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.85 149.74 78.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -58.1 -29.77 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -59.2 -35.96 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 105' ' ' LEU . 49.7 tp -69.87 -36.9 75.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.85 -28.02 69.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -82.43 -39.93 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.55 -32.56 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 m-30 -54.73 -55.23 40.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.715 0.769 . . . . 0.0 110.94 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 29.4 Cg_endo -61.69 -34.01 84.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.314 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -68.63 -46.42 69.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.94 -31.61 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -69.2 -57.11 5.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.71 -34.04 69.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -68.26 -31.12 74.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.696 HD11 ' HA3' ' A' ' 125' ' ' GLY . 57.7 tp -86.2 128.84 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.892 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.87 159.56 68.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.524 0.678 . . . . 0.0 110.911 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.04 133.53 46.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.44 48.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.696 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -75.54 168.3 54.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' A' ' 28' ' ' ILE . 96.1 t -131.95 140.16 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -106.46 131.88 53.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.7 134.4 66.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.19 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 59.6 tp -127.19 127.18 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 172.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.84 139.74 15.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.08 30.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.539 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.435 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 72.9 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.902 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.876 0.369 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 168' ' ' ALA . 3.3 pp -48.2 -30.78 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 96.6 mt-10 -65.1 -36.51 84.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.1 p -75.15 -31.84 61.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 156' ' ' LEU . 10.1 tt -64.2 -45.17 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 4.4 pt20 -66.46 -28.22 68.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.3 p -73.18 -16.09 61.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -78.97 -13.27 59.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.71 108.25 61.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.674 0.749 . . . . 0.0 110.947 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.4 -20.67 3.92 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.763 2.309 . . . . 0.0 112.309 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.5 p -71.66 -24.67 61.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -159.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.7 pp -143.2 168.1 20.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -104.94 144.61 31.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -96.56 128.66 43.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -88.72 -31.67 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -172.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 190' ' ' LEU . 43.3 pt -138.27 147.83 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.087 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -146.55 117.64 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 166.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -130.02 140.02 50.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -103.87 122.66 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 49.5 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -170.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.1 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.7 0.286 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 44.7 pt -114.11 142.48 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -135.25 123.06 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.72 147.65 26.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 191' ' ' LEU . 9.9 tt -139.74 129.89 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.25 147.6 18.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.461 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.882 -179.414 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -155.03 166.8 32.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.937 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -162.0 160.07 27.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -129.9 149.97 51.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -159.22 129.01 5.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.99 168.11 28.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 t -151.66 139.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.1 160.0 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -165.79 137.26 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.884 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -161.7 164.61 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.75 163.45 39.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.63 80.51 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.17 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.35 172.38 7.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.32 176.48 22.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -153.8 154.95 34.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.694 0.283 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.92 149.16 62.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.79 154.39 48.71 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.33 156.13 43.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.65 105.61 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.39 110.82 22.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.0 tp -70.12 -51.18 33.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 189' ' ' GLN . 49.0 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.6 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.605 0.716 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.41 131.32 27.26 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 0.0 112.335 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 84.4 mt-30 -75.91 13.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.947 -176.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.17 155.05 26.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 61.86 68.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 110.859 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 52' ' ' TYR . 47.7 mm -115.01 126.51 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.42 120.71 43.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.5 t -108.49 125.94 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.6 mt -108.63 135.45 49.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.11 45.77 25.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CD ' ' HB1' ' A' ' 56' ' ' ALA . 19.8 pm0 -71.45 -18.33 62.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 -175.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.18 -66.95 3.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -130.33 11.61 5.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 82.98 5.24 89.51 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.507 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -64.86 -36.94 85.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.938 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.51 88.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.6 m -68.46 -38.38 81.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.845 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -58.47 -51.95 67.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.1 mt -59.71 -40.06 86.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.29 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.073 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.1 p -69.75 -17.83 63.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.87 1.06 41.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.77 4.61 65.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.498 ' HB3' HG13 ' A' ' 33' ' ' ILE . 10.1 m-30 -74.12 147.0 43.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 0.0 111.004 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -84.98 101.96 12.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.856 166.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.22 124.5 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -165.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.6 m -112.28 126.06 54.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 165.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HB1' ' CD ' ' A' ' 38' ' ' GLU . . . -110.05 126.61 54.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.24 128.33 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -176.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.23 155.92 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -78.99 -20.02 50.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -93.67 110.96 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 94.3 p -67.81 -34.85 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.85 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.43 -30.92 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.92 97.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.42 -36.53 81.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.871 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.74 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.25 -38.62 91.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 173.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.65 -43.33 93.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.86 -44.72 96.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -66.82 -41.13 87.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.35 -41.07 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.35 93.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.158 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.81 -39.21 93.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.92 -32.87 73.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.948 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.82 -10.1 41.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.57 32.98 58.92 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.499 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.79 160.1 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.23 137.68 45.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.972 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.77 164.19 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -119.21 133.5 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.6 p -118.49 135.01 54.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.147 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.0 t -128.08 119.96 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -84.09 113.63 21.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -173.04 143.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -54.86 124.06 15.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.29 -37.35 67.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -32.08 72.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.75 -8.18 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.85 127.21 30.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.978 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.21 114.93 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 pt -126.58 141.82 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.089 168.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.91 -179.8 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.46 -34.11 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -173.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -29.23 70.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.0 94.54 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.074 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 122' ' ' LYS . 41.7 m0 -89.89 104.84 17.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.945 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.92 126.08 15.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.86 158.7 36.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -112.12 118.7 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.129 -171.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.1 t -121.37 124.34 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 103' ' ' CYS . 58.8 m -130.1 108.44 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.9 mm -114.53 125.67 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.159 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 48.61 40.26 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -171.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 100' ' ' SER . 87.1 m -118.67 82.13 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.892 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.1 130.98 34.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.9 mt -121.1 146.96 45.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.2 Cg_endo -67.67 147.6 76.26 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.604 2.203 . . . . 0.0 112.389 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -54.23 -40.25 67.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.913 -172.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.3 m -60.49 -38.91 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.841 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.6 tt -71.91 -39.98 69.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -59.71 -40.24 87.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.59 -29.42 70.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -83.62 -39.82 19.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.9 tp -72.15 -41.62 66.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.576 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 3.2 m-30 -55.37 -49.51 92.07 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.667 0.746 . . . . 0.0 110.951 -165.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 96.4 Cg_exo -47.32 -39.36 27.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.98 -47.89 19.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.38 -25.21 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -64.95 -47.67 76.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 175.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.9 -24.91 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.9 59.94 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.486 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -81.93 153.07 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 63.9 pttt -75.43 155.84 85.54 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.524 0.678 . . . . 0.0 110.895 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -56.22 122.7 12.25 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.64 -1.69 81.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.491 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.92 177.01 48.55 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.7 t -129.31 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.141 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -107.22 129.0 54.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.92 123.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 190' ' ' LEU . 63.2 tp -131.63 127.08 36.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 166.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -157.14 140.06 15.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.97 -178.59 35.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 175.707 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.9 tp -52.89 -46.81 68.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.63 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.4 m -63.37 -40.47 97.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.8 mt -59.81 -39.95 86.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -64.0 -34.25 77.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -81.88 -25.01 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -77.58 -15.47 59.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.88 98.28 28.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.51 -28.33 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.278 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 92.0 p -73.55 -20.69 60.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.785 -163.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.4 pp -134.12 159.11 41.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -103.42 139.72 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -88.16 124.9 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.26 -31.74 14.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.665 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -140.17 146.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.29 117.42 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -139.11 146.75 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -113.72 129.98 56.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.792 0.33 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.71 142.68 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.43 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.6 pt20 -143.19 128.13 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.71 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.61 147.57 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.665 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.7 tt -139.75 127.19 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -174.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -112.06 141.83 16.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.441 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.872 177.619 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mmm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.05 165.02 38.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -160.93 160.01 30.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.954 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -158.78 128.42 5.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.974 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.96 168.73 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -149.69 139.08 21.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.0 160.0 38.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.9 t -161.95 139.96 8.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.827 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -160.86 160.88 31.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -153.71 129.97 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.921 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -120.5 125.05 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -159.99 134.95 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.19 -175.91 40.96 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 t -153.9 155.04 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.99 148.08 58.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.752 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 155.04 47.92 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -129.9 160.02 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.806 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -141.76 99.85 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.39 132.57 44.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.56 -44.09 75.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 189' ' ' GLN . 67.9 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.579 0.705 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -39.31 125.05 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.347 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -60.06 -5.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.903 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.28 -174.56 17.62 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' TRP . 72.0 mmtt 64.98 65.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.58 131.8 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 58.9 tp -104.35 119.85 39.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 174.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -105.89 122.5 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.04 127.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -171.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 62.73 50.09 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 20.0 pm0 -75.61 -19.19 59.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.29 -70.06 3.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.493 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.54 -4.03 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.4 12.77 64.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.455 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.71 -37.41 84.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -67.29 -41.06 86.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.14 90.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.4 m -72.37 -34.2 67.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.62 -51.73 68.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.952 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.01 -35.82 80.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.18 86.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -71.07 -20.67 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.02 2.77 51.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.81 4.86 61.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -82.92 137.84 34.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 111.006 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -87.81 110.11 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.99 130.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 -170.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.6 m -102.9 125.01 49.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 163.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.29 124.41 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 -170.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.85 126.79 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.111 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -157.17 154.68 29.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -79.26 -19.99 49.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.961 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -93.67 111.61 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.828 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 96.1 p -67.36 -33.95 76.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.1 -31.29 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.042 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.68 -39.73 97.83 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 170.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.37 -34.64 76.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.14 82.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -62.5 -39.88 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.771 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.28 -41.66 97.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.061 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.93 -44.53 95.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -40.78 90.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 81.8 mt -61.71 -40.52 95.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.83 96.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.41 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.26 -34.09 76.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.84 -9.5 43.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.44 33.97 63.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.412 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.23 160.72 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.158 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -105.37 132.31 51.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.965 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.78 160.88 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.07 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -116.7 134.01 55.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.2 p -123.51 140.99 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 80.1 t -132.7 122.76 47.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.6 tm0? -83.37 116.91 22.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -174.83 145.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -55.18 123.17 12.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.901 172.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 113' ' ' LEU . 50.0 tp -55.78 -36.88 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.909 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -34.4 77.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.84 -7.22 27.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.29 134.8 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.948 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.37 111.29 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.8 mt -94.87 120.44 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.6 131.59 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.04 -43.59 33.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.12 -20.59 59.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.848 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.33 125.18 30.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 82.7 m95 -75.18 94.95 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 98.6 mt-10 -149.95 123.71 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 170.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.64 53.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.53 115.99 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 -172.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.96 129.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -135.04 112.67 10.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.424 HG22 ' CD2' ' A' ' 102' ' ' PHE . 25.6 mm -115.81 130.95 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 101' ' ' ILE . 71.3 m-85 53.51 44.87 29.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -173.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -117.07 85.67 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -80.79 121.6 26.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.3 pp -142.92 153.58 60.95 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.588 0.709 . . . . 0.0 110.966 -174.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.15 153.95 46.58 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 0.0 112.333 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -59.52 -33.24 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -60.13 -32.32 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 105' ' ' LEU . 52.8 tp -74.13 -39.31 63.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -56.4 -42.68 78.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.02 -32.23 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -78.9 -40.49 32.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' HG ' ' A' ' 85' ' ' LEU . 63.4 mt -73.73 -40.1 63.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.894 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.8 m-30 -53.55 -51.17 78.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.691 0.758 . . . . 0.0 110.877 -164.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 89.9 Cg_exo -46.94 -43.39 24.42 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 174.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.88 -45.99 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.6 -30.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -170.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -63.88 -51.18 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -71.68 -25.99 62.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.947 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.31 -52.61 51.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.404 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -81.31 153.97 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -88.88 155.87 49.88 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 110.923 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.01 130.17 26.88 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.772 2.315 . . . . 0.0 112.334 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.08 77.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.451 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.68 175.46 47.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.518 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.64 139.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -109.69 127.87 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.9 mt -122.44 128.37 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.035 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tt -134.34 128.3 33.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -155.55 139.97 16.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.54 -174.48 34.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 176.04 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.25 -45.39 87.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -34.98 79.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.8 m -64.84 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.158 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.95 -51.11 71.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.13 -31.82 69.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.7 p -75.56 -24.2 56.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 161' ' ' PRO . 97.3 mt-10 -83.82 -2.08 55.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.9 mt -104.47 95.11 7.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.597 0.713 . . . . 0.0 110.986 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 66.2 Cg_endo -83.14 -31.52 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.655 2.237 . . . . 0.0 112.277 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.7 p -75.81 -17.05 59.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.786 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 163' ' ' LEU . 4.5 pp -132.01 162.06 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 -176.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -107.63 130.56 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.862 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -87.27 134.8 33.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -170.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.42 -30.09 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' HB3' ' A' ' 191' ' ' LEU . 59.8 mt -129.91 138.47 53.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -170.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.06 111.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.078 162.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -138.31 145.91 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.16 129.93 56.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 170.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.96 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.752 0.311 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.2 pt -120.03 143.72 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.417 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.5 pt20 -138.16 134.36 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.918 174.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -152.11 150.54 30.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.74 ' HB3' HD12 ' A' ' 167' ' ' ILE . 3.5 tt -139.93 129.68 24.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -112.75 146.64 18.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.497 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.836 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -154.94 165.03 37.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -144.97 -175.79 4.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.825 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -162.15 163.57 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -137.05 166.88 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -150.59 126.0 10.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -107.79 168.14 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -125.03 154.94 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -159.94 170.0 22.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -160.79 160.48 31.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.0 168.59 26.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.22 160.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 53.4 p90 -163.45 149.95 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.89 172.07 42.14 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.403 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -156.65 -174.93 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.77 151.49 42.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.674 0.749 . . . . 0.0 110.937 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.57 123.07 11.17 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.58 2.187 . . . . 0.0 112.309 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -143.03 -164.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -84.95 -170.07 2.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.72 142.93 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.35 -49.33 64.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -179.41 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.608 0.718 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.8 133.13 55.99 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.613 2.209 . . . . 0.0 112.375 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.16 -2.65 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -78.06 -145.81 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.407 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.03 141.0 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.827 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.32 134.02 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 tp -102.38 121.89 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.33 113.99 25.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 64.3 mt -90.95 59.25 4.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -172.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.01 -60.26 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.53 39.06 95.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 171.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 60.98 19.73 10.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.82 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.85 15.62 67.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.437 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.95 -46.1 82.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 -172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.23 -40.09 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.02 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.041 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.7 m -65.51 -38.38 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.58 -51.64 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.71 -35.07 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.23 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.062 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 p -63.13 -13.99 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.24 -5.91 55.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 97.38 -6.39 63.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -102.41 148.19 25.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.04 117.71 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.37 147.5 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -114.39 130.56 56.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.91 129.95 56.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.1 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 81' ' ' VAL . 49.3 t -117.29 132.47 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -159.74 162.52 34.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.07 -28.8 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -86.52 109.56 19.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -171.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.491 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 91.3 p -69.2 -36.25 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.85 -33.37 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.77 96.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.4 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.07 -34.89 79.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.55 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.95 -36.18 82.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.17 96.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.17 -42.48 98.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.0 -40.76 95.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.9 -41.35 97.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.73 95.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -64.2 -38.54 91.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.8 -33.55 75.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.4 -9.08 42.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.75 59.38 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.438 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.98 159.99 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.125 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -101.74 130.72 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.43 159.95 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.1 m -117.99 133.3 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -121.73 137.09 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 57' ' ' VAL . 96.1 t -127.84 119.88 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.13 173.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.0 tm0? -85.09 114.42 22.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.866 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -173.41 145.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -58.41 125.22 22.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.93 -33.29 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.04 77.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -97.14 -8.54 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.49 132.4 49.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.75 111.91 23.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.5 HG22 ' HA3' ' A' ' 120' ' ' GLY . 89.9 mt -85.12 114.76 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.3 134.34 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -170.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.6 40.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.57 -22.56 56.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.835 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.37 92.54 7.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CZ3' ' HA3' ' A' ' 31' ' ' GLY . 87.9 t90 -69.8 117.64 11.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -172.96 159.74 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.25 167.86 49.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.414 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.22 125.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.118 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.49 125.81 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.2 t -116.52 113.63 23.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.68 117.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 45.1 54.97 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 74.3 m -105.03 92.07 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -82.71 120.09 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.0 pp -156.14 150.88 20.46 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.991 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.1 149.48 89.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.76 2.307 . . . . 0.0 112.43 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -57.7 -29.71 64.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 -38.11 71.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 105' ' ' LEU . 25.7 tp -77.19 -35.96 55.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -54.59 -43.66 72.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.97 -24.64 67.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -85.09 -37.61 20.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.49 -35.84 68.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.931 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.0 m-85 -55.02 -52.66 69.19 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 0.0 110.926 -171.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.2 Cg_endo -65.23 -27.74 56.07 Favored 'Trans proline' 0 N--CA 1.466 -0.129 0 C-N-CA 122.739 2.293 . . . . 0.0 112.361 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -70.43 -39.11 74.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.791 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.7 -40.65 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.05 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.67 -57.25 10.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.47 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.5 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -72.18 -40.7 55.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.528 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.3 tp -79.78 121.06 24.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.394 . . . . 0.0 110.876 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -80.01 153.76 74.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 110.888 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.91 129.9 35.16 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.342 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.32 -1.4 64.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.416 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.554 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -81.75 170.28 51.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 164.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.5 t -125.16 141.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -106.65 129.36 54.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 169.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.43 129.61 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt -126.8 130.07 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.99 132.58 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.49 -168.6 32.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.453 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.975 178.277 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.53 -49.48 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.912 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.56 -33.11 74.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 53.5 m -71.57 -56.99 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.08 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.57 -20.65 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.601 ' N ' HD13 ' A' ' 156' ' ' LEU . 10.4 pt20 -75.72 -33.34 60.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -78.53 -19.26 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -84.43 -14.57 48.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.25 109.87 63.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.81 -20.28 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.356 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.3 p -61.63 -29.04 69.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -158.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.705 HD11 ' HA3' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -148.14 164.14 34.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -174.23 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLN . 96.6 m-20 -92.58 148.02 22.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -89.65 128.43 36.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.55 -33.8 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.9 pt -139.3 146.99 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.06 116.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -145.01 148.53 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -109.91 133.11 53.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -174.876 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.792 0.329 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.58 143.45 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -149.01 136.2 20.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.653 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.8 pt? -155.72 150.02 25.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 167' ' ' ILE . 6.4 tt -140.66 131.37 25.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.934 -169.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 163' ' ' LEU . . . -84.96 173.77 49.09 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 -172.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 164' ' ' ASN . 66.5 tt0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -124.9 -74.99 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -162.0 160.82 28.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -126.01 154.67 42.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -151.76 130.07 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -160.47 165.04 31.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -157.42 169.94 23.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -159.94 132.77 6.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.4 p -156.9 168.02 28.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.81 134.96 15.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.866 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -155.86 167.26 30.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.0 160.71 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -162.27 165.24 26.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.06 176.75 24.24 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.579 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 17' ' ' PRO . 85.7 m -125.08 119.51 28.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -125.42 77.76 68.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.654 0.74 . . . . 0.0 110.932 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.665 ' HD3' HG22 ' A' ' 15' ' ' THR . 73.5 Cg_endo -76.62 153.54 34.34 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.651 2.234 . . . . 0.0 112.429 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -77.35 157.19 30.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.12 -35.98 70.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -113.81 152.51 30.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.82 -55.2 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -169.571 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.64 0.733 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.18 144.77 82.51 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -75.51 11.22 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -170.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.18 -130.37 3.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.53 139.31 32.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -174.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 81.8 mt -124.22 131.79 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 173.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 tp -106.91 120.28 41.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -105.63 127.04 52.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.7 120.8 40.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . . . 55.48 54.61 8.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 pm0 -70.23 -17.71 63.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 -172.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 -111.54 4.26 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.66 -41.5 70.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 110.904 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.59 13.88 62.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.447 176.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -65.83 -35.06 79.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.81 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.51 -33.07 72.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.92 97.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.8 m -65.82 -35.89 81.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -62.61 -44.51 96.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.56 -43.0 99.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.906 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.81 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.5 p -71.02 -20.26 62.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.878 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.2 mt -85.68 -1.59 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.41 8.59 59.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.51 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.78 147.69 35.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.33 105.05 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.82 120.73 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -165.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.8 m -117.44 124.95 50.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.26 131.87 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.157 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.02 134.83 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -155.31 157.21 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.28 -20.09 41.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.0 t -93.13 111.38 23.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.7 p -67.8 -34.41 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.29 -31.35 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.105 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.26 98.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.92 -38.09 89.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.74 86.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.132 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.81 -39.98 94.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -63.16 -41.88 99.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.33 -43.28 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.7 -45.5 93.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.06 -41.3 98.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.87 93.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -64.56 -38.92 92.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.79 -31.79 69.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.21 -8.3 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.19 56.05 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.469 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.66 160.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.348 . . . . 0.0 111.195 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.85 135.5 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.866 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.4 pt -137.32 160.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -108.55 135.4 49.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.3 p -117.65 135.62 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.97 122.78 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -87.45 111.44 21.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.954 172.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -172.93 143.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -59.51 125.67 24.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 171.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.46 -36.38 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.5 -31.48 68.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -100.06 -9.23 22.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -89.79 112.22 23.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -98.59 115.75 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.29 139.36 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.25 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.76 -23.79 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.922 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -52.38 10.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.79 139.82 32.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -164.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -126.72 166.47 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 42.73 71.05 0.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.482 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -92.73 130.47 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.08 130.39 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -173.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.4 t -103.71 118.09 35.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.01 115.03 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -169.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 61.6 m-85 47.38 48.81 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 88.8 m -99.61 74.04 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.874 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -76.7 114.96 16.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -153.48 153.38 29.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.517 0.675 . . . . 0.0 110.952 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 149.56 89.14 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.7 p -57.79 -30.57 65.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.812 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.6 p -62.77 -31.28 72.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.1 -35.53 66.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -55.16 -39.93 70.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.764 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -63.18 -30.86 71.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -82.77 -35.68 26.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -73.51 -41.55 62.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 8.3 m-30 -55.01 -48.06 96.96 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.71 0.767 . . . . 0.0 110.907 -164.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 84.8 Cg_exo -49.82 -41.75 45.99 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.254 . . . . 0.0 112.353 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -78.67 -46.03 20.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 77.9 t -73.31 -54.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.035 -165.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -80.04 -38.66 31.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 -168.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -69.15 -30.13 68.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -70.92 -14.85 73.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.27 124.33 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.07 139.78 97.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 0.0 110.9 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.27 130.37 32.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.92 -1.52 85.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.425 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.82 178.65 51.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.462 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.06 147.04 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -112.98 133.45 54.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mp -121.97 135.52 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 190' ' ' LEU . 47.3 tp -121.17 129.35 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 171.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -157.54 134.18 9.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 172.81 -171.67 44.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.513 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -177.458 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.619 ' N ' ' HG1' ' A' ' 155' ' ' THR . 61.2 mmtt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.821 0.343 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 156' ' ' LEU . 45.6 tp -49.48 -40.45 37.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 171.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.95 -30.74 71.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.619 ' HG1' ' N ' ' A' ' 152' ' ' LYS . 95.7 m -66.5 -60.24 2.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -171.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.076 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.43 -16.5 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -177.032 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.603 ' N ' HD22 ' A' ' 156' ' ' LEU . 65.0 tt0 -66.18 -40.91 90.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 170.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.9 p -79.25 -17.81 54.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.792 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.84 -13.3 60.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 163' ' ' LEU . 65.9 tp -104.58 107.46 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.624 0.726 . . . . 0.0 110.946 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.13 -29.64 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.705 2.27 . . . . 0.0 112.293 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -80.45 -22.53 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -160.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 160' ' ' LEU . 98.4 mt -123.43 150.73 43.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -174.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -94.54 139.61 30.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 98.5 m95 -93.49 126.94 38.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.3 mt -93.47 -31.05 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.653 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.7 pt -138.06 148.47 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.19 122.59 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -128.92 134.88 48.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -117.08 119.95 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.7 pp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.767 0.318 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.65 144.66 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.94 134.19 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -154.51 152.55 30.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.653 ' HB3' HG12 ' A' ' 167' ' ' ILE . 1.5 tt -138.17 130.59 29.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.6 171.21 52.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.538 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -169.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.747 0.308 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -155.02 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.961 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -159.87 159.95 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.24 133.46 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.51 144.93 51.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -167.77 165.03 14.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -159.53 169.95 22.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.839 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.0 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -158.98 168.14 27.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.27 162.31 25.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -149.98 125.09 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.7 t -120.6 110.88 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -163.97 139.87 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.35 171.15 43.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -129.46 170.47 13.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -124.63 147.84 57.1 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.658 0.742 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.44 154.51 71.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -147.53 178.43 8.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -164.29 161.79 22.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.2 143.88 56.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.836 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 95.7 mt -81.88 -47.68 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.23 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -125.77 -46.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 162.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.18 19.43 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.836 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -65.14 -6.71 9.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.094 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -61.89 -5.82 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.43 -2.43 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.3 132.97 91.4 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 111.105 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.98 146.93 88.68 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.65 2.233 . . . . 0.0 112.373 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 pm0 -74.49 3.15 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -148.83 7.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.6 mttt -74.99 129.99 38.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.683 0.278 . . . . 0.0 110.968 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.61 129.07 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.101 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.06 120.56 40.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.32 124.44 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.0 mt -109.93 139.41 45.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -170.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.01 50.52 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 171.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -89.9 -21.43 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.1 -65.53 4.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -114.8 -27.92 7.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.92 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.26 31.37 55.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.548 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -65.68 -45.18 83.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -71.86 -27.41 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.98 87.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.8 m -67.82 -34.62 77.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.02 -45.56 90.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.78 -38.39 90.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.62 79.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.19 -15.62 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -83.97 -1.45 54.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.868 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.87 2.51 62.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.6 m-30 -78.68 145.34 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.32 106.65 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.23 125.61 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.4 m -109.47 126.64 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.85 127.33 56.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 81' ' ' VAL . 69.2 t -121.38 131.91 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.98 159.31 40.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -81.7 -21.44 38.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -93.8 114.08 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -67.16 -34.56 77.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.97 -31.66 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.194 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.66 97.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.17 -35.98 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.756 0.313 . . . . 0.0 110.915 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 -38.75 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.21 -43.72 90.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -62.33 -44.81 95.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.15 -42.24 94.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.76 96.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.39 -40.02 96.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.955 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.96 -30.08 70.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.89 -6.55 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.93 33.71 59.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.478 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.72 162.23 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.096 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -96.57 137.17 36.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.92 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 tt -137.25 150.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -111.7 135.24 52.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.3 p -123.2 135.19 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.119 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 57' ' ' VAL . 90.0 t -130.83 123.79 55.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -85.39 116.08 23.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -171.33 142.22 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -65.59 131.49 46.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 169.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 113' ' ' LEU . 87.1 mt -59.52 -28.83 67.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.81 68.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -103.35 -11.24 18.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.18 131.02 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -96.74 112.71 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.824 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.1 mt -94.19 119.86 42.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.48 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.144 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.38 93.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.81 -28.5 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.66 83.06 3.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.63 95.78 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -135.15 129.72 34.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.1 159.26 28.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.757 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.8 mm -109.93 117.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.49 127.42 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.406 ' CB ' HH22 ' A' ' 110' ' ' ARG . 64.1 m -115.4 115.87 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.49 120.94 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.16 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 41.33 54.82 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 71.3 m -101.57 95.4 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.902 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -75.24 110.44 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -156.38 151.98 22.2 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.558 0.694 . . . . 0.0 110.952 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 145.1 81.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.609 2.206 . . . . 0.0 112.385 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -58.08 -29.21 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.1 p -60.43 -30.85 69.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.7 tp -70.14 -40.84 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.406 HH22 ' CB ' ' A' ' 100' ' ' SER . 41.4 mmt180 -58.49 -40.31 82.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.29 -31.45 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -81.2 -36.07 30.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 85' ' ' LEU . 81.8 mt -70.42 -32.78 70.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.559 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.6 m-30 -50.76 -55.15 29.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.683 0.754 . . . . 0.0 110.891 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 36.0 Cg_endo -63.86 -32.78 66.21 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.09 -51.29 59.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.757 ' HB ' HG13 ' A' ' 98' ' ' ILE . 34.1 m -75.43 -31.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.11 -53.04 51.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.42 -33.38 75.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.51 -47.8 60.59 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.442 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 48.9 tp -89.59 138.98 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -62.07 151.82 79.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.898 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.95 138.94 51.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.24 3.22 82.37 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.505 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.442 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -73.0 172.88 49.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.513 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 194' ' ' LYS . 2.7 p -127.64 140.09 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 111.154 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -111.1 136.46 50.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 191' ' ' LEU . 35.3 mm -120.66 128.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt -129.98 125.73 36.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -146.68 130.36 16.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 144.84 -172.2 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -63.32 157.4 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 188' ' ' ILE . . . -96.7 153.99 38.55 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.516 0.675 . . . . 0.0 111.175 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.56 -28.89 23.2 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.658 2.239 . . . . 0.0 112.318 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -54.68 -17.88 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -57.39 -17.99 15.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.964 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.842 HD13 ' HD3' ' A' ' 144' ' ' PRO . 44.2 mt -60.63 -25.53 66.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -63.24 -15.88 58.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 90.0 t80 -62.43 -50.32 71.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.33 -45.53 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -162.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.5 p -118.01 -22.78 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -162.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.29 -3.07 68.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.39 172.18 14.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.47 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.842 ' HD3' HD13 ' A' ' 137' ' ' LEU . 60.9 Cg_endo -73.29 -43.11 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.723 2.282 . . . . 0.0 112.312 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.55 -20.03 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 150.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -168.54 136.18 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.7 tt -53.07 -27.65 21.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -65.48 -20.5 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -81.39 -9.95 59.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.52 132.48 38.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.35 130.99 7.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.305 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -78.24 161.21 27.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 163.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.36 -31.18 71.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.13 -37.14 86.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 84.5 m -65.99 -45.23 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.53 -46.32 83.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -70.14 -26.83 64.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 94.5 p -83.87 -27.64 28.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.88 -9.39 58.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.68 105.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.624 0.726 . . . . 0.0 110.866 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.46 -21.88 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.331 -170.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 94.8 p -65.23 -23.52 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.943 -159.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.5 pp -141.18 163.1 33.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.07 145.9 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.52 131.55 40.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.62 -33.99 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 191' ' ' LEU . 46.1 pt -139.51 143.32 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.207 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 121.71 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -138.14 139.71 39.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -100.65 121.92 42.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 165.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.5 mt -109.37 145.91 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -106.8 123.5 48.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -157.06 152.09 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.95 138.25 58.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.3 125.79 27.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -74.16 149.41 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.26 39.4 28.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.68 -164.27 32.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.42 172.98 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 111.105 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -51.9 -45.26 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -64.44 136.83 57.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -60.2 170.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.436 ' HA3' ' CE1' ' A' ' 139' ' ' TYR . . . 175.02 115.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.432 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -74.12 158.01 34.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.882 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.7 152.28 36.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.88 138.6 32.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.81 143.27 46.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 133' ' ' ALA . 92.3 mt -113.03 127.94 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.94 123.98 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 171.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.5 pt? -153.78 151.62 29.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.91 130.77 24.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 -173.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.48 169.34 50.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.527 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -90.87 126.86 36.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 126' ' ' VAL . 53.9 tttm -106.25 113.39 26.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 171.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.1 mt -99.81 137.61 38.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.945 162.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -41.66 129.98 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.488 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 85.3 t60 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.6 p-90 -155.03 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.99 160.0 32.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -153.21 133.82 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.834 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -106.88 144.86 32.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.94 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.76 165.01 14.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -157.85 169.99 23.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.05 160.0 40.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.84 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -156.9 165.34 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -163.12 160.08 23.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -150.08 124.97 9.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.93 112.77 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.089 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.74 135.11 5.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.41 -165.29 36.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -125.03 174.42 8.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.108 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -125.48 152.21 71.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.8 148.46 90.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' HD22 ' A' ' 50' ' ' LEU . 29.5 p30 -126.79 -170.14 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -162.64 158.84 23.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -75.3 144.98 42.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.86 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 93.1 mt -73.87 -43.2 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 170.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -116.39 -82.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.136 -167.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.3 p -129.45 -36.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 161.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG23 HD13 ' A' ' 191' ' ' LEU . 23.3 m -124.67 6.6 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -66.18 -5.73 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -66.56 -0.01 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 168.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 24' ' ' VAL . 89.0 mm-40 -88.58 -0.33 57.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 171.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.63 130.2 82.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 111.139 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 147.47 74.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.398 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 18.7 pm0 -76.31 13.87 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.32 -135.59 2.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.3 mttt -96.23 131.44 42.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.842 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 52' ' ' TYR . 4.8 mp -123.42 131.67 72.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 tp -102.42 122.26 43.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.943 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -111.67 122.96 49.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.0 mt -107.22 131.95 53.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -168.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.95 52.53 11.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.03 -19.75 24.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.88 -64.89 4.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.542 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.64 -33.08 5.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.87 44.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.516 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.07 -43.14 88.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.69 -29.39 66.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -63.29 -46.24 87.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.2 m -64.33 -35.47 80.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.98 -43.79 98.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.836 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.52 -42.96 93.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.86 -35.08 74.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.6 p -68.72 -15.64 63.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 18' ' ' ASN . 56.0 mt -85.58 0.05 53.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.72 63.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.553 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.45 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 2.5 m-30 -77.79 147.51 35.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.946 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -92.82 104.44 16.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.975 171.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 44' ' ' ALA . 97.2 t -105.85 124.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.132 -167.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -109.6 128.03 54.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.7 127.37 56.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.7 t -122.78 134.12 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.03 160.98 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -77.38 -27.97 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -90.99 116.64 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 95.0 p -68.01 -35.13 77.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.85 -31.89 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.083 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.21 -40.36 97.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.511 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.78 -36.67 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.21 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.108 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.09 -36.98 83.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.66 95.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.047 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.07 -45.47 93.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.72 -38.84 84.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.34 -39.55 93.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.22 98.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.113 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.86 -38.43 90.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -32.37 73.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.6 -9.17 48.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.78 33.82 54.63 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.86 165.02 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.178 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.36 141.25 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -138.28 153.0 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -122.62 122.08 37.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.1 p -119.99 141.05 50.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -133.17 121.78 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -82.18 114.73 20.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.984 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -170.67 140.06 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -61.75 131.2 49.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 113' ' ' LEU . 82.7 mt -59.02 -28.73 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -28.68 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.07 -11.33 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.69 130.87 45.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.92 113.3 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.52 119.65 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.4 t -86.59 140.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.165 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -46.05 81.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.12 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -58.11 -24.01 57.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.17 88.74 6.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . 37.7 m0 -83.86 104.76 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -172.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.2 mt-10 -140.98 140.91 34.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.82 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.4 173.39 43.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.1 mm -121.8 120.5 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.1 127.59 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.122 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -121.31 114.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.78 123.5 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.75 53.7 7.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.47 99.42 9.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -86.28 114.03 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 172.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.49 153.69 28.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.656 0.741 . . . . 0.0 110.974 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.12 141.58 76.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.676 2.251 . . . . 0.0 112.291 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.1 p -58.57 -29.94 66.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.7 p -62.17 -29.85 70.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.1 tp -68.84 -39.61 79.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -60.1 -39.51 86.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -61.65 -34.19 75.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -76.78 -38.13 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.008 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 85' ' ' LEU . 75.1 mt -69.91 -33.71 72.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.55 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m-30 -50.01 -56.37 18.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.559 0.695 . . . . 0.0 110.945 -167.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 27.1 Cg_endo -60.81 -33.73 92.44 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.747 2.298 . . . . 0.0 112.311 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.28 -52.74 44.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.93 -29.02 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -64.91 -50.09 67.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.75 -32.3 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.864 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.46 -14.74 73.02 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.495 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.33 133.21 46.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.946 0.403 . . . . 0.0 110.932 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 95' ' ' TRP . 86.4 tttt -70.53 139.12 86.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 167.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.1 123.2 10.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.05 5.07 86.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.69 176.1 46.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -135.5 148.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.057 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -104.01 129.42 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.782 167.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.49 ' CD1' HD12 ' A' ' 191' ' ' LEU . 31.3 mm -117.3 123.82 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.12 125.88 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -152.26 138.01 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.5 34.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.47 153.79 42.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.788 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -85.81 129.32 54.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.495 0.664 . . . . 0.0 111.176 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.424 ' HB3' HD22 ' A' ' 150' ' ' LEU . 57.9 Cg_exo -52.07 -33.37 52.96 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.641 2.227 . . . . 0.0 112.35 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 99.2 mt-10 -51.28 -20.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -51.85 -25.54 8.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.833 HD13 ' HD3' ' A' ' 144' ' ' PRO . 20.9 mt -66.04 -28.3 68.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 20.9 pt20 -63.31 -15.26 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -169.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -89.08 -35.48 16.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -97.83 -52.84 3.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 -165.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 59.5 p -131.59 -13.8 3.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.194 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.07 -28.26 8.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.47 -172.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.64 173.41 34.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.833 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.2 Cg_endo -74.56 -41.77 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.693 2.262 . . . . 0.0 112.299 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -129.79 -27.09 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.817 154.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -160.25 142.32 12.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.915 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.437 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -52.35 -25.0 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 170.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.48 -23.41 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -78.07 -14.71 59.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.511 HD21 ' HD3' ' A' ' 144' ' ' PRO . 22.2 mt -90.27 120.0 69.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 110.864 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.74 127.93 5.07 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.798 2.332 . . . . 0.0 112.371 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.02 148.21 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 153' ' ' LEU . 4.4 tt -55.17 -45.36 75.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.08 -36.72 82.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.7 m -60.76 -39.59 89.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.12 -49.91 65.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -72.43 -26.24 61.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.5 p -79.63 -24.08 42.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.12 -10.62 43.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.47 97.06 50.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.884 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -91.8 -17.15 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -172.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.5 p -64.53 -22.19 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -159.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.958 HD12 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -137.93 154.85 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -74.87 139.24 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.94 119.79 36.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.87 -28.97 17.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.836 -169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 191' ' ' LEU . 41.4 pt -140.11 149.41 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.04 115.47 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 165.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -137.28 142.59 41.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -102.25 124.84 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.4 mt -107.09 149.07 28.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -109.27 125.71 52.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -158.51 147.89 19.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -54.82 134.11 47.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.54 122.17 15.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -79.6 151.52 30.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.778 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 53.77 34.98 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.01 -134.92 4.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.51 144.94 55.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.114 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -64.25 -48.11 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -65.85 152.6 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -49.98 157.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.6 117.01 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -72.8 149.93 43.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -153.19 147.72 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.83 139.21 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.72 146.4 44.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.915 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.11 129.74 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -130.6 127.29 38.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -153.56 146.48 24.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.936 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.733 HD13 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -140.04 129.98 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -171.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.702 ' HA3' HD22 ' A' ' 163' ' ' LEU . . . -77.58 171.56 55.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.535 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -85.39 119.56 25.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 194' ' ' LYS . 14.8 tmtt? -108.99 110.02 21.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.34 137.51 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -54.89 123.78 14.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.508 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 85.0 t60 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mmm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -154.63 175.93 13.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.13 160.02 32.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.23 135.43 14.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -121.93 144.91 48.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.39 165.06 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.1 p -158.5 169.95 23.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.96 159.98 40.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -157.8 166.03 33.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -162.65 160.01 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -129.93 142.55 50.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.57 106.43 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.094 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -155.96 163.02 40.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.89 -174.41 43.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -119.94 166.77 12.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.71 0.29 . . . . 0.0 111.162 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.8 149.93 70.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.68 156.43 60.94 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 0.0 112.367 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -139.99 -170.38 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.47 160.82 20.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -74.27 148.29 41.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.797 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 2.8 tt -73.32 -46.25 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG11 ' HG3' ' A' ' 130' ' ' GLU . 60.4 t -114.97 -81.9 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.128 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.2 p -128.74 -37.72 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.772 HG23 HD13 ' A' ' 191' ' ' LEU . 23.8 m -123.09 5.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.184 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.797 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -66.91 -3.04 6.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.055 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -66.85 -0.38 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.865 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.555 ' HB2' HD11 ' A' ' 191' ' ' LEU . 90.1 mm-40 -88.75 -4.31 58.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 170.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 25' ' ' ALA . 97.1 mt -70.55 130.77 88.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 0.0 111.091 171.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 145.05 86.29 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.242 . . . . 0.0 112.379 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -73.5 1.82 9.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.36 -147.71 5.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.8 mttt -77.33 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -122.02 129.62 75.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 tp -102.21 121.47 42.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -105.81 129.2 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.28 126.49 55.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.99 54.25 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.162 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -89.99 -15.72 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 63' ' ' GLY . . . 88.92 -63.25 3.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.06 -9.19 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.23 23.28 76.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.87 -39.54 90.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -73.89 -28.51 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.88 92.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 70' ' ' LEU . 87.3 m -68.19 -35.13 77.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.4 -47.3 84.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.03 -36.22 83.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.56 83.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.413 ' HA ' HG11 ' A' ' 76' ' ' VAL . 60.5 p -68.64 -16.57 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.85 -0.27 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 3.62 63.98 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -81.08 145.77 30.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 -174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -85.24 104.97 15.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.947 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -109.64 126.84 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 -167.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -109.06 126.27 52.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 166.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.98 128.24 56.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -119.56 130.07 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.49 156.9 32.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -80.55 -20.12 44.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -90.49 115.2 27.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.6 p -66.9 -36.08 81.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.62 -31.91 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 39' ' ' GLY . . . -64.09 -40.93 98.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.552 171.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.12 -35.96 78.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.25 80.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.112 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.07 -38.51 91.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -62.65 -41.6 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.61 -44.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -62.64 -45.47 92.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 79.8 mt -62.62 -42.03 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -44.91 96.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.36 -40.17 96.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.19 -29.89 70.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -89.95 -5.15 57.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.43 56.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.9 m -128.76 163.88 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.174 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.12 144.83 27.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.03 149.9 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.2 m -110.88 133.0 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -124.22 136.75 54.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.9 t -129.58 122.08 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.48 116.25 23.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -172.38 143.25 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -57.53 125.77 24.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -55.22 -35.09 64.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.0 -29.63 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -100.61 -9.36 22.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.932 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.19 132.67 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -97.85 115.23 27.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.75 120.39 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.87 138.11 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.5 87.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.48 -25.99 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.22 86.48 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.143 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.49 95.36 5.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -132.24 135.29 46.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.23 162.33 53.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.7 mm -109.83 118.16 56.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -174.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.7 124.47 70.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 m -121.65 117.73 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.91 121.83 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.189 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 42.69 55.02 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.5 m -99.64 87.59 3.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -74.98 114.36 13.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -157.52 151.13 19.14 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.633 0.73 . . . . 0.0 110.927 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.43 142.51 80.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.619 2.213 . . . . 0.0 112.384 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -58.89 -31.41 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.9 p -61.73 -29.15 69.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.9 tp -69.21 -40.63 77.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -60.77 -38.87 86.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 114' ' ' TYR . 89.0 mt-30 -64.81 -32.49 74.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -74.15 -39.45 63.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.71 -29.78 66.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 m-30 -49.9 -56.12 19.48 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.64 0.733 . . . . 0.0 110.882 -168.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 30.3 Cg_endo -62.41 -34.31 76.92 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.762 2.308 . . . . 0.0 112.314 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.97 -49.83 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 98' ' ' ILE . 28.0 m -74.74 -30.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -65.43 -51.73 58.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.08 -34.49 78.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.12 -49.07 63.92 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.473 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 47.9 tp -95.01 135.83 36.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.995 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.53 153.11 84.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.859 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.8 141.75 53.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.41 2.33 79.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.473 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -70.45 170.83 44.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.18 139.79 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.159 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.91 139.57 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.89 124.88 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.52 124.96 29.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.772 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.439 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -157.89 139.86 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.42 -172.66 32.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -67.18 149.56 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.894 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.31 162.73 23.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.125 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.444 ' HB3' HD22 ' A' ' 150' ' ' LEU . 52.6 Cg_exo -51.34 -24.93 16.95 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -53.97 -27.32 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -64.17 -19.85 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.463 ' CD2' ' HD3' ' A' ' 144' ' ' PRO . 37.8 mt -58.46 -30.13 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.8 -16.24 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -63.44 -54.67 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -107.24 -55.88 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 -158.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.7 p -124.97 -16.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.131 -170.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.08 75.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.465 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.0 157.51 8.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.475 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.463 ' HD3' ' CD2' ' A' ' 137' ' ' LEU . 40.2 Cg_endo -72.47 -53.95 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.678 2.252 . . . . 0.0 112.293 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.61 -34.52 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.83 161.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -157.25 133.71 9.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.894 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.405 HD23 HD11 ' A' ' 150' ' ' LEU . 96.0 mt -59.74 -24.21 63.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.21 -24.12 67.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.17 -10.97 59.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -176.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 134' ' ' PRO . 54.1 mt -83.02 130.16 58.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.578 0.704 . . . . 0.0 110.916 -166.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.86 121.29 4.5 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.752 2.301 . . . . 0.0 112.286 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -71.04 145.63 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 153' ' ' LEU . 3.0 tt -54.92 -45.26 74.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.43 -36.71 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.5 m -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.1 -50.33 61.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -70.07 -25.61 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.7 p -79.21 -23.99 43.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.7 -15.39 37.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.2 107.31 60.07 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.583 0.706 . . . . 0.0 110.849 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -88.55 -21.45 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.748 2.299 . . . . 0.0 112.403 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.8 p -70.22 -27.14 64.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -157.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -139.31 161.48 37.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.942 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.34 140.28 30.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -95.7 128.07 42.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.11 -29.3 16.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' A' ' 190' ' ' LEU . 36.3 pt -139.8 148.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.24 114.77 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.006 166.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -140.06 144.62 36.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -99.92 126.01 45.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 165.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -107.76 146.92 31.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.1 123.78 49.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -157.46 151.56 24.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.66 138.12 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.87 126.11 26.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.977 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.51 149.51 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.21 38.24 28.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.42 -163.89 33.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.512 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.33 171.32 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.108 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -55.42 -43.49 75.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 136.22 57.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -53.83 169.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.02 115.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.538 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.07 157.44 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -149.86 150.93 32.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.1 141.05 28.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.16 148.45 44.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.34 134.31 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -131.56 128.51 39.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -152.09 146.56 25.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -139.96 130.02 24.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -173.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.58 170.88 48.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.568 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -105.98 126.55 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.926 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.57 112.91 24.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.93 139.93 30.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.958 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -44.79 128.23 6.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 84.3 t60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -155.05 175.33 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -159.75 160.0 33.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.842 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.0 136.02 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -120.49 144.87 47.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -168.86 164.98 11.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -157.58 169.98 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.03 160.01 40.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.6 p -157.15 166.73 32.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.15 161.08 24.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -150.02 126.24 10.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.37 113.16 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -163.88 139.95 6.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.19 -177.76 48.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.489 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 p -122.77 161.5 23.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.331 . . . . 0.0 111.114 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.85 150.57 76.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.854 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.81 155.3 69.96 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -139.44 -176.53 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -167.17 167.92 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -69.41 145.6 52.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.819 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 3.0 tt -73.98 -50.69 18.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 130' ' ' GLU . 61.8 t -111.84 -79.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -130.17 -38.16 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.815 164.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 191' ' ' LEU . 31.3 m -121.47 4.49 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 -169.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.819 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -66.48 -4.23 7.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.014 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -66.89 -0.23 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.717 ' HB2' HD11 ' A' ' 191' ' ' LEU . 91.2 mm-40 -88.12 -4.28 58.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 170.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 129.7 88.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.101 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.95 147.96 89.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.617 2.212 . . . . 0.0 112.426 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -74.38 1.21 12.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -142.48 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.55 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.1 mttt -85.0 132.74 34.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.928 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.13 130.29 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.1 tp -101.19 121.61 42.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.81 131.94 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 mt -114.05 123.06 48.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.9 54.51 8.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -87.87 -17.2 31.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.56 -59.53 2.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.543 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -125.01 -3.92 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.905 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.607 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 71.9 20.95 79.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.585 176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm105 -67.61 -40.39 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -73.02 -28.14 62.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -45.64 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.073 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.6 m -67.52 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.888 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -58.62 -48.26 81.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.2 -36.3 83.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.07 81.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.34 -0.48 52.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.41 62.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -82.57 147.27 28.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.74 106.88 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.94 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -110.4 125.96 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.165 -166.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 m -110.76 127.1 55.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.48 129.58 55.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.69 131.81 71.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -156.69 158.74 37.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -77.81 -28.5 50.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -90.86 112.09 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.8 p -67.82 -33.28 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.67 -31.14 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.38 -39.2 96.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.462 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.74 -36.43 80.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.875 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.73 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.128 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.77 -39.45 94.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.32 -40.73 95.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.67 -47.28 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.09 -41.23 90.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.99 -39.21 91.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.98 -41.63 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.83 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.83 -32.63 73.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -91.15 -10.67 41.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.92 34.7 55.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.44 161.7 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.09 130.12 48.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -134.76 160.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -114.11 137.94 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.9 p -120.05 135.41 54.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.144 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.7 t -129.41 118.63 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.03 114.58 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -171.93 144.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -57.95 124.39 19.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -55.48 -37.01 67.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.13 79.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.08 -5.44 27.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.05 133.83 55.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -91.24 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.4 HG22 ' HA3' ' A' ' 120' ' ' GLY . 91.2 mt -95.22 119.43 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.52 137.3 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.36 -45.64 79.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.36 -27.62 68.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.98 76.44 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -76.04 100.3 4.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 91.2 mt-10 -131.7 138.2 48.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.22 162.89 39.36 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.517 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.31 117.76 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.54 122.71 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -125.43 115.89 20.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.9 124.85 65.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.141 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 43.93 55.08 5.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 73.7 m -107.08 90.94 3.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.948 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -73.99 119.97 18.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HB2' HD23 ' A' ' 109' ' ' LEU . 4.3 pp -148.5 152.27 38.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 150.21 53.99 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.616 2.21 . . . . 0.0 112.36 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -56.62 -34.7 67.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.788 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.2 p -62.11 -30.05 70.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 105' ' ' LEU . 55.2 tp -69.97 -37.84 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.953 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -57.22 -39.3 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.82 -31.63 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.98 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -80.37 -40.83 25.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.934 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.42 -36.74 66.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.966 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.6 m-30 -52.9 -56.56 22.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.63 0.728 . . . . 0.0 110.957 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 17.8 Cg_endo -55.66 -34.81 91.63 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.4 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.75 -47.05 56.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.19 -30.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.76 -51.61 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.986 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.26 -32.91 72.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.898 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -71.6 -42.56 54.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.1 tp -84.0 133.2 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.948 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -69.24 152.0 96.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.23 136.32 54.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 194' ' ' LYS . . . 88.3 4.0 77.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.494 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.09 175.21 35.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 194' ' ' LYS . 7.0 p -127.09 139.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -109.71 135.14 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mm -115.26 122.33 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.95 124.71 31.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.839 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -154.92 138.42 15.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 153.95 -173.52 32.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.427 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 58.7 m-85 -66.03 149.98 49.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.82 156.06 39.77 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.554 0.692 . . . . 0.0 111.077 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.52 -27.16 24.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.718 2.279 . . . . 0.0 112.308 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.08 -20.8 18.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -58.8 -20.26 48.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.818 HD13 ' HD3' ' A' ' 144' ' ' PRO . 41.4 mt -59.19 -26.63 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.08 -17.17 56.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.07 -50.87 52.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -108.52 -51.48 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.834 -159.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 p -120.0 -15.09 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -166.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . 75.4 5.14 76.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 139.58 173.04 12.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.818 ' HD3' HD13 ' A' ' 137' ' ' LEU . 64.5 Cg_endo -71.44 -48.21 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.615 2.21 . . . . 0.0 112.296 171.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.45 -19.64 3.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.769 151.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -169.07 142.61 2.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.947 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 142' ' ' GLY . 94.8 mt -56.21 -26.08 49.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.39 -19.86 63.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.98 -8.21 59.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.413 HD21 ' HD3' ' A' ' 144' ' ' PRO . 77.2 mt -83.99 141.07 40.31 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 0.0 110.883 -166.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.36 136.04 17.3 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.729 2.286 . . . . 0.0 112.303 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.06 155.76 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 168.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 153' ' ' LEU . 4.0 tt -57.26 -41.27 79.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.963 169.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.21 -34.18 75.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.2 m -63.23 -41.75 99.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.75 -49.62 72.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.37 -24.59 62.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.9 p -81.66 -24.67 36.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -82.76 -17.06 45.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tt -113.89 102.71 55.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.635 0.731 . . . . 0.0 110.869 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.28 -20.23 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.736 2.291 . . . . 0.0 112.356 -170.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.4 p -65.86 -23.81 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 -156.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 163' ' ' LEU . 2.8 pp -134.02 167.96 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.008 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -93.33 136.99 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 172.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -92.05 126.31 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.1 mt -91.39 -31.51 16.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.665 ' CG2' ' HB3' ' A' ' 191' ' ' LEU . 15.8 tt -143.41 137.38 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -166.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.05 116.66 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -140.06 144.27 36.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -98.65 125.54 43.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.7 mt -110.67 149.92 29.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.97 126.6 53.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -156.9 147.47 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.66 134.78 56.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 185' ' ' ALA . 45.8 tp -68.44 126.53 29.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.31 150.03 42.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 59.81 35.8 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -104.09 -151.92 22.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.521 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.87 163.12 28.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.679 0.276 . . . . 0.0 111.136 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -54.62 -46.14 73.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -64.4 141.92 58.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.817 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -60.01 171.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.06 114.99 0.41 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.28 153.04 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 175' ' ' LEU . . . -150.8 150.91 31.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.07 34.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.129 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 132' ' ' PHE . 5.7 mp -120.09 146.65 45.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -109.52 132.14 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -132.99 129.07 37.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 168.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.542 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -153.47 146.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.934 171.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -143.64 131.06 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -170.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.92 170.62 36.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.526 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -102.85 126.34 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 124' ' ' GLY . 85.9 tttt -89.62 115.18 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 169.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.7 137.37 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.886 165.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -46.61 125.15 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 197' ' ' HIS . 86.1 t60 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -164.83 142.2 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.97 169.94 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.922 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -156.98 139.24 14.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -136.34 175.09 9.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.907 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.92 165.03 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.5 p -155.65 169.97 23.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.03 159.95 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -164.56 131.76 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.01 149.97 47.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -151.97 129.67 11.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.8 t -119.27 125.41 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -159.43 134.52 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.947 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.76 176.69 29.12 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.521 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.619 HG22 ' HD3' ' A' ' 17' ' ' PRO . 89.9 m -126.0 137.63 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.153 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -122.47 78.08 45.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.694 0.759 . . . . 0.0 110.943 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD3' HG22 ' A' ' 15' ' ' THR . 65.1 Cg_endo -76.77 155.58 34.93 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.712 2.274 . . . . 0.0 112.401 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -130.07 68.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -95.9 -160.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -48.92 145.59 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 30.1 tp -69.18 -60.35 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -173.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.79 -83.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.162 -168.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -127.85 -47.22 1.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.809 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.765 HG23 HD13 ' A' ' 191' ' ' LEU . 28.6 m -122.92 21.03 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.064 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -57.54 -19.11 22.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -69.4 -4.21 17.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -90.31 -2.79 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt -77.24 129.25 78.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.565 0.697 . . . . 0.0 111.173 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.44 137.28 25.41 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.83 3.12 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -169.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.44 -151.99 8.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.08 148.95 41.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.15 135.07 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.6 tp -105.96 121.24 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -109.17 126.89 53.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.91 138.32 42.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.45 53.3 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.34 99.74 11.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.858 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.36 88.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.518 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.1 7.46 6.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.8 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.63 25.08 70.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -67.35 -42.21 83.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.78 -28.39 55.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.937 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' HG11 ' A' ' 54' ' ' VAL . . . -63.2 -43.97 96.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.8 m -68.28 -35.81 78.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -65.35 -45.57 83.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 54' ' ' VAL . 80.2 mt -64.85 -38.84 92.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.01 76.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -68.45 -22.05 64.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.02 -4.42 59.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.37 56.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.454 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -80.55 140.34 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -89.79 109.52 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 167.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 47' ' ' LEU . 62.7 t -112.96 134.16 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.8 m -107.71 125.07 50.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.168 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.74 130.95 55.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.88 136.04 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.171 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -157.46 159.35 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -78.6 -25.07 45.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -102.93 128.38 49.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.6 p -69.82 -30.44 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.45 -33.95 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.9 95.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.521 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 -34.83 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.07 86.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.94 -35.46 81.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.8 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.65 -42.01 98.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.092 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.63 -42.35 98.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.83 -41.5 97.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.6 -40.8 98.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.67 94.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.033 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.16 -39.1 93.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -33.97 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.93 -11.97 34.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.01 35.3 57.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.38 160.55 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 0.0 111.14 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.38 131.1 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -134.65 163.28 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.4 m -115.74 135.88 53.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.2 p -121.56 134.97 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.9 t -132.01 123.94 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.73 120.04 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 t -173.66 144.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -62.16 127.44 31.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.67 -33.52 68.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.5 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.41 -7.0 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -63.26 130.96 46.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -94.07 113.11 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.576 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.3 mt -91.81 115.41 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.9 t -86.58 137.93 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.03 52.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.102 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.76 -27.18 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.817 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.77 86.18 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.107 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -76.55 100.09 5.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.22 109.88 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.58 127.96 35.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.483 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -100.6 125.1 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.397 . . . . 0.0 111.104 -161.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.6 129.01 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.3 m -101.95 117.98 35.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.54 114.75 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.582 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 53.6 m-85 50.2 56.19 8.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.2 m -107.92 88.77 2.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.848 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -86.62 111.72 20.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.2 pp -145.49 153.02 51.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.924 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.46 152.32 70.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.647 2.231 . . . . 0.0 112.295 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -58.69 -29.81 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.8 m -57.89 -36.11 71.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 105' ' ' LEU . 47.0 tp -71.65 -36.03 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -54.02 -44.02 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -62.92 -28.65 70.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 -37.16 28.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.76 -39.19 73.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.5 m-85 -52.01 -52.49 61.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.722 0.772 . . . . 0.0 110.961 -165.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.1 Cg_endo -68.37 -32.1 26.67 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.637 2.225 . . . . 0.0 112.329 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -71.72 -44.12 64.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.0 -34.33 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -71.16 -52.77 17.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.53 -31.57 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.576 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -63.35 -31.04 79.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.64 135.42 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.19 157.55 78.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.561 0.696 . . . . 0.0 110.887 165.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.41 125.1 11.67 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.77 2.313 . . . . 0.0 112.332 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.17 67.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.496 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.14 176.91 46.38 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.386 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.32 139.05 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 0.0 111.155 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -120.64 128.92 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 191' ' ' LEU . 86.9 mt -124.67 136.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 39.3 tp -123.99 125.66 44.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -153.04 136.13 15.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 148.62 -164.54 29.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.541 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.538 ' HB3' ' HG2' ' A' ' 136' ' ' GLN . 68.8 m-85 -65.09 140.25 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -97.09 163.7 19.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 0.0 111.104 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 133' ' ' ALA . 84.5 Cg_exo -47.23 -34.44 18.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 147' ' ' LEU . 98.4 mt-10 -58.2 -29.55 65.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -174.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.538 ' HG2' ' HB3' ' A' ' 132' ' ' PHE . 3.7 pp0? -64.86 -24.99 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -168.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.598 ' C ' HD12 ' A' ' 137' ' ' LEU . 3.8 pp -68.55 -23.84 64.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -165.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.518 ' HG3' ' HA3' ' A' ' 142' ' ' GLY . 36.2 tt0 -60.17 -28.71 68.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.49 ' C ' ' O ' ' A' ' 138' ' ' GLN . 86.8 t80 -25.06 -65.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 171.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -116.5 -24.01 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.7 p -117.93 17.02 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.05 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.518 ' HA3' ' HG3' ' A' ' 138' ' ' GLN . . . -64.81 126.04 31.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.52 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.0 -115.05 0.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.428 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.1 -25.96 31.15 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.393 170.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.63 32.99 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.26 161.97 8.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 147' ' ' LEU . 2.8 pp -65.86 -15.07 62.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 -160.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -79.74 -18.72 50.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.17 -1.5 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 -171.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 147' ' ' LEU . 82.9 mt -99.49 159.62 29.56 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 110.95 -160.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.67 142.2 82.8 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.324 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.6 167.78 10.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.874 HD23 ' O ' ' A' ' 153' ' ' LEU . 5.3 tt -49.76 -37.16 28.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 170.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.21 -27.23 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 92.2 m -63.34 -59.75 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.045 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.09 -15.07 61.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.801 ' N ' HD22 ' A' ' 156' ' ' LEU . 62.9 tt0 -68.98 -40.07 79.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.2 p -79.68 -20.78 45.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.01 -19.5 58.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 103.07 55.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.719 . . . . 0.0 110.842 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.83 -21.85 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.0 p -73.14 -23.35 60.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -158.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.485 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -135.59 158.33 44.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.935 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.64 143.07 28.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.519 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 99.2 m95 -98.91 128.74 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.9 mt -94.3 -30.21 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.937 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.55 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.0 pt -135.31 147.55 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 115.71 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -133.7 140.13 46.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.04 129.77 55.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 mt -107.99 132.55 53.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -116.26 128.75 55.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -130.38 144.52 51.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -67.59 119.61 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 127.81 32.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.925 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.598 ' OD2' ' HB3' ' A' ' 179' ' ' ALA . 59.5 t0 -77.85 132.2 37.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -117.06 -27.57 6.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.25 -55.05 2.56 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.411 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.598 ' HB3' ' OD2' ' A' ' 176' ' ' ASP . . . -87.65 168.14 13.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.21 13.47 14.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -125.98 62.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.8 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.92 162.44 35.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.939 169.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.81 22.98 5.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.66 144.56 32.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -155.36 157.05 36.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.14 130.93 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.74 151.8 44.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 133' ' ' ALA . 39.6 pt -125.46 143.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.71 129.55 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -153.01 149.7 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.765 HD13 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -140.08 132.23 28.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.26 173.24 54.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.549 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -91.34 108.25 19.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.651 ' C ' ' HD2' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -95.24 108.03 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 169.293 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.93 131.41 37.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 173.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -109.41 115.66 30.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' A' ' 197' ' ' HIS . 65.7 t-80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 ttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.758 0.313 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.1 m0 59.12 44.87 15.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -114.92 159.98 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -126.87 150.0 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.75 145.03 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.845 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.09 165.07 37.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -154.33 169.98 22.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.64 170.03 8.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.2 t -159.92 139.95 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.91 129.9 14.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.99 172.52 12.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -143.5 140.04 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -149.74 164.95 33.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.93 124.6 3.89 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.569 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.731 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 84.9 m -131.17 130.13 42.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.652 0.263 . . . . 0.0 111.258 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -134.61 115.97 12.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.813 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.27 146.3 50.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.596 2.197 . . . . 0.0 112.328 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -127.63 156.75 41.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -117.62 152.44 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 62.72 35.38 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.6 tt -61.0 -36.29 79.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.95 -82.6 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.127 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m -127.06 -35.24 2.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 152.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 24' ' ' VAL . 8.3 p -128.64 16.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 28' ' ' ILE . . . -60.55 -10.37 4.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -64.49 -4.51 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -95.51 -11.56 27.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HD11 ' A' ' 128' ' ' ILE . 81.7 mt -79.99 132.99 58.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 111.132 -172.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.23 111.46 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -79.44 16.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -168.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -99.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -101.44 133.22 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.65 127.78 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.85 125.95 50.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -106.2 122.85 47.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.69 43.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 178.67 105.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 8.4 tm-20 -60.36 -59.85 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.15 33.22 82.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 65.49 15.88 10.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.49 16.87 70.07 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.43 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -64.43 -46.68 82.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -79.33 -28.24 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.77 63.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.19 -30.02 68.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.13 -48.94 74.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -65.54 -37.13 85.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.09 85.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -67.86 -19.95 65.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -89.21 0.83 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 93.35 4.21 64.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -85.19 142.12 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.946 0.403 . . . . 0.0 110.819 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -89.73 104.43 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.92 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' A' ' 47' ' ' LEU . 96.1 t -107.35 125.76 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.054 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.6 m -112.53 125.04 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 167.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.06 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.13 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.78 134.07 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.9 t70 -155.17 158.85 39.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.7 -26.58 37.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.9 p -97.01 144.96 26.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.874 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.2 m -76.99 -37.78 54.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.68 -35.03 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 -170.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.6 -44.87 94.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.66 -36.17 80.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.56 -39.12 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.09 -36.67 83.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -60.6 -42.85 97.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.03 -43.69 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -63.72 -45.41 90.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -61.85 -41.51 97.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.98 92.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.45 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.01 -29.95 70.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.53 -5.56 55.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 31.87 60.94 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.05 161.39 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.159 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.23 131.34 54.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.37 169.45 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.093 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -122.88 131.95 53.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 p -120.8 133.95 55.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.7 123.34 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.174 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -86.65 113.37 22.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.981 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -172.19 141.6 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.75 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.31 133.79 55.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.82 -31.54 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -72.3 -27.12 62.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -101.87 -13.75 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -69.44 134.62 49.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.27 109.91 20.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.684 HG22 ' HA3' ' A' ' 120' ' ' GLY . 94.9 mt -87.64 124.63 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.66 138.19 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.97 -53.45 12.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.4 -27.81 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.18 86.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.109 -164.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -132.6 161.88 32.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.35 -44.17 4.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.06 157.55 15.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.4 mt -129.37 129.7 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.71 128.89 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -171.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 t -112.35 118.59 35.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.02 113.87 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.4 t80 42.72 52.2 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -105.53 96.42 6.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -82.16 121.0 26.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HD23 ' A' ' 109' ' ' LEU . 1.7 pt? -134.64 150.76 74.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.582 0.706 . . . . 0.0 110.905 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.61 151.68 69.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.8 p -53.94 -34.93 61.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.6 p -62.68 -35.98 81.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 105' ' ' LEU . 16.5 tp -75.45 -34.05 60.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -58.5 -43.82 89.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.18 -28.19 68.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.6 -42.99 12.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.85 -43.58 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -170.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.7 m-30 -54.05 -53.45 58.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 -170.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 38.0 Cg_endo -65.61 -29.8 51.83 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.59 -39.7 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.12 -43.41 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -63.87 -51.1 66.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.66 -31.45 72.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.684 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -81.15 -16.97 73.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.478 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.34 138.29 33.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.931 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.85 152.58 93.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.831 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.28 125.94 16.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.23 -2.7 88.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.562 -167.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.82 49.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.487 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.416 HG11 HG12 ' A' ' 28' ' ' ILE . 80.8 t -131.19 146.87 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 0.0 111.107 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -121.72 137.41 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 174.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' CD1' ' A' ' 28' ' ' ILE . 60.9 mt -116.92 135.89 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.5 124.57 40.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.958 162.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 23.5 pt-20 -154.11 145.63 23.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.928 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.68 -172.64 33.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -61.75 148.26 43.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.749 0.309 . . . . 0.0 110.903 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.15 34.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.52 0.676 . . . . 0.0 111.139 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.34 -31.07 45.58 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.659 2.239 . . . . 0.0 112.416 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' A' ' 147' ' ' LEU . 67.1 mt-10 -61.51 -33.12 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.806 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.675 ' HG3' ' HB1' ' A' ' 185' ' ' ALA . 24.8 tm0? -67.3 -21.96 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.002 HD23 ' O ' ' A' ' 137' ' ' LEU . 5.8 tt -56.9 -25.36 57.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 139' ' ' TYR . 15.2 pt20 -59.92 -21.84 61.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.848 -171.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.1 t80 -28.32 -65.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -96.18 -36.62 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.833 -156.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.1 p -130.73 -7.7 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.087 -169.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.43 0.29 71.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.79 155.77 6.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.447 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.594 ' HD3' HD13 ' A' ' 137' ' ' LEU . 51.8 Cg_endo -72.34 -42.19 1.49 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 0.0 112.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 97.6 mttt -127.53 -20.99 3.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.893 153.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.554 ' HB3' HD13 ' A' ' 149' ' ' LEU . 67.8 t0 179.55 129.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.401 HD11 ' HA ' ' A' ' 135' ' ' GLU . 18.3 tp -56.33 -24.85 46.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -76.62 -21.76 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -170.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 146' ' ' ASP . 6.4 mp -84.58 -2.76 57.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -169.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.09 154.03 38.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.611 0.719 . . . . 0.0 110.916 -160.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -58.12 107.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -68.3 149.95 48.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 166.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -65.82 -36.61 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 81.6 m -63.97 -40.8 97.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.64 -37.69 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -64.12 -36.07 82.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.4 p -83.76 -28.18 28.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -80.5 -13.93 58.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 160' ' ' LEU . 3.3 tt -115.49 97.89 49.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.739 . . . . 0.0 110.981 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -91.08 -25.13 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 -170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 82.7 p -66.09 -20.47 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -161.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 163' ' ' LEU . 1.8 pp -128.18 154.21 46.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -94.83 140.58 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.67 121.49 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.08 -32.7 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.4 pt -139.93 147.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.165 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.04 117.11 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.62 137.1 46.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -112.09 123.04 49.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.4 pp -124.1 143.59 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -125.61 136.16 52.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -128.97 151.54 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -56.82 114.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -165.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.71 130.32 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.05 146.57 49.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -93.32 -19.69 21.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.62 54.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.85 166.38 33.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 111.023 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -50.52 124.43 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -55.34 126.97 27.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.858 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.3 -3.32 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.36 -10.46 50.4 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.511 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.08 138.63 31.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 0.0 110.863 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.675 ' HB1' ' HG3' ' A' ' 136' ' ' GLN . . . -148.89 157.01 43.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.65 130.99 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.121 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.4 152.6 40.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.952 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.76 143.18 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 67.8 mt-30 -139.72 132.81 29.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.82 150.12 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.683 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.9 tt -139.92 127.5 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -108.49 140.28 15.48 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -106.0 130.48 53.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.402 . . . . 0.0 110.91 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -90.23 129.56 36.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.72 140.88 34.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 24.2 pm0 -77.96 -10.02 59.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 178.51 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.793 0.33 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.4 m0 58.96 44.98 15.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.51 159.93 17.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.16 149.95 49.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.96 145.02 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.98 164.94 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -154.94 169.99 22.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.67 170.0 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.96 139.98 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.04 129.56 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -161.57 163.81 29.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -121.78 131.03 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.114 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -143.76 163.09 34.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.14 155.13 8.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.53 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 17' ' ' PRO . 87.6 m -135.39 130.09 34.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 111.274 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -139.96 83.67 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 0.0 110.829 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD3' HG22 ' A' ' 15' ' ' THR . 25.2 Cg_endo -69.3 136.47 34.31 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.702 2.268 . . . . 0.0 112.305 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -122.7 172.12 8.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -144.86 -179.96 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 56.32 50.36 13.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 66.4 tp -60.84 -49.71 76.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.65 -81.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -126.81 -47.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 158.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 191' ' ' LEU . 34.2 m -119.49 15.22 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.165 -171.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -12.32 9.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -173.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -57.31 -13.12 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.36 -7.8 56.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 25' ' ' ALA . 12.3 tt -71.52 137.14 83.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.654 0.74 . . . . 0.0 111.034 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.55 112.43 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.314 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -78.68 3.27 16.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.939 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.38 -87.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.463 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 99.3 mttt -119.13 133.02 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.54 136.86 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 30.1 tp -94.74 121.01 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -103.11 110.5 22.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 90.5 mt -85.19 51.62 2.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.88 104.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.118 -171.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.5 tm-20 -56.18 -59.78 4.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.93 33.72 86.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.53 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 61.72 18.92 10.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.829 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.48 17.69 68.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -64.74 -51.74 60.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.325 . . . . 0.0 110.814 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -80.39 -29.27 37.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.74 82.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.039 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.21 -35.52 76.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.85 -51.13 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.509 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -66.88 -35.17 79.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.01 76.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.183 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -70.67 -15.97 62.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -86.46 -5.26 59.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.25 2.46 59.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.442 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -82.82 142.56 31.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -91.11 108.66 20.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.892 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 47' ' ' LEU . 90.9 t -108.76 131.0 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -109.66 124.12 50.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.95 130.88 55.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.53 134.43 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.2 t70 -154.3 159.45 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -80.77 -21.83 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -108.78 127.84 54.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.7 p -69.62 -29.81 67.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.77 -33.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.054 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.68 90.81 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.494 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.01 -34.83 78.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.32 94.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.17 -36.84 85.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.75 95.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.88 -41.13 97.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.29 -45.69 93.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.9 -40.44 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.36 97.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.98 -38.29 90.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.65 -31.81 71.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.32 -6.98 49.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.87 33.07 60.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.462 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.15 160.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 111.193 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -104.31 131.96 51.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.23 161.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.5 m -114.2 133.62 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.3 p -123.15 133.93 54.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.189 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.34 124.96 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.2 116.5 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 173.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -174.99 143.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.8 t30 -60.47 131.02 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.06 -36.96 73.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.46 -30.32 65.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -100.7 -7.06 24.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 84' ' ' ASN . 4.8 t80 -57.69 129.0 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -94.69 108.05 20.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.75 143.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.145 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.82 131.81 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.28 -48.99 60.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.139 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -66.82 -22.62 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.45 -22.26 66.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.041 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 34' ' ' LEU . 30.7 p90 -147.95 167.08 25.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -118.58 -31.35 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.45 154.74 16.75 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.67 128.08 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 111.121 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.84 132.59 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -111.02 120.45 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -110.4 115.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.185 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.686 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 68.0 m-85 46.37 43.01 11.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -104.02 68.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -172.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -74.34 117.49 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.41 153.16 81.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.629 0.728 . . . . 0.0 110.905 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -63.52 148.86 92.23 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.643 2.229 . . . . 0.0 112.369 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -54.15 -30.38 48.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -60.07 -42.75 95.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -73.02 -32.58 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -57.34 -45.08 84.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -32.3 73.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -43.06 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.44 -30.41 67.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.518 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -50.07 -57.99 10.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.67 0.747 . . . . 0.0 110.917 -172.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 33.8 Cg_endo -63.43 -29.57 71.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 2.243 . . . . 0.0 112.309 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -68.52 -40.08 80.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.69 -42.97 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -63.18 -53.03 59.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.62 -33.34 74.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.54 -31.76 53.19 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.427 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.3 tp -75.9 134.42 40.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.998 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.67 139.84 80.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.668 0.747 . . . . 0.0 110.86 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.94 126.69 17.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.776 2.317 . . . . 0.0 112.304 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.82 1.5 87.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.514 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.15 173.31 54.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.45 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.79 139.49 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -115.42 131.39 56.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.51 131.28 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.078 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -124.61 126.38 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -152.12 131.75 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 147.7 -155.76 26.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.446 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -64.02 140.54 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -110.14 159.15 33.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.52 0.676 . . . . 0.0 111.165 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.12 -26.61 26.64 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.17 -28.59 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -57.63 -37.24 72.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.004 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.935 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.88 -15.16 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 178.055 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' A' ' 139' ' ' TYR . 66.4 tt0 -67.11 -2.77 6.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.618 ' C ' ' O ' ' A' ' 138' ' ' GLN . 74.6 m-85 -17.63 -77.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -175.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -129.7 -41.41 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.866 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.9 p -91.84 -0.34 57.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.498 ' HA2' ' HG3' ' A' ' 138' ' ' GLN . . . 65.47 20.94 68.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.437 171.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.68 173.26 12.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.803 ' HD3' HD13 ' A' ' 137' ' ' LEU . 70.3 Cg_endo -71.5 -35.03 8.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.699 2.266 . . . . 0.0 112.315 173.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.11 -29.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 158.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -172.27 155.78 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.818 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 142' ' ' GLY . 35.5 tp -60.78 -18.48 55.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -73.54 -30.27 62.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -161.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.713 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -105.12 11.76 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.894 -173.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.46 148.74 39.55 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.66 0.743 . . . . 0.0 110.901 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.69 129.47 34.11 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.736 2.291 . . . . 0.0 112.337 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 155' ' ' THR . 98.7 mttt -100.23 159.55 15.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.919 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 153' ' ' LEU . 5.7 tt -53.66 -41.77 67.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.22 -33.95 76.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 152' ' ' LYS . 87.4 m -61.49 -43.22 99.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.36 -39.12 92.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.35 -36.27 83.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.1 p -83.29 -29.71 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.787 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -83.3 -19.56 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.4 tp -107.44 106.41 58.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.868 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -88.53 -22.98 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.421 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.2 p -69.18 -23.65 63.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 -159.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.662 HD13 ' HA3' ' A' ' 192' ' ' GLY . 4.3 pp -139.22 160.42 39.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -105.56 136.12 45.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.17 127.77 35.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -170.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.03 -33.83 12.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.694 HG12 ' HB3' ' A' ' 191' ' ' LEU . 49.8 pt -139.12 145.77 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.09 120.6 2.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -132.12 140.96 48.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.761 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -110.84 132.01 54.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.8 pp -128.87 146.73 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -118.11 139.85 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -133.07 154.87 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 171.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -57.81 119.68 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -167.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.6 mt -93.75 139.84 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -73.55 147.03 44.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.59 -29.42 12.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.99 55.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.62 166.14 34.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -54.47 129.29 35.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.839 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -54.01 120.93 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -86.56 -11.03 52.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.28 -26.83 9.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.53 137.84 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -155.29 154.72 32.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -79.82 127.48 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 172.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 mt -126.17 153.63 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.977 -168.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 133' ' ' ALA . 30.9 pt -122.27 147.52 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.56 122.72 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.684 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -151.13 149.31 29.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.4 tt -140.04 128.39 22.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.662 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -116.41 148.72 18.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.453 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -112.74 130.9 55.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -96.89 134.33 40.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.03 138.21 38.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.12 -41.11 74.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.505 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.745 0.307 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.95 44.94 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -111.4 159.94 17.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.64 150.02 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.6 145.0 46.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.97 164.94 38.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -153.51 169.94 21.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.58 169.98 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.94 140.01 11.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -145.36 121.98 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -159.52 165.04 33.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -101.16 131.11 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -149.73 166.09 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 154.52 21.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.547 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.2 m -126.18 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.75 0.309 . . . . 0.0 111.159 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -140.0 89.96 10.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.62 125.16 18.19 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -121.24 169.99 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -140.38 -177.89 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.16 58.9 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.604 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 64.2 tp -61.58 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.61 -84.19 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.176 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.1 m -126.52 -35.22 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 160.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.428 ' CG1' HD13 ' A' ' 191' ' ' LEU . 3.9 p -129.42 8.71 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.173 -168.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -63.2 -6.82 4.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.181 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -7.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -91.68 -8.4 47.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' HB ' ' A' ' 126' ' ' VAL . 11.4 tt -74.94 137.49 73.02 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.722 . . . . 0.0 111.151 -174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.09 112.26 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.339 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -77.65 10.99 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 -170.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.26 -96.79 0.35 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -109.63 131.39 55.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.25 130.04 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.7 tp -101.48 122.66 44.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -114.8 114.97 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.923 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 85.0 mt -91.91 58.9 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.991 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -54.31 -60.07 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.78 35.58 92.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 60.11 19.54 8.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.832 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 16.07 63.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.557 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -65.09 -48.9 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -81.17 -30.15 34.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.97 -51.14 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -65.28 -35.77 82.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.53 -51.65 68.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.66 -37.11 86.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.82 78.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.2 p -68.11 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.7 mt -86.13 -3.28 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.97 3.64 61.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.519 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.3 m-30 -80.13 146.34 31.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -89.99 103.43 16.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.941 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -104.57 126.19 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 -170.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 m -112.78 128.93 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.163 166.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.2 126.67 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.155 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.27 129.97 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -157.89 163.43 37.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -78.19 -26.38 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -99.12 111.67 24.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.9 p -68.84 -27.99 66.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.91 -47.48 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.87 99.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.543 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.75 -36.48 84.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.4 89.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.26 -35.05 77.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.09 98.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.064 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.47 -40.87 98.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.17 -40.79 90.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.06 -40.59 96.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.66 92.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.83 -38.61 91.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.53 -32.74 73.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.43 -9.32 45.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.69 33.05 58.57 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.448 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.63 161.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 111.131 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -104.87 131.6 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.1 pt -135.03 165.99 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -123.21 131.87 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -120.72 134.71 55.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.125 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.41 124.86 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -85.09 119.54 25.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.1 t -172.06 140.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -57.34 130.6 46.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.78 -32.69 67.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -71.93 -29.74 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.042 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.04 -13.32 19.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.29 135.87 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.35 110.01 21.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.664 HG22 ' HA3' ' A' ' 120' ' ' GLY . 93.6 mt -84.07 125.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.2 t -100.76 139.17 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.96 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 99.1 m-20 -65.27 -28.3 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.61 68.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 -163.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -130.05 162.38 28.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.547 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 48.0 mp0 -114.66 -37.86 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.47 151.51 18.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.532 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.5 mt -129.19 127.99 66.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.345 . . . . 0.0 111.138 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.86 131.86 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -115.66 116.17 27.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.01 118.77 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.176 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 41.05 48.26 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.79 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.2 t -113.73 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -73.48 119.61 17.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.97 148.42 69.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.941 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.33 146.63 75.94 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.3 p -56.51 -35.33 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.3 m -60.48 -40.24 90.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 86' ' ' ALA . 45.3 tp -70.88 -39.94 72.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.932 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -55.46 -42.83 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.17 -28.56 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -82.19 -37.01 26.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.3 mt -71.79 -37.31 70.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.3 m-30 -50.07 -54.4 33.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.604 0.716 . . . . 0.0 110.92 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 31.8 Cg_endo -62.73 -32.53 78.32 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.765 2.31 . . . . 0.0 112.357 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -71.66 -39.7 70.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.51 -42.7 90.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -64.68 -53.85 40.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.74 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.977 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.84 -22.43 63.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.59 135.89 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.931 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.547 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.5 mttt -78.25 152.68 79.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.617 0.723 . . . . 0.0 110.815 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.14 125.64 19.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.43 3.58 86.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.65 171.18 50.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 28' ' ' ILE . 76.9 t -131.1 142.09 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 111.117 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -119.64 136.0 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -120.15 132.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 50.5 tp -125.6 129.11 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 168.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.53 129.42 13.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.0 -171.25 37.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -76.49 158.78 30.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.904 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.05 149.97 44.29 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.496 0.665 . . . . 0.0 111.169 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.29 -34.3 98.49 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.187 . . . . 0.0 112.349 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.96 -34.77 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.799 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.435 ' HG3' ' HB1' ' A' ' 185' ' ' ALA . 23.2 tm0? -66.36 -30.69 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 137' ' ' LEU . 4.9 tt -59.9 -29.46 68.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -174.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 139' ' ' TYR . 19.8 pt20 -61.03 -23.54 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -169.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 138' ' ' GLN . 83.3 t80 -28.23 -65.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -103.03 -33.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.846 -159.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.9 p -118.29 -20.65 8.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -170.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.08 -14.38 27.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.437 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 142.74 143.3 4.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.06 -43.16 1.71 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.624 2.216 . . . . 0.0 112.346 -175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -121.28 -27.89 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 157.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.548 ' HB3' HD13 ' A' ' 149' ' ' LEU . 5.4 t70 -170.7 150.62 3.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 HD12 ' A' ' 150' ' ' LEU . 17.7 tp -60.73 -25.95 66.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -80.03 -28.7 39.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.792 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.548 HD13 ' HB3' ' A' ' 146' ' ' ASP . 4.4 mp -78.64 -4.93 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -170.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 93.4 mt -85.46 143.83 39.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.662 0.744 . . . . 0.0 110.903 -164.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 71.9 Cg_exo -56.32 107.44 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -71.08 152.38 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 174.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 54.4 tp -55.4 -39.87 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.09 -30.12 71.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 64.1 m -62.27 -59.66 4.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.008 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.27 -16.08 62.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -173.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.671 ' N ' HD22 ' A' ' 156' ' ' LEU . 88.0 mt-30 -69.35 -42.65 74.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.958 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.0 p -77.58 -21.84 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.18 -11.53 59.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 tp -114.13 100.99 53.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.935 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.78 -23.53 1.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.715 2.276 . . . . 0.0 112.425 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 74.6 m -76.12 -25.33 55.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -165.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -96.84 136.32 37.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -88.42 123.55 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -167.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.05 -32.23 16.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.643 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.2 pt -138.13 145.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.63 113.46 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 167.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -133.25 141.87 48.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.13 130.48 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 167.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp -123.48 150.6 43.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.82 142.2 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.924 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -128.66 150.27 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 167.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -63.32 118.85 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -165.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.0 mt -93.44 138.34 31.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -72.0 146.32 47.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.16 -25.23 20.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.67 55.12 0.18 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -151.95 166.34 31.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 111.09 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -53.2 124.91 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -55.38 127.55 30.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -84.67 -4.77 59.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.66 13.33 57.0 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.5 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.7 147.98 22.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.799 0.333 . . . . 0.0 110.888 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.435 ' HB1' ' HG3' ' A' ' 136' ' ' GLN . . . -152.26 146.1 25.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.9 130.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.73 152.42 40.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 -168.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 46.3 pt -120.23 143.47 31.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -144.54 127.1 16.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.85 149.44 28.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.4 tt -139.98 128.28 22.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.91 140.05 15.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -111.04 134.59 52.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.896 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -97.89 136.28 38.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.01 142.95 39.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.17 -22.78 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 58.8 m170 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.825 178.278 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.8 44.98 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.69 158.56 18.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.18 149.95 49.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.62 144.97 46.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -157.37 165.06 36.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -152.89 169.01 23.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.65 169.87 8.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.884 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -159.97 140.02 11.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.21 126.64 11.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -160.06 165.02 32.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.57 133.34 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -150.05 166.83 28.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.75 147.83 9.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -134.89 135.49 41.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.6 84.4 22.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.746 0.784 . . . . 0.0 110.87 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -59.91 129.89 32.41 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 0.0 112.296 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -133.53 158.95 41.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 172.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -123.32 -170.13 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 59.17 53.67 5.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.662 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 94.8 mt -64.62 -34.26 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.49 -83.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.215 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.6 m -126.12 -39.6 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 157.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 191' ' ' LEU . 34.7 m -126.02 14.48 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 -170.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.662 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -59.97 -10.85 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.114 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -7.2 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 171.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -90.37 -11.06 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.7 tt -74.27 137.68 75.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 111.106 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.97 108.15 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.73 2.287 . . . . 0.0 112.298 168.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -80.03 18.35 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -166.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.23 -94.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.17 133.38 52.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.823 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.95 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.4 tp -101.3 122.38 43.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.7 t -106.07 112.6 25.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.45 52.04 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.06 105.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.042 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -63.2 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.05 35.49 92.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 60.0 20.02 9.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.817 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.3 68.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -64.87 -46.06 83.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.925 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.92 -33.0 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.26 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.1 m -69.18 -34.9 75.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.62 -49.43 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 3.1 mp -64.39 -38.19 90.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.68 79.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -68.96 -19.71 64.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 65.1 mt -93.3 2.99 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.29 6.03 64.98 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 73.1 m-85 -82.32 136.23 35.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.938 0.399 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -89.29 104.4 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.904 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -104.57 127.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.6 m -108.61 125.17 51.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.151 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.85 129.08 55.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.61 133.32 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.61 157.6 37.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -77.99 -22.38 49.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.0 p -114.53 132.19 56.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.1 p -67.07 -25.19 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.19 -44.63 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.028 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.43 93.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.08 -30.8 71.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.918 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.88 -34.97 72.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.068 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.39 -38.42 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.72 95.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.22 -47.57 76.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.969 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.34 -42.95 78.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.24 -39.48 82.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.941 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.98 94.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.06 -37.89 89.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.25 -33.1 74.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.47 -7.34 47.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.46 30.62 62.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.04 165.03 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.63 131.88 54.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.1 165.5 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -123.3 131.28 53.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.5 p -119.62 132.98 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.0 t -126.51 123.63 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -86.36 114.15 22.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -173.26 140.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -51.69 125.95 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.7 tp -58.33 -35.93 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.01 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.25 -7.71 31.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -64.44 135.16 55.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.6 111.02 22.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.702 HG22 ' HA3' ' A' ' 120' ' ' GLY . 90.6 mt -84.68 121.05 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.19 140.62 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.16 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.027 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.86 -29.19 66.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.93 79.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.062 -164.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -129.91 158.72 38.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.72 -42.37 5.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.96 157.06 15.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.18 126.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.82 132.34 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -112.83 118.17 34.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -111.4 114.11 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.194 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 42.89 46.43 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.413 ' SG ' HD23 ' A' ' 105' ' ' LEU . 32.4 t -103.25 91.75 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -80.98 121.06 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.4 pp -152.75 153.1 29.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.563 0.697 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.48 154.81 55.53 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.671 2.247 . . . . 0.0 112.371 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.0 p -57.32 -32.97 67.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.821 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -60.01 -39.34 85.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 105' ' ' LEU . 38.2 tp -71.68 -35.41 70.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.415 ' HG3' HD12 ' A' ' 105' ' ' LEU . 27.7 mtt180 -56.76 -40.2 75.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.998 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.36 -27.73 69.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.896 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.37 -39.81 16.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.14 -39.03 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.6 m-30 -52.23 -54.67 39.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.658 0.742 . . . . 0.0 110.873 -171.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.6 Cg_endo -61.93 -30.1 83.16 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.708 2.272 . . . . 0.0 112.341 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -72.5 -39.66 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.44 -40.93 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -64.21 -54.65 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.33 -30.2 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.989 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.702 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -78.59 -24.35 62.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.455 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.2 tp -82.16 136.81 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 110.911 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.1 154.67 86.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 0.0 110.847 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.91 125.78 16.67 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.705 2.27 . . . . 0.0 112.353 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.47 88.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.49 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.27 169.95 45.78 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 28' ' ' ILE . 79.7 t -129.02 142.58 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -119.27 136.52 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.1 mt -120.11 131.45 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.442 HD22 HD21 ' A' ' 190' ' ' LEU . 4.1 tt -127.93 130.5 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 167.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -150.15 140.87 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -164.47 -168.3 26.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.18 165.85 19.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.21 156.05 39.97 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 173.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -52.52 -36.34 70.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.624 2.216 . . . . 0.0 112.418 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 97.8 mt-10 -60.56 -34.85 74.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.809 -169.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.7 tm0? -64.33 -29.99 71.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 144' ' ' PRO . 31.9 mt -66.55 -20.85 66.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.625 ' O ' ' C ' ' A' ' 139' ' ' TYR . 16.8 pt20 -66.89 -13.74 62.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.625 ' C ' ' O ' ' A' ' 138' ' ' GLN . 33.9 t80 -18.57 -78.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -132.18 0.25 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 -167.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -124.52 -14.13 6.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.87 -14.42 31.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.436 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.53 171.43 18.09 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.438 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.519 ' HD3' HD13 ' A' ' 137' ' ' LEU . 49.4 Cg_endo -70.47 -50.19 0.41 Allowed 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.679 2.253 . . . . 0.0 112.378 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 99.6 mttt -131.99 -28.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.967 161.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.506 ' HB3' HD11 ' A' ' 149' ' ' LEU . 49.1 t0 171.24 124.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 -177.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 137' ' ' LEU . 53.6 mt -68.37 -20.07 64.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 -167.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -75.49 -36.65 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 -161.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.867 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -103.53 25.95 9.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.837 -171.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.12 162.33 46.72 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.643 0.735 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.97 116.83 2.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -79.16 137.9 37.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.995 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.45 -45.19 80.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.879 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.05 -35.04 78.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 m -62.43 -41.19 98.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.2 mt -60.61 -42.14 96.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.81 -37.11 81.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.8 p -81.46 -28.12 34.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.03 -11.32 55.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.13 98.87 52.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.736 0.779 . . . . 0.0 110.962 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.99 -22.26 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.4 p -68.53 -21.48 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.0 pp -130.17 153.98 47.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.78 138.99 35.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -88.13 121.79 30.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.78 -30.43 19.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.6 pt -138.46 147.09 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 111.91 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 164.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -136.62 143.08 43.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.51 119.81 39.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 165.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 mt -102.68 140.3 37.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -120.01 133.88 55.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -172.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -128.41 153.3 47.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 165.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -58.48 116.18 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.836 -166.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.2 mt -97.1 138.25 34.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -77.34 143.42 38.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -101.23 -22.44 14.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.72 55.08 0.19 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.441 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.68 166.25 34.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -54.87 130.01 39.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -55.07 119.24 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.82 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.25 -10.95 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -173.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 112.59 3.78 25.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -91.29 142.38 27.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -145.54 145.1 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.15 130.62 35.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 170.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.7 mt -124.0 157.12 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.004 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.1 pt -121.46 141.59 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -138.47 137.49 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -155.64 147.69 23.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.833 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.654 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.1 tt -140.1 128.37 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.84 139.42 15.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -107.14 133.04 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -98.13 132.66 43.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.68 144.84 30.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.42 -32.91 68.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.835 179.326 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.87 44.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.63 160.0 17.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.69 150.01 49.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.48 145.04 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.97 164.98 37.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.848 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -154.96 169.97 22.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -169.64 169.97 8.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -156.2 133.78 10.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -154.26 135.07 13.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.7 p90 -155.95 157.31 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.987 176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -122.26 132.97 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.091 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -137.13 126.69 25.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.52 166.81 23.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.631 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 86.9 m -119.85 132.31 55.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.727 0.298 . . . . 0.0 111.206 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -127.36 114.51 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 110.817 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.32 144.97 42.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.35 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.05 168.06 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 26' ' ' ASN . 52.4 p30 -130.65 169.1 16.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 51.25 41.49 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.877 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 62.5 tp -66.38 -43.1 86.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.96 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -124.95 -51.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 152.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 HD13 ' A' ' 191' ' ' LEU . 35.9 m -118.05 13.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . . . -59.32 -12.19 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 19' ' ' ASP . 53.1 p30 -62.01 -5.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 173.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -90.57 -12.15 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 126' ' ' VAL . 8.7 tt -75.47 138.46 71.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.665 0.745 . . . . 0.0 111.059 -176.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.3 114.35 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 0.0 112.324 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -74.93 -0.58 19.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.61 -96.13 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -170.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -99.05 125.6 44.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.4 127.68 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.11 121.54 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.868 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -108.09 112.67 25.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt -87.73 58.13 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.993 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.97 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.65 -60.0 4.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.64 32.24 83.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 62.08 18.52 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.9 16.16 72.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.539 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -63.54 -45.52 90.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.906 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -79.46 -29.97 41.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.77 -51.98 59.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 p -70.9 -29.62 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.03 -52.06 58.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.5 mt -67.41 -35.45 79.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.24 82.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.173 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -68.98 -17.39 63.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.26 0.61 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.937 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.71 2.68 61.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -87.1 144.86 26.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -90.17 109.02 20.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 47' ' ' LEU . 94.6 t -109.27 126.56 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.8 m -110.54 124.9 52.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 167.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.52 130.54 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.69 132.62 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.62 163.91 39.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -83.41 -21.22 33.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -104.52 117.88 35.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.0 p -67.12 -27.8 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.84 -46.1 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.77 -40.64 98.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.607 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.09 -35.62 81.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.33 . . . . 0.0 110.889 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.54 84.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.42 -36.86 85.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.34 99.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.35 -42.21 93.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -62.24 -46.98 86.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mp -61.49 -37.22 82.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.03 -45.98 83.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.69 -37.68 87.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -65.44 -29.82 70.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -92.88 -4.4 52.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.81 32.82 58.61 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.428 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.14 161.8 26.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.398 . . . . 0.0 111.104 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.58 131.13 54.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -133.54 163.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.7 m -119.56 135.48 54.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.0 p -120.23 134.58 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.195 -177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.8 t -128.56 123.5 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.177 170.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.88 114.88 23.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -173.49 141.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.834 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -54.99 130.79 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.96 -35.03 74.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.36 69.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -98.73 -9.51 24.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.05 136.74 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -92.89 108.76 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.698 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.3 mt -83.32 119.45 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.78 140.32 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -172.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.49 -54.69 7.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -71.21 -29.4 65.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.51 81.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -129.36 164.45 23.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.7 -40.62 4.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.56 155.59 16.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.76 127.0 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 0.0 111.19 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.78 130.44 72.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.8 m -114.96 115.95 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.801 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.42 115.95 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 49.8 43.75 24.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -101.0 73.12 1.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -80.49 124.03 28.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -144.83 150.98 48.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.658 0.742 . . . . 0.0 110.878 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.37 154.86 71.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.762 2.308 . . . . 0.0 112.339 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.2 p -54.26 -30.82 51.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.1 m -58.17 -40.7 82.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.38 -34.22 65.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.888 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -55.87 -44.73 78.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.25 -30.38 71.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -85.85 -46.4 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.19 -42.16 80.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 6.5 m-30 -53.02 -54.98 38.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -168.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.5 Cg_endo -62.0 -28.74 80.87 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.349 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.46 -36.85 65.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.97 -41.13 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.151 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.55 -53.55 50.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.65 -31.49 72.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.937 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -76.56 -26.98 62.03 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.476 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.93 136.6 36.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.918 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.45 154.55 85.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 126.98 19.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.39 88.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.475 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.26 169.98 50.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.532 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 28' ' ' ILE . 60.4 t -129.56 143.82 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -119.77 136.93 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.88 128.71 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 51.8 tp -123.41 129.77 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -153.46 134.72 14.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.952 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.01 -178.1 40.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -72.28 150.1 43.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.963 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -94.84 154.77 39.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.504 0.668 . . . . 0.0 111.174 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.74 -25.1 78.13 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 174.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 59.4 mt-10 -58.84 -23.37 60.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -54.3 -27.7 37.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.968 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.08 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.6 tt -57.88 -16.28 11.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 139' ' ' TYR . 20.1 pt20 -67.19 -4.89 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.611 ' C ' ' O ' ' A' ' 138' ' ' GLN . 77.6 m-85 -18.73 -77.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.96 -51.24 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.0 p -85.63 -1.95 57.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.24 35.13 87.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.35 170.59 13.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.826 ' HD3' HD13 ' A' ' 137' ' ' LEU . 93.7 Cg_endo -79.48 -31.94 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.762 2.308 . . . . 0.0 112.308 173.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 -26.6 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 161.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -171.46 154.6 3.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.48 -9.78 37.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 168.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.7 -25.02 26.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.96 -7.56 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -171.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.99 154.7 91.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.634 0.731 . . . . 0.0 110.88 -158.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.62 150.3 22.09 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.641 2.227 . . . . 0.0 112.367 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -104.94 137.49 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.417 HD11 HD22 ' A' ' 190' ' ' LEU . 64.2 tp -55.03 -38.12 67.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.878 161.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.78 -33.76 72.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 73.8 m -63.22 -41.89 99.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.98 -40.75 94.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.972 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.08 -36.53 84.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -83.98 -27.64 28.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -169.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -80.31 -13.28 59.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -111.75 100.55 48.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.938 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.35 -21.66 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.4 p -68.53 -20.81 64.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -163.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.2 pp -132.55 155.35 48.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -99.43 137.53 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.08 125.08 32.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -93.0 -30.75 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.633 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.6 pt -139.73 146.16 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.09 116.41 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -131.47 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -123.24 129.98 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 171.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp -130.49 152.9 49.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -119.49 138.05 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -130.77 154.9 47.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 173.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -69.1 133.74 48.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -166.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.419 HD12 ' HG3' ' A' ' 138' ' ' GLN . 85.2 mt -98.1 154.6 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.09 137.58 55.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 170.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.4 -38.68 78.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.822 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.18 55.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -164.38 -178.67 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 111.066 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -43.5 127.11 4.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -55.11 127.71 30.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.858 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -74.78 -23.0 58.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.89 -24.72 9.31 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.55 140.58 41.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -162.31 158.03 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.62 132.44 44.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 mt -122.16 149.97 42.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 133' ' ' ALA . 20.7 pt -124.27 142.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -145.0 129.15 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.67 150.84 28.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.867 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.688 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.7 tt -139.95 129.93 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -175.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.03 140.19 15.92 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -106.65 131.46 53.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.935 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -96.63 133.01 41.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.79 145.0 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.05 -33.92 70.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.506 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.703 0.287 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.3 m95 59.22 43.0 17.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.65 160.0 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.29 149.99 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.42 145.03 46.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.99 165.01 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.5 p -151.15 169.85 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.51 170.08 8.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -159.66 140.0 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.35 134.94 16.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.97 167.59 29.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.13 128.23 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.191 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.06 164.87 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.97 147.77 22.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.74 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 85.3 m -113.04 124.78 53.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 0.0 111.167 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.98 129.81 24.84 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.0 110.793 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 131.17 23.13 Favored 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.676 2.251 . . . . 0.0 112.343 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -135.01 167.12 21.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 56.1 p30 -141.98 179.33 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 56.56 37.86 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.724 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.9 tt -64.49 -40.46 95.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 170.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.25 -83.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.213 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -128.72 -37.0 1.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 154.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.54 HG23 HD13 ' A' ' 191' ' ' LEU . 27.3 m -121.86 17.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 -167.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.622 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -56.99 -11.03 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 46.9 t30 -52.57 -17.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.816 171.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -86.99 -20.0 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 126' ' ' VAL . 84.6 mt -79.47 129.84 70.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 0.0 111.097 -171.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.51 119.22 5.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 0.0 112.31 166.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -74.38 5.53 4.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.41 -96.11 0.51 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -167.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -100.81 125.08 47.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -120.43 129.34 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.6 tp -101.42 125.75 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.4 t -115.92 114.84 25.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.59 57.68 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.93 104.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.065 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.9 tm-20 -59.64 -60.05 4.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -176.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.83 35.93 92.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 173.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 60.41 19.75 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.25 20.53 60.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.476 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -65.29 -48.47 73.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.07 -31.1 50.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.79 -50.96 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.987 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.09 -35.71 81.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.28 -51.23 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -67.73 -35.34 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.8 81.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.128 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -67.28 -17.58 64.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.73 -1.81 58.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.74 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.28 4.16 61.21 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.534 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.9 m-30 -85.43 142.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.861 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -89.97 105.86 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.926 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.3 t -106.76 127.68 62.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -109.64 125.24 52.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.174 168.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.44 128.55 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 133.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.082 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.7 t70 -154.15 161.31 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -82.3 -21.13 36.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.9 p -108.54 131.32 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.6 p -71.73 -26.2 62.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.96 -47.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.01 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.34 98.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.56 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.34 -36.48 84.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.22 81.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.17 -35.57 79.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -62.36 -43.39 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.58 -41.25 96.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -62.19 -46.82 87.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.7 tp -60.07 -41.04 91.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.33 -43.73 96.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.53 -36.5 83.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -69.45 -31.17 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.42 -7.5 50.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 32.1 58.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.427 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.31 163.59 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.867 0.365 . . . . 0.0 111.194 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.97 131.33 53.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -135.39 166.41 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -122.88 134.17 54.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.159 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 p -120.01 134.04 55.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.113 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -127.55 123.97 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 170.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 63.8 tt0 -88.46 117.24 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.1 t -174.61 142.58 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -61.29 132.14 52.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.85 -25.02 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.92 60.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -104.42 -13.74 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.23 132.73 46.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.96 112.32 24.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' HA3' ' A' ' 120' ' ' GLY . 82.1 mt -81.39 122.11 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.85 139.92 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.134 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -59.41 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.18 -28.27 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.07 78.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -132.89 161.07 35.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -105.34 -44.99 4.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.97 153.87 17.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.466 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.1 mt -124.09 125.44 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.107 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.1 131.88 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.7 m -111.92 117.08 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mm -106.58 111.29 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 43.87 45.08 6.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 43.4 t -106.26 94.89 5.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -94.01 120.68 34.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt -128.29 150.16 73.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 39.2 Cg_endo -63.83 145.64 90.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.358 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.2 p -54.98 -34.35 63.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.1 p -62.34 -35.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.721 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.3 tt -76.27 -34.46 59.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.912 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -57.16 -42.62 81.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.97 -27.35 68.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.82 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -86.27 -36.01 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.27 -41.2 66.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -52.25 -55.06 34.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.69 0.757 . . . . 0.0 110.905 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 20.0 Cg_endo -59.74 -29.74 90.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.333 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.05 -41.02 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.98 92.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -63.69 -55.23 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.44 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.614 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.97 -23.93 60.76 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.62 137.52 34.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.78 154.1 87.14 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.1 126.93 18.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.778 2.318 . . . . 0.0 112.261 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.85 89.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.526 -167.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.13 173.82 47.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 28' ' ' ILE . 56.5 t -132.9 146.55 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.17 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -122.43 138.78 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' ILE . 69.2 mt -118.66 132.18 69.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.432 HD22 HD21 ' A' ' 190' ' ' LEU . 5.0 tt -126.28 130.1 50.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 167.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -147.64 135.58 21.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.81 -167.86 23.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.418 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -99.78 149.29 35.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.499 0.666 . . . . 0.0 111.213 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 150' ' ' LEU . 71.7 Cg_exo -50.13 -36.7 46.43 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.248 . . . . 0.0 112.44 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -58.01 -30.64 66.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -64.24 -25.45 68.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 -173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.475 ' CD1' ' HD3' ' A' ' 144' ' ' PRO . 1.6 mm? -62.73 -15.69 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -168.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.625 ' O ' ' C ' ' A' ' 139' ' ' TYR . 64.7 tt0 -63.4 -17.71 62.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.899 -174.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.625 ' C ' ' O ' ' A' ' 138' ' ' GLN . 60.5 m-85 -19.19 -81.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -169.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -144.19 0.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.3 p -125.12 -13.43 6.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 -173.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 147' ' ' LEU . . . 84.64 -18.5 24.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.432 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 137' ' ' LEU . . . 138.7 -172.88 22.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.475 ' HD3' ' CD1' ' A' ' 137' ' ' LEU . 57.8 Cg_endo -73.03 -43.35 0.77 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.718 2.279 . . . . 0.0 112.336 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.87 -32.28 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 160.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.737 ' HB3' HD12 ' A' ' 149' ' ' LEU . 16.7 t0 -176.03 153.86 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 142' ' ' GLY . 26.5 tp -59.0 -35.38 73.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -79.84 -35.07 38.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -155.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.005 ' C ' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -98.95 9.89 42.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -158.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 134' ' ' PRO . 75.8 mt -79.98 159.55 70.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 110.964 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -55.17 137.79 77.58 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.664 2.242 . . . . 0.0 112.407 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -92.81 139.21 30.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.5 -40.11 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 172.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.85 -30.97 68.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 90.7 m -60.6 -44.86 95.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.23 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.58 -39.35 94.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.36 -36.59 84.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -85.99 -26.35 25.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.05 -8.67 59.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.34 99.34 49.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 0.0 110.902 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -89.24 -20.74 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.699 2.266 . . . . 0.0 112.412 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -68.08 -22.12 64.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.4 pp -131.76 154.8 48.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.57 140.86 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -86.98 123.09 31.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 92.5 mt -89.63 -33.4 16.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.8 pt -141.57 148.41 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.067 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.99 114.21 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.036 167.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -131.39 140.58 49.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -117.6 129.03 55.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 168.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.1 pp -122.95 151.69 41.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.83 142.59 48.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -175.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.62 154.11 47.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 168.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -58.93 123.11 15.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 64.1 mt -87.54 134.94 33.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.4 140.43 39.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.56 -22.48 8.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.875 -175.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.0 55.01 0.19 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -160.1 168.38 25.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -52.36 122.68 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.825 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -55.06 121.53 8.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -83.92 -17.23 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.97 -0.0 41.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.5 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.09 140.36 33.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.736 0.303 . . . . 0.0 110.899 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -152.99 152.93 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.081 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.38 129.76 34.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 167.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.11 151.55 43.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.961 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' A' ' 133' ' ' ALA . 29.9 pt -124.08 141.42 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 174.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -139.05 138.39 37.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.2 pt? -156.25 152.51 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 191' ' ' LEU . 6.8 tt -139.9 129.79 24.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.505 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.13 138.59 14.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.511 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -107.07 131.84 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.93 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -97.52 133.27 42.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 139.5 42.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.21 -42.5 93.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.461 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 45.02 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -110.56 159.34 17.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.78 149.94 49.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.16 145.01 47.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.84 165.03 37.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.839 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.5 p -152.52 169.87 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.74 170.05 8.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.36 139.93 12.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.83 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.35 130.03 14.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -164.01 168.72 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.85 139.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.156 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.39 165.01 32.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.65 167.53 14.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.553 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.674 HG22 ' HD3' ' A' ' 17' ' ' PRO . 96.6 m -93.8 120.04 33.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.281 . . . . 0.0 111.229 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.66 80.32 22.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.771 0.795 . . . . 0.0 110.863 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HD3' HG22 ' A' ' 15' ' ' THR . 55.9 Cg_endo -74.18 146.16 35.91 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 0.0 112.288 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -137.9 157.73 45.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -150.64 -171.2 3.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 54.99 46.27 24.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.58 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 59.1 tp -65.0 -43.01 93.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.19 -86.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.144 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.5 t -125.74 -48.79 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 158.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 HD13 ' A' ' 191' ' ' LEU . 33.4 m -115.35 17.73 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.177 -170.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -60.18 -9.24 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -61.57 -3.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.72 -12.31 25.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' HB ' ' A' ' 126' ' ' VAL . 10.7 tt -74.27 137.52 75.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.654 0.74 . . . . 0.0 111.049 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.08 112.79 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.616 2.211 . . . . 0.0 112.311 167.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -75.03 10.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.59 -100.4 0.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.98 133.36 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 88.9 mt -123.72 136.05 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 tp -95.19 121.77 37.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.899 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.42 113.97 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 83.0 mt -94.66 57.12 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.96 104.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -67.08 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 38.19 94.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 61.87 18.91 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.918 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.97 10.73 81.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.531 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -63.48 -45.58 90.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.945 0.402 . . . . 0.0 110.944 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.26 -33.6 37.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.09 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.3 m -66.23 -36.57 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.6 -49.29 75.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -60.83 -39.09 87.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.26 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.5 p -69.04 -18.32 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -83.34 0.24 46.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.77 64.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.512 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -80.11 143.68 33.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -86.97 103.57 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 47' ' ' LEU . 67.5 t -105.38 127.77 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -168.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.8 m -112.49 125.17 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.6 129.26 56.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.63 133.91 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -154.63 163.62 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -83.79 -20.77 32.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.974 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.7 t -101.75 117.26 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.808 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -65.0 -28.15 69.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.53 -47.97 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.01 99.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.52 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.28 -35.55 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.945 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.0 99.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.36 -42.84 99.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -66.64 -41.16 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.3 -39.78 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -40.99 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.43 -38.19 90.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.5 -33.72 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.38 -8.23 45.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.84 33.06 60.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.32 160.97 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.38 . . . . 0.0 111.113 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.57 131.01 53.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.814 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -134.73 166.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -124.85 131.2 53.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 p -120.32 135.17 55.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.132 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -130.26 125.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -84.89 116.6 23.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 t -173.76 142.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.501 HD21 ' HB3' ' A' ' 86' ' ' ALA . 26.8 t30 -58.73 130.06 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.38 -30.58 65.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 84' ' ' ASN . . . -76.12 -23.53 54.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -104.92 -13.45 15.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.884 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 84' ' ' ASN . 72.1 t80 -70.38 137.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -94.01 107.42 19.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.2 mt -88.2 125.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.34 138.88 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.74 -44.58 61.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.17 -26.62 66.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.69 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -164.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -130.1 156.73 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.796 -172.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.95 -40.04 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.76 159.92 15.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 88.3 mt -129.99 125.65 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.107 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.64 130.78 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -129.02 118.27 22.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.62 128.91 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.132 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.1 t80 43.73 52.64 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 51.0 t -115.53 88.32 2.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -80.84 117.55 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.8 mt -121.17 145.3 41.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.585 0.707 . . . . 0.0 110.899 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.9 Cg_endo -67.78 148.81 77.93 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.757 2.305 . . . . 0.0 112.303 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.7 m -54.17 -42.97 70.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.0 m -60.38 -39.77 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.54 -38.97 74.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 178.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.32 -41.65 89.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -83.56 -42.88 16.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.26 -42.22 60.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 -172.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.2 m-30 -54.51 -52.32 70.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.722 0.772 . . . . 0.0 110.923 -169.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 86.8 Cg_exo -45.1 -37.6 13.13 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 0.0 112.379 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -76.34 -37.07 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.51 -45.02 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.179 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 118' ' ' TYR . 2.7 m-30 -66.29 -54.45 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -176.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.07 -30.2 71.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.87 -29.56 67.04 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.512 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.18 133.6 38.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.344 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.48 153.12 78.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.701 0.762 . . . . 0.0 110.863 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.08 124.81 16.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.766 2.311 . . . . 0.0 112.31 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.56 87.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.524 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.54 170.91 47.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.441 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG13 ' A' ' 28' ' ' ILE . 77.5 t -129.18 140.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.116 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.97 132.54 56.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.8 129.88 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.069 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 190' ' ' LEU . 56.7 tp -126.01 123.54 38.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -148.98 132.85 17.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.71 -169.35 35.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -68.13 157.32 35.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 136' ' ' GLN . . . -86.09 129.41 54.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.221 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.79 -36.28 72.89 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.624 2.216 . . . . 0.0 112.427 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -47.95 -35.13 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.814 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 133' ' ' ALA . 8.1 pt20 -58.63 -33.1 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.235 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.8 tt -59.73 -19.23 48.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -164.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 139' ' ' TYR . 22.4 pt20 -63.25 -13.26 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.945 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.588 ' C ' ' O ' ' A' ' 138' ' ' GLN . 33.2 m-85 -20.37 -74.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -120.74 -19.85 7.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -161.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.0 p -123.51 -16.81 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -164.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.62 -19.98 13.25 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.44 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.57 178.36 36.36 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.443 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.722 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.0 Cg_endo -73.51 -42.5 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.388 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.02 -28.04 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 155.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -165.69 159.78 16.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.455 HD23 HD12 ' A' ' 150' ' ' LEU . 90.2 mt -51.17 -26.31 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 170.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.84 -30.25 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.4 mp -78.8 -18.2 54.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.88 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.518 HD21 ' HD3' ' A' ' 144' ' ' PRO . 93.0 mt -87.84 113.67 55.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.914 -172.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 23.9 Cg_exo -70.66 124.11 10.42 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.66 2.24 . . . . 0.0 112.366 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.01 154.09 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.15 -42.64 91.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.903 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.49 -31.77 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.4 m -68.48 -56.17 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.111 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.31 -17.87 62.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 156' ' ' LEU . 66.5 mt-30 -73.84 -42.35 60.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 170.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -74.44 -20.71 59.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -83.59 -11.94 56.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.961 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -118.03 93.84 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 0.0 110.905 -174.096 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -89.2 -22.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.721 2.281 . . . . 0.0 112.397 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.2 p -69.9 -20.49 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -161.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.6 pp -131.49 154.96 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.09 142.14 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -89.35 119.35 29.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -169.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.64 -31.47 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 191' ' ' LEU . 47.8 pt -139.99 145.58 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.57 114.49 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -128.6 138.82 52.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -122.86 132.67 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.589 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.5 pp -124.68 141.92 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 175.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -118.79 135.01 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.856 -165.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -131.46 158.19 41.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -51.89 119.02 3.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -166.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.79 139.77 34.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.978 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -79.38 143.86 34.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -98.45 -21.68 16.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.62 54.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.456 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -158.35 169.09 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -61.72 135.02 57.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 183' ' ' GLY . 18.7 t-160 -57.64 121.01 9.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -90.15 -5.02 56.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 181' ' ' HIS . . . 116.19 -27.73 7.98 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.453 175.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.23 141.14 40.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' HB1' ' OE1' ' A' ' 136' ' ' GLN . . . -149.56 148.58 29.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.53 137.05 39.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.74 146.03 49.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 133' ' ' ALA . 43.9 pt -126.05 148.46 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.93 132.81 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.86 149.84 26.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.677 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.2 tt -140.85 127.7 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -176.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.89 142.09 16.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -111.27 129.93 55.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -90.17 133.66 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.01 140.57 40.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.76 -22.63 63.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 59.3 m170 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.81 178.86 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 44.97 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.62 157.97 19.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.61 149.79 49.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.5 145.03 46.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -157.89 165.07 36.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.787 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -155.38 169.96 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.62 170.02 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.918 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 t -159.99 139.84 11.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.18 128.54 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.672 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 54.2 p90 -156.96 159.04 37.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.947 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.6 t -122.95 132.98 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -138.13 125.15 21.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.57 158.73 15.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.69 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 94.2 m -112.66 131.78 55.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.49 105.12 21.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.727 0.775 . . . . 0.0 110.813 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -71.9 142.78 39.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.599 2.199 . . . . 0.0 112.323 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -127.25 170.34 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -126.88 149.29 49.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 60.25 49.5 7.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 66.4 tp -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.96 -79.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -126.55 -37.31 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 154.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 24' ' ' VAL . 5.4 p -130.07 16.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -169.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -64.7 -2.12 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -174.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -54.74 -13.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.97 -16.4 31.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 25' ' ' ALA . 9.4 tt -76.53 138.26 67.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.706 0.765 . . . . 0.0 111.074 -173.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 52.8 Cg_exo -53.7 119.26 5.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.274 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -78.93 2.29 20.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -90.32 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.478 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.74 134.02 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 0.0 110.858 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -124.31 132.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.9 tp -101.62 122.66 44.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.82 117.36 33.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 85' ' ' LEU . 47.8 mt -88.01 54.88 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.95 105.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -168.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -60.12 -60.34 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.86 78.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.45 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 63.2 16.12 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.89 22.08 71.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.67 -51.59 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.76 -28.8 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -69.5 -34.6 74.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.901 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 97.9 mt -69.6 -35.05 74.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.76 85.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.4 p -68.72 -18.38 64.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.853 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.83 -0.87 57.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 96.27 4.81 59.58 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.408 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.18 145.23 26.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -91.53 108.06 19.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 93.9 t -108.65 131.24 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -110.4 128.9 55.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.21 132.51 56.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.3 137.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.122 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -155.01 162.46 41.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.821 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.45 -24.18 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.8 t -102.87 119.63 39.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.9 p -68.03 -26.67 65.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 170.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.19 -46.22 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.035 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -41.96 99.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.41 -35.94 82.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.95 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.87 92.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.94 -37.54 88.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.867 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.98 96.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.068 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.11 -42.64 99.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -64.72 -41.32 96.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.94 -40.18 92.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.85 95.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.103 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.11 -37.84 88.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.03 -33.09 75.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.21 -9.68 41.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 72.02 34.68 61.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.419 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.02 161.31 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -104.41 130.15 52.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -133.06 162.01 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -115.37 132.0 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.9 p -123.77 134.74 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.84 125.14 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -85.24 117.7 24.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.926 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -175.17 145.1 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.3 t30 -55.25 128.24 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 170.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.421 HD11 HD22 ' A' ' 36' ' ' LEU . 43.8 tp -57.93 -36.36 72.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.14 70.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -100.0 -6.12 27.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 84' ' ' ASN . 53.7 t80 -62.07 133.23 55.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -84.94 103.35 13.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.4 mt -87.49 123.14 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.133 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.2 t -102.02 134.21 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.54 -59.45 2.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.53 -22.76 64.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.97 68.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 -172.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.474 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 64.6 p-90 -147.46 160.77 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.44 -36.9 4.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.19 16.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.488 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 98' ' ' ILE . 3.1 tp -132.83 123.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 111.199 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.83 129.7 71.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -113.21 116.37 29.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.59 113.75 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.143 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 40.22 50.48 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.1 t -98.99 90.02 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -76.32 119.46 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 105' ' ' LEU . 2.3 pp -145.51 149.28 40.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.39 155.22 71.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.691 2.26 . . . . 0.0 112.331 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.6 p -54.16 -29.37 45.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -58.73 -40.43 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.798 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.9 -34.02 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -55.3 -44.42 75.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.08 -31.28 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -87.29 -50.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.86 -43.17 84.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -55.82 -54.26 53.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.698 0.761 . . . . 0.0 110.964 -167.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.0 Cg_endo -66.75 -29.33 42.79 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -67.51 -40.24 85.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -39.77 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.57 -49.7 75.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -64.74 -32.02 73.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.957 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.46 -31.3 54.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.3 tp -73.59 132.04 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -75.49 155.06 85.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -54.29 127.46 25.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.688 2.258 . . . . 0.0 112.294 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.58 4.1 87.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.457 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.0 168.83 51.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.0 t -127.0 139.18 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -111.8 132.66 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.94 131.23 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.21 123.94 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -150.28 128.98 12.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.04 -175.24 43.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.475 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -70.06 159.38 33.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.59 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -105.58 150.53 39.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.523 0.678 . . . . 0.0 111.146 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.35 -21.43 72.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.313 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -57.63 -29.05 64.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.768 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.81 -26.63 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.003 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.089 HD23 ' O ' ' A' ' 137' ' ' LEU . 5.2 tt -58.29 -22.05 51.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -165.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.578 ' O ' ' C ' ' A' ' 139' ' ' TYR . 21.5 pt20 -61.37 -13.84 22.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -170.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.578 ' C ' ' O ' ' A' ' 138' ' ' GLN . 48.1 m-85 -20.54 -78.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -119.97 -19.26 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 -157.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 p -121.25 -13.3 8.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -166.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . 65.81 16.88 64.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.49 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.18 165.85 10.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.859 ' HD3' HD13 ' A' ' 137' ' ' LEU . 87.7 Cg_endo -76.69 -42.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.64 -25.36 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 151.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -169.23 145.9 3.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 142' ' ' GLY . 90.4 mt -61.0 -21.0 63.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 172.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -77.89 -21.81 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.35 -7.74 59.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.06 142.94 39.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.686 0.755 . . . . 0.0 110.879 -170.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 142.11 27.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.785 2.323 . . . . 0.0 112.308 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -98.55 156.59 16.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 153' ' ' LEU . 5.4 tt -53.59 -44.0 69.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.99 -35.38 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.5 m -64.62 -41.74 95.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.24 -35.53 80.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.93 -33.77 70.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.0 p -78.27 -21.53 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -175.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.62 -22.4 56.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' CZ2' ' A' ' 165' ' ' TRP . 18.4 mt -105.36 102.85 39.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.679 0.752 . . . . 0.0 110.912 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.58 -27.76 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.788 2.325 . . . . 0.0 112.343 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.6 m -78.77 -17.07 56.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -165.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.639 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.9 pp -130.82 154.76 47.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.13 140.4 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.444 ' CZ2' HD12 ' A' ' 160' ' ' LEU . 99.1 m95 -85.08 126.24 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -172.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.86 -32.65 13.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.682 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.6 pt -140.1 146.73 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 153' ' ' LEU . . . -159.18 119.24 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 168.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -132.3 140.26 48.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.809 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -113.9 120.42 40.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.94 145.68 36.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -119.2 136.72 54.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -132.06 154.75 49.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 168.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -59.26 120.07 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.1 141.86 28.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -73.73 145.38 45.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -93.56 -39.05 11.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.26 54.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.461 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -153.37 174.73 13.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.773 0.32 . . . . 0.0 111.103 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.88 130.18 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.69 119.54 7.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -85.29 -12.92 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -172.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 118.82 -21.32 9.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.541 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.19 139.47 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 0.0 110.925 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -154.9 155.26 33.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.056 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.59 129.11 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 167.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.0 mt -120.15 149.51 42.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.93 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.59 HG23 ' HB2' ' A' ' 133' ' ' ALA . 31.7 pt -124.82 142.52 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 172.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.36 124.45 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -153.82 148.55 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -174.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.3 tt -140.03 129.73 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 -172.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -119.98 152.36 17.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.515 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -118.75 135.84 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.921 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -92.49 130.1 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.94 144.55 30.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.84 -32.91 70.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 179.221 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.2 m0 59.1 45.04 15.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -115.01 160.05 20.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -127.47 149.96 49.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.09 144.98 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.776 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -157.02 165.06 37.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -155.04 169.93 22.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.52 169.95 8.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -159.94 140.06 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.85 128.7 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.9 p90 -163.64 162.67 24.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -130.22 136.76 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -138.34 149.25 45.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.93 172.41 42.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.64 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 88.7 m -124.3 129.56 50.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -119.76 96.23 49.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.702 0.763 . . . . 0.0 110.823 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.02 139.6 70.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.658 2.238 . . . . 0.0 112.355 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -129.5 170.22 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 56.0 p30 -129.96 165.15 22.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 52.55 39.44 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 63.3 tp -65.7 -40.51 92.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.59 -80.85 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -130.95 -36.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 152.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.85 14.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.166 -168.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -58.64 -13.84 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 10.3 p-10 -62.69 -8.47 6.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.9 -14.83 27.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.978 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.479 ' CD1' HD11 ' A' ' 128' ' ' ILE . 79.1 mt -80.43 132.62 58.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.69 0.757 . . . . 0.0 111.13 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.66 117.54 3.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.296 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -77.87 9.18 3.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.29 -101.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -99.95 133.6 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.703 0.287 . . . . 0.0 110.87 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.5 131.7 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.19 125.89 51.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.958 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.4 t -114.94 115.28 26.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 74.7 mt -88.37 58.11 4.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.05 105.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.088 -172.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 10.1 tm-20 -57.77 -59.74 4.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.09 34.85 90.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.469 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 62.06 18.34 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.946 0.403 . . . . 0.0 110.889 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.38 15.16 67.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.477 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -64.66 -49.63 70.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -79.36 -29.91 42.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.29 67.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.88 -33.97 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -61.15 -50.89 71.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 54' ' ' VAL . 95.4 mt -67.6 -36.82 81.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.47 82.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.159 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -70.59 -16.72 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -91.3 0.15 57.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.969 172.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.95 4.65 60.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.584 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -89.85 145.91 24.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -90.23 109.15 20.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.953 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.2 t -109.21 128.75 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -110.05 125.71 53.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.127 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.26 129.79 55.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 -172.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 134.68 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.83 160.55 41.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.836 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -80.6 -24.0 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -106.07 140.74 38.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -77.19 -28.01 53.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.88 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.04 -46.76 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.82 99.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.13 -37.08 84.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.0 110.882 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.57 90.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.39 -37.48 87.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -61.16 -43.2 99.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.085 175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -61.36 -46.45 90.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.59 -40.67 92.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.47 94.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.3 -38.17 90.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.84 -31.89 72.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.44 -8.22 45.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.923 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.8 34.18 56.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.437 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.8 160.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -104.38 130.81 52.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.86 165.33 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.3 m -119.43 133.82 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.4 p -120.73 132.75 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.12 122.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -88.51 116.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.3 t -173.35 141.49 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 88' ' ' PHE . 49.1 t30 -57.45 129.41 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.05 -35.08 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.916 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.32 68.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.079 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -99.83 -8.31 24.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ASN . 79.4 t80 -66.45 134.55 52.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.45 108.9 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.779 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.9 mt -81.4 122.16 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.7 t -94.31 138.74 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.15 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' GLY . . . -72.7 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -24.39 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.05 70.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -165.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.484 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 67.7 p-90 -149.55 161.28 42.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 45.8 mp0 -116.42 -35.46 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.73 147.89 16.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.484 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 15.9 tt -133.0 129.73 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.8 134.88 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -169.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -109.55 117.67 34.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.51 113.05 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.096 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 48.3 44.48 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.1 t -114.46 72.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -73.03 122.38 21.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.814 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.0 mt -131.59 151.76 79.24 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.565 0.698 . . . . 0.0 110.962 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.76 146.25 91.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.374 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -57.91 -33.33 68.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.0 m -61.28 -40.9 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.0 tp -72.31 -36.47 68.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -54.15 -46.61 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -65.86 -26.09 67.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.11 -38.2 32.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.19 -31.87 66.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.4 m-30 -53.09 -53.6 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.671 0.748 . . . . 0.0 110.956 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.7 Cg_endo -65.55 -31.28 50.94 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.698 2.265 . . . . 0.0 112.378 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.49 -42.67 82.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.94 -39.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.84 -53.66 52.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.54 -30.02 70.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' ALA . . . -80.16 -28.15 50.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.407 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.9 tp -78.84 131.75 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.2 mttt -78.92 153.08 77.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.634 0.73 . . . . 0.0 110.839 172.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.45 128.14 28.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.335 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.12 -3.59 86.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.457 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -71.62 171.89 46.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.431 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.23 142.52 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 163' ' ' LEU . 68.1 t80 -115.74 135.21 54.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 28' ' ' ILE . 84.5 mt -120.04 131.86 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.407 HD23 HD21 ' A' ' 190' ' ' LEU . 54.4 tp -128.82 126.59 40.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.961 169.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -151.91 142.65 22.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.33 -166.9 34.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -64.73 153.33 40.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -93.35 156.56 39.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.54 0.686 . . . . 0.0 111.153 174.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.53 -23.81 49.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.642 2.228 . . . . 0.0 112.397 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -54.94 -27.58 44.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.766 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -58.52 -29.68 66.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.52 -10.73 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -162.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.615 ' O ' ' C ' ' A' ' 139' ' ' TYR . 65.3 tt0 -67.44 -8.48 33.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -176.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 138' ' ' GLN . 75.7 m-85 -20.0 -79.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.011 -170.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -134.65 -1.32 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.866 -166.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.3 p -131.67 -6.77 3.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.35 60.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.79 170.83 11.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.448 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.78 -39.63 19.64 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.659 2.239 . . . . 0.0 112.32 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 98.4 mttt -129.34 -29.53 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 154.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.451 ' HB3' HD13 ' A' ' 149' ' ' LEU . 68.2 t0 179.24 126.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.493 ' C ' HD12 ' A' ' 147' ' ' LEU . 1.2 pp -56.3 -20.08 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -77.74 -20.17 53.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.907 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.8 mp -82.97 -6.52 59.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -163.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.19 154.96 40.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 110.918 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -52.98 114.4 1.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.784 2.322 . . . . 0.0 112.307 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.45 152.59 45.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 153' ' ' LEU . 4.8 tt -55.26 -46.78 76.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.58 -37.12 85.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.5 m -62.56 -42.02 99.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.84 -39.56 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.958 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -62.99 -37.75 88.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.2 p -82.98 -28.13 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -81.74 -14.36 56.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 160' ' ' LEU . 4.9 tt -107.71 102.19 43.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 0.0 110.899 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -89.12 -24.2 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.386 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.2 m -68.96 -25.28 64.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -164.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 127' ' ' PHE . 4.2 mp -123.06 145.89 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -95.31 136.75 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.73 124.88 35.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -165.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.1 mt -92.01 -35.93 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.5 pt -141.78 146.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.05 119.38 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -135.05 141.05 46.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -176.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -116.17 130.91 57.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 166.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.8 pp -127.01 149.96 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -114.14 136.8 52.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -133.55 155.86 48.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -55.16 117.06 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -170.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.79 133.0 36.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.49 140.78 55.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -100.01 -29.92 12.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.55 54.96 0.18 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -156.53 167.33 30.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.135 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -51.74 130.54 28.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.909 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -53.02 115.41 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -85.18 -12.72 52.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 120.9 -35.54 3.65 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.511 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.91 135.07 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.9 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -170.58 162.08 7.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.82 44.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt -118.58 149.85 40.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 133' ' ' ALA . 42.4 pt -120.81 142.73 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -142.21 126.96 18.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -146.72 148.57 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.721 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.8 tt -143.07 128.16 18.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.459 ' N ' HD23 ' A' ' 191' ' ' LEU . . . -122.2 154.7 16.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -125.32 144.36 50.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -95.59 136.39 36.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.5 mt -72.7 141.5 48.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.832 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.11 -23.16 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 178.485 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.722 0.296 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.05 44.99 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.86 140.23 37.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.11 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -133.93 145.02 49.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.1 165.06 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -150.9 169.79 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.65 170.02 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -159.42 140.04 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.81 134.94 18.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -153.71 169.29 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.74 132.73 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -145.19 165.04 29.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 147.25 21.27 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.777 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 92.0 m -116.48 129.02 55.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.633 0.254 . . . . 0.0 111.173 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -139.14 125.05 12.19 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.56 149.18 49.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -125.27 149.88 47.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.92 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -113.5 149.51 34.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 62.57 25.21 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.941 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.9 tt -64.52 -39.94 94.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.97 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.02 -82.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.3 m -128.15 -37.56 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 143.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' CG2' HD13 ' A' ' 191' ' ' LEU . 27.0 m -124.96 29.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.202 -176.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -53.05 -15.08 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.121 -174.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -64.99 -2.01 2.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -100.59 -17.78 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 128' ' ' ILE . 89.7 mt -75.82 134.36 72.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.637 0.732 . . . . 0.0 111.177 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.96 108.37 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.315 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -78.27 18.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -167.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' HA3' ' OE1' ' A' ' 96' ' ' GLU . . . -84.59 -97.7 0.66 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -102.94 128.69 49.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.811 -171.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.2 127.99 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.089 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . 63.8 tp -106.66 123.36 48.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 t -111.44 116.79 31.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.16 60.21 5.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.99 105.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -67.07 -60.52 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -170.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.65 35.0 91.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 59.03 20.73 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.74 61.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.521 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -65.68 -46.4 79.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -77.57 -27.89 51.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.59 59.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.3 p -69.43 -29.18 66.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -64.83 -50.76 65.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.2 mt -65.27 -37.84 88.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.79 85.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -66.87 -20.17 65.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -89.63 0.44 56.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 94.92 5.0 61.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.474 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.88 143.88 27.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -90.02 106.85 18.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.896 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 47' ' ' LEU . 77.5 t -107.21 125.66 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.4 m -112.08 128.59 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 167.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.49 130.57 56.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.128 -174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 133.19 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -155.79 156.62 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -77.93 -27.78 49.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.039 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.0 p -96.03 149.62 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -168.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -80.11 -31.29 39.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.949 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.74 -48.19 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.51 98.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.574 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.62 -36.71 81.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.14 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.88 -37.3 81.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.72 99.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 174.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.18 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -68.41 -41.21 80.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.36 -40.51 96.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.16 96.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.51 -37.72 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -32.7 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.98 -7.28 49.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.69 59.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.89 163.77 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 111.165 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.24 131.35 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.43 170.19 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -123.93 130.66 52.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.5 p -121.92 134.35 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.87 123.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -85.86 114.37 22.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -173.6 143.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -55.4 133.23 49.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -57.77 -35.61 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 109' ' ' LEU . . . -71.62 -27.22 62.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.078 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -99.92 -11.92 20.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.23 135.02 52.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -93.19 112.63 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.501 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.4 mt -87.66 125.12 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.9 t -102.95 138.05 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.192 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 -61.13 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -168.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.42 -35.04 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.05 -38.97 65.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 34' ' ' LEU . 17.8 m-90 -132.28 154.83 49.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 122' ' ' LYS . 53.7 mt-10 -107.38 -43.56 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.52 149.87 18.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mm -113.91 123.93 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.28 129.47 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.5 m -115.51 118.23 32.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.6 mm -113.67 116.69 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.176 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 47.42 42.97 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.2 t -108.06 96.44 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -89.9 120.39 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.5 150.04 74.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.637 0.732 . . . . 0.0 110.926 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 144.32 88.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.285 . . . . 0.0 112.324 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -60.12 -40.3 89.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 37.1 tp -73.83 -33.38 64.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.937 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -56.38 -44.97 80.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -75.07 -30.23 60.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -69.98 -39.89 75.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.31 -34.83 68.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 115' ' ' PRO . 35.7 t80 -51.37 -48.92 84.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.917 -163.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 114' ' ' TYR . 98.0 Cg_exo -47.34 -46.09 20.78 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.386 176.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -76.81 -36.24 57.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.18 -47.13 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.23 -54.53 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.16 -30.45 71.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -84.91 -11.97 75.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.467 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.67 129.63 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 96' ' ' GLU . 83.8 tttt -67.91 139.9 93.52 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.857 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.5 127.61 18.71 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.722 2.282 . . . . 0.0 112.345 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.94 1.26 88.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.483 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -73.71 170.41 52.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.418 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.83 142.82 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.791 0.329 . . . . 0.0 111.206 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -109.59 128.27 55.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 28' ' ' ILE . 38.1 mm -118.5 131.67 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.139 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.526 HD23 HD21 ' A' ' 190' ' ' LEU . 58.4 tp -129.84 123.77 31.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 165.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -143.93 130.77 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.22 -167.38 30.13 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.7 158.74 9.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -86.57 131.22 46.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 111.215 174.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.42 -38.42 63.38 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.564 2.176 . . . . 0.0 112.373 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -47.21 -35.41 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 133' ' ' ALA . 6.9 pt20 -56.71 -30.95 64.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.266 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.4 tt -59.04 -17.59 26.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 139' ' ' TYR . 15.8 pt20 -63.05 -16.45 59.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.566 ' C ' ' O ' ' A' ' 138' ' ' GLN . 37.9 m-85 -24.77 -66.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -120.13 -18.13 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.832 -161.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.6 p -126.37 -17.06 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -163.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.37 -22.88 7.88 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.424 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.63 175.76 37.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.544 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.77 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.8 Cg_endo -73.44 -41.1 1.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.754 2.303 . . . . 0.0 112.353 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -129.79 -27.96 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 156.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -161.92 155.87 21.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 169.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 HD12 ' A' ' 150' ' ' LEU . 53.5 tp -50.19 -23.86 2.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 169.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.15 -28.7 70.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 1.1 mp -78.49 -14.13 59.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.975 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.421 HD12 HD12 ' A' ' 147' ' ' LEU . 83.7 mt -95.81 112.13 58.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.931 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.76 132.27 6.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.379 -173.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.8 149.79 48.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 166.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.6 tp -55.45 -44.81 76.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.95 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.1 -38.39 90.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.0 m -60.4 -37.08 79.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.19 -42.58 93.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.949 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -65.91 -36.23 82.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.1 p -78.18 -25.89 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -84.58 -13.77 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 tt -119.36 92.95 46.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.663 0.744 . . . . 0.0 110.946 -175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -89.53 -24.65 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 0.0 112.347 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.7 p -81.18 -15.36 55.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -162.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -114.51 140.03 49.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -86.35 132.85 33.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -92.29 114.48 27.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 191' ' ' LEU . 83.8 mt -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -175.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -138.61 145.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.37 113.73 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -129.11 139.19 52.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -118.41 128.76 54.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -110.05 123.27 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -106.83 128.17 54.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -163.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -132.73 156.44 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 158.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -56.69 120.88 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -167.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.0 mt -97.1 142.09 29.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.81 150.92 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -98.3 -27.93 13.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.01 54.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.488 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.95 166.55 33.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -57.56 136.16 56.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 183' ' ' GLY . 20.1 t-160 -57.06 120.1 7.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -91.05 -5.55 55.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -173.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 181' ' ' HIS . . . 118.14 -31.47 5.64 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 175.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.45 139.74 46.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.917 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -150.09 148.21 28.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.109 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -104.19 137.69 41.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.027 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.99 145.44 49.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.434 HG23 ' HB2' ' A' ' 133' ' ' ALA . 44.2 pt -124.01 146.22 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.194 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -143.23 130.85 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -152.19 150.28 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.877 HD23 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.73 129.77 23.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.0 141.59 16.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -107.65 132.87 52.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -98.39 131.6 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.33 145.18 31.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -73.52 -18.0 61.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.746 177.724 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.756 0.312 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -164.79 142.75 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.05 159.99 40.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -123.89 119.42 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.83 148.11 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -126.39 154.93 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.7 p -153.52 169.96 21.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.07 40.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.8 p -156.79 164.42 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -126.06 146.86 49.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.61 164.98 23.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.0 134.96 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.059 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -149.29 164.96 33.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.46 163.09 11.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -121.06 102.13 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.95 69.88 35.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 0.0 110.902 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.14 155.14 42.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.743 2.295 . . . . 0.0 112.314 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.2 155.02 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.46 170.14 22.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -60.02 133.38 56.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.83 -32.34 20.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.009 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.11 -93.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.2 t -124.97 -51.82 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 24' ' ' VAL . 40.1 t -126.82 26.11 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.092 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.72 -8.86 7.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -62.46 -7.69 4.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -89.27 -10.7 45.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.883 175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 126' ' ' VAL . 68.8 mt -79.24 130.76 68.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 111.207 173.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.88 153.06 79.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.741 2.294 . . . . 0.0 112.277 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.31 12.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 -173.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.58 -143.4 7.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.524 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.01 144.47 30.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.695 0.283 . . . . 0.0 110.948 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.49 135.05 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 55' ' ' THR . 51.0 tp -105.57 126.03 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -106.42 124.9 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.57 133.24 39.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.06 53.76 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.059 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' H ' ' A' ' 41' ' ' GLY . 54.0 tp10 -90.16 123.33 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.14 16.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.425 -166.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -129.99 10.02 5.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 38' ' ' GLU . . . 75.01 22.05 77.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.76 -42.11 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -75.12 -29.15 60.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.845 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.43 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.55 -37.27 76.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -63.06 -47.34 83.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 54' ' ' VAL . 70.0 mt -63.54 -38.82 92.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.28 79.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -70.64 -20.51 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.844 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -87.58 0.12 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.74 7.66 58.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -83.96 145.0 28.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.17 112.61 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 165.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 47' ' ' LEU . 89.9 t -111.44 135.72 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 34' ' ' LEU . 97.5 m -107.75 125.34 51.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 165.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.98 133.92 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.079 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.33 129.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 59' ' ' GLN . 49.5 t0 -154.5 153.24 31.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.424 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 92.4 mt-30 -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 174.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.3 t -95.67 115.45 27.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.83 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.0 p -69.07 -33.71 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.02 -31.37 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.78 -41.64 97.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.54 169.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.78 -35.04 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.29 88.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -64.29 -38.79 92.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.972 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.63 91.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.01 -43.16 99.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.1 -40.14 92.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -33.91 77.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.9 -10.99 34.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.92 66.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.416 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.39 161.7 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.169 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -97.37 129.97 44.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 pt -137.08 163.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.143 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.0 m -121.65 134.08 54.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.5 p -119.17 133.05 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.91 122.38 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -85.12 118.79 24.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 t -174.53 143.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.29 128.16 35.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.31 -38.59 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.33 -32.56 74.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -97.78 -6.37 32.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.99 129.89 42.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.9 114.93 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.879 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -93.76 117.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.191 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -83.69 136.23 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.051 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.39 -49.51 54.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -56.92 -26.09 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.74 80.6 9.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -69.86 130.14 41.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -173.14 150.81 1.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.49 163.33 46.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.473 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.6 mm -114.84 117.89 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.45 124.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.7 m -112.6 115.03 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.46 123.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' CG ' ' A' ' 102' ' ' PHE . 53.8 t80 43.19 49.83 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.1 m -97.27 79.02 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -75.46 114.8 14.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.8 pp -152.04 152.71 30.24 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.618 0.723 . . . . 0.0 110.821 -169.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.85 149.74 78.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -58.1 -29.77 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -59.2 -35.96 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 105' ' ' LEU . 49.7 tp -69.87 -36.9 75.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.85 -28.02 69.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -82.43 -39.93 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.55 -32.56 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 m-30 -54.73 -55.23 40.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.715 0.769 . . . . 0.0 110.94 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 29.4 Cg_endo -61.69 -34.01 84.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.314 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -68.63 -46.42 69.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.94 -31.61 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -69.2 -57.11 5.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.71 -34.04 69.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -68.26 -31.12 74.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.696 HD11 ' HA3' ' A' ' 125' ' ' GLY . 57.7 tp -86.2 128.84 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.892 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.87 159.56 68.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.524 0.678 . . . . 0.0 110.911 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.04 133.53 46.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.44 48.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.696 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -75.54 168.3 54.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' A' ' 28' ' ' ILE . 96.1 t -131.95 140.16 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -106.46 131.88 53.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.7 134.4 66.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.19 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 59.6 tp -127.19 127.18 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 172.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.84 139.74 15.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.08 30.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.539 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.435 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 72.9 m-85 -65.17 150.34 48.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.902 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -112.1 161.83 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 0.0 111.132 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -49.71 -30.02 21.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 0.0 112.309 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.1 -22.27 49.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 -175.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -59.78 -23.31 63.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.96 -20.03 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -172.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.469 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 58.7 tp60 -60.86 -24.5 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 -170.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.732 ' CZ ' ' HA3' ' A' ' 183' ' ' GLY . 43.3 t80 -47.42 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.012 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -117.61 -10.31 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 69.4 p -120.45 12.15 11.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -167.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 138' ' ' GLN . . . -82.38 81.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.464 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.41 -130.92 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.0 -31.67 35.49 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.706 2.271 . . . . 0.0 112.33 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -86.34 39.8 0.85 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.955 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.05 170.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.872 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.8 tp -53.96 -27.86 33.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -166.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -77.38 -22.48 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.8 mp -92.81 -9.6 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -170.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.92 150.48 42.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 0.0 110.926 -156.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.79 167.07 28.16 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.617 2.211 . . . . 0.0 112.393 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -129.94 154.33 47.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 168' ' ' ALA . 3.3 pp -48.2 -30.78 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 96.6 mt-10 -65.1 -36.51 84.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.1 p -75.15 -31.84 61.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 156' ' ' LEU . 10.1 tt -64.2 -45.17 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 4.4 pt20 -66.46 -28.22 68.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.3 p -73.18 -16.09 61.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -78.97 -13.27 59.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.71 108.25 61.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.674 0.749 . . . . 0.0 110.947 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.4 -20.67 3.92 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.763 2.309 . . . . 0.0 112.309 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.5 p -71.66 -24.67 61.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -159.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.7 pp -143.2 168.1 20.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -104.94 144.61 31.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -96.56 128.66 43.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -88.72 -31.67 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -172.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 190' ' ' LEU . 43.3 pt -138.27 147.83 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.087 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -146.55 117.64 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 166.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -130.02 140.02 50.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -103.87 122.66 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 49.5 mt -111.08 143.22 42.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.98 124.29 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB2' HD11 ' A' ' 187' ' ' LEU . 88.5 mmt-85 -140.07 174.31 10.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -79.77 140.09 37.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.87 138.29 58.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.16 143.53 48.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.34 119.94 20.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.96 -88.17 0.12 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.58 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.25 170.17 9.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -84.65 -167.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.879 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -100.32 108.64 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.732 ' HA3' ' CZ ' ' A' ' 139' ' ' TYR . . . -179.31 -158.01 20.79 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.451 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -70.38 146.1 50.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 0.0 110.971 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.17 142.85 35.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.046 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -104.4 131.13 52.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.1 mp -126.94 153.02 46.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.928 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.54 HG23 ' HB2' ' A' ' 133' ' ' ALA . 44.7 pt -114.11 142.48 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -135.25 123.06 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.72 147.65 26.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 191' ' ' LEU . 9.9 tt -139.74 129.89 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.25 147.6 18.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.461 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.58 130.14 54.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.882 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 1.239 ' HD2' ' O ' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -80.06 115.33 19.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 175.381 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.83 140.25 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.72 34.83 5.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -176.553 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -155.03 166.8 32.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.937 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -162.0 160.07 27.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -129.9 149.97 51.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -159.22 129.01 5.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.99 168.11 28.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 t -151.66 139.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.1 160.0 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -165.79 137.26 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.884 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -161.7 164.61 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.75 163.45 39.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.63 80.51 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.17 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.35 172.38 7.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.32 176.48 22.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -153.8 154.95 34.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.694 0.283 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.92 149.16 62.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.79 154.39 48.71 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.33 156.13 43.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.65 105.61 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.39 110.82 22.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 48.0 tp -70.12 -51.18 33.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 189' ' ' GLN . 49.0 t -101.85 -82.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 -174.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.4 m -128.34 -39.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.821 158.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.63 15.65 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -63.89 -19.03 64.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.115 -166.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -57.3 -16.7 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.818 173.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.32 1.24 51.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.445 HD12 ' HB1' ' A' ' 25' ' ' ALA . 85.6 mt -67.48 133.84 92.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.716 . . . . 0.0 111.143 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.41 131.32 27.26 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 0.0 112.335 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 84.4 mt-30 -75.91 13.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.947 -176.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.17 155.05 26.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 61.86 68.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 110.859 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 52' ' ' TYR . 47.7 mm -115.01 126.51 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.42 120.71 43.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.5 t -108.49 125.94 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.6 mt -108.63 135.45 49.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.11 45.77 25.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CD ' ' HB1' ' A' ' 56' ' ' ALA . 19.8 pm0 -71.45 -18.33 62.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 -175.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.18 -66.95 3.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -130.33 11.61 5.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 82.98 5.24 89.51 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.507 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -64.86 -36.94 85.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.938 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.51 88.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.6 m -68.46 -38.38 81.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.845 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -58.47 -51.95 67.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.1 mt -59.71 -40.06 86.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.29 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.073 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.1 p -69.75 -17.83 63.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.87 1.06 41.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.77 4.61 65.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.498 ' HB3' HG13 ' A' ' 33' ' ' ILE . 10.1 m-30 -74.12 147.0 43.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 0.0 111.004 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -84.98 101.96 12.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.856 166.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.22 124.5 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -165.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.6 m -112.28 126.06 54.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 165.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HB1' ' CD ' ' A' ' 38' ' ' GLU . . . -110.05 126.61 54.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.24 128.33 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -176.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.23 155.92 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -78.99 -20.02 50.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -93.67 110.96 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 94.3 p -67.81 -34.85 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.85 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.43 -30.92 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.92 97.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.42 -36.53 81.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.871 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.74 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.25 -38.62 91.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 173.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.65 -43.33 93.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.86 -44.72 96.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -66.82 -41.13 87.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.35 -41.07 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.35 93.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.158 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.81 -39.21 93.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.92 -32.87 73.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.948 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.82 -10.1 41.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.57 32.98 58.92 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.499 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.79 160.1 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.23 137.68 45.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.972 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.77 164.19 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -119.21 133.5 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.6 p -118.49 135.01 54.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.147 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.0 t -128.08 119.96 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -84.09 113.63 21.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -173.04 143.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -54.86 124.06 15.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.29 -37.35 67.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -32.08 72.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.75 -8.18 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.85 127.21 30.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.978 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.21 114.93 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 pt -126.58 141.82 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.089 168.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.91 -179.8 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.46 -34.11 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -173.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -29.23 70.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.0 94.54 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.074 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 122' ' ' LYS . 41.7 m0 -89.89 104.84 17.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.945 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.92 126.08 15.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.86 158.7 36.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -112.12 118.7 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.129 -171.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.1 t -121.37 124.34 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 103' ' ' CYS . 58.8 m -130.1 108.44 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.9 mm -114.53 125.67 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.159 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 48.61 40.26 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -171.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 100' ' ' SER . 87.1 m -118.67 82.13 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.892 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.1 130.98 34.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.9 mt -121.1 146.96 45.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.2 Cg_endo -67.67 147.6 76.26 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.604 2.203 . . . . 0.0 112.389 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -54.23 -40.25 67.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.913 -172.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.3 m -60.49 -38.91 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.841 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.6 tt -71.91 -39.98 69.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -59.71 -40.24 87.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.59 -29.42 70.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -83.62 -39.82 19.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.9 tp -72.15 -41.62 66.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.576 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 3.2 m-30 -55.37 -49.51 92.07 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.667 0.746 . . . . 0.0 110.951 -165.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 96.4 Cg_exo -47.32 -39.36 27.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.98 -47.89 19.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.38 -25.21 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -64.95 -47.67 76.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 175.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.9 -24.91 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.9 59.94 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.486 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' A' ' 194' ' ' LYS . 1.9 pt? -81.93 153.07 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 63.9 pttt -75.43 155.84 85.54 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.524 0.678 . . . . 0.0 110.895 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -56.22 122.7 12.25 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.64 -1.69 81.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.491 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.92 177.01 48.55 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.7 t -129.31 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.141 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -107.22 129.0 54.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.92 123.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 190' ' ' LEU . 63.2 tp -131.63 127.08 36.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 166.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -157.14 140.06 15.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.97 -178.59 35.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -58.35 160.86 4.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.96 142.03 98.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 111.049 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . 80.9 Cg_exo -51.93 -48.78 19.83 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -45.72 -34.86 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.64 -22.72 66.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.775 HD23 ' N ' ' A' ' 138' ' ' GLN . 0.2 OUTLIER -78.76 -8.58 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -164.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.775 ' N ' HD23 ' A' ' 137' ' ' LEU . 77.4 mt-30 -72.54 -25.13 61.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -171.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.9 t80 -25.45 -65.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -110.84 -24.81 10.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.6 p -112.64 11.73 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.233 -167.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.02 104.21 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.608 ' H ' ' H ' ' A' ' 145' ' ' LYS . . . -174.98 -74.97 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -66.76 -3.27 9.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.645 2.23 . . . . 0.0 112.265 154.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.608 ' H ' ' H ' ' A' ' 143' ' ' GLY . 75.3 mmtt -114.29 38.22 3.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -69.76 147.85 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.802 -169.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 150' ' ' LEU . 19.2 tp -54.3 -26.25 28.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.21 -31.72 72.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 149' ' ' LEU . 5.4 mp -82.89 -13.53 55.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 147' ' ' LEU . 86.4 mt -93.33 123.19 61.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.692 0.758 . . . . 0.0 110.901 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 77.5 Cg_endo -84.57 135.05 5.81 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.363 -169.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.28 145.07 56.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 164.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.9 tp -52.89 -46.81 68.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.63 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.4 m -63.37 -40.47 97.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 54.8 mt -59.81 -39.95 86.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -64.0 -34.25 77.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -81.88 -25.01 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -77.58 -15.47 59.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.88 98.28 28.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.51 -28.33 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.278 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 92.0 p -73.55 -20.69 60.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.785 -163.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.4 pp -134.12 159.11 41.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -103.42 139.72 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -88.16 124.9 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.26 -31.74 14.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.665 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -140.17 146.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.29 117.42 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -139.11 146.75 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -113.72 129.98 56.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp -135.27 154.15 51.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -106.37 130.64 54.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -174.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -143.78 169.18 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.78 137.42 55.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.9 tp -67.45 129.09 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -69.72 131.37 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -169.85 157.04 6.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.93 -81.19 1.08 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.14 70.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 111.104 -175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.94 151.96 23.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -130.11 -34.93 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -74.79 129.99 38.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.62 125.74 1.21 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.557 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.856 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.16 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.098 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.09 136.74 38.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.061 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.89 144.94 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.71 142.68 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.43 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.6 pt20 -143.19 128.13 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.71 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.61 147.57 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.665 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.7 tt -139.75 127.19 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -174.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -112.06 141.83 16.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.441 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -108.9 129.37 55.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.872 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.437 ' HD2' HD21 ' A' ' 121' ' ' LEU . 83.5 tttt -89.29 130.05 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.75 145.05 28.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.945 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.49 149.93 36.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.803 177.646 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mmm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.05 165.02 38.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -160.93 160.01 30.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.954 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -158.78 128.42 5.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.974 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.96 168.73 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -149.69 139.08 21.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.0 160.0 38.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.9 t -161.95 139.96 8.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.827 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -160.86 160.88 31.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -153.71 129.97 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.921 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -120.5 125.05 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -159.99 134.95 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.19 -175.91 40.96 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 t -153.9 155.04 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.99 148.08 58.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.752 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 155.04 47.92 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -129.9 160.02 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.806 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -141.76 99.85 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.39 132.57 44.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 47.4 tp -68.56 -44.09 75.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 189' ' ' GLN . 67.9 t -111.35 -83.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 t -130.61 -37.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 163.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.17 2.96 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . . . -63.36 -24.24 67.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -162.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -63.3 -14.7 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -78.25 -4.09 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.32 139.69 96.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.579 0.705 . . . . 0.0 111.168 169.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -39.31 125.05 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.347 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -60.06 -5.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.903 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.28 -174.56 17.62 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' TRP . 72.0 mmtt 64.98 65.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.58 131.8 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 58.9 tp -104.35 119.85 39.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 174.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -105.89 122.5 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.04 127.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -171.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 62.73 50.09 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 20.0 pm0 -75.61 -19.19 59.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.29 -70.06 3.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.493 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.54 -4.03 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.4 12.77 64.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.455 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.71 -37.41 84.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -67.29 -41.06 86.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.14 90.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.4 m -72.37 -34.2 67.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.62 -51.73 68.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.952 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.01 -35.82 80.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.18 86.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -71.07 -20.67 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.02 2.77 51.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.81 4.86 61.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -82.92 137.84 34.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 111.006 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -87.81 110.11 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.99 130.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 -170.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.6 m -102.9 125.01 49.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 163.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.29 124.41 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 -170.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.85 126.79 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.111 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -157.17 154.68 29.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -79.26 -19.99 49.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.961 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -93.67 111.61 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.828 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 96.1 p -67.36 -33.95 76.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.1 -31.29 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.042 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.68 -39.73 97.83 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 170.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.37 -34.64 76.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.14 82.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -62.5 -39.88 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.771 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.28 -41.66 97.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.061 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.93 -44.53 95.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -40.78 90.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 81.8 mt -61.71 -40.52 95.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.83 96.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.41 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.26 -34.09 76.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.84 -9.5 43.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.44 33.97 63.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.412 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.23 160.72 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.158 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -105.37 132.31 51.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.965 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.78 160.88 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.07 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -116.7 134.01 55.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.2 p -123.51 140.99 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 80.1 t -132.7 122.76 47.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.6 tm0? -83.37 116.91 22.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -174.83 145.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -55.18 123.17 12.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.901 172.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 113' ' ' LEU . 50.0 tp -55.78 -36.88 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.909 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -34.4 77.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.84 -7.22 27.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.29 134.8 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.948 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.37 111.29 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.8 mt -94.87 120.44 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.6 131.59 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.04 -43.59 33.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.12 -20.59 59.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.848 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.33 125.18 30.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 82.7 m95 -75.18 94.95 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 98.6 mt-10 -149.95 123.71 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 170.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.64 53.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.53 115.99 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 -172.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.96 129.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -135.04 112.67 10.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.424 HG22 ' CD2' ' A' ' 102' ' ' PHE . 25.6 mm -115.81 130.95 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 101' ' ' ILE . 71.3 m-85 53.51 44.87 29.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -173.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -117.07 85.67 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -80.79 121.6 26.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.3 pp -142.92 153.58 60.95 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.588 0.709 . . . . 0.0 110.966 -174.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.15 153.95 46.58 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 0.0 112.333 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -59.52 -33.24 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -60.13 -32.32 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 105' ' ' LEU . 52.8 tp -74.13 -39.31 63.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -56.4 -42.68 78.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.02 -32.23 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -78.9 -40.49 32.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' HG ' ' A' ' 85' ' ' LEU . 63.4 mt -73.73 -40.1 63.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.894 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.8 m-30 -53.55 -51.17 78.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.691 0.758 . . . . 0.0 110.877 -164.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 89.9 Cg_exo -46.94 -43.39 24.42 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 174.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.88 -45.99 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.6 -30.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -170.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -63.88 -51.18 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -71.68 -25.99 62.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.947 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.31 -52.61 51.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.404 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.405 HD21 ' HD2' ' A' ' 194' ' ' LYS . 1.6 pt? -81.31 153.97 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -88.88 155.87 49.88 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 110.923 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.01 130.17 26.88 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.772 2.315 . . . . 0.0 112.334 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.08 77.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.451 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.68 175.46 47.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.518 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.64 139.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -109.69 127.87 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.9 mt -122.44 128.37 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.035 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tt -134.34 128.3 33.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -155.55 139.97 16.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.54 -174.48 34.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -56.01 160.8 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -59.9 136.97 90.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.5 0.667 . . . . 0.0 111.107 171.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . 96.5 Cg_exo -52.04 -40.32 68.14 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -47.51 -30.34 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -57.6 -28.0 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -171.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 138' ' ' GLN . 0.2 OUTLIER -74.24 -16.63 60.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -165.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.627 ' N ' HD23 ' A' ' 137' ' ' LEU . 70.9 mt-30 -68.93 -21.3 64.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 -170.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.568 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.4 t80 -25.1 -65.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -114.12 -22.3 10.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.1 p -113.85 6.52 16.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.6 114.66 7.0 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.456 ' H ' ' H ' ' A' ' 145' ' ' LYS . . . -175.04 -75.28 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.451 169.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.06 -11.07 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.625 2.217 . . . . 0.0 112.363 155.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 137' ' ' LEU . 73.8 mmtt -96.18 34.28 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB3' HD13 ' A' ' 149' ' ' LEU . 10.9 t70 -66.27 146.5 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -169.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.493 ' HA ' HD12 ' A' ' 150' ' ' LEU . 19.4 tp -56.45 -24.74 47.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.66 -31.03 71.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.5 mp -85.78 -16.46 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 175.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 147' ' ' LEU . 89.5 mt -86.66 134.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.609 0.719 . . . . 0.0 110.982 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.35 135.72 6.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 -171.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.8 155.69 37.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.25 -45.39 87.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -34.98 79.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.8 m -64.84 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.158 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.95 -51.11 71.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.13 -31.82 69.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.7 p -75.56 -24.2 56.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 161' ' ' PRO . 97.3 mt-10 -83.82 -2.08 55.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.9 mt -104.47 95.11 7.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.597 0.713 . . . . 0.0 110.986 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 66.2 Cg_endo -83.14 -31.52 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.655 2.237 . . . . 0.0 112.277 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.7 p -75.81 -17.05 59.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.786 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.5 pp -132.01 162.06 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 -176.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -107.63 130.56 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.862 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -87.27 134.8 33.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -170.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.42 -30.09 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' HB3' ' A' ' 191' ' ' LEU . 59.8 mt -129.91 138.47 53.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -170.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.06 111.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.078 162.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -138.31 145.91 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.16 129.93 56.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 170.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp -132.13 154.33 49.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.99 134.63 50.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.85 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -140.19 173.66 11.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.51 135.59 56.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.78 127.2 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.985 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.55 139.54 45.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -169.94 156.29 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.98 -73.02 1.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.518 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.62 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 111.023 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.82 166.76 10.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.96 -34.96 1.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -88.29 156.09 19.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 136.45 148.43 5.52 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.56 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.96 151.87 25.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.16 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.11 133.92 43.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.71 145.54 49.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.2 pt -120.03 143.72 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.417 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.5 pt20 -138.16 134.36 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.918 174.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -152.11 150.54 30.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.74 ' HB3' HD12 ' A' ' 167' ' ' ILE . 3.5 tt -139.93 129.68 24.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -112.75 146.64 18.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.497 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -114.18 128.97 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.836 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.405 ' HD2' HD21 ' A' ' 121' ' ' LEU . 82.5 tttt -83.3 125.23 31.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 145.1 26.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 -175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.83 154.5 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 178.038 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -154.94 165.03 37.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -144.97 -175.79 4.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.825 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -162.15 163.57 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -137.05 166.88 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -150.59 126.0 10.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -107.79 168.14 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -125.03 154.94 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -159.94 170.0 22.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -160.79 160.48 31.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.0 168.59 26.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.22 160.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 53.4 p90 -163.45 149.95 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.89 172.07 42.14 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.403 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -156.65 -174.93 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.77 151.49 42.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.674 0.749 . . . . 0.0 110.937 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.57 123.07 11.17 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.58 2.187 . . . . 0.0 112.309 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -143.03 -164.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -84.95 -170.07 2.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.72 142.93 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 58.1 tp -67.35 -49.33 64.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.61 -81.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.2 t -122.45 -54.38 1.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 165.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' CG2' HD22 ' A' ' 191' ' ' LEU . 34.6 m -125.87 20.53 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . . . -57.92 -19.99 34.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -160.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -65.38 -7.56 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.05 0.07 54.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 25' ' ' ALA . 23.2 pt -81.0 152.0 71.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.608 0.718 . . . . 0.0 111.115 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.8 133.13 55.99 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.613 2.209 . . . . 0.0 112.375 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.16 -2.65 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -78.06 -145.81 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.407 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.03 141.0 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.827 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.32 134.02 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 tp -102.38 121.89 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.33 113.99 25.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 64.3 mt -90.95 59.25 4.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -172.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.01 -60.26 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.53 39.06 95.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 171.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 60.98 19.73 10.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.82 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.85 15.62 67.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.437 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.95 -46.1 82.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 -172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.23 -40.09 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.02 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.041 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.7 m -65.51 -38.38 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.58 -51.64 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.71 -35.07 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.23 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.062 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 p -63.13 -13.99 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.24 -5.91 55.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 97.38 -6.39 63.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -102.41 148.19 25.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.04 117.71 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.37 147.5 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -114.39 130.56 56.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.91 129.95 56.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.1 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 81' ' ' VAL . 49.3 t -117.29 132.47 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -159.74 162.52 34.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.07 -28.8 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -86.52 109.56 19.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -171.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.491 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 91.3 p -69.2 -36.25 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.85 -33.37 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.77 96.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.4 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.07 -34.89 79.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.55 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.95 -36.18 82.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.17 96.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.17 -42.48 98.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.0 -40.76 95.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.9 -41.35 97.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.73 95.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -64.2 -38.54 91.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.8 -33.55 75.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.4 -9.08 42.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.75 59.38 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.438 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.98 159.99 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.125 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -101.74 130.72 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.43 159.95 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.1 m -117.99 133.3 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -121.73 137.09 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 57' ' ' VAL . 96.1 t -127.84 119.88 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.13 173.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.0 tm0? -85.09 114.42 22.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.866 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -173.41 145.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -58.41 125.22 22.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.93 -33.29 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.04 77.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -97.14 -8.54 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.49 132.4 49.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.75 111.91 23.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.5 HG22 ' HA3' ' A' ' 120' ' ' GLY . 89.9 mt -85.12 114.76 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.3 134.34 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -170.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.6 40.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.57 -22.56 56.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.835 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.37 92.54 7.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CZ3' ' HA3' ' A' ' 31' ' ' GLY . 87.9 t90 -69.8 117.64 11.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -172.96 159.74 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.25 167.86 49.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.414 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.22 125.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.118 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.49 125.81 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.2 t -116.52 113.63 23.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.68 117.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 45.1 54.97 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 74.3 m -105.03 92.07 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -82.71 120.09 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.0 pp -156.14 150.88 20.46 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.991 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.1 149.48 89.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.76 2.307 . . . . 0.0 112.43 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -57.7 -29.71 64.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 -38.11 71.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 105' ' ' LEU . 25.7 tp -77.19 -35.96 55.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -54.59 -43.66 72.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.97 -24.64 67.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -85.09 -37.61 20.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.49 -35.84 68.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.931 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.0 m-85 -55.02 -52.66 69.19 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 0.0 110.926 -171.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.2 Cg_endo -65.23 -27.74 56.07 Favored 'Trans proline' 0 N--CA 1.466 -0.129 0 C-N-CA 122.739 2.293 . . . . 0.0 112.361 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -70.43 -39.11 74.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.791 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.7 -40.65 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.05 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.67 -57.25 10.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.47 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.5 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -72.18 -40.7 55.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.528 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.3 tp -79.78 121.06 24.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.394 . . . . 0.0 110.876 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -80.01 153.76 74.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 110.888 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.91 129.9 35.16 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.342 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.32 -1.4 64.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.416 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.554 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -81.75 170.28 51.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 164.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.5 t -125.16 141.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -106.65 129.36 54.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 169.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.43 129.61 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt -126.8 130.07 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.99 132.58 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.49 -168.6 32.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.453 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -91.52 159.4 15.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.975 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.08 145.89 35.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 0.0 111.112 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.434 ' HB2' HD23 ' A' ' 147' ' ' LEU . 33.4 Cg_endo -62.52 -33.25 79.11 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.279 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.82 -29.96 70.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -63.0 -41.06 99.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.757 HD23 HD22 ' A' ' 150' ' ' LEU . 2.5 mm? -93.67 -5.02 49.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -69.16 -3.1 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -169.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -74.74 -165.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -74.39 -6.76 50.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -162.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.3 p -94.95 -2.37 50.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.23 34.48 90.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.712 ' CA ' ' HB3' ' A' ' 137' ' ' LEU . . . 56.17 -160.56 7.29 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.573 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.486 ' HD3' ' HG ' ' A' ' 137' ' ' LEU . 43.3 Cg_endo -69.96 -47.99 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.347 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.68 -41.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 162.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -164.36 119.76 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.829 ' C ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.77 -10.12 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.933 -177.282 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.7 ' N ' HD22 ' A' ' 147' ' ' LEU . 95.4 m-20 -64.29 -23.92 67.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 176.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.6 mp -70.7 -12.09 61.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.757 HD22 HD23 ' A' ' 137' ' ' LEU . 7.9 mp -103.58 128.03 28.28 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.887 -176.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 156' ' ' LEU . 87.0 Cg_endo -80.3 143.03 15.36 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.698 2.265 . . . . 0.0 112.416 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -76.98 139.98 40.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.53 -49.48 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.912 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.56 -33.11 74.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 53.5 m -71.57 -56.99 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.08 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.57 -20.65 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.601 ' N ' HD13 ' A' ' 156' ' ' LEU . 10.4 pt20 -75.72 -33.34 60.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -78.53 -19.26 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -84.43 -14.57 48.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.25 109.87 63.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.81 -20.28 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.356 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.3 p -61.63 -29.04 69.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -158.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.705 HD11 ' HA3' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -148.14 164.14 34.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -174.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLN . 96.6 m-20 -92.58 148.02 22.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -89.65 128.43 36.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.55 -33.8 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.9 pt -139.3 146.99 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.06 116.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -145.01 148.53 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -109.91 133.11 53.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -120.9 152.76 38.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -111.69 137.68 49.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.9 mmt-85 -142.92 165.55 27.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.866 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -78.95 130.84 36.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 172.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.683 ' HB2' ' HB2' ' A' ' 185' ' ' ALA . 59.4 tp -90.15 126.45 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -77.91 122.84 26.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 171.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -175.78 160.03 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -104.11 4.99 45.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.509 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -75.57 168.84 19.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.726 0.298 . . . . 0.0 111.085 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -106.6 1.18 25.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -77.68 170.04 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -50.64 125.02 12.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.39 21.01 40.32 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.47 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.53 143.78 55.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 110.883 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 175' ' ' LEU . . . -129.31 152.03 49.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.09 128.19 23.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.22 147.48 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.58 143.45 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -149.01 136.2 20.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.653 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.8 pt? -155.72 150.02 25.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 167' ' ' ILE . 6.4 tt -140.66 131.37 25.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.934 -169.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 163' ' ' LEU . . . -84.96 173.77 49.09 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 -172.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 164' ' ' ASN . 66.5 tt0 -105.92 129.33 54.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.895 ' HD2' ' O ' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -92.42 99.99 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 170.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.0 mt -99.1 133.63 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 157.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -87.66 -35.85 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -177.575 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -124.9 -74.99 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -162.0 160.82 28.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -126.01 154.67 42.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -151.76 130.07 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -160.47 165.04 31.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -157.42 169.94 23.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -159.94 132.77 6.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.4 p -156.9 168.02 28.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.81 134.96 15.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.866 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -155.86 167.26 30.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.0 160.71 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -162.27 165.24 26.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.06 176.75 24.24 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.579 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 17' ' ' PRO . 85.7 m -125.08 119.51 28.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -125.42 77.76 68.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.654 0.74 . . . . 0.0 110.932 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.665 ' HD3' HG22 ' A' ' 15' ' ' THR . 73.5 Cg_endo -76.62 153.54 34.34 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.651 2.234 . . . . 0.0 112.429 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -77.35 157.19 30.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.12 -35.98 70.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -113.81 152.51 30.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.802 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 49.1 tp -76.82 -55.2 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.79 -81.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -169.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -125.08 -46.05 1.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 163.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.799 ' O ' HG12 ' A' ' 24' ' ' VAL . 94.7 t -124.84 17.27 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -170.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.802 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -65.41 -11.21 40.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -65.9 -6.19 11.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -90.66 0.25 57.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.533 HD12 ' HB1' ' A' ' 25' ' ' ALA . 96.8 mt -70.05 132.7 88.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.64 0.733 . . . . 0.0 111.124 174.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.18 144.77 82.51 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -75.51 11.22 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -170.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.18 -130.37 3.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.53 139.31 32.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -174.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 81.8 mt -124.22 131.79 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 173.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 tp -106.91 120.28 41.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -105.63 127.04 52.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.7 120.8 40.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . . . 55.48 54.61 8.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 pm0 -70.23 -17.71 63.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 -172.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 -111.54 4.26 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.66 -41.5 70.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 110.904 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.59 13.88 62.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.447 176.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -65.83 -35.06 79.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.81 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.51 -33.07 72.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.92 97.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.8 m -65.82 -35.89 81.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -62.61 -44.51 96.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.56 -43.0 99.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.906 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.81 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.5 p -71.02 -20.26 62.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.878 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.2 mt -85.68 -1.59 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.41 8.59 59.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.51 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.78 147.69 35.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.33 105.05 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.82 120.73 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -165.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.8 m -117.44 124.95 50.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.26 131.87 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.157 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.02 134.83 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -155.31 157.21 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.28 -20.09 41.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.0 t -93.13 111.38 23.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.7 p -67.8 -34.41 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.29 -31.35 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.105 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.26 98.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.92 -38.09 89.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.74 86.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.132 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.81 -39.98 94.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -63.16 -41.88 99.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.33 -43.28 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.7 -45.5 93.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.06 -41.3 98.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.87 93.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -64.56 -38.92 92.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.79 -31.79 69.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.21 -8.3 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.19 56.05 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.469 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.66 160.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.348 . . . . 0.0 111.195 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.85 135.5 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.866 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.4 pt -137.32 160.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -108.55 135.4 49.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.3 p -117.65 135.62 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.97 122.78 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -87.45 111.44 21.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.954 172.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -172.93 143.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -59.51 125.67 24.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 171.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.46 -36.38 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.5 -31.48 68.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -100.06 -9.23 22.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -89.79 112.22 23.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -98.59 115.75 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.29 139.36 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.25 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.76 -23.79 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.922 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -52.38 10.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.79 139.82 32.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -164.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -126.72 166.47 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 42.73 71.05 0.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.482 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -92.73 130.47 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.08 130.39 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -173.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.4 t -103.71 118.09 35.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.01 115.03 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -169.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 61.6 m-85 47.38 48.81 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 88.8 m -99.61 74.04 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.874 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -76.7 114.96 16.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -153.48 153.38 29.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.517 0.675 . . . . 0.0 110.952 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 149.56 89.14 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.7 p -57.79 -30.57 65.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.812 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.6 p -62.77 -31.28 72.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.1 -35.53 66.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -55.16 -39.93 70.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.764 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -63.18 -30.86 71.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -82.77 -35.68 26.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -73.51 -41.55 62.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 8.3 m-30 -55.01 -48.06 96.96 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.71 0.767 . . . . 0.0 110.907 -164.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 84.8 Cg_exo -49.82 -41.75 45.99 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.254 . . . . 0.0 112.353 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -78.67 -46.03 20.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 77.9 t -73.31 -54.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.035 -165.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -80.04 -38.66 31.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 -168.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -69.15 -30.13 68.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -70.92 -14.85 73.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.27 124.33 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.07 139.78 97.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 0.0 110.9 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.27 130.37 32.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.92 -1.52 85.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.425 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.82 178.65 51.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.462 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.06 147.04 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -112.98 133.45 54.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mp -121.97 135.52 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 190' ' ' LEU . 47.3 tp -121.17 129.35 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 171.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -157.54 134.18 9.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 172.81 -171.67 44.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.513 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -65.51 140.89 58.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.55 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -90.94 144.9 30.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.582 0.706 . . . . 0.0 111.077 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.38 -26.49 21.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' HD11 ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.3 -25.05 31.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -57.17 -24.8 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.42 HD12 ' HG ' ' A' ' 150' ' ' LEU . 92.5 mt -62.64 -13.03 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.002 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 139' ' ' TYR . 21.5 tm0? -56.73 -12.16 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.588 ' C ' ' O ' ' A' ' 138' ' ' GLN . 63.2 m-85 -21.16 -69.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.96 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -135.11 -57.05 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.944 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.1 p -102.32 0.9 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 138' ' ' GLN . . . 84.88 -5.69 81.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.48 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 142.59 -171.45 24.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.01 -32.8 16.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.569 2.179 . . . . 0.0 112.367 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.63 -45.03 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.484 ' HB3' HD13 ' A' ' 149' ' ' LEU . 22.3 t0 -173.56 151.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.898 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 135' ' ' GLU . 16.3 tp -62.97 -22.97 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 170.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -74.67 -20.59 59.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 -168.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.4 mp -81.07 -9.58 59.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -174.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 150' ' ' LEU . 3.2 mm? -89.02 142.29 30.1 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.546 0.689 . . . . 0.0 110.978 -165.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.48 145.75 38.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -94.77 165.82 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 156' ' ' LEU . 45.6 tp -49.48 -40.45 37.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 171.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.95 -30.74 71.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.7 m -66.5 -60.24 2.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -171.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.076 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.43 -16.5 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -177.032 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.603 ' N ' HD22 ' A' ' 156' ' ' LEU . 65.0 tt0 -66.18 -40.91 90.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 170.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.9 p -79.25 -17.81 54.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.792 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.84 -13.3 60.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 163' ' ' LEU . 65.9 tp -104.58 107.46 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.624 0.726 . . . . 0.0 110.946 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.13 -29.64 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.705 2.27 . . . . 0.0 112.293 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -80.45 -22.53 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -160.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 160' ' ' LEU . 98.4 mt -123.43 150.73 43.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -174.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -94.54 139.61 30.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 98.5 m95 -93.49 126.94 38.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.3 mt -93.47 -31.05 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.653 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.7 pt -138.06 148.47 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.19 122.59 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -128.92 134.88 48.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -117.08 119.95 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 171' ' ' LEU . 3.7 pp -127.57 147.91 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -172.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.58 138.09 52.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -132.47 152.39 51.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -56.43 119.83 6.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.74 125.73 27.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.988 -166.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -123.46 28.99 6.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -94.3 -143.92 14.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.509 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.63 -178.39 5.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.057 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -73.24 75.0 1.32 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -144.95 -178.47 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.8 151.54 31.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.57 -168.37 35.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.521 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -76.84 142.2 40.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -164.13 159.51 20.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.26 130.66 41.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.9 mt -124.43 150.83 45.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.973 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 133' ' ' ALA . 33.2 pt -125.65 144.66 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.94 134.19 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -154.51 152.55 30.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.653 ' HB3' HG12 ' A' ' 167' ' ' ILE . 1.5 tt -138.17 130.59 29.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.6 171.21 52.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.538 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -84.92 123.36 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -115.33 109.96 18.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.26 134.16 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.906 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.34 -40.14 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.842 -179.775 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.747 0.308 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -155.02 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.961 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -159.87 159.95 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.24 133.46 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.51 144.93 51.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -167.77 165.03 14.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -159.53 169.95 22.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.839 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.0 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -158.98 168.14 27.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.27 162.31 25.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -149.98 125.09 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.7 t -120.6 110.88 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -163.97 139.87 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.35 171.15 43.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -129.46 170.47 13.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -124.63 147.84 57.1 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.658 0.742 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.44 154.51 71.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -147.53 178.43 8.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -164.29 161.79 22.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.2 143.88 56.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.88 -47.68 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -169.281 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.656 0.741 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.98 146.93 88.68 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.65 2.233 . . . . 0.0 112.373 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 pm0 -74.49 3.15 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -148.83 7.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.6 mttt -74.99 129.99 38.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.683 0.278 . . . . 0.0 110.968 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.61 129.07 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.101 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.06 120.56 40.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.32 124.44 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.0 mt -109.93 139.41 45.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -170.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.01 50.52 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 171.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -89.9 -21.43 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.1 -65.53 4.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -114.8 -27.92 7.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.92 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.26 31.37 55.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.548 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -65.68 -45.18 83.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -71.86 -27.41 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.98 87.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.8 m -67.82 -34.62 77.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.02 -45.56 90.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.78 -38.39 90.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.62 79.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.19 -15.62 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -83.97 -1.45 54.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.868 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.87 2.51 62.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 4.6 m-30 -78.68 145.34 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.32 106.65 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.23 125.61 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.4 m -109.47 126.64 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.85 127.33 56.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 81' ' ' VAL . 69.2 t -121.38 131.91 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.98 159.31 40.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -81.7 -21.44 38.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -93.8 114.08 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -67.16 -34.56 77.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.97 -31.66 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.194 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.66 97.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.17 -35.98 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.756 0.313 . . . . 0.0 110.915 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 -38.75 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.21 -43.72 90.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -62.33 -44.81 95.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.15 -42.24 94.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.76 96.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.39 -40.02 96.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.955 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.96 -30.08 70.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.89 -6.55 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.93 33.71 59.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.478 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.72 162.23 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.096 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -96.57 137.17 36.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.92 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 tt -137.25 150.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -111.7 135.24 52.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.3 p -123.2 135.19 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.119 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 57' ' ' VAL . 90.0 t -130.83 123.79 55.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -85.39 116.08 23.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -171.33 142.22 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -65.59 131.49 46.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 169.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 113' ' ' LEU . 87.1 mt -59.52 -28.83 67.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.81 68.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -103.35 -11.24 18.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.18 131.02 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -96.74 112.71 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.824 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.1 mt -94.19 119.86 42.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.48 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.144 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.38 93.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.81 -28.5 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.66 83.06 3.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.63 95.78 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -135.15 129.72 34.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.1 159.26 28.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.757 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.8 mm -109.93 117.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.49 127.42 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.406 ' CB ' HH22 ' A' ' 110' ' ' ARG . 64.1 m -115.4 115.87 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.49 120.94 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.16 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 41.33 54.82 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 71.3 m -101.57 95.4 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.902 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -75.24 110.44 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -156.38 151.98 22.2 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.558 0.694 . . . . 0.0 110.952 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 145.1 81.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.609 2.206 . . . . 0.0 112.385 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -58.08 -29.21 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.1 p -60.43 -30.85 69.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.7 tp -70.14 -40.84 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.406 HH22 ' CB ' ' A' ' 100' ' ' SER . 41.4 mmt180 -58.49 -40.31 82.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.29 -31.45 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -81.2 -36.07 30.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 85' ' ' LEU . 81.8 mt -70.42 -32.78 70.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.559 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.6 m-30 -50.76 -55.15 29.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.683 0.754 . . . . 0.0 110.891 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 36.0 Cg_endo -63.86 -32.78 66.21 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.09 -51.29 59.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.757 ' HB ' HG13 ' A' ' 98' ' ' ILE . 34.1 m -75.43 -31.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.11 -53.04 51.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.42 -33.38 75.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.51 -47.8 60.59 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.442 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 48.9 tp -89.59 138.98 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -62.07 151.82 79.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.898 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.95 138.94 51.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.24 3.22 82.37 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.505 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.442 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -73.0 172.88 49.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.513 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.64 140.09 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 111.154 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -111.1 136.46 50.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 191' ' ' LEU . 35.3 mm -120.66 128.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt -129.98 125.73 36.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -146.68 130.36 16.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 144.84 -172.2 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 177.3 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.798 0.333 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.36 -31.18 71.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.13 -37.14 86.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 84.5 m -65.99 -45.23 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.53 -46.32 83.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -70.14 -26.83 64.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 94.5 p -83.87 -27.64 28.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.88 -9.39 58.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.68 105.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.624 0.726 . . . . 0.0 110.866 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.46 -21.88 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.331 -170.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 94.8 p -65.23 -23.52 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.943 -159.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.5 pp -141.18 163.1 33.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.07 145.9 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.52 131.55 40.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.62 -33.99 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 191' ' ' LEU . 46.1 pt -139.51 143.32 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.207 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 121.71 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -138.14 139.71 39.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -100.65 121.92 42.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 165.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -172.376 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.799 0.333 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.03 127.94 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.94 123.98 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 171.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.521 ' N ' HD23 ' A' ' 190' ' ' LEU . 2.5 pt? -153.78 151.62 29.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.671 ' O ' HD23 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.91 130.77 24.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 -173.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.48 169.34 50.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.527 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 -173.406 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.6 p-90 -155.03 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.99 160.0 32.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -153.21 133.82 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.834 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -106.88 144.86 32.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.94 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.76 165.01 14.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -157.85 169.99 23.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.05 160.0 40.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.84 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -156.9 165.34 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -163.12 160.08 23.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -150.08 124.97 9.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.93 112.77 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.089 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.74 135.11 5.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.41 -165.29 36.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -125.03 174.42 8.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.108 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -125.48 152.21 71.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.8 148.46 90.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' HD22 ' A' ' 50' ' ' LEU . 29.5 p30 -126.79 -170.14 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -162.64 158.84 23.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -75.3 144.98 42.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.1 mt -73.87 -43.2 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.136 -167.185 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 121.648 0.737 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 147.47 74.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.398 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 18.7 pm0 -76.31 13.87 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.32 -135.59 2.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.3 mttt -96.23 131.44 42.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.842 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 52' ' ' TYR . 4.8 mp -123.42 131.67 72.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 tp -102.42 122.26 43.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.943 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -111.67 122.96 49.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.0 mt -107.22 131.95 53.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -168.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.95 52.53 11.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.03 -19.75 24.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.88 -64.89 4.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.542 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.64 -33.08 5.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.87 44.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.516 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.07 -43.14 88.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.69 -29.39 66.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -63.29 -46.24 87.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.2 m -64.33 -35.47 80.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.98 -43.79 98.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.836 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.52 -42.96 93.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.86 -35.08 74.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.6 p -68.72 -15.64 63.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 18' ' ' ASN . 56.0 mt -85.58 0.05 53.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.72 63.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.553 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.45 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 2.5 m-30 -77.79 147.51 35.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.946 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -92.82 104.44 16.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.975 171.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 44' ' ' ALA . 97.2 t -105.85 124.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.132 -167.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -109.6 128.03 54.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.7 127.37 56.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.7 t -122.78 134.12 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.03 160.98 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -77.38 -27.97 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -90.99 116.64 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 95.0 p -68.01 -35.13 77.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.85 -31.89 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.083 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.21 -40.36 97.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.511 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.78 -36.67 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.21 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.108 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.09 -36.98 83.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.66 95.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.047 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.07 -45.47 93.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.72 -38.84 84.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.34 -39.55 93.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.22 98.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.113 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.86 -38.43 90.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -32.37 73.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.6 -9.17 48.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.78 33.82 54.63 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.86 165.02 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.178 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.36 141.25 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -138.28 153.0 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -122.62 122.08 37.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.1 p -119.99 141.05 50.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -133.17 121.78 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -82.18 114.73 20.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.984 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -170.67 140.06 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -61.75 131.2 49.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 113' ' ' LEU . 82.7 mt -59.02 -28.73 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -28.68 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.07 -11.33 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.69 130.87 45.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.92 113.3 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.52 119.65 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.4 t -86.59 140.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.165 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -46.05 81.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.12 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -58.11 -24.01 57.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.17 88.74 6.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . 37.7 m0 -83.86 104.76 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -172.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.2 mt-10 -140.98 140.91 34.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.82 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.4 173.39 43.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.1 mm -121.8 120.5 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.1 127.59 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.122 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -121.31 114.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.78 123.5 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.75 53.7 7.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.47 99.42 9.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -86.28 114.03 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 172.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.49 153.69 28.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.656 0.741 . . . . 0.0 110.974 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.12 141.58 76.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.676 2.251 . . . . 0.0 112.291 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.1 p -58.57 -29.94 66.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.7 p -62.17 -29.85 70.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.1 tp -68.84 -39.61 79.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -60.1 -39.51 86.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -61.65 -34.19 75.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -76.78 -38.13 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.008 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 85' ' ' LEU . 75.1 mt -69.91 -33.71 72.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.55 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m-30 -50.01 -56.37 18.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.559 0.695 . . . . 0.0 110.945 -167.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 27.1 Cg_endo -60.81 -33.73 92.44 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.747 2.298 . . . . 0.0 112.311 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.28 -52.74 44.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.93 -29.02 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -64.91 -50.09 67.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.75 -32.3 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.864 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.46 -14.74 73.02 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.495 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.33 133.21 46.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.946 0.403 . . . . 0.0 110.932 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 95' ' ' TRP . 86.4 tttt -70.53 139.12 86.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 167.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.1 123.2 10.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.05 5.07 86.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.69 176.1 46.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -135.5 148.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.057 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -104.01 129.42 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.782 167.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.49 ' CD1' HD12 ' A' ' 191' ' ' LEU . 31.3 mm -117.3 123.82 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.12 125.88 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -152.26 138.01 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.5 34.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.788 175.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 77.9 tttt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.792 0.329 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.793 ' O ' HD23 ' A' ' 153' ' ' LEU . 4.4 tt -55.17 -45.36 75.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.08 -36.72 82.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.7 m -60.76 -39.59 89.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.12 -49.91 65.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -72.43 -26.24 61.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.5 p -79.63 -24.08 42.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.12 -10.62 43.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.47 97.06 50.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.884 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -91.8 -17.15 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -172.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.5 p -64.53 -22.19 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -159.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.958 HD12 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -137.93 154.85 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -74.87 139.24 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.94 119.79 36.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.87 -28.97 17.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.836 -169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 191' ' ' LEU . 41.4 pt -140.11 149.41 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.04 115.47 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 165.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -137.28 142.59 41.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -102.25 124.84 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -175.739 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.736 0.303 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.11 129.74 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -130.6 127.29 38.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -153.56 146.48 24.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.936 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.5 ' O ' HD23 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -140.04 129.98 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -171.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.702 ' HA3' HD22 ' A' ' 163' ' ' LEU . . . -77.58 171.56 55.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.535 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 -174.51 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mmm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -154.63 175.93 13.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.13 160.02 32.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.23 135.43 14.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -121.93 144.91 48.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.39 165.06 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.1 p -158.5 169.95 23.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.96 159.98 40.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -157.8 166.03 33.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -162.65 160.01 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -129.93 142.55 50.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.57 106.43 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.094 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -155.96 163.02 40.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.89 -174.41 43.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -119.94 166.77 12.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.71 0.29 . . . . 0.0 111.162 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.8 149.93 70.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.68 156.43 60.94 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 0.0 112.367 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -139.99 -170.38 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.47 160.82 20.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -74.27 148.29 41.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.482 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.8 tt -73.32 -46.25 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG11 ' HG3' ' A' ' 130' ' ' GLU . 60.4 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.128 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.604 0.716 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 145.05 86.29 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.242 . . . . 0.0 112.379 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -73.5 1.82 9.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.36 -147.71 5.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.8 mttt -77.33 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -122.02 129.62 75.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 tp -102.21 121.47 42.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -105.81 129.2 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.28 126.49 55.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.99 54.25 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.162 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -89.99 -15.72 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 63' ' ' GLY . . . 88.92 -63.25 3.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.06 -9.19 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.23 23.28 76.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.87 -39.54 90.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -73.89 -28.51 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.88 92.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 70' ' ' LEU . 87.3 m -68.19 -35.13 77.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.4 -47.3 84.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.03 -36.22 83.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.56 83.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.413 ' HA ' HG11 ' A' ' 76' ' ' VAL . 60.5 p -68.64 -16.57 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.85 -0.27 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 3.62 63.98 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -81.08 145.77 30.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 -174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -85.24 104.97 15.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.947 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -109.64 126.84 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 -167.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -109.06 126.27 52.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 166.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.98 128.24 56.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -119.56 130.07 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.49 156.9 32.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -80.55 -20.12 44.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -90.49 115.2 27.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.6 p -66.9 -36.08 81.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.62 -31.91 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 39' ' ' GLY . . . -64.09 -40.93 98.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.552 171.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.12 -35.96 78.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.25 80.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.112 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.07 -38.51 91.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -62.65 -41.6 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.61 -44.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -62.64 -45.47 92.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 79.8 mt -62.62 -42.03 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -44.91 96.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.36 -40.17 96.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.19 -29.89 70.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -89.95 -5.15 57.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.43 56.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.9 m -128.76 163.88 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.174 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.12 144.83 27.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.03 149.9 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.2 m -110.88 133.0 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -124.22 136.75 54.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.9 t -129.58 122.08 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.48 116.25 23.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -172.38 143.25 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -57.53 125.77 24.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -55.22 -35.09 64.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.0 -29.63 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -100.61 -9.36 22.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.932 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.19 132.67 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -97.85 115.23 27.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.75 120.39 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.87 138.11 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.5 87.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.48 -25.99 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.22 86.48 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.143 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.49 95.36 5.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -132.24 135.29 46.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.23 162.33 53.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.7 mm -109.83 118.16 56.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -174.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.7 124.47 70.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 m -121.65 117.73 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.91 121.83 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.189 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 42.69 55.02 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.5 m -99.64 87.59 3.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -74.98 114.36 13.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -157.52 151.13 19.14 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.633 0.73 . . . . 0.0 110.927 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.43 142.51 80.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.619 2.213 . . . . 0.0 112.384 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -58.89 -31.41 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.9 p -61.73 -29.15 69.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.9 tp -69.21 -40.63 77.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -60.77 -38.87 86.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 114' ' ' TYR . 89.0 mt-30 -64.81 -32.49 74.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -74.15 -39.45 63.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.71 -29.78 66.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 m-30 -49.9 -56.12 19.48 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.64 0.733 . . . . 0.0 110.882 -168.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 30.3 Cg_endo -62.41 -34.31 76.92 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.762 2.308 . . . . 0.0 112.314 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.97 -49.83 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 98' ' ' ILE . 28.0 m -74.74 -30.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -65.43 -51.73 58.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.08 -34.49 78.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.12 -49.07 63.92 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.473 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 47.9 tp -95.01 135.83 36.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.995 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.53 153.11 84.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.859 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.8 141.75 53.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.41 2.33 79.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.473 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -70.45 170.83 44.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.18 139.79 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.159 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.91 139.57 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.89 124.88 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.52 124.96 29.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.772 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.439 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -157.89 139.86 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.42 -172.66 32.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.894 179.686 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 153' ' ' LEU . 3.0 tt -54.92 -45.26 74.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.43 -36.71 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.5 m -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.1 -50.33 61.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -70.07 -25.61 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.7 p -79.21 -23.99 43.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.7 -15.39 37.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.2 107.31 60.07 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.583 0.706 . . . . 0.0 110.849 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -88.55 -21.45 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.748 2.299 . . . . 0.0 112.403 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.8 p -70.22 -27.14 64.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -157.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -139.31 161.48 37.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.942 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.34 140.28 30.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -95.7 128.07 42.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.11 -29.3 16.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' A' ' 190' ' ' LEU . 36.3 pt -139.8 148.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.24 114.77 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.006 166.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -140.06 144.62 36.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -99.92 126.01 45.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 165.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -175.341 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.34 134.31 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -131.56 128.51 39.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -152.09 146.56 25.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -139.96 130.02 24.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -173.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.58 170.88 48.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.568 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.926 178.684 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -155.05 175.33 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -159.75 160.0 33.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.842 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.0 136.02 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -120.49 144.87 47.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -168.86 164.98 11.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -157.58 169.98 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.03 160.01 40.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.6 p -157.15 166.73 32.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.15 161.08 24.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -150.02 126.24 10.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.37 113.16 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -163.88 139.95 6.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.19 -177.76 48.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.489 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 p -122.77 161.5 23.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.331 . . . . 0.0 111.114 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.85 150.57 76.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.854 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.81 155.3 69.96 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -139.44 -176.53 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -167.17 167.92 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -69.41 145.6 52.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.489 ' O ' HD23 ' A' ' 21' ' ' LEU . 3.0 tt -73.98 -50.69 18.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 130' ' ' GLU . 61.8 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.639 0.733 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.95 147.96 89.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.617 2.212 . . . . 0.0 112.426 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -74.38 1.21 12.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -142.48 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.55 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.1 mttt -85.0 132.74 34.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.928 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.13 130.29 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.1 tp -101.19 121.61 42.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.81 131.94 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 mt -114.05 123.06 48.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.9 54.51 8.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -87.87 -17.2 31.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.56 -59.53 2.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.543 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -125.01 -3.92 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.905 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.607 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 71.9 20.95 79.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.585 176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm105 -67.61 -40.39 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -73.02 -28.14 62.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -45.64 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.073 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.6 m -67.52 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.888 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -58.62 -48.26 81.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.2 -36.3 83.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.07 81.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.34 -0.48 52.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.41 62.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -82.57 147.27 28.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.74 106.88 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.94 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -110.4 125.96 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.165 -166.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 m -110.76 127.1 55.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.48 129.58 55.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.69 131.81 71.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -156.69 158.74 37.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -77.81 -28.5 50.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -90.86 112.09 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.8 p -67.82 -33.28 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.67 -31.14 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.38 -39.2 96.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.462 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.74 -36.43 80.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.875 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.73 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.128 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.77 -39.45 94.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.32 -40.73 95.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.67 -47.28 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.09 -41.23 90.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.99 -39.21 91.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.98 -41.63 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.83 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.83 -32.63 73.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -91.15 -10.67 41.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.92 34.7 55.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.44 161.7 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.09 130.12 48.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -134.76 160.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -114.11 137.94 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.9 p -120.05 135.41 54.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.144 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.7 t -129.41 118.63 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.03 114.58 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -171.93 144.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -57.95 124.39 19.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -55.48 -37.01 67.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.13 79.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.08 -5.44 27.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.05 133.83 55.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -91.24 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.4 HG22 ' HA3' ' A' ' 120' ' ' GLY . 91.2 mt -95.22 119.43 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.52 137.3 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.36 -45.64 79.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.36 -27.62 68.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.98 76.44 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -76.04 100.3 4.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 91.2 mt-10 -131.7 138.2 48.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.22 162.89 39.36 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.517 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.31 117.76 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.54 122.71 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -125.43 115.89 20.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.9 124.85 65.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.141 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 43.93 55.08 5.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 73.7 m -107.08 90.94 3.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.948 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -73.99 119.97 18.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HB2' HD23 ' A' ' 109' ' ' LEU . 4.3 pp -148.5 152.27 38.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 150.21 53.99 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.616 2.21 . . . . 0.0 112.36 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -56.62 -34.7 67.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.788 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.2 p -62.11 -30.05 70.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 105' ' ' LEU . 55.2 tp -69.97 -37.84 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.953 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -57.22 -39.3 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.82 -31.63 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.98 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -80.37 -40.83 25.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.934 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.42 -36.74 66.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.966 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.6 m-30 -52.9 -56.56 22.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.63 0.728 . . . . 0.0 110.957 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 17.8 Cg_endo -55.66 -34.81 91.63 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.4 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.75 -47.05 56.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.19 -30.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.76 -51.61 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.986 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.26 -32.91 72.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.898 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -71.6 -42.56 54.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.1 tp -84.0 133.2 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.948 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -69.24 152.0 96.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.23 136.32 54.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.0 77.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.494 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.09 175.21 35.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.0 p -127.09 139.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -109.71 135.14 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mm -115.26 122.33 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.95 124.71 31.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.839 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -154.92 138.42 15.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 153.95 -173.52 32.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.427 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 58.7 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 153' ' ' LEU . 4.0 tt -57.26 -41.27 79.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.963 169.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.21 -34.18 75.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.2 m -63.23 -41.75 99.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.75 -49.62 72.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.37 -24.59 62.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.9 p -81.66 -24.67 36.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -82.76 -17.06 45.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tt -113.89 102.71 55.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.635 0.731 . . . . 0.0 110.869 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.28 -20.23 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.736 2.291 . . . . 0.0 112.356 -170.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.4 p -65.86 -23.81 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 -156.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 163' ' ' LEU . 2.8 pp -134.02 167.96 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.008 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -93.33 136.99 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 172.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -92.05 126.31 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.1 mt -91.39 -31.51 16.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.665 ' CG2' ' HB3' ' A' ' 191' ' ' LEU . 15.8 tt -143.41 137.38 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -166.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.05 116.66 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -140.06 144.27 36.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -98.65 125.54 43.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -173.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 132' ' ' PHE . 5.7 mp . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.736 0.303 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -109.52 132.14 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -132.99 129.07 37.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 168.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.542 ' N ' HD23 ' A' ' 190' ' ' LEU . 2.4 pt? -153.47 146.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.934 171.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.665 ' HB3' ' CG2' ' A' ' 167' ' ' ILE . 0.3 OUTLIER -143.64 131.06 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -170.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.92 170.62 36.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.526 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 178.121 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -164.83 142.2 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.97 169.94 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.922 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -156.98 139.24 14.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -136.34 175.09 9.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.907 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.92 165.03 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.5 p -155.65 169.97 23.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.03 159.95 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -164.56 131.76 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.01 149.97 47.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -151.97 129.67 11.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.8 t -119.27 125.41 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -159.43 134.52 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.947 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.76 176.69 29.12 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.521 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.619 HG22 ' HD3' ' A' ' 17' ' ' PRO . 89.9 m -126.0 137.63 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.153 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -122.47 78.08 45.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.694 0.759 . . . . 0.0 110.943 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD3' HG22 ' A' ' 15' ' ' THR . 65.1 Cg_endo -76.77 155.58 34.93 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.712 2.274 . . . . 0.0 112.401 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -130.07 68.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -95.9 -160.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -48.92 145.59 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.18 -60.35 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.162 -168.412 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 121.565 0.697 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.44 137.28 25.41 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.83 3.12 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -169.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.44 -151.99 8.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.08 148.95 41.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.15 135.07 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.6 tp -105.96 121.24 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -109.17 126.89 53.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.91 138.32 42.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.45 53.3 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.34 99.74 11.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.858 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.36 88.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.518 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.1 7.46 6.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.8 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.63 25.08 70.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -67.35 -42.21 83.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.78 -28.39 55.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.937 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' HG11 ' A' ' 54' ' ' VAL . . . -63.2 -43.97 96.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.8 m -68.28 -35.81 78.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -65.35 -45.57 83.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 54' ' ' VAL . 80.2 mt -64.85 -38.84 92.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.01 76.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -68.45 -22.05 64.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.02 -4.42 59.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.37 56.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.454 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -80.55 140.34 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -89.79 109.52 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 167.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 47' ' ' LEU . 62.7 t -112.96 134.16 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.8 m -107.71 125.07 50.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.168 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.74 130.95 55.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.88 136.04 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.171 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -157.46 159.35 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -78.6 -25.07 45.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -102.93 128.38 49.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.6 p -69.82 -30.44 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.45 -33.95 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.9 95.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.521 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 -34.83 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.07 86.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.94 -35.46 81.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.8 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.65 -42.01 98.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.092 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.63 -42.35 98.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.83 -41.5 97.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.6 -40.8 98.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.67 94.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.033 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.16 -39.1 93.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -33.97 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.93 -11.97 34.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.01 35.3 57.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.38 160.55 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 0.0 111.14 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.38 131.1 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -134.65 163.28 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.4 m -115.74 135.88 53.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.2 p -121.56 134.97 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.9 t -132.01 123.94 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.73 120.04 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 t -173.66 144.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -62.16 127.44 31.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.67 -33.52 68.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.5 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.41 -7.0 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -63.26 130.96 46.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -94.07 113.11 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.576 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.3 mt -91.81 115.41 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.9 t -86.58 137.93 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.03 52.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.102 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.76 -27.18 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.817 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.77 86.18 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.107 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -76.55 100.09 5.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.22 109.88 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.58 127.96 35.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.483 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -100.6 125.1 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.397 . . . . 0.0 111.104 -161.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.6 129.01 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.3 m -101.95 117.98 35.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.54 114.75 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.582 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 53.6 m-85 50.2 56.19 8.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.2 m -107.92 88.77 2.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.848 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -86.62 111.72 20.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.2 pp -145.49 153.02 51.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.924 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.46 152.32 70.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.647 2.231 . . . . 0.0 112.295 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -58.69 -29.81 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.8 m -57.89 -36.11 71.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 105' ' ' LEU . 47.0 tp -71.65 -36.03 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -54.02 -44.02 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -62.92 -28.65 70.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 -37.16 28.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.76 -39.19 73.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.5 m-85 -52.01 -52.49 61.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.722 0.772 . . . . 0.0 110.961 -165.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.1 Cg_endo -68.37 -32.1 26.67 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.637 2.225 . . . . 0.0 112.329 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -71.72 -44.12 64.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.0 -34.33 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -71.16 -52.77 17.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.53 -31.57 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.576 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -63.35 -31.04 79.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.64 135.42 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.19 157.55 78.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.561 0.696 . . . . 0.0 110.887 165.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.41 125.1 11.67 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.77 2.313 . . . . 0.0 112.332 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.17 67.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.496 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.14 176.91 46.38 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.386 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.32 139.05 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 0.0 111.155 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -120.64 128.92 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 191' ' ' LEU . 86.9 mt -124.67 136.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 39.3 tp -123.99 125.66 44.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -153.04 136.13 15.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 148.62 -164.54 29.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.541 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -173.729 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.625 ' N ' ' HG1' ' A' ' 155' ' ' THR . 96.9 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.789 0.328 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.874 ' O ' HD23 ' A' ' 153' ' ' LEU . 5.3 tt -49.76 -37.16 28.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 170.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.21 -27.23 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.625 ' HG1' ' N ' ' A' ' 152' ' ' LYS . 92.2 m -63.34 -59.75 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -168.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.045 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.09 -15.07 61.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.801 ' N ' HD22 ' A' ' 156' ' ' LEU . 62.9 tt0 -68.98 -40.07 79.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.2 p -79.68 -20.78 45.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.01 -19.5 58.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 103.07 55.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.719 . . . . 0.0 110.842 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.83 -21.85 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.0 p -73.14 -23.35 60.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -158.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.485 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -135.59 158.33 44.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.935 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.64 143.07 28.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.519 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 99.2 m95 -98.91 128.74 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.9 mt -94.3 -30.21 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.937 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.55 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.0 pt -135.31 147.55 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 115.71 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -133.7 140.13 46.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.04 129.77 55.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 175.477 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 39.6 pt -125.46 143.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.71 129.55 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -153.01 149.7 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 167' ' ' ILE . 0.1 OUTLIER -140.08 132.23 28.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.26 173.24 54.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.549 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -171.877 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 ttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.758 0.313 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.1 m0 59.12 44.87 15.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -114.92 159.98 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -126.87 150.0 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.75 145.03 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.845 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.09 165.07 37.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -154.33 169.98 22.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.64 170.03 8.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.2 t -159.92 139.95 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.91 129.9 14.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.99 172.52 12.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -143.5 140.04 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -149.74 164.95 33.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.93 124.6 3.89 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.569 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.731 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 84.9 m -131.17 130.13 42.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.652 0.263 . . . . 0.0 111.258 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -134.61 115.97 12.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.813 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.27 146.3 50.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.596 2.197 . . . . 0.0 112.328 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -127.63 156.75 41.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -117.62 152.44 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 62.72 35.38 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.6 tt -61.0 -36.29 79.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.127 176.611 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HD11 ' A' ' 128' ' ' ILE . 81.7 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.648 0.737 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.23 111.46 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -79.44 16.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -168.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -99.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -101.44 133.22 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.65 127.78 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.85 125.95 50.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -106.2 122.85 47.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.69 43.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 178.67 105.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 8.4 tm-20 -60.36 -59.85 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.15 33.22 82.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 65.49 15.88 10.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.49 16.87 70.07 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.43 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -64.43 -46.68 82.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -79.33 -28.24 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.77 63.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.19 -30.02 68.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.13 -48.94 74.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -65.54 -37.13 85.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.09 85.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -67.86 -19.95 65.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -89.21 0.83 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 93.35 4.21 64.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -85.19 142.12 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.946 0.403 . . . . 0.0 110.819 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -89.73 104.43 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.92 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' A' ' 47' ' ' LEU . 96.1 t -107.35 125.76 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.054 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.6 m -112.53 125.04 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 167.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.06 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.13 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.78 134.07 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.9 t70 -155.17 158.85 39.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.7 -26.58 37.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.9 p -97.01 144.96 26.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.874 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.2 m -76.99 -37.78 54.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.68 -35.03 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 -170.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.6 -44.87 94.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.66 -36.17 80.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.56 -39.12 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.09 -36.67 83.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -60.6 -42.85 97.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.03 -43.69 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -63.72 -45.41 90.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -61.85 -41.51 97.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.98 92.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.45 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.01 -29.95 70.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.53 -5.56 55.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 31.87 60.94 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.05 161.39 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.159 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.23 131.34 54.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.37 169.45 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.093 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -122.88 131.95 53.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 p -120.8 133.95 55.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.7 123.34 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.174 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -86.65 113.37 22.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.981 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -172.19 141.6 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.75 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.31 133.79 55.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.82 -31.54 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -72.3 -27.12 62.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -101.87 -13.75 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -69.44 134.62 49.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.27 109.91 20.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.684 HG22 ' HA3' ' A' ' 120' ' ' GLY . 94.9 mt -87.64 124.63 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.66 138.19 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.97 -53.45 12.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.4 -27.81 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.18 86.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.109 -164.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -132.6 161.88 32.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.35 -44.17 4.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.06 157.55 15.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.4 mt -129.37 129.7 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.71 128.89 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -171.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 t -112.35 118.59 35.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.02 113.87 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.4 t80 42.72 52.2 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -105.53 96.42 6.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -82.16 121.0 26.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HD23 ' A' ' 109' ' ' LEU . 1.7 pt? -134.64 150.76 74.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.582 0.706 . . . . 0.0 110.905 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.61 151.68 69.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.8 p -53.94 -34.93 61.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.6 p -62.68 -35.98 81.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 105' ' ' LEU . 16.5 tp -75.45 -34.05 60.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -58.5 -43.82 89.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.18 -28.19 68.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.6 -42.99 12.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.85 -43.58 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -170.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.7 m-30 -54.05 -53.45 58.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 -170.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 38.0 Cg_endo -65.61 -29.8 51.83 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.59 -39.7 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.12 -43.41 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -63.87 -51.1 66.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.66 -31.45 72.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.684 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -81.15 -16.97 73.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.478 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.34 138.29 33.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.931 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.85 152.58 93.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.831 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.28 125.94 16.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.23 -2.7 88.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.562 -167.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.82 49.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.487 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.416 HG11 HG12 ' A' ' 28' ' ' ILE . 80.8 t -131.19 146.87 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 0.0 111.107 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -121.72 137.41 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 174.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' CD1' ' A' ' 28' ' ' ILE . 60.9 mt -116.92 135.89 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.5 124.57 40.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.958 162.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 23.5 pt-20 -154.11 145.63 23.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.928 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.68 -172.64 33.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.749 0.309 . . . . 0.0 110.903 178.586 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.815 0.34 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -65.82 -36.61 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 81.6 m -63.97 -40.8 97.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.64 -37.69 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -64.12 -36.07 82.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.4 p -83.76 -28.18 28.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -80.5 -13.93 58.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 160' ' ' LEU . 3.3 tt -115.49 97.89 49.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.739 . . . . 0.0 110.981 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -91.08 -25.13 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 -170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 82.7 p -66.09 -20.47 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -161.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 163' ' ' LEU . 1.8 pp -128.18 154.21 46.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -94.83 140.58 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.67 121.49 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.08 -32.7 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.4 pt -139.93 147.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.165 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.04 117.11 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.62 137.1 46.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -112.09 123.04 49.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.4 pp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.76 143.18 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 67.8 mt-30 -139.72 132.81 29.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.82 150.12 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.683 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.9 tt -139.92 127.5 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -108.49 140.28 15.48 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.402 . . . . 0.0 110.91 178.64 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.793 0.33 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.4 m0 58.96 44.98 15.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.51 159.93 17.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.16 149.95 49.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.96 145.02 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.98 164.94 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -154.94 169.99 22.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.67 170.0 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.96 139.98 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.04 129.56 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -161.57 163.81 29.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -121.78 131.03 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.114 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -143.76 163.09 34.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.14 155.13 8.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.53 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 17' ' ' PRO . 87.6 m -135.39 130.09 34.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 111.274 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -139.96 83.67 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 0.0 110.829 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD3' HG22 ' A' ' 15' ' ' THR . 25.2 Cg_endo -69.3 136.47 34.31 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.702 2.268 . . . . 0.0 112.305 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -122.7 172.12 8.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -144.86 -179.96 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 56.32 50.36 13.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -60.84 -49.71 76.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.654 0.74 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.55 112.43 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.314 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -78.68 3.27 16.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.939 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.38 -87.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.463 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 99.3 mttt -119.13 133.02 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.54 136.86 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 30.1 tp -94.74 121.01 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -103.11 110.5 22.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 90.5 mt -85.19 51.62 2.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.88 104.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.118 -171.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.5 tm-20 -56.18 -59.78 4.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.93 33.72 86.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.53 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 61.72 18.92 10.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.829 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.48 17.69 68.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -64.74 -51.74 60.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.325 . . . . 0.0 110.814 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -80.39 -29.27 37.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.74 82.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.039 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.21 -35.52 76.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.85 -51.13 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.509 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -66.88 -35.17 79.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.01 76.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.183 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -70.67 -15.97 62.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -86.46 -5.26 59.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.25 2.46 59.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.442 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -82.82 142.56 31.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -91.11 108.66 20.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.892 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 47' ' ' LEU . 90.9 t -108.76 131.0 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -109.66 124.12 50.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.95 130.88 55.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.53 134.43 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.2 t70 -154.3 159.45 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -80.77 -21.83 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -108.78 127.84 54.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.7 p -69.62 -29.81 67.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.77 -33.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.054 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.68 90.81 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.494 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.01 -34.83 78.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.32 94.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.17 -36.84 85.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.75 95.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.88 -41.13 97.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.29 -45.69 93.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.9 -40.44 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.36 97.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.98 -38.29 90.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.65 -31.81 71.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.32 -6.98 49.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.87 33.07 60.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.462 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.15 160.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 111.193 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -104.31 131.96 51.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.23 161.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.5 m -114.2 133.62 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.3 p -123.15 133.93 54.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.189 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.34 124.96 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.2 116.5 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 173.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -174.99 143.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.8 t30 -60.47 131.02 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.06 -36.96 73.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.46 -30.32 65.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -100.7 -7.06 24.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 84' ' ' ASN . 4.8 t80 -57.69 129.0 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -94.69 108.05 20.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.75 143.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.145 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.82 131.81 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.28 -48.99 60.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.139 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -66.82 -22.62 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.45 -22.26 66.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.041 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 34' ' ' LEU . 30.7 p90 -147.95 167.08 25.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -118.58 -31.35 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.45 154.74 16.75 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.67 128.08 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 111.121 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.84 132.59 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -111.02 120.45 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -110.4 115.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.185 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.686 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 68.0 m-85 46.37 43.01 11.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -104.02 68.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -172.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -74.34 117.49 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.41 153.16 81.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.629 0.728 . . . . 0.0 110.905 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -63.52 148.86 92.23 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.643 2.229 . . . . 0.0 112.369 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -54.15 -30.38 48.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -60.07 -42.75 95.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -73.02 -32.58 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -57.34 -45.08 84.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -32.3 73.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -43.06 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.44 -30.41 67.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.518 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -50.07 -57.99 10.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.67 0.747 . . . . 0.0 110.917 -172.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 33.8 Cg_endo -63.43 -29.57 71.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 2.243 . . . . 0.0 112.309 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -68.52 -40.08 80.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.69 -42.97 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -63.18 -53.03 59.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.62 -33.34 74.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.54 -31.76 53.19 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.427 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.3 tp -75.9 134.42 40.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.998 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.67 139.84 80.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.668 0.747 . . . . 0.0 110.86 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.94 126.69 17.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.776 2.317 . . . . 0.0 112.304 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.82 1.5 87.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.514 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.15 173.31 54.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.45 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.79 139.49 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -115.42 131.39 56.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.51 131.28 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.078 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -124.61 126.38 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -152.12 131.75 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 147.7 -155.76 26.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.446 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 -165.563 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 155' ' ' THR . 98.7 mttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.724 ' O ' HD23 ' A' ' 153' ' ' LEU . 5.7 tt -53.66 -41.77 67.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.22 -33.95 76.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 152' ' ' LYS . 87.4 m -61.49 -43.22 99.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.36 -39.12 92.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.35 -36.27 83.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.1 p -83.29 -29.71 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.787 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -83.3 -19.56 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.4 tp -107.44 106.41 58.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.868 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -88.53 -22.98 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.421 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.2 p -69.18 -23.65 63.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 -159.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.662 HD13 ' HA3' ' A' ' 192' ' ' GLY . 4.3 pp -139.22 160.42 39.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -105.56 136.12 45.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.17 127.77 35.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -170.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.03 -33.83 12.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.694 HG12 ' HB3' ' A' ' 191' ' ' LEU . 49.8 pt -139.12 145.77 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.09 120.6 2.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -132.12 140.96 48.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.761 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -110.84 132.01 54.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.71 0.291 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 30.9 pt -122.27 147.52 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.56 122.72 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.684 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -151.13 149.31 29.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.4 tt -140.04 128.39 22.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.662 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -116.41 148.72 18.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.453 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 177.35 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.745 0.307 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.95 44.94 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -111.4 159.94 17.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.64 150.02 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.6 145.0 46.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.97 164.94 38.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -153.51 169.94 21.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.58 169.98 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.94 140.01 11.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -145.36 121.98 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -159.52 165.04 33.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -101.16 131.11 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -149.73 166.09 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 154.52 21.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.547 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.2 m -126.18 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.75 0.309 . . . . 0.0 111.159 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -140.0 89.96 10.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.62 125.16 18.19 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -121.24 169.99 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -140.38 -177.89 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.16 58.9 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.58 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.176 -175.773 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' HB ' ' A' ' 126' ' ' VAL . 11.4 tt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.615 0.722 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.09 112.26 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.339 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -77.65 10.99 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 -170.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.26 -96.79 0.35 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -109.63 131.39 55.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.25 130.04 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.7 tp -101.48 122.66 44.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -114.8 114.97 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.923 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 85.0 mt -91.91 58.9 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.991 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -54.31 -60.07 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.78 35.58 92.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 60.11 19.54 8.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.832 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 16.07 63.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.557 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -65.09 -48.9 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -81.17 -30.15 34.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.97 -51.14 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -65.28 -35.77 82.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.53 -51.65 68.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.66 -37.11 86.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.82 78.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.2 p -68.11 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.7 mt -86.13 -3.28 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.97 3.64 61.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.519 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.3 m-30 -80.13 146.34 31.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -89.99 103.43 16.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.941 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -104.57 126.19 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 -170.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 m -112.78 128.93 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.163 166.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.2 126.67 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.155 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.27 129.97 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -157.89 163.43 37.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -78.19 -26.38 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -99.12 111.67 24.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.9 p -68.84 -27.99 66.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.91 -47.48 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.87 99.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.543 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.75 -36.48 84.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.4 89.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.26 -35.05 77.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.09 98.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.064 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.47 -40.87 98.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.17 -40.79 90.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.06 -40.59 96.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.66 92.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.83 -38.61 91.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.53 -32.74 73.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.43 -9.32 45.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.69 33.05 58.57 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.448 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.63 161.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 111.131 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -104.87 131.6 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.1 pt -135.03 165.99 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -123.21 131.87 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -120.72 134.71 55.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.125 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.41 124.86 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -85.09 119.54 25.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.1 t -172.06 140.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -57.34 130.6 46.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.78 -32.69 67.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -71.93 -29.74 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.042 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.04 -13.32 19.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.29 135.87 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.35 110.01 21.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.664 HG22 ' HA3' ' A' ' 120' ' ' GLY . 93.6 mt -84.07 125.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.2 t -100.76 139.17 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.96 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 99.1 m-20 -65.27 -28.3 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.61 68.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 -163.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -130.05 162.38 28.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.547 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 48.0 mp0 -114.66 -37.86 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.47 151.51 18.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.532 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.5 mt -129.19 127.99 66.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.345 . . . . 0.0 111.138 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.86 131.86 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -115.66 116.17 27.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.01 118.77 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.176 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 41.05 48.26 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.79 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.2 t -113.73 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -73.48 119.61 17.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.97 148.42 69.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.941 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.33 146.63 75.94 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.3 p -56.51 -35.33 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.3 m -60.48 -40.24 90.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 86' ' ' ALA . 45.3 tp -70.88 -39.94 72.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.932 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -55.46 -42.83 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.17 -28.56 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -82.19 -37.01 26.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.3 mt -71.79 -37.31 70.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.3 m-30 -50.07 -54.4 33.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.604 0.716 . . . . 0.0 110.92 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 31.8 Cg_endo -62.73 -32.53 78.32 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.765 2.31 . . . . 0.0 112.357 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -71.66 -39.7 70.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.51 -42.7 90.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -64.68 -53.85 40.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.74 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.977 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.84 -22.43 63.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.59 135.89 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.931 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.547 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.5 mttt -78.25 152.68 79.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.617 0.723 . . . . 0.0 110.815 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.14 125.64 19.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.43 3.58 86.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.65 171.18 50.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 28' ' ' ILE . 76.9 t -131.1 142.09 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 111.117 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -119.64 136.0 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -120.15 132.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 50.5 tp -125.6 129.11 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 168.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.53 129.42 13.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.0 -171.25 37.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.7 p90 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.904 179.107 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 54.4 tp -55.4 -39.87 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.09 -30.12 71.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 64.1 m -62.27 -59.66 4.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.008 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.27 -16.08 62.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -173.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.671 ' N ' HD22 ' A' ' 156' ' ' LEU . 88.0 mt-30 -69.35 -42.65 74.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.958 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.0 p -77.58 -21.84 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.18 -11.53 59.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 tp -114.13 100.99 53.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.935 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.78 -23.53 1.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.715 2.276 . . . . 0.0 112.425 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 74.6 m -76.12 -25.33 55.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -165.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -96.84 136.32 37.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -88.42 123.55 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -167.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.05 -32.23 16.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.643 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.2 pt -138.13 145.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.63 113.46 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 167.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -133.25 141.87 48.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.13 130.48 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 167.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.72 0.295 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 46.3 pt -120.23 143.47 31.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -144.54 127.1 16.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.85 149.44 28.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.4 tt -139.98 128.28 22.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.91 140.05 15.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.896 174.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.8 44.98 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.69 158.56 18.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.18 149.95 49.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.62 144.97 46.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -157.37 165.06 36.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -152.89 169.01 23.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.65 169.87 8.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.884 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -159.97 140.02 11.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.21 126.64 11.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -160.06 165.02 32.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.57 133.34 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -150.05 166.83 28.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.75 147.83 9.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -134.89 135.49 41.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.6 84.4 22.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.746 0.784 . . . . 0.0 110.87 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -59.91 129.89 32.41 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 0.0 112.296 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -133.53 158.95 41.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 172.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -123.32 -170.13 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 59.17 53.67 5.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.62 -34.26 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.215 -178.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.7 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.653 0.74 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.97 108.15 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.73 2.287 . . . . 0.0 112.298 168.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -80.03 18.35 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -166.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.23 -94.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.17 133.38 52.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.823 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.95 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.4 tp -101.3 122.38 43.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.7 t -106.07 112.6 25.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.45 52.04 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.06 105.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.042 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -63.2 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.05 35.49 92.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 60.0 20.02 9.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.817 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.3 68.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -64.87 -46.06 83.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.925 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.92 -33.0 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.26 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.1 m -69.18 -34.9 75.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.62 -49.43 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 3.1 mp -64.39 -38.19 90.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.68 79.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -68.96 -19.71 64.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 65.1 mt -93.3 2.99 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.29 6.03 64.98 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 73.1 m-85 -82.32 136.23 35.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.938 0.399 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -89.29 104.4 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.904 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -104.57 127.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.6 m -108.61 125.17 51.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.151 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.85 129.08 55.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.61 133.32 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.61 157.6 37.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -77.99 -22.38 49.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.0 p -114.53 132.19 56.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.1 p -67.07 -25.19 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.19 -44.63 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.028 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.43 93.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.08 -30.8 71.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.918 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.88 -34.97 72.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.068 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.39 -38.42 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.72 95.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.22 -47.57 76.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.969 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.34 -42.95 78.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.24 -39.48 82.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.941 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.98 94.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.06 -37.89 89.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.25 -33.1 74.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.47 -7.34 47.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.46 30.62 62.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.04 165.03 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.63 131.88 54.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.1 165.5 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -123.3 131.28 53.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.5 p -119.62 132.98 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.0 t -126.51 123.63 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -86.36 114.15 22.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -173.26 140.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -51.69 125.95 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.7 tp -58.33 -35.93 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.01 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.25 -7.71 31.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -64.44 135.16 55.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.6 111.02 22.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.702 HG22 ' HA3' ' A' ' 120' ' ' GLY . 90.6 mt -84.68 121.05 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.19 140.62 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.16 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.027 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.86 -29.19 66.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.93 79.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.062 -164.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -129.91 158.72 38.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.72 -42.37 5.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.96 157.06 15.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.18 126.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.82 132.34 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -112.83 118.17 34.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -111.4 114.11 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.194 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 42.89 46.43 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.413 ' SG ' HD23 ' A' ' 105' ' ' LEU . 32.4 t -103.25 91.75 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -80.98 121.06 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.4 pp -152.75 153.1 29.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.563 0.697 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.48 154.81 55.53 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.671 2.247 . . . . 0.0 112.371 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.0 p -57.32 -32.97 67.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.821 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -60.01 -39.34 85.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 105' ' ' LEU . 38.2 tp -71.68 -35.41 70.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.415 ' HG3' HD12 ' A' ' 105' ' ' LEU . 27.7 mtt180 -56.76 -40.2 75.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.998 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.36 -27.73 69.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.896 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.37 -39.81 16.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.14 -39.03 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.6 m-30 -52.23 -54.67 39.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.658 0.742 . . . . 0.0 110.873 -171.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.6 Cg_endo -61.93 -30.1 83.16 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.708 2.272 . . . . 0.0 112.341 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -72.5 -39.66 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.44 -40.93 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -64.21 -54.65 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.33 -30.2 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.989 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.702 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -78.59 -24.35 62.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.455 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.2 tp -82.16 136.81 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 110.911 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.1 154.67 86.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 0.0 110.847 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.91 125.78 16.67 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.705 2.27 . . . . 0.0 112.353 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.47 88.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.49 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.27 169.95 45.78 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 28' ' ' ILE . 79.7 t -129.02 142.58 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -119.27 136.52 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.1 mt -120.11 131.45 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.442 HD22 HD21 ' A' ' 190' ' ' LEU . 4.1 tt -127.93 130.5 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 167.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -150.15 140.87 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -164.47 -168.3 26.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.4 p90 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -178.635 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.729 0.3 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.45 -45.19 80.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.879 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.05 -35.04 78.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 m -62.43 -41.19 98.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.2 mt -60.61 -42.14 96.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.81 -37.11 81.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.8 p -81.46 -28.12 34.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.03 -11.32 55.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.13 98.87 52.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.736 0.779 . . . . 0.0 110.962 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.99 -22.26 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.4 p -68.53 -21.48 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.0 pp -130.17 153.98 47.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.78 138.99 35.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -88.13 121.79 30.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.78 -30.43 19.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.6 pt -138.46 147.09 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 111.91 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 164.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -136.62 143.08 43.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.51 119.81 39.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 165.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.136 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.7 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.1 pt -121.46 141.59 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -138.47 137.49 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -155.64 147.69 23.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.833 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.654 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.1 tt -140.1 128.37 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.84 139.42 15.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 174.469 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.87 44.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.63 160.0 17.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.69 150.01 49.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.48 145.04 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.97 164.98 37.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.848 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -154.96 169.97 22.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -169.64 169.97 8.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -156.2 133.78 10.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -154.26 135.07 13.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.7 p90 -155.95 157.31 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.987 176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -122.26 132.97 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.091 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -137.13 126.69 25.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.52 166.81 23.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.631 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 86.9 m -119.85 132.31 55.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.727 0.298 . . . . 0.0 111.206 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -127.36 114.51 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 110.817 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.32 144.97 42.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.35 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -130.05 168.06 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -130.65 169.1 16.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 51.25 41.49 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.877 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.38 -43.1 86.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 172.898 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 126' ' ' VAL . 8.7 tt . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.665 0.745 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.3 114.35 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 0.0 112.324 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -74.93 -0.58 19.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.61 -96.13 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -170.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -99.05 125.6 44.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.4 127.68 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.11 121.54 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.868 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -108.09 112.67 25.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt -87.73 58.13 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.993 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.97 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.65 -60.0 4.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.64 32.24 83.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 62.08 18.52 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.9 16.16 72.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.539 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -63.54 -45.52 90.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.906 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -79.46 -29.97 41.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.77 -51.98 59.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 p -70.9 -29.62 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.03 -52.06 58.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.5 mt -67.41 -35.45 79.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.24 82.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.173 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -68.98 -17.39 63.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.26 0.61 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.937 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.71 2.68 61.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -87.1 144.86 26.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -90.17 109.02 20.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 47' ' ' LEU . 94.6 t -109.27 126.56 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.8 m -110.54 124.9 52.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 167.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.52 130.54 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.69 132.62 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.62 163.91 39.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -83.41 -21.22 33.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -104.52 117.88 35.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.0 p -67.12 -27.8 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.84 -46.1 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.77 -40.64 98.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.607 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.09 -35.62 81.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.33 . . . . 0.0 110.889 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.54 84.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.42 -36.86 85.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.34 99.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.35 -42.21 93.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -62.24 -46.98 86.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mp -61.49 -37.22 82.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.03 -45.98 83.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.69 -37.68 87.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -65.44 -29.82 70.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -92.88 -4.4 52.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.81 32.82 58.61 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.428 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.14 161.8 26.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.398 . . . . 0.0 111.104 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.58 131.13 54.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -133.54 163.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.7 m -119.56 135.48 54.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.0 p -120.23 134.58 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.195 -177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.8 t -128.56 123.5 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.177 170.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.88 114.88 23.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -173.49 141.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.834 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -54.99 130.79 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.96 -35.03 74.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.36 69.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -98.73 -9.51 24.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.05 136.74 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -92.89 108.76 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.698 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.3 mt -83.32 119.45 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.78 140.32 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -172.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.49 -54.69 7.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -71.21 -29.4 65.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.51 81.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -129.36 164.45 23.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.7 -40.62 4.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.56 155.59 16.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.76 127.0 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 0.0 111.19 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.78 130.44 72.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.8 m -114.96 115.95 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.801 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.42 115.95 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 49.8 43.75 24.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -101.0 73.12 1.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -80.49 124.03 28.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -144.83 150.98 48.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.658 0.742 . . . . 0.0 110.878 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.37 154.86 71.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.762 2.308 . . . . 0.0 112.339 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.2 p -54.26 -30.82 51.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.1 m -58.17 -40.7 82.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.38 -34.22 65.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.888 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -55.87 -44.73 78.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.25 -30.38 71.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -85.85 -46.4 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.19 -42.16 80.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 6.5 m-30 -53.02 -54.98 38.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -168.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.5 Cg_endo -62.0 -28.74 80.87 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.349 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.46 -36.85 65.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.97 -41.13 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.151 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.55 -53.55 50.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.65 -31.49 72.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.937 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -76.56 -26.98 62.03 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.476 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.93 136.6 36.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.918 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.45 154.55 85.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 126.98 19.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.39 88.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.475 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.26 169.98 50.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.532 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 28' ' ' ILE . 60.4 t -129.56 143.82 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -119.77 136.93 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.88 128.71 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 51.8 tp -123.41 129.77 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -153.46 134.72 14.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.952 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.01 -178.1 40.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.963 175.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.728 0.299 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.417 HD11 HD22 ' A' ' 190' ' ' LEU . 64.2 tp -55.03 -38.12 67.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.878 161.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.78 -33.76 72.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 73.8 m -63.22 -41.89 99.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.98 -40.75 94.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.972 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.08 -36.53 84.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -83.98 -27.64 28.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -169.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -80.31 -13.28 59.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -111.75 100.55 48.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.938 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.35 -21.66 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.4 p -68.53 -20.81 64.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -163.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.2 pp -132.55 155.35 48.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -99.43 137.53 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.08 125.08 32.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -93.0 -30.75 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.633 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.6 pt -139.73 146.16 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.09 116.41 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -131.47 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -123.24 129.98 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 171.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.78 0.324 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.7 pt -124.27 142.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -145.0 129.15 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.67 150.84 28.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.867 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.688 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.7 tt -139.95 129.93 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -175.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.03 140.19 15.92 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.935 174.125 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.703 0.287 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.3 m95 59.22 43.0 17.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.65 160.0 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.29 149.99 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.42 145.03 46.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.99 165.01 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.5 p -151.15 169.85 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.51 170.08 8.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -159.66 140.0 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.35 134.94 16.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.97 167.59 29.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.13 128.23 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.191 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.06 164.87 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.97 147.77 22.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.74 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 85.3 m -113.04 124.78 53.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 0.0 111.167 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.98 129.81 24.84 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.0 110.793 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 131.17 23.13 Favored 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.676 2.251 . . . . 0.0 112.343 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -135.01 167.12 21.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -141.98 179.33 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 56.56 37.86 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.724 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.9 tt -64.49 -40.46 95.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 170.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.213 174.117 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 126' ' ' VAL . 84.6 mt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.664 0.745 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.51 119.22 5.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 0.0 112.31 166.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -74.38 5.53 4.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.41 -96.11 0.51 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -167.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -100.81 125.08 47.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -120.43 129.34 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.6 tp -101.42 125.75 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.4 t -115.92 114.84 25.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.59 57.68 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.93 104.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.065 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.9 tm-20 -59.64 -60.05 4.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -176.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.83 35.93 92.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 173.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 60.41 19.75 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.25 20.53 60.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.476 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -65.29 -48.47 73.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.07 -31.1 50.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.79 -50.96 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.987 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.09 -35.71 81.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.28 -51.23 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -67.73 -35.34 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.8 81.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.128 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -67.28 -17.58 64.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.73 -1.81 58.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.74 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.28 4.16 61.21 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.534 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.9 m-30 -85.43 142.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.861 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -89.97 105.86 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.926 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.3 t -106.76 127.68 62.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -109.64 125.24 52.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.174 168.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.44 128.55 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 133.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.082 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.7 t70 -154.15 161.31 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -82.3 -21.13 36.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.9 p -108.54 131.32 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.6 p -71.73 -26.2 62.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.96 -47.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.01 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.34 98.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.56 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.34 -36.48 84.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.22 81.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.17 -35.57 79.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -62.36 -43.39 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.58 -41.25 96.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -62.19 -46.82 87.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.7 tp -60.07 -41.04 91.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.33 -43.73 96.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.53 -36.5 83.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -69.45 -31.17 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.42 -7.5 50.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 32.1 58.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.427 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.31 163.59 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.867 0.365 . . . . 0.0 111.194 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.97 131.33 53.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -135.39 166.41 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -122.88 134.17 54.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.159 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 p -120.01 134.04 55.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.113 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -127.55 123.97 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 170.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 63.8 tt0 -88.46 117.24 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.1 t -174.61 142.58 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -61.29 132.14 52.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.85 -25.02 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.92 60.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -104.42 -13.74 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.23 132.73 46.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.96 112.32 24.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' HA3' ' A' ' 120' ' ' GLY . 82.1 mt -81.39 122.11 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.85 139.92 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.134 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -59.41 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.18 -28.27 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.07 78.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -132.89 161.07 35.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -105.34 -44.99 4.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.97 153.87 17.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.466 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.1 mt -124.09 125.44 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.107 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.1 131.88 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.7 m -111.92 117.08 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mm -106.58 111.29 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 43.87 45.08 6.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 43.4 t -106.26 94.89 5.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -94.01 120.68 34.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt -128.29 150.16 73.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 39.2 Cg_endo -63.83 145.64 90.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.358 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.2 p -54.98 -34.35 63.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.1 p -62.34 -35.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 109' ' ' LEU . 1.3 tt -76.27 -34.46 59.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.912 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -57.16 -42.62 81.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.97 -27.35 68.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.82 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -86.27 -36.01 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.27 -41.2 66.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -52.25 -55.06 34.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.69 0.757 . . . . 0.0 110.905 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 20.0 Cg_endo -59.74 -29.74 90.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.333 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.05 -41.02 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.98 92.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -63.69 -55.23 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.44 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.614 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.97 -23.93 60.76 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.62 137.52 34.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.78 154.1 87.14 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.1 126.93 18.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.778 2.318 . . . . 0.0 112.261 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.85 89.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.526 -167.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.13 173.82 47.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 28' ' ' ILE . 56.5 t -132.9 146.55 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.17 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -122.43 138.78 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' ILE . 69.2 mt -118.66 132.18 69.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.432 HD22 HD21 ' A' ' 190' ' ' LEU . 5.0 tt -126.28 130.1 50.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 167.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -147.64 135.58 21.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.81 -167.86 23.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.418 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 -178.21 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.5 -40.11 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 172.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.85 -30.97 68.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 90.7 m -60.6 -44.86 95.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.23 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.58 -39.35 94.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.36 -36.59 84.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -85.99 -26.35 25.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.05 -8.67 59.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.34 99.34 49.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 0.0 110.902 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -89.24 -20.74 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.699 2.266 . . . . 0.0 112.412 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -68.08 -22.12 64.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.4 pp -131.76 154.8 48.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.57 140.86 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -86.98 123.09 31.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 92.5 mt -89.63 -33.4 16.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.8 pt -141.57 148.41 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.067 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.99 114.21 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.036 167.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -131.39 140.58 49.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -117.6 129.03 55.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 168.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 29.9 pt -124.08 141.42 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -139.05 138.39 37.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.2 pt? -156.25 152.51 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 191' ' ' LEU . 6.8 tt -139.9 129.79 24.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.505 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.13 138.59 14.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.511 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.93 175.186 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 45.02 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -110.56 159.34 17.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.78 149.94 49.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.16 145.01 47.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.84 165.03 37.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.839 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.5 p -152.52 169.87 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.74 170.05 8.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.36 139.93 12.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.83 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.35 130.03 14.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -164.01 168.72 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.85 139.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.156 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.39 165.01 32.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.65 167.53 14.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.553 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.674 HG22 ' HD3' ' A' ' 17' ' ' PRO . 96.6 m -93.8 120.04 33.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.281 . . . . 0.0 111.229 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.66 80.32 22.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.771 0.795 . . . . 0.0 110.863 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HD3' HG22 ' A' ' 15' ' ' THR . 55.9 Cg_endo -74.18 146.16 35.91 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 0.0 112.288 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -137.9 157.73 45.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -150.64 -171.2 3.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 54.99 46.27 24.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.0 -43.01 93.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.144 -177.088 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' HB ' ' A' ' 126' ' ' VAL . 10.7 tt . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.654 0.74 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.08 112.79 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.616 2.211 . . . . 0.0 112.311 167.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -75.03 10.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.59 -100.4 0.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.98 133.36 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 88.9 mt -123.72 136.05 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 tp -95.19 121.77 37.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.899 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.42 113.97 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 83.0 mt -94.66 57.12 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.96 104.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -67.08 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 38.19 94.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 61.87 18.91 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.918 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.97 10.73 81.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.531 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -63.48 -45.58 90.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.945 0.402 . . . . 0.0 110.944 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.26 -33.6 37.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.09 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.3 m -66.23 -36.57 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.6 -49.29 75.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -60.83 -39.09 87.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.26 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.5 p -69.04 -18.32 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -83.34 0.24 46.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.77 64.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.512 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -80.11 143.68 33.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -86.97 103.57 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 47' ' ' LEU . 67.5 t -105.38 127.77 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -168.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.8 m -112.49 125.17 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.6 129.26 56.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.63 133.91 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -154.63 163.62 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -83.79 -20.77 32.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.974 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.7 t -101.75 117.26 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.808 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -65.0 -28.15 69.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.53 -47.97 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.01 99.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.52 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.28 -35.55 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.945 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.0 99.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.36 -42.84 99.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -66.64 -41.16 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.3 -39.78 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -40.99 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.43 -38.19 90.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.5 -33.72 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.38 -8.23 45.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.84 33.06 60.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.32 160.97 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.38 . . . . 0.0 111.113 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.57 131.01 53.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.814 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -134.73 166.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -124.85 131.2 53.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 p -120.32 135.17 55.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.132 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -130.26 125.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -84.89 116.6 23.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 t -173.76 142.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.501 HD21 ' HB3' ' A' ' 86' ' ' ALA . 26.8 t30 -58.73 130.06 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.38 -30.58 65.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 84' ' ' ASN . . . -76.12 -23.53 54.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -104.92 -13.45 15.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.884 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 84' ' ' ASN . 72.1 t80 -70.38 137.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -94.01 107.42 19.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.2 mt -88.2 125.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.34 138.88 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.74 -44.58 61.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.17 -26.62 66.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.69 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -164.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -130.1 156.73 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.796 -172.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.95 -40.04 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.76 159.92 15.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 88.3 mt -129.99 125.65 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.107 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.64 130.78 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -129.02 118.27 22.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.62 128.91 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.132 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.1 t80 43.73 52.64 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 51.0 t -115.53 88.32 2.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -80.84 117.55 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.8 mt -121.17 145.3 41.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.585 0.707 . . . . 0.0 110.899 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.9 Cg_endo -67.78 148.81 77.93 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.757 2.305 . . . . 0.0 112.303 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.7 m -54.17 -42.97 70.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.0 m -60.38 -39.77 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.54 -38.97 74.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 178.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.32 -41.65 89.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -83.56 -42.88 16.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.26 -42.22 60.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 -172.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.2 m-30 -54.51 -52.32 70.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.722 0.772 . . . . 0.0 110.923 -169.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 86.8 Cg_exo -45.1 -37.6 13.13 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 0.0 112.379 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -76.34 -37.07 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.51 -45.02 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.179 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 118' ' ' TYR . 2.7 m-30 -66.29 -54.45 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.07 -30.2 71.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.87 -29.56 67.04 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.512 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.18 133.6 38.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.344 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.48 153.12 78.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.701 0.762 . . . . 0.0 110.863 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.08 124.81 16.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.766 2.311 . . . . 0.0 112.31 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.56 87.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.524 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.54 170.91 47.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.441 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG13 ' A' ' 28' ' ' ILE . 77.5 t -129.18 140.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.116 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.97 132.54 56.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.8 129.88 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.069 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 190' ' ' LEU . 56.7 tp -126.01 123.54 38.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -148.98 132.85 17.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.71 -169.35 35.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 178.823 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.844 0.354 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.15 -42.64 91.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.903 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.49 -31.77 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.4 m -68.48 -56.17 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.111 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.31 -17.87 62.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 156' ' ' LEU . 66.5 mt-30 -73.84 -42.35 60.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 170.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -74.44 -20.71 59.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -83.59 -11.94 56.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.961 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -118.03 93.84 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 0.0 110.905 -174.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -89.2 -22.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.721 2.281 . . . . 0.0 112.397 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.2 p -69.9 -20.49 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -161.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.6 pp -131.49 154.96 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.09 142.14 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -89.35 119.35 29.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -169.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.64 -31.47 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 191' ' ' LEU . 47.8 pt -139.99 145.58 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.57 114.49 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -128.6 138.82 52.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -122.86 132.67 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.589 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.5 pp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.743 0.306 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.05 148.46 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.93 132.81 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.86 149.84 26.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.677 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.2 tt -140.85 127.7 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -176.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.89 142.09 16.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 178.156 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 44.97 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.62 157.97 19.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.61 149.79 49.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.5 145.03 46.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -157.89 165.07 36.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.787 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -155.38 169.96 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.62 170.02 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.918 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 t -159.99 139.84 11.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.18 128.54 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.672 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 54.2 p90 -156.96 159.04 37.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.947 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.6 t -122.95 132.98 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -138.13 125.15 21.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.57 158.73 15.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.69 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 94.2 m -112.66 131.78 55.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.49 105.12 21.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.727 0.775 . . . . 0.0 110.813 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -71.9 142.78 39.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.599 2.199 . . . . 0.0 112.323 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -127.25 170.34 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -126.88 149.29 49.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 60.25 49.5 7.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 177.486 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.4 tt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 121.706 0.765 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 52.8 Cg_exo -53.7 119.26 5.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.274 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -78.93 2.29 20.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -90.32 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.478 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.74 134.02 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 0.0 110.858 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -124.31 132.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.9 tp -101.62 122.66 44.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.82 117.36 33.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 85' ' ' LEU . 47.8 mt -88.01 54.88 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.95 105.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -168.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -60.12 -60.34 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.86 78.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.45 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 63.2 16.12 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.89 22.08 71.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.67 -51.59 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.76 -28.8 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -69.5 -34.6 74.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.901 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 97.9 mt -69.6 -35.05 74.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.76 85.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.4 p -68.72 -18.38 64.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.853 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.83 -0.87 57.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 96.27 4.81 59.58 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.408 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.18 145.23 26.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -91.53 108.06 19.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 93.9 t -108.65 131.24 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -110.4 128.9 55.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.21 132.51 56.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.3 137.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.122 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -155.01 162.46 41.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.821 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.45 -24.18 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.8 t -102.87 119.63 39.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.9 p -68.03 -26.67 65.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 170.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.19 -46.22 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.035 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -41.96 99.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.41 -35.94 82.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.95 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.87 92.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.94 -37.54 88.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.867 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.98 96.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.068 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.11 -42.64 99.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -64.72 -41.32 96.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.94 -40.18 92.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.85 95.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.103 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.11 -37.84 88.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.03 -33.09 75.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.21 -9.68 41.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 72.02 34.68 61.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.419 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.02 161.31 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -104.41 130.15 52.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -133.06 162.01 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -115.37 132.0 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.9 p -123.77 134.74 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.84 125.14 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -85.24 117.7 24.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.926 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -175.17 145.1 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.3 t30 -55.25 128.24 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 170.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.421 HD11 HD22 ' A' ' 36' ' ' LEU . 43.8 tp -57.93 -36.36 72.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.14 70.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -100.0 -6.12 27.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 84' ' ' ASN . 53.7 t80 -62.07 133.23 55.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -84.94 103.35 13.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.4 mt -87.49 123.14 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.133 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.2 t -102.02 134.21 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.54 -59.45 2.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.53 -22.76 64.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.97 68.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 -172.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.474 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 64.6 p-90 -147.46 160.77 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.44 -36.9 4.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.19 16.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.488 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 98' ' ' ILE . 3.1 tp -132.83 123.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 111.199 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.83 129.7 71.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -113.21 116.37 29.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.59 113.75 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.143 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 40.22 50.48 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.1 t -98.99 90.02 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -76.32 119.46 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 105' ' ' LEU . 2.3 pp -145.51 149.28 40.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.39 155.22 71.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.691 2.26 . . . . 0.0 112.331 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.6 p -54.16 -29.37 45.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -58.73 -40.43 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.798 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.9 -34.02 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -55.3 -44.42 75.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.08 -31.28 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -87.29 -50.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.86 -43.17 84.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -55.82 -54.26 53.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.698 0.761 . . . . 0.0 110.964 -167.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.0 Cg_endo -66.75 -29.33 42.79 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -67.51 -40.24 85.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -39.77 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.57 -49.7 75.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -64.74 -32.02 73.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.957 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.46 -31.3 54.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.3 tp -73.59 132.04 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -75.49 155.06 85.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -54.29 127.46 25.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.688 2.258 . . . . 0.0 112.294 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.58 4.1 87.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.457 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.0 168.83 51.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.0 t -127.0 139.18 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -111.8 132.66 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.94 131.23 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.21 123.94 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -150.28 128.98 12.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.04 -175.24 43.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.475 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 132' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.849 0.356 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.754 ' O ' HD23 ' A' ' 153' ' ' LEU . 5.4 tt -53.59 -44.0 69.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.99 -35.38 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.5 m -64.62 -41.74 95.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.24 -35.53 80.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.93 -33.77 70.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.0 p -78.27 -21.53 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -175.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.62 -22.4 56.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' CZ2' ' A' ' 165' ' ' TRP . 18.4 mt -105.36 102.85 39.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.679 0.752 . . . . 0.0 110.912 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.58 -27.76 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.788 2.325 . . . . 0.0 112.343 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.6 m -78.77 -17.07 56.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -165.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.639 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.9 pp -130.82 154.76 47.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.13 140.4 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.444 ' CZ2' HD12 ' A' ' 160' ' ' LEU . 99.1 m95 -85.08 126.24 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -172.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.86 -32.65 13.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.682 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.6 pt -140.1 146.73 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 153' ' ' LEU . . . -159.18 119.24 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 168.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -132.3 140.26 48.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.809 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -113.9 120.42 40.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.3 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -176.475 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.728 0.299 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.82 142.52 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.36 124.45 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -153.82 148.55 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -174.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.3 tt -140.03 129.73 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 -172.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -119.98 152.36 17.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.515 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.921 178.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.2 m0 59.1 45.04 15.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -115.01 160.05 20.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -127.47 149.96 49.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.09 144.98 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.776 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -157.02 165.06 37.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -155.04 169.93 22.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.52 169.95 8.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -159.94 140.06 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.85 128.7 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.65 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.9 p90 -163.64 162.67 24.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -130.22 136.76 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -138.34 149.25 45.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.93 172.41 42.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.64 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 88.7 m -124.3 129.56 50.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -119.76 96.23 49.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.702 0.763 . . . . 0.0 110.823 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.02 139.6 70.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.658 2.238 . . . . 0.0 112.355 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.414 ' H ' ' HH ' ' A' ' 52' ' ' TYR . 71.4 m-80 -129.5 170.22 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -129.96 165.15 22.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 52.55 39.44 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.7 -40.51 92.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 174.691 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.479 ' CD1' HD11 ' A' ' 128' ' ' ILE . 79.1 mt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.69 0.757 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.66 117.54 3.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.296 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -77.87 9.18 3.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.29 -101.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -99.95 133.6 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.703 0.287 . . . . 0.0 110.87 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.5 131.7 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.19 125.89 51.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.958 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.4 t -114.94 115.28 26.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 74.7 mt -88.37 58.11 4.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.05 105.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.088 -172.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 10.1 tm-20 -57.77 -59.74 4.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.09 34.85 90.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.469 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 62.06 18.34 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.946 0.403 . . . . 0.0 110.889 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.38 15.16 67.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.477 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -64.66 -49.63 70.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -79.36 -29.91 42.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.29 67.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.88 -33.97 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -61.15 -50.89 71.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 54' ' ' VAL . 95.4 mt -67.6 -36.82 81.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.47 82.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.159 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -70.59 -16.72 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -91.3 0.15 57.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.969 172.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.95 4.65 60.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.584 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.414 ' HH ' ' H ' ' A' ' 18' ' ' ASN . 20.6 m-85 -89.85 145.91 24.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -90.23 109.15 20.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.953 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.2 t -109.21 128.75 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -110.05 125.71 53.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.127 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.26 129.79 55.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 -172.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 134.68 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.83 160.55 41.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.836 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -80.6 -24.0 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -106.07 140.74 38.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -77.19 -28.01 53.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.88 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.04 -46.76 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.82 99.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.13 -37.08 84.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.0 110.882 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.57 90.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.39 -37.48 87.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -61.16 -43.2 99.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.085 175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -61.36 -46.45 90.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.59 -40.67 92.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.47 94.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.3 -38.17 90.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.84 -31.89 72.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.44 -8.22 45.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.923 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.8 34.18 56.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.437 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.8 160.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -104.38 130.81 52.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.86 165.33 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.3 m -119.43 133.82 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.4 p -120.73 132.75 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.12 122.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -88.51 116.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.3 t -173.35 141.49 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 88' ' ' PHE . 49.1 t30 -57.45 129.41 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.05 -35.08 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.916 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.32 68.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.079 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -99.83 -8.31 24.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ASN . 79.4 t80 -66.45 134.55 52.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.45 108.9 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.779 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.9 mt -81.4 122.16 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.7 t -94.31 138.74 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.15 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' GLY . . . -72.7 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -24.39 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.05 70.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -165.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.484 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 67.7 p-90 -149.55 161.28 42.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 45.8 mp0 -116.42 -35.46 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.73 147.89 16.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.484 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 15.9 tt -133.0 129.73 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.8 134.88 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -169.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -109.55 117.67 34.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.51 113.05 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.096 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 48.3 44.48 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.1 t -114.46 72.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -73.03 122.38 21.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.814 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.0 mt -131.59 151.76 79.24 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.565 0.698 . . . . 0.0 110.962 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.76 146.25 91.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.374 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -57.91 -33.33 68.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.0 m -61.28 -40.9 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.0 tp -72.31 -36.47 68.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -54.15 -46.61 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -65.86 -26.09 67.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.11 -38.2 32.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.19 -31.87 66.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.4 m-30 -53.09 -53.6 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.671 0.748 . . . . 0.0 110.956 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.7 Cg_endo -65.55 -31.28 50.94 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.698 2.265 . . . . 0.0 112.378 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.49 -42.67 82.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.94 -39.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.84 -53.66 52.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.54 -30.02 70.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' ALA . . . -80.16 -28.15 50.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.407 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.9 tp -78.84 131.75 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.2 mttt -78.92 153.08 77.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.634 0.73 . . . . 0.0 110.839 172.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.45 128.14 28.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.335 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.12 -3.59 86.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.457 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -71.62 171.89 46.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.431 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.23 142.52 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 163' ' ' LEU . 68.1 t80 -115.74 135.21 54.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 28' ' ' ILE . 84.5 mt -120.04 131.86 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.407 HD23 HD21 ' A' ' 190' ' ' LEU . 54.4 tp -128.82 126.59 40.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.961 169.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -151.91 142.65 22.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.33 -166.9 34.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.866 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.789 0.328 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.681 ' O ' HD23 ' A' ' 153' ' ' LEU . 4.8 tt -55.26 -46.78 76.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.58 -37.12 85.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.5 m -62.56 -42.02 99.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.84 -39.56 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.958 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -62.99 -37.75 88.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.2 p -82.98 -28.13 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -81.74 -14.36 56.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 160' ' ' LEU . 4.9 tt -107.71 102.19 43.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 0.0 110.899 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -89.12 -24.2 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.386 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.2 m -68.96 -25.28 64.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -164.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 127' ' ' PHE . 4.2 mp -123.06 145.89 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -95.31 136.75 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.73 124.88 35.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -165.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.1 mt -92.01 -35.93 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.5 pt -141.78 146.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.05 119.38 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -135.05 141.05 46.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -176.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -116.17 130.91 57.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 166.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.596 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.8 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 42.4 pt -120.81 142.73 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 169.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -142.21 126.96 18.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -146.72 148.57 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.721 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.8 tt -143.07 128.16 18.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.459 ' N ' HD23 ' A' ' 191' ' ' LEU . . . -122.2 154.7 16.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 176.074 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.722 0.296 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.05 44.99 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.86 140.23 37.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.11 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -133.93 145.02 49.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.1 165.06 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -150.9 169.79 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.65 170.02 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -159.42 140.04 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.81 134.94 18.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -153.71 169.29 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.74 132.73 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -145.19 165.04 29.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 147.25 21.27 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.777 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 92.0 m -116.48 129.02 55.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.633 0.254 . . . . 0.0 111.173 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -139.14 125.05 12.19 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.56 149.18 49.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -125.27 149.88 47.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.92 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -113.5 149.51 34.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 62.57 25.21 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.941 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.9 tt -64.52 -39.94 94.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.97 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.843 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 128' ' ' ILE . 89.7 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.637 0.732 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.96 108.37 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.315 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -78.27 18.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -167.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' HA3' ' OE1' ' A' ' 96' ' ' GLU . . . -84.59 -97.7 0.66 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -102.94 128.69 49.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.811 -171.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.2 127.99 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.089 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . 63.8 tp -106.66 123.36 48.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 t -111.44 116.79 31.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.16 60.21 5.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.99 105.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -67.07 -60.52 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -170.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.65 35.0 91.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 59.03 20.73 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.74 61.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.521 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -65.68 -46.4 79.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -77.57 -27.89 51.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.59 59.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.3 p -69.43 -29.18 66.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -64.83 -50.76 65.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.2 mt -65.27 -37.84 88.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.79 85.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -66.87 -20.17 65.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -89.63 0.44 56.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 94.92 5.0 61.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.474 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.88 143.88 27.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -90.02 106.85 18.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.896 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 47' ' ' LEU . 77.5 t -107.21 125.66 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.4 m -112.08 128.59 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 167.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.49 130.57 56.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.128 -174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 133.19 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -155.79 156.62 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -77.93 -27.78 49.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.039 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.0 p -96.03 149.62 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -168.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -80.11 -31.29 39.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.949 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.74 -48.19 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.51 98.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.574 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.62 -36.71 81.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.14 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.88 -37.3 81.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.72 99.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 174.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.18 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -68.41 -41.21 80.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.36 -40.51 96.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.16 96.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.51 -37.72 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -32.7 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.98 -7.28 49.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.69 59.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.89 163.77 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 111.165 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.24 131.35 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.43 170.19 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -123.93 130.66 52.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.5 p -121.92 134.35 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.87 123.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -85.86 114.37 22.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -173.6 143.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -55.4 133.23 49.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -57.77 -35.61 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 109' ' ' LEU . . . -71.62 -27.22 62.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.078 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -99.92 -11.92 20.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.23 135.02 52.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -93.19 112.63 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.501 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.4 mt -87.66 125.12 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.9 t -102.95 138.05 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.192 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 -61.13 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -168.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.42 -35.04 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.05 -38.97 65.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 34' ' ' LEU . 17.8 m-90 -132.28 154.83 49.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 122' ' ' LYS . 53.7 mt-10 -107.38 -43.56 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.52 149.87 18.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mm -113.91 123.93 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.28 129.47 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.5 m -115.51 118.23 32.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.6 mm -113.67 116.69 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.176 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 47.42 42.97 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.2 t -108.06 96.44 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -89.9 120.39 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.5 150.04 74.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.637 0.732 . . . . 0.0 110.926 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 144.32 88.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.285 . . . . 0.0 112.324 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -60.12 -40.3 89.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 37.1 tp -73.83 -33.38 64.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.937 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -56.38 -44.97 80.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -75.07 -30.23 60.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -69.98 -39.89 75.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.31 -34.83 68.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 115' ' ' PRO . 35.7 t80 -51.37 -48.92 84.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.917 -163.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 114' ' ' TYR . 98.0 Cg_exo -47.34 -46.09 20.78 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.386 176.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -76.81 -36.24 57.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.18 -47.13 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.23 -54.53 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.16 -30.45 71.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -84.91 -11.97 75.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.467 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.67 129.63 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 96' ' ' GLU . 83.8 tttt -67.91 139.9 93.52 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.857 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.5 127.61 18.71 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.722 2.282 . . . . 0.0 112.345 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.94 1.26 88.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.483 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -73.71 170.41 52.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.418 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.83 142.82 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.791 0.329 . . . . 0.0 111.206 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -109.59 128.27 55.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 28' ' ' ILE . 38.1 mm -118.5 131.67 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.139 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.526 HD23 HD21 ' A' ' 190' ' ' LEU . 58.4 tp -129.84 123.77 31.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 165.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -143.93 130.77 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.22 -167.38 30.13 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 176.558 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.859 0.361 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.6 tp -55.45 -44.81 76.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.95 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.1 -38.39 90.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.0 m -60.4 -37.08 79.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.19 -42.58 93.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.949 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -65.91 -36.23 82.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.1 p -78.18 -25.89 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -84.58 -13.77 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 tt -119.36 92.95 46.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.663 0.744 . . . . 0.0 110.946 -175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -89.53 -24.65 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 0.0 112.347 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.7 p -81.18 -15.36 55.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -162.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -114.51 140.03 49.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -86.35 132.85 33.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -92.29 114.48 27.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 191' ' ' LEU . 83.8 mt -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -175.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -138.61 145.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.37 113.73 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -129.11 139.19 52.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -118.41 128.76 54.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 175.273 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.697 0.284 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 44.2 pt -124.01 146.22 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.194 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -143.23 130.85 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -152.19 150.28 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.877 ' O ' HD23 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.73 129.77 23.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.0 141.59 16.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 174.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.756 0.312 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -164.79 142.75 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.05 159.99 40.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -123.89 119.42 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.83 148.11 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -126.39 154.93 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.7 p -153.52 169.96 21.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.07 40.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.8 p -156.79 164.42 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -126.06 146.86 49.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.61 164.98 23.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.0 134.96 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.059 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -149.29 164.96 33.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.46 163.09 11.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -121.06 102.13 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.95 69.88 35.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 0.0 110.902 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.14 155.14 42.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.743 2.295 . . . . 0.0 112.314 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.2 155.02 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.46 170.14 22.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -60.02 133.38 56.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.83 -32.34 20.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.009 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 179.695 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 126' ' ' VAL . 68.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.62 0.724 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.88 153.06 79.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.741 2.294 . . . . 0.0 112.277 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.31 12.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 -173.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.58 -143.4 7.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.524 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.01 144.47 30.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.695 0.283 . . . . 0.0 110.948 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.49 135.05 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 55' ' ' THR . 51.0 tp -105.57 126.03 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -106.42 124.9 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.57 133.24 39.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.06 53.76 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.059 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' H ' ' A' ' 41' ' ' GLY . 54.0 tp10 -90.16 123.33 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.14 16.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.425 -166.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -129.99 10.02 5.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 38' ' ' GLU . . . 75.01 22.05 77.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.76 -42.11 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -75.12 -29.15 60.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.845 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.43 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.55 -37.27 76.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -63.06 -47.34 83.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 54' ' ' VAL . 70.0 mt -63.54 -38.82 92.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.28 79.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -70.64 -20.51 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.844 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -87.58 0.12 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.74 7.66 58.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -83.96 145.0 28.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.17 112.61 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 165.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 47' ' ' LEU . 89.9 t -111.44 135.72 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 34' ' ' LEU . 97.5 m -107.75 125.34 51.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 165.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.98 133.92 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.079 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.33 129.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 59' ' ' GLN . 49.5 t0 -154.5 153.24 31.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.424 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 92.4 mt-30 -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 174.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.3 t -95.67 115.45 27.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.83 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.0 p -69.07 -33.71 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.02 -31.37 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.78 -41.64 97.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.54 169.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.78 -35.04 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.29 88.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -64.29 -38.79 92.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.972 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.63 91.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.01 -43.16 99.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.1 -40.14 92.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -33.91 77.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.9 -10.99 34.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.92 66.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.416 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.39 161.7 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.169 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -97.37 129.97 44.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 pt -137.08 163.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.143 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.0 m -121.65 134.08 54.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.5 p -119.17 133.05 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.91 122.38 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -85.12 118.79 24.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 t -174.53 143.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.29 128.16 35.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.31 -38.59 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.33 -32.56 74.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -97.78 -6.37 32.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.99 129.89 42.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.9 114.93 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.879 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.426 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -93.76 117.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.191 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -83.69 136.23 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.051 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.39 -49.51 54.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -56.92 -26.09 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.74 80.6 9.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -69.86 130.14 41.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -173.14 150.81 1.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.49 163.33 46.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.473 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.6 mm -114.84 117.89 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.45 124.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.7 m -112.6 115.03 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.46 123.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 102' ' ' PHE . 53.8 t80 43.19 49.83 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.1 m -97.27 79.02 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -75.46 114.8 14.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.8 pp -152.04 152.71 30.24 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.618 0.723 . . . . 0.0 110.821 -169.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.85 149.74 78.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -58.1 -29.77 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -59.2 -35.96 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 105' ' ' LEU . 49.7 tp -69.87 -36.9 75.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.85 -28.02 69.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -82.43 -39.93 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.55 -32.56 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 m-30 -54.73 -55.23 40.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.715 0.769 . . . . 0.0 110.94 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 29.4 Cg_endo -61.69 -34.01 84.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.314 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -68.63 -46.42 69.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.94 -31.61 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -69.2 -57.11 5.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.71 -34.04 69.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -68.26 -31.12 74.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.696 HD11 ' HA3' ' A' ' 125' ' ' GLY . 57.7 tp -86.2 128.84 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.892 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.87 159.56 68.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.524 0.678 . . . . 0.0 110.911 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.04 133.53 46.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.44 48.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.696 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -75.54 168.3 54.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' A' ' 28' ' ' ILE . 96.1 t -131.95 140.16 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -106.46 131.88 53.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.7 134.4 66.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.19 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 59.6 tp -127.19 127.18 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 172.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.84 139.74 15.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.08 30.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.539 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.435 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 72.9 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.902 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.876 0.369 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 168' ' ' ALA . 3.3 pp -48.2 -30.78 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 96.6 mt-10 -65.1 -36.51 84.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.1 p -75.15 -31.84 61.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 156' ' ' LEU . 10.1 tt -64.2 -45.17 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 4.4 pt20 -66.46 -28.22 68.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.3 p -73.18 -16.09 61.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -78.97 -13.27 59.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.71 108.25 61.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.674 0.749 . . . . 0.0 110.947 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.4 -20.67 3.92 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.763 2.309 . . . . 0.0 112.309 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.5 p -71.66 -24.67 61.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -159.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.7 pp -143.2 168.1 20.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -104.94 144.61 31.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -96.56 128.66 43.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -88.72 -31.67 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -172.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 190' ' ' LEU . 43.3 pt -138.27 147.83 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.087 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -146.55 117.64 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 166.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -130.02 140.02 50.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -103.87 122.66 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 49.5 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -170.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.1 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.7 0.286 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 44.7 pt -114.11 142.48 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -135.25 123.06 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.72 147.65 26.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 191' ' ' LEU . 9.9 tt -139.74 129.89 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.25 147.6 18.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.461 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.882 -179.414 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -155.03 166.8 32.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.937 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -162.0 160.07 27.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -129.9 149.97 51.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -159.22 129.01 5.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.99 168.11 28.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 t -151.66 139.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.1 160.0 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -165.79 137.26 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.884 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -161.7 164.61 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.75 163.45 39.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.63 80.51 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.17 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.35 172.38 7.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.32 176.48 22.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -153.8 154.95 34.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.694 0.283 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.92 149.16 62.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.79 154.39 48.71 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.33 156.13 43.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.65 105.61 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.39 110.82 22.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.0 tp -70.12 -51.18 33.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 189' ' ' GLN . 49.0 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.6 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.605 0.716 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.41 131.32 27.26 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 0.0 112.335 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 84.4 mt-30 -75.91 13.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.947 -176.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.17 155.05 26.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 61.86 68.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 110.859 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 52' ' ' TYR . 47.7 mm -115.01 126.51 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.42 120.71 43.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.5 t -108.49 125.94 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.6 mt -108.63 135.45 49.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.11 45.77 25.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CD ' ' HB1' ' A' ' 56' ' ' ALA . 19.8 pm0 -71.45 -18.33 62.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 -175.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.18 -66.95 3.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -130.33 11.61 5.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 82.98 5.24 89.51 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.507 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -64.86 -36.94 85.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.938 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.51 88.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.6 m -68.46 -38.38 81.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.845 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -58.47 -51.95 67.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.1 mt -59.71 -40.06 86.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.29 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.073 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.1 p -69.75 -17.83 63.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.87 1.06 41.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.77 4.61 65.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.498 ' HB3' HG13 ' A' ' 33' ' ' ILE . 10.1 m-30 -74.12 147.0 43.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 0.0 111.004 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -84.98 101.96 12.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.856 166.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.22 124.5 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -165.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.6 m -112.28 126.06 54.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 165.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HB1' ' CD ' ' A' ' 38' ' ' GLU . . . -110.05 126.61 54.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.24 128.33 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -176.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.23 155.92 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -78.99 -20.02 50.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -93.67 110.96 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 94.3 p -67.81 -34.85 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.85 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.43 -30.92 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.92 97.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.42 -36.53 81.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.871 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.74 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.25 -38.62 91.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 173.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.65 -43.33 93.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.86 -44.72 96.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -66.82 -41.13 87.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.35 -41.07 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.35 93.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.158 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.81 -39.21 93.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.92 -32.87 73.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.948 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.82 -10.1 41.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.57 32.98 58.92 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.499 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.79 160.1 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.23 137.68 45.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.972 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.77 164.19 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -119.21 133.5 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.6 p -118.49 135.01 54.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.147 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.0 t -128.08 119.96 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -84.09 113.63 21.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -173.04 143.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -54.86 124.06 15.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.29 -37.35 67.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -32.08 72.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.75 -8.18 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.85 127.21 30.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.978 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.21 114.93 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 pt -126.58 141.82 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.089 168.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.91 -179.8 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.46 -34.11 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -173.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -29.23 70.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.0 94.54 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.074 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 122' ' ' LYS . 41.7 m0 -89.89 104.84 17.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.945 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.92 126.08 15.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.86 158.7 36.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -112.12 118.7 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.129 -171.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.1 t -121.37 124.34 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 103' ' ' CYS . 58.8 m -130.1 108.44 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.9 mm -114.53 125.67 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.159 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 48.61 40.26 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -171.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 100' ' ' SER . 87.1 m -118.67 82.13 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.892 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.1 130.98 34.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.9 mt -121.1 146.96 45.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.2 Cg_endo -67.67 147.6 76.26 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.604 2.203 . . . . 0.0 112.389 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -54.23 -40.25 67.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.913 -172.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.3 m -60.49 -38.91 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 109' ' ' LEU . 3.6 tt -71.91 -39.98 69.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -59.71 -40.24 87.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.59 -29.42 70.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -83.62 -39.82 19.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.9 tp -72.15 -41.62 66.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.576 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 3.2 m-30 -55.37 -49.51 92.07 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.667 0.746 . . . . 0.0 110.951 -165.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 96.4 Cg_exo -47.32 -39.36 27.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.98 -47.89 19.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.38 -25.21 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -64.95 -47.67 76.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 175.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.9 -24.91 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.9 59.94 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.486 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -81.93 153.07 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 63.9 pttt -75.43 155.84 85.54 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.524 0.678 . . . . 0.0 110.895 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -56.22 122.7 12.25 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.64 -1.69 81.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.491 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.92 177.01 48.55 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.7 t -129.31 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.141 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -107.22 129.0 54.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.92 123.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 190' ' ' LEU . 63.2 tp -131.63 127.08 36.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 166.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -157.14 140.06 15.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.97 -178.59 35.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 175.707 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.9 tp -52.89 -46.81 68.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.63 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.4 m -63.37 -40.47 97.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.8 mt -59.81 -39.95 86.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -64.0 -34.25 77.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -81.88 -25.01 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -77.58 -15.47 59.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.88 98.28 28.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.51 -28.33 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.278 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 92.0 p -73.55 -20.69 60.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.785 -163.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.4 pp -134.12 159.11 41.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -103.42 139.72 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -88.16 124.9 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.26 -31.74 14.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.665 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -140.17 146.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.29 117.42 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -139.11 146.75 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -113.72 129.98 56.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 168.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.792 0.33 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.71 142.68 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.43 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.6 pt20 -143.19 128.13 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.71 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.61 147.57 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.665 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.7 tt -139.75 127.19 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -174.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -112.06 141.83 16.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.441 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.872 177.619 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mmm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.05 165.02 38.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -160.93 160.01 30.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.954 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -158.78 128.42 5.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.974 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.96 168.73 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -149.69 139.08 21.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.0 160.0 38.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.9 t -161.95 139.96 8.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.827 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -160.86 160.88 31.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -153.71 129.97 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.921 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -120.5 125.05 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -159.99 134.95 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.19 -175.91 40.96 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 t -153.9 155.04 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.99 148.08 58.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.752 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 155.04 47.92 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -129.9 160.02 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.806 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -141.76 99.85 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.39 132.57 44.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.56 -44.09 75.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 189' ' ' GLN . 67.9 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.579 0.705 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -39.31 125.05 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.347 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -60.06 -5.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.903 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.28 -174.56 17.62 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' TRP . 72.0 mmtt 64.98 65.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.58 131.8 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 58.9 tp -104.35 119.85 39.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 174.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -105.89 122.5 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.04 127.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -171.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 62.73 50.09 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 20.0 pm0 -75.61 -19.19 59.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.29 -70.06 3.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.493 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.54 -4.03 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.4 12.77 64.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.455 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.71 -37.41 84.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -67.29 -41.06 86.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.14 90.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.4 m -72.37 -34.2 67.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.62 -51.73 68.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.952 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.01 -35.82 80.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.18 86.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -71.07 -20.67 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.02 2.77 51.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.81 4.86 61.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -82.92 137.84 34.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 111.006 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -87.81 110.11 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.99 130.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 -170.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.6 m -102.9 125.01 49.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 163.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.29 124.41 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 -170.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.85 126.79 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.111 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -157.17 154.68 29.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -79.26 -19.99 49.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.961 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -93.67 111.61 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.828 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 96.1 p -67.36 -33.95 76.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.1 -31.29 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.042 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.68 -39.73 97.83 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 170.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.37 -34.64 76.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.14 82.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -62.5 -39.88 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.771 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.28 -41.66 97.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.061 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.93 -44.53 95.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -40.78 90.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 81.8 mt -61.71 -40.52 95.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.83 96.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.41 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.26 -34.09 76.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.84 -9.5 43.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.44 33.97 63.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.412 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.23 160.72 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.158 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -105.37 132.31 51.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.965 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.78 160.88 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.07 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -116.7 134.01 55.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.2 p -123.51 140.99 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 80.1 t -132.7 122.76 47.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.6 tm0? -83.37 116.91 22.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -174.83 145.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -55.18 123.17 12.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.901 172.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 113' ' ' LEU . 50.0 tp -55.78 -36.88 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.909 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -34.4 77.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.84 -7.22 27.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.29 134.8 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.948 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.37 111.29 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.8 mt -94.87 120.44 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.6 131.59 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.04 -43.59 33.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.12 -20.59 59.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.848 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.33 125.18 30.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 82.7 m95 -75.18 94.95 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 98.6 mt-10 -149.95 123.71 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 170.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.64 53.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.53 115.99 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 -172.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.96 129.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -135.04 112.67 10.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.424 HG22 ' CD2' ' A' ' 102' ' ' PHE . 25.6 mm -115.81 130.95 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 101' ' ' ILE . 71.3 m-85 53.51 44.87 29.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -173.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -117.07 85.67 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -80.79 121.6 26.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.3 pp -142.92 153.58 60.95 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.588 0.709 . . . . 0.0 110.966 -174.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.15 153.95 46.58 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 0.0 112.333 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -59.52 -33.24 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -60.13 -32.32 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 105' ' ' LEU . 52.8 tp -74.13 -39.31 63.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -56.4 -42.68 78.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.02 -32.23 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -78.9 -40.49 32.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' HG ' ' A' ' 85' ' ' LEU . 63.4 mt -73.73 -40.1 63.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.894 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.8 m-30 -53.55 -51.17 78.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.691 0.758 . . . . 0.0 110.877 -164.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 89.9 Cg_exo -46.94 -43.39 24.42 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 174.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.88 -45.99 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.6 -30.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -170.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -63.88 -51.18 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -71.68 -25.99 62.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.947 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.31 -52.61 51.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.404 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -81.31 153.97 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -88.88 155.87 49.88 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 110.923 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.01 130.17 26.88 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.772 2.315 . . . . 0.0 112.334 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.08 77.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.451 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.68 175.46 47.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.518 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.64 139.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -109.69 127.87 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.9 mt -122.44 128.37 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.035 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tt -134.34 128.3 33.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -155.55 139.97 16.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.54 -174.48 34.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 176.04 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.25 -45.39 87.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -34.98 79.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.8 m -64.84 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.158 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.95 -51.11 71.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.13 -31.82 69.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.7 p -75.56 -24.2 56.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 161' ' ' PRO . 97.3 mt-10 -83.82 -2.08 55.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.9 mt -104.47 95.11 7.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.597 0.713 . . . . 0.0 110.986 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 66.2 Cg_endo -83.14 -31.52 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.655 2.237 . . . . 0.0 112.277 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.7 p -75.81 -17.05 59.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.786 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.5 pp -132.01 162.06 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 -176.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -107.63 130.56 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.862 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -87.27 134.8 33.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -170.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.42 -30.09 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' HB3' ' A' ' 191' ' ' LEU . 59.8 mt -129.91 138.47 53.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -170.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.06 111.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.078 162.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -138.31 145.91 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.16 129.93 56.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 170.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 171' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.96 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.752 0.311 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.2 pt -120.03 143.72 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.417 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.5 pt20 -138.16 134.36 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.918 174.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 190' ' ' LEU . 2.4 pt? -152.11 150.54 30.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.74 ' HB3' HD12 ' A' ' 167' ' ' ILE . 3.5 tt -139.93 129.68 24.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -112.75 146.64 18.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.497 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.836 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -154.94 165.03 37.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -144.97 -175.79 4.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.825 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -162.15 163.57 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -137.05 166.88 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -150.59 126.0 10.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -107.79 168.14 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -125.03 154.94 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -159.94 170.0 22.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -160.79 160.48 31.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.0 168.59 26.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.22 160.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 53.4 p90 -163.45 149.95 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.89 172.07 42.14 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.403 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -156.65 -174.93 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.77 151.49 42.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.674 0.749 . . . . 0.0 110.937 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.57 123.07 11.17 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.58 2.187 . . . . 0.0 112.309 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -143.03 -164.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -84.95 -170.07 2.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.72 142.93 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.35 -49.33 64.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -179.41 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.608 0.718 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.8 133.13 55.99 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.613 2.209 . . . . 0.0 112.375 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.16 -2.65 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -78.06 -145.81 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.407 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.03 141.0 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.827 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.32 134.02 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 tp -102.38 121.89 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.33 113.99 25.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 64.3 mt -90.95 59.25 4.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -172.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.01 -60.26 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.53 39.06 95.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 171.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 60.98 19.73 10.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.82 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.85 15.62 67.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.437 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.95 -46.1 82.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 -172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.23 -40.09 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.02 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.041 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.7 m -65.51 -38.38 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.58 -51.64 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.71 -35.07 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.23 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.062 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 p -63.13 -13.99 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.24 -5.91 55.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 97.38 -6.39 63.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -102.41 148.19 25.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.04 117.71 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.37 147.5 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -114.39 130.56 56.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.91 129.95 56.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.1 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 81' ' ' VAL . 49.3 t -117.29 132.47 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -159.74 162.52 34.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.07 -28.8 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -86.52 109.56 19.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -171.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.491 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 91.3 p -69.2 -36.25 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.85 -33.37 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.77 96.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.4 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.07 -34.89 79.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.55 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.95 -36.18 82.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.17 96.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.17 -42.48 98.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.0 -40.76 95.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.9 -41.35 97.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.73 95.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -64.2 -38.54 91.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.8 -33.55 75.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.4 -9.08 42.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.75 59.38 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.438 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.98 159.99 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.125 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -101.74 130.72 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.43 159.95 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.1 m -117.99 133.3 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -121.73 137.09 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 57' ' ' VAL . 96.1 t -127.84 119.88 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.13 173.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.0 tm0? -85.09 114.42 22.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.866 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -173.41 145.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -58.41 125.22 22.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.93 -33.29 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.04 77.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -97.14 -8.54 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.49 132.4 49.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.75 111.91 23.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.5 HG22 ' HA3' ' A' ' 120' ' ' GLY . 89.9 mt -85.12 114.76 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.3 134.34 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -170.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.6 40.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.57 -22.56 56.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.835 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.37 92.54 7.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CZ3' ' HA3' ' A' ' 31' ' ' GLY . 87.9 t90 -69.8 117.64 11.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -172.96 159.74 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.25 167.86 49.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.414 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.22 125.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.118 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.49 125.81 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.2 t -116.52 113.63 23.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.68 117.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 45.1 54.97 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 74.3 m -105.03 92.07 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -82.71 120.09 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.0 pp -156.14 150.88 20.46 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.991 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.1 149.48 89.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.76 2.307 . . . . 0.0 112.43 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -57.7 -29.71 64.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 -38.11 71.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 105' ' ' LEU . 25.7 tp -77.19 -35.96 55.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -54.59 -43.66 72.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.97 -24.64 67.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -85.09 -37.61 20.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.49 -35.84 68.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.931 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.0 m-85 -55.02 -52.66 69.19 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 0.0 110.926 -171.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.2 Cg_endo -65.23 -27.74 56.07 Favored 'Trans proline' 0 N--CA 1.466 -0.129 0 C-N-CA 122.739 2.293 . . . . 0.0 112.361 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -70.43 -39.11 74.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.791 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.7 -40.65 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.05 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.67 -57.25 10.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.47 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.5 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -72.18 -40.7 55.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.528 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.3 tp -79.78 121.06 24.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.394 . . . . 0.0 110.876 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -80.01 153.76 74.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 110.888 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.91 129.9 35.16 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.342 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.32 -1.4 64.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.416 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.554 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -81.75 170.28 51.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 164.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.5 t -125.16 141.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -106.65 129.36 54.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 169.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.43 129.61 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt -126.8 130.07 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.99 132.58 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.49 -168.6 32.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.453 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.975 178.277 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.53 -49.48 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.912 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.56 -33.11 74.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 53.5 m -71.57 -56.99 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.08 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.57 -20.65 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.601 ' N ' HD13 ' A' ' 156' ' ' LEU . 10.4 pt20 -75.72 -33.34 60.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -78.53 -19.26 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -84.43 -14.57 48.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.25 109.87 63.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.81 -20.28 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.356 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.3 p -61.63 -29.04 69.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -158.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.705 HD11 ' HA3' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -148.14 164.14 34.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -174.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLN . 96.6 m-20 -92.58 148.02 22.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -89.65 128.43 36.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.55 -33.8 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.9 pt -139.3 146.99 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.06 116.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -145.01 148.53 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -109.91 133.11 53.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -174.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.792 0.329 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.58 143.45 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -149.01 136.2 20.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.653 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.8 pt? -155.72 150.02 25.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 167' ' ' ILE . 6.4 tt -140.66 131.37 25.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.934 -169.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 163' ' ' LEU . . . -84.96 173.77 49.09 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 -172.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 164' ' ' ASN . 66.5 tt0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -124.9 -74.99 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -162.0 160.82 28.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -126.01 154.67 42.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -151.76 130.07 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -160.47 165.04 31.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -157.42 169.94 23.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -159.94 132.77 6.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.4 p -156.9 168.02 28.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.81 134.96 15.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.866 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -155.86 167.26 30.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.0 160.71 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -162.27 165.24 26.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.06 176.75 24.24 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.579 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 17' ' ' PRO . 85.7 m -125.08 119.51 28.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -125.42 77.76 68.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.654 0.74 . . . . 0.0 110.932 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.665 ' HD3' HG22 ' A' ' 15' ' ' THR . 73.5 Cg_endo -76.62 153.54 34.34 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.651 2.234 . . . . 0.0 112.429 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -77.35 157.19 30.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.12 -35.98 70.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -113.81 152.51 30.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.82 -55.2 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -169.571 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.64 0.733 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.18 144.77 82.51 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -75.51 11.22 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -170.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.18 -130.37 3.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.53 139.31 32.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -174.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 81.8 mt -124.22 131.79 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 173.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 tp -106.91 120.28 41.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -105.63 127.04 52.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.7 120.8 40.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . . . 55.48 54.61 8.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 pm0 -70.23 -17.71 63.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 -172.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 -111.54 4.26 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.66 -41.5 70.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 110.904 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.59 13.88 62.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.447 176.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -65.83 -35.06 79.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.81 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.51 -33.07 72.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.92 97.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.8 m -65.82 -35.89 81.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -62.61 -44.51 96.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.56 -43.0 99.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.906 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.81 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.5 p -71.02 -20.26 62.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.878 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.2 mt -85.68 -1.59 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.41 8.59 59.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.51 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.78 147.69 35.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.33 105.05 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.82 120.73 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -165.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.8 m -117.44 124.95 50.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.26 131.87 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.157 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.02 134.83 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -155.31 157.21 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.28 -20.09 41.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.0 t -93.13 111.38 23.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.7 p -67.8 -34.41 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.29 -31.35 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.105 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.26 98.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.92 -38.09 89.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.74 86.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.132 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.81 -39.98 94.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -63.16 -41.88 99.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.33 -43.28 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.7 -45.5 93.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.06 -41.3 98.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.87 93.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -64.56 -38.92 92.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.79 -31.79 69.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.21 -8.3 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.19 56.05 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.469 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.66 160.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.348 . . . . 0.0 111.195 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.85 135.5 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.866 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.4 pt -137.32 160.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -108.55 135.4 49.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.3 p -117.65 135.62 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.97 122.78 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -87.45 111.44 21.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.954 172.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -172.93 143.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -59.51 125.67 24.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 171.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.46 -36.38 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.5 -31.48 68.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -100.06 -9.23 22.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -89.79 112.22 23.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -98.59 115.75 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.29 139.36 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.25 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.76 -23.79 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.922 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -52.38 10.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.79 139.82 32.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -164.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -126.72 166.47 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 42.73 71.05 0.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.482 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -92.73 130.47 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.08 130.39 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -173.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.4 t -103.71 118.09 35.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.01 115.03 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -169.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 61.6 m-85 47.38 48.81 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 88.8 m -99.61 74.04 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.874 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -76.7 114.96 16.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -153.48 153.38 29.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.517 0.675 . . . . 0.0 110.952 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 149.56 89.14 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.7 p -57.79 -30.57 65.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.812 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.6 p -62.77 -31.28 72.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.1 -35.53 66.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -55.16 -39.93 70.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.764 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -63.18 -30.86 71.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -82.77 -35.68 26.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -73.51 -41.55 62.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 8.3 m-30 -55.01 -48.06 96.96 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.71 0.767 . . . . 0.0 110.907 -164.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 84.8 Cg_exo -49.82 -41.75 45.99 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.254 . . . . 0.0 112.353 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -78.67 -46.03 20.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 77.9 t -73.31 -54.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.035 -165.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -80.04 -38.66 31.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 -168.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -69.15 -30.13 68.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -70.92 -14.85 73.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.27 124.33 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.07 139.78 97.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 0.0 110.9 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.27 130.37 32.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.92 -1.52 85.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.425 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.82 178.65 51.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.462 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.06 147.04 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -112.98 133.45 54.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mp -121.97 135.52 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 190' ' ' LEU . 47.3 tp -121.17 129.35 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 171.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -157.54 134.18 9.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 172.81 -171.67 44.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.513 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -177.458 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.619 ' N ' ' HG1' ' A' ' 155' ' ' THR . 61.2 mmtt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.821 0.343 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 156' ' ' LEU . 45.6 tp -49.48 -40.45 37.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 171.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.95 -30.74 71.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.619 ' HG1' ' N ' ' A' ' 152' ' ' LYS . 95.7 m -66.5 -60.24 2.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -171.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.076 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.43 -16.5 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -177.032 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.603 ' N ' HD22 ' A' ' 156' ' ' LEU . 65.0 tt0 -66.18 -40.91 90.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 170.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.9 p -79.25 -17.81 54.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.792 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.84 -13.3 60.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 163' ' ' LEU . 65.9 tp -104.58 107.46 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.624 0.726 . . . . 0.0 110.946 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.13 -29.64 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.705 2.27 . . . . 0.0 112.293 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -80.45 -22.53 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -160.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 160' ' ' LEU . 98.4 mt -123.43 150.73 43.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -174.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -94.54 139.61 30.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 98.5 m95 -93.49 126.94 38.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.3 mt -93.47 -31.05 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.653 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.7 pt -138.06 148.47 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.19 122.59 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -128.92 134.88 48.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -117.08 119.95 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.7 pp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.767 0.318 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -125.65 144.66 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.94 134.19 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -154.51 152.55 30.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.653 ' HB3' HG12 ' A' ' 167' ' ' ILE . 1.5 tt -138.17 130.59 29.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.6 171.21 52.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.538 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -169.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.747 0.308 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -155.02 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.961 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -159.87 159.95 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.24 133.46 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.51 144.93 51.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.961 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -167.77 165.03 14.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -159.53 169.95 22.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.839 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.0 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -158.98 168.14 27.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.27 162.31 25.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -149.98 125.09 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.7 t -120.6 110.88 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.148 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -163.97 139.87 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.35 171.15 43.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -129.46 170.47 13.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -124.63 147.84 57.1 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.658 0.742 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.44 154.51 71.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -147.53 178.43 8.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -164.29 161.79 22.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -67.2 143.88 56.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.836 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 95.7 mt -81.88 -47.68 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -103.23 -82.32 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -125.77 -46.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 162.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.18 19.43 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.836 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -65.14 -6.71 9.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.094 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -61.89 -5.82 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.43 -2.43 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.3 132.97 91.4 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 111.105 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.98 146.93 88.68 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.65 2.233 . . . . 0.0 112.373 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 pm0 -74.49 3.15 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -148.83 7.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.6 mttt -74.99 129.99 38.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.683 0.278 . . . . 0.0 110.968 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.61 129.07 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.101 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.06 120.56 40.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.32 124.44 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.936 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.0 mt -109.93 139.41 45.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -170.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.01 50.52 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 171.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -89.9 -21.43 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.1 -65.53 4.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.486 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -114.8 -27.92 7.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.92 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.26 31.37 55.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.548 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -65.68 -45.18 83.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.906 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -71.86 -27.41 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.98 87.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.131 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.8 m -67.82 -34.62 77.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.02 -45.56 90.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.78 -38.39 90.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.62 79.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.19 -15.62 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -83.97 -1.45 54.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.868 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.87 2.51 62.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 4.6 m-30 -78.68 145.34 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.32 106.65 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.23 125.61 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 -168.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.4 m -109.47 126.64 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.85 127.33 56.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 81' ' ' VAL . 69.2 t -121.38 131.91 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.98 159.31 40.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -81.7 -21.44 38.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -93.8 114.08 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -67.16 -34.56 77.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.97 -31.66 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.194 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.66 97.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.17 -35.98 81.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.756 0.313 . . . . 0.0 110.915 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.75 80.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 -38.75 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.21 -43.72 90.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -62.33 -44.81 95.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.15 -42.24 94.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.76 96.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.39 -40.02 96.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.955 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.96 -30.08 70.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.89 -6.55 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.93 33.71 59.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.478 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.72 162.23 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 0.0 111.096 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -96.57 137.17 36.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.92 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 tt -137.25 150.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -111.7 135.24 52.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.3 p -123.2 135.19 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.119 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 57' ' ' VAL . 90.0 t -130.83 123.79 55.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.119 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -85.39 116.08 23.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -171.33 142.22 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -65.59 131.49 46.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 169.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 113' ' ' LEU . 87.1 mt -59.52 -28.83 67.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.954 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 -30.81 68.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -103.35 -11.24 18.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.18 131.02 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -96.74 112.71 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.824 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.1 mt -94.19 119.86 42.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.48 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.144 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.38 93.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.81 -28.5 67.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.66 83.06 3.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.63 95.78 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -135.15 129.72 34.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 175.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -61.1 159.26 28.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.494 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.757 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.8 mm -109.93 117.03 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.49 127.42 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.406 ' CB ' HH22 ' A' ' 110' ' ' ARG . 64.1 m -115.4 115.87 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.49 120.94 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.16 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 41.33 54.82 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 71.3 m -101.57 95.4 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.902 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -75.24 110.44 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -156.38 151.98 22.2 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.558 0.694 . . . . 0.0 110.952 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.52 145.1 81.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.609 2.206 . . . . 0.0 112.385 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -58.08 -29.21 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.1 p -60.43 -30.85 69.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.7 tp -70.14 -40.84 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.406 HH22 ' CB ' ' A' ' 100' ' ' SER . 41.4 mmt180 -58.49 -40.31 82.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.29 -31.45 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -81.2 -36.07 30.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 85' ' ' LEU . 81.8 mt -70.42 -32.78 70.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.559 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.6 m-30 -50.76 -55.15 29.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.683 0.754 . . . . 0.0 110.891 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 36.0 Cg_endo -63.86 -32.78 66.21 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.09 -51.29 59.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.757 ' HB ' HG13 ' A' ' 98' ' ' ILE . 34.1 m -75.43 -31.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.104 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.11 -53.04 51.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.42 -33.38 75.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.51 -47.8 60.59 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.442 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 48.9 tp -89.59 138.98 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.942 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -62.07 151.82 79.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.898 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.95 138.94 51.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.24 3.22 82.37 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.505 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.442 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -73.0 172.88 49.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.513 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 194' ' ' LYS . 2.7 p -127.64 140.09 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 111.154 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -111.1 136.46 50.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.419 ' CD1' HD12 ' A' ' 191' ' ' LEU . 35.3 mm -120.66 128.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt -129.98 125.73 36.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -146.68 130.36 16.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 144.84 -172.2 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -63.32 157.4 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 188' ' ' ILE . . . -96.7 153.99 38.55 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.516 0.675 . . . . 0.0 111.175 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.56 -28.89 23.2 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.658 2.239 . . . . 0.0 112.318 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -54.68 -17.88 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -57.39 -17.99 15.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.964 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.842 HD13 ' HD3' ' A' ' 144' ' ' PRO . 44.2 mt -60.63 -25.53 66.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -63.24 -15.88 58.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CE1' ' HA3' ' A' ' 183' ' ' GLY . 90.0 t80 -62.43 -50.32 71.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.33 -45.53 2.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -162.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.5 p -118.01 -22.78 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -162.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.29 -3.07 68.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.39 172.18 14.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.47 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.842 ' HD3' HD13 ' A' ' 137' ' ' LEU . 60.9 Cg_endo -73.29 -43.11 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.723 2.282 . . . . 0.0 112.312 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.55 -20.03 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 150.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -168.54 136.18 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.7 tt -53.07 -27.65 21.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -65.48 -20.5 66.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -81.39 -9.95 59.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.52 132.48 38.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 110.879 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.35 130.99 7.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.305 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -78.24 161.21 27.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 163.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.36 -31.18 71.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.13 -37.14 86.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 84.5 m -65.99 -45.23 82.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.53 -46.32 83.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -70.14 -26.83 64.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 94.5 p -83.87 -27.64 28.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.88 -9.39 58.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.68 105.42 56.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.624 0.726 . . . . 0.0 110.866 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.46 -21.88 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.331 -170.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 94.8 p -65.23 -23.52 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.943 -159.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.591 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.5 pp -141.18 163.1 33.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.07 145.9 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.52 131.55 40.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -95.62 -33.99 12.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 191' ' ' LEU . 46.1 pt -139.51 143.32 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.207 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 121.71 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -138.14 139.71 39.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -100.65 121.92 42.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 165.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.5 mt -109.37 145.91 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -106.8 123.5 48.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -157.06 152.09 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.95 138.25 58.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.3 125.79 27.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -74.16 149.41 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.26 39.4 28.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.68 -164.27 32.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.42 172.98 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 111.105 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -51.9 -45.26 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -64.44 136.83 57.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -60.2 170.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.436 ' HA3' ' CE1' ' A' ' 139' ' ' TYR . . . 175.02 115.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.432 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -74.12 158.01 34.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.882 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.7 152.28 36.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.88 138.6 32.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.81 143.27 46.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 133' ' ' ALA . 92.3 mt -113.03 127.94 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.94 123.98 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 171.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.5 pt? -153.78 151.62 29.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.671 ' O ' HD23 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.91 130.77 24.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.883 -173.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.48 169.34 50.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.527 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -90.87 126.86 36.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 126' ' ' VAL . 53.9 tttm -106.25 113.39 26.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 171.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.1 mt -99.81 137.61 38.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.945 162.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -41.66 129.98 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' A' ' 197' ' ' HIS . 85.3 t60 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.6 p-90 -155.03 175.22 14.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -159.99 160.0 32.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -153.21 133.82 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.834 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -106.88 144.86 32.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.94 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.76 165.01 14.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.8 p -157.85 169.99 23.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.05 160.0 40.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.84 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -156.9 165.34 36.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -163.12 160.08 23.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -150.08 124.97 9.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.93 112.77 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.089 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -162.74 135.11 5.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.41 -165.29 36.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -125.03 174.42 8.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.108 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -125.48 152.21 71.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.8 148.46 90.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' HD22 ' A' ' 50' ' ' LEU . 29.5 p30 -126.79 -170.14 2.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -162.64 158.84 23.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -75.3 144.98 42.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.86 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 93.1 mt -73.87 -43.2 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 170.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -116.39 -82.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.136 -167.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.3 p -129.45 -36.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 161.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG23 HD13 ' A' ' 191' ' ' LEU . 23.3 m -124.67 6.6 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -66.18 -5.73 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -66.56 -0.01 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 168.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 24' ' ' VAL . 89.0 mm-40 -88.58 -0.33 57.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 171.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.63 130.2 82.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 111.139 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 147.47 74.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.398 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 18.7 pm0 -76.31 13.87 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.32 -135.59 2.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.3 mttt -96.23 131.44 42.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.694 0.283 . . . . 0.0 110.842 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 52' ' ' TYR . 4.8 mp -123.42 131.67 72.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.8 tp -102.42 122.26 43.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.943 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -111.67 122.96 49.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.0 mt -107.22 131.95 53.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -168.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.95 52.53 11.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.03 -19.75 24.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.88 -64.89 4.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.542 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -115.64 -33.08 5.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.87 44.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.516 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.07 -43.14 88.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.908 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.69 -29.39 66.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 54' ' ' VAL . . . -63.29 -46.24 87.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.2 m -64.33 -35.47 80.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.98 -43.79 98.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.836 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.52 -42.96 93.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.86 -35.08 74.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.6 p -68.72 -15.64 63.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 18' ' ' ASN . 56.0 mt -85.58 0.05 53.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.72 63.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.553 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.45 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 2.5 m-30 -77.79 147.51 35.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.946 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -92.82 104.44 16.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.975 171.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG11 ' HB1' ' A' ' 44' ' ' ALA . 97.2 t -105.85 124.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.132 -167.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -109.6 128.03 54.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.7 127.37 56.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.7 t -122.78 134.12 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.03 160.98 41.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -77.38 -27.97 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -90.99 116.64 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 95.0 p -68.01 -35.13 77.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.85 -31.89 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.083 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.21 -40.36 97.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.511 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.4 mt -67.78 -36.67 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.967 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.21 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.108 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.09 -36.98 83.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.66 95.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.047 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.07 -45.47 93.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.72 -38.84 84.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.34 -39.55 93.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.22 98.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.113 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.86 -38.43 90.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -32.37 73.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.6 -9.17 48.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.78 33.82 54.63 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.86 165.02 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.178 -175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.36 141.25 32.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -138.28 153.0 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -122.62 122.08 37.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.1 p -119.99 141.05 50.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.6 t -133.17 121.78 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -82.18 114.73 20.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.984 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -170.67 140.06 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -61.75 131.2 49.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 113' ' ' LEU . 82.7 mt -59.02 -28.73 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.66 -28.68 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.07 -11.33 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.69 130.87 45.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.92 113.3 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.8 mt -97.52 119.65 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.4 t -86.59 140.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.165 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -46.05 81.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.12 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -58.11 -24.01 57.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.17 88.74 6.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . 37.7 m0 -83.86 104.76 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -172.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.2 mt-10 -140.98 140.91 34.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.82 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.4 173.39 43.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.469 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.1 mm -121.8 120.5 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.903 0.382 . . . . 0.0 111.15 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.1 127.59 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.122 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -121.31 114.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.78 123.5 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.75 53.7 7.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.47 99.42 9.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -86.28 114.03 22.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 172.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.49 153.69 28.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.656 0.741 . . . . 0.0 110.974 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.12 141.58 76.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.676 2.251 . . . . 0.0 112.291 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.1 p -58.57 -29.94 66.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 92.7 p -62.17 -29.85 70.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.1 tp -68.84 -39.61 79.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -60.1 -39.51 86.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -61.65 -34.19 75.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -76.78 -38.13 54.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.008 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 85' ' ' LEU . 75.1 mt -69.91 -33.71 72.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.55 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m-30 -50.01 -56.37 18.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.559 0.695 . . . . 0.0 110.945 -167.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 27.1 Cg_endo -60.81 -33.73 92.44 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.747 2.298 . . . . 0.0 112.311 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -66.28 -52.74 44.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.93 -29.02 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -64.91 -50.09 67.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.75 -32.3 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.864 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.46 -14.74 73.02 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.495 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.33 133.21 46.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.946 0.403 . . . . 0.0 110.932 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 95' ' ' TRP . 86.4 tttt -70.53 139.12 86.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 167.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.1 123.2 10.51 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.72 2.28 . . . . 0.0 112.346 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.05 5.07 86.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.69 176.1 46.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -135.5 148.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.057 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -104.01 129.42 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.782 167.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.49 ' CD1' HD12 ' A' ' 191' ' ' LEU . 31.3 mm -117.3 123.82 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -129.12 125.88 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -152.26 138.01 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.5 34.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.47 153.79 42.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.788 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -85.81 129.32 54.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.495 0.664 . . . . 0.0 111.176 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.424 ' HB3' HD22 ' A' ' 150' ' ' LEU . 57.9 Cg_exo -52.07 -33.37 52.96 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.641 2.227 . . . . 0.0 112.35 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 99.2 mt-10 -51.28 -20.34 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -51.85 -25.54 8.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.833 HD13 ' HD3' ' A' ' 144' ' ' PRO . 20.9 mt -66.04 -28.3 68.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 20.9 pt20 -63.31 -15.26 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.85 -169.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -89.08 -35.48 16.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -97.83 -52.84 3.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.891 -165.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 59.5 p -131.59 -13.8 3.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.194 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.07 -28.26 8.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.47 -172.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.64 173.41 34.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.469 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.833 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.2 Cg_endo -74.56 -41.77 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.693 2.262 . . . . 0.0 112.299 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -129.79 -27.09 2.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.817 154.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -160.25 142.32 12.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.915 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -52.35 -25.0 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 170.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.48 -23.41 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -78.07 -14.71 59.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.511 HD21 ' HD3' ' A' ' 144' ' ' PRO . 22.2 mt -90.27 120.0 69.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 110.864 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.74 127.93 5.07 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.798 2.332 . . . . 0.0 112.371 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.02 148.21 48.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.913 162.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.793 ' O ' HD23 ' A' ' 153' ' ' LEU . 4.4 tt -55.17 -45.36 75.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.08 -36.72 82.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.7 m -60.76 -39.59 89.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.191 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.4 mt -66.12 -49.91 65.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -72.43 -26.24 61.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.5 p -79.63 -24.08 42.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.12 -10.62 43.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.47 97.06 50.37 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.884 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -91.8 -17.15 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -172.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.5 p -64.53 -22.19 66.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -159.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.958 HD12 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -137.93 154.85 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -74.87 139.24 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.94 119.79 36.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.87 -28.97 17.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.836 -169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 191' ' ' LEU . 41.4 pt -140.11 149.41 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.04 115.47 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 165.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -137.28 142.59 41.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -102.25 124.84 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 164.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.4 mt -107.09 149.07 28.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -109.27 125.71 52.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.82 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -158.51 147.89 19.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -54.82 134.11 47.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.853 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.54 122.17 15.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -79.6 151.52 30.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.778 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 53.77 34.98 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -125.01 -134.92 4.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.51 144.94 55.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.676 0.274 . . . . 0.0 111.114 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -64.25 -48.11 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.939 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -65.85 152.6 44.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -49.98 157.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.6 117.01 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -72.8 149.93 43.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -153.19 147.72 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.83 139.21 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.72 146.4 44.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.915 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.11 129.74 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -130.6 127.29 38.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -153.56 146.48 24.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.936 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.733 HD13 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -140.04 129.98 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -171.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.702 ' HA3' HD22 ' A' ' 163' ' ' LEU . . . -77.58 171.56 55.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.535 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -85.39 119.56 25.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 110.902 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 194' ' ' LYS . 14.8 tmtt? -108.99 110.02 21.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.919 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.34 137.51 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -54.89 123.78 14.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 197' ' ' HIS . 85.0 t60 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.906 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mmm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -154.63 175.93 13.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.13 160.02 32.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.23 135.43 14.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -121.93 144.91 48.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.39 165.06 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.1 p -158.5 169.95 23.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.96 159.98 40.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.871 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -157.8 166.03 33.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -162.65 160.01 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -129.93 142.55 50.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -125.57 106.43 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.094 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -155.96 163.02 40.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.89 -174.41 43.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.1 p -119.94 166.77 12.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.71 0.29 . . . . 0.0 111.162 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.8 149.93 70.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.68 156.43 60.94 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 0.0 112.367 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -139.99 -170.38 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -164.47 160.82 20.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -74.27 148.29 41.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.797 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 2.8 tt -73.32 -46.25 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG11 ' HG3' ' A' ' 130' ' ' GLU . 60.4 t -114.97 -81.9 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.128 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.2 p -128.74 -37.72 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.772 HG23 HD13 ' A' ' 191' ' ' LEU . 23.8 m -123.09 5.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.184 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.797 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -66.91 -3.04 6.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.055 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -66.85 -0.38 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.865 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.555 ' HB2' HD11 ' A' ' 191' ' ' LEU . 90.1 mm-40 -88.75 -4.31 58.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 170.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 25' ' ' ALA . 97.1 mt -70.55 130.77 88.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 0.0 111.091 171.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 145.05 86.29 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.242 . . . . 0.0 112.379 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -73.5 1.82 9.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.36 -147.71 5.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.8 mttt -77.33 126.99 31.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -122.02 129.62 75.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.111 -174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 tp -102.21 121.47 42.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -105.81 129.2 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.28 126.49 55.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.99 54.25 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.162 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -89.99 -15.72 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 63' ' ' GLY . . . 88.92 -63.25 3.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -120.06 -9.19 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.23 23.28 76.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.87 -39.54 90.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -73.89 -28.51 61.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.88 92.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 70' ' ' LEU . 87.3 m -68.19 -35.13 77.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.4 -47.3 84.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.03 -36.22 83.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.56 83.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.413 ' HA ' HG11 ' A' ' 76' ' ' VAL . 60.5 p -68.64 -16.57 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.85 -0.27 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 3.62 63.98 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -81.08 145.77 30.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 -174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -85.24 104.97 15.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.947 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -109.64 126.84 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 -167.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -109.06 126.27 52.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 166.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.98 128.24 56.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -119.56 130.07 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.49 156.9 32.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -80.55 -20.12 44.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -90.49 115.2 27.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.6 p -66.9 -36.08 81.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.62 -31.91 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 39' ' ' GLY . . . -64.09 -40.93 98.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.552 171.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.12 -35.96 78.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.25 80.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.112 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -65.07 -38.51 91.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -62.65 -41.6 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.61 -44.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -62.64 -45.47 92.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 79.8 mt -62.62 -42.03 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.35 -44.91 96.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.087 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.36 -40.17 96.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.19 -29.89 70.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -89.95 -5.15 57.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.59 34.43 56.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.9 m -128.76 163.88 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 111.174 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.12 144.83 27.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 tt -142.03 149.9 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.2 m -110.88 133.0 53.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -124.22 136.75 54.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.9 t -129.58 122.08 54.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.48 116.25 23.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -172.38 143.25 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -57.53 125.77 24.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -55.22 -35.09 64.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.0 -29.63 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -100.61 -9.36 22.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.932 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.19 132.67 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -97.85 115.23 27.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -92.75 120.39 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.87 138.11 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.5 87.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.48 -25.99 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.22 86.48 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.143 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.49 95.36 5.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 94.4 mt-10 -132.24 135.29 46.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.828 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.23 162.33 53.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 117' ' ' VAL . 46.7 mm -109.83 118.16 56.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 111.179 -174.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.7 124.47 70.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 m -121.65 117.73 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.91 121.83 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.189 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 42.69 55.02 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 96.5 m -99.64 87.59 3.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -74.98 114.36 13.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -157.52 151.13 19.14 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.633 0.73 . . . . 0.0 110.927 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.43 142.51 80.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.619 2.213 . . . . 0.0 112.384 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -58.89 -31.41 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.9 p -61.73 -29.15 69.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.9 tp -69.21 -40.63 77.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -60.77 -38.87 86.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HA ' ' CD2' ' A' ' 114' ' ' TYR . 89.0 mt-30 -64.81 -32.49 74.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -74.15 -39.45 63.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.71 -29.78 66.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 m-30 -49.9 -56.12 19.48 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.64 0.733 . . . . 0.0 110.882 -168.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 30.3 Cg_endo -62.41 -34.31 76.92 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.762 2.308 . . . . 0.0 112.314 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.97 -49.83 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 98' ' ' ILE . 28.0 m -74.74 -30.88 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -65.43 -51.73 58.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.08 -34.49 78.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.12 -49.07 63.92 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.473 ' CD2' ' HA3' ' A' ' 125' ' ' GLY . 47.9 tp -95.01 135.83 36.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.995 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.53 153.11 84.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.859 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.8 141.75 53.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.41 2.33 79.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.473 ' HA3' ' CD2' ' A' ' 121' ' ' LEU . . . -70.45 170.83 44.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 p -125.18 139.79 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.159 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.91 139.57 48.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.89 124.88 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 tt -132.52 124.96 29.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.772 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.439 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -157.89 139.86 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.42 -172.66 32.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -67.18 149.56 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.894 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.31 162.73 23.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.125 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.444 ' HB3' HD22 ' A' ' 150' ' ' LEU . 52.6 Cg_exo -51.34 -24.93 16.95 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -53.97 -27.32 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -64.17 -19.85 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.463 ' CD2' ' HD3' ' A' ' 144' ' ' PRO . 37.8 mt -58.46 -30.13 66.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.8 -16.24 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -63.44 -54.67 32.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -107.24 -55.88 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 -158.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.7 p -124.97 -16.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.131 -170.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.08 75.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.465 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.0 157.51 8.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.475 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.463 ' HD3' ' CD2' ' A' ' 137' ' ' LEU . 40.2 Cg_endo -72.47 -53.95 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.678 2.252 . . . . 0.0 112.293 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.61 -34.52 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.83 161.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -157.25 133.71 9.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.894 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.405 HD23 HD11 ' A' ' 150' ' ' LEU . 96.0 mt -59.74 -24.21 63.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.21 -24.12 67.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -77.17 -10.97 59.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -176.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 134' ' ' PRO . 54.1 mt -83.02 130.16 58.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.578 0.704 . . . . 0.0 110.916 -166.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.86 121.29 4.5 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.752 2.301 . . . . 0.0 112.286 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -71.04 145.63 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 166.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 153' ' ' LEU . 3.0 tt -54.92 -45.26 74.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.43 -36.71 84.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.5 m -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.1 -50.33 61.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -70.07 -25.61 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.7 p -79.21 -23.99 43.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.7 -15.39 37.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.2 107.31 60.07 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.583 0.706 . . . . 0.0 110.849 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -88.55 -21.45 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.748 2.299 . . . . 0.0 112.403 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.8 p -70.22 -27.14 64.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -157.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -139.31 161.48 37.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.942 -174.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.34 140.28 30.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -95.7 128.07 42.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.11 -29.3 16.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' A' ' 190' ' ' LEU . 36.3 pt -139.8 148.36 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 -176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.24 114.77 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.006 166.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -140.06 144.62 36.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -99.92 126.01 45.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 165.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -107.76 146.92 31.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.1 123.78 49.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -157.46 151.56 24.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.66 138.12 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.87 126.11 26.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.977 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.51 149.51 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.21 38.24 28.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.42 -163.89 33.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.512 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.33 171.32 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 111.108 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -55.42 -43.49 75.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 136.22 57.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -53.83 169.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.02 115.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.538 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -81.07 157.44 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -149.86 150.93 32.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.1 141.05 28.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.16 148.45 44.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.34 134.31 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -131.56 128.51 39.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -152.09 146.56 25.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -139.96 130.02 24.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 -173.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.58 170.88 48.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.568 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -105.98 126.55 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.846 0.355 . . . . 0.0 110.926 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.57 112.91 24.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 169.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.93 139.93 30.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.958 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -44.79 128.23 6.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 197' ' ' HIS . 84.3 t60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -155.05 175.33 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -159.75 160.0 33.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.842 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -153.0 136.02 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.853 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -120.49 144.87 47.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -168.86 164.98 11.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -157.58 169.98 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.835 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.03 160.01 40.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.6 p -157.15 166.73 32.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -163.15 161.08 24.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -150.02 126.24 10.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.37 113.16 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -163.88 139.95 6.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.19 -177.76 48.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.489 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 p -122.77 161.5 23.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.331 . . . . 0.0 111.114 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.85 150.57 76.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.854 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.81 155.3 69.96 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -139.44 -176.53 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -167.17 167.92 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -69.41 145.6 52.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.819 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 3.0 tt -73.98 -50.69 18.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 130' ' ' GLU . 61.8 t -111.84 -79.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -130.17 -38.16 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.815 164.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 191' ' ' LEU . 31.3 m -121.47 4.49 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.119 -169.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.819 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -66.48 -4.23 7.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.014 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -66.89 -0.23 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.717 ' HB2' HD11 ' A' ' 191' ' ' LEU . 91.2 mm-40 -88.12 -4.28 58.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.883 170.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 129.7 88.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.101 172.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.95 147.96 89.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.617 2.212 . . . . 0.0 112.426 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pm0 -74.38 1.21 12.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -142.48 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.55 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 98.1 mttt -85.0 132.74 34.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.928 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.13 130.29 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.1 tp -101.19 121.61 42.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.81 131.94 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.0 mt -114.05 123.06 48.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.9 54.51 8.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -87.87 -17.2 31.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.56 -59.53 2.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.543 173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -125.01 -3.92 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.905 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.607 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 71.9 20.95 79.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.585 176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm105 -67.61 -40.39 84.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 -176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -73.02 -28.14 62.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -45.64 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.073 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.6 m -67.52 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.888 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -58.62 -48.26 81.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.2 -36.3 83.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.07 81.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.34 -0.48 52.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.41 62.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -82.57 147.27 28.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.74 106.88 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.94 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -110.4 125.96 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.165 -166.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 m -110.76 127.1 55.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 167.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.48 129.58 55.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.69 131.81 71.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -156.69 158.74 37.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -77.81 -28.5 50.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.3 t -90.86 112.09 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.8 p -67.82 -33.28 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.859 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.67 -31.14 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.38 -39.2 96.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.462 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.74 -36.43 80.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.875 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.73 82.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.128 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.77 -39.45 94.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.32 -40.73 95.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.67 -47.28 81.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.09 -41.23 90.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.99 -39.21 91.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.998 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.98 -41.63 98.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.83 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.83 -32.63 73.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -91.15 -10.67 41.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.92 34.7 55.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.44 161.7 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.09 130.12 48.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -134.76 160.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -114.11 137.94 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.9 p -120.05 135.41 54.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.144 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.7 t -129.41 118.63 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.03 114.58 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -171.93 144.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -57.95 124.39 19.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -55.48 -37.01 67.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.13 79.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.08 -5.44 27.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.05 133.83 55.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -91.24 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.4 HG22 ' HA3' ' A' ' 120' ' ' GLY . 91.2 mt -95.22 119.43 43.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.52 137.3 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.36 -45.64 79.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.36 -27.62 68.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.98 76.44 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -76.04 100.3 4.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 32' ' ' LYS . 91.2 mt-10 -131.7 138.2 48.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.22 162.89 39.36 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.517 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.31 117.76 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.54 122.71 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.1 m -125.43 115.89 20.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.9 124.85 65.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.141 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 43.93 55.08 5.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 73.7 m -107.08 90.94 3.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.948 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -73.99 119.97 18.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HB2' HD23 ' A' ' 109' ' ' LEU . 4.3 pp -148.5 152.27 38.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 150.21 53.99 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.616 2.21 . . . . 0.0 112.36 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.8 m -56.62 -34.7 67.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.788 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.2 p -62.11 -30.05 70.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 105' ' ' LEU . 55.2 tp -69.97 -37.84 75.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.953 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -57.22 -39.3 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.82 -31.63 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.98 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -80.37 -40.83 25.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.934 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.42 -36.74 66.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.966 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.6 m-30 -52.9 -56.56 22.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.63 0.728 . . . . 0.0 110.957 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 17.8 Cg_endo -55.66 -34.81 91.63 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 0.0 112.4 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.75 -47.05 56.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.19 -30.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.76 -51.61 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.986 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.26 -32.91 72.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.898 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -71.6 -42.56 54.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.1 tp -84.0 133.2 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.948 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -69.24 152.0 96.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.23 136.32 54.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 194' ' ' LYS . . . 88.3 4.0 77.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.494 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.09 175.21 35.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 194' ' ' LYS . 7.0 p -127.09 139.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -109.71 135.14 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.1 mm -115.26 122.33 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.95 124.71 31.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.839 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 22' ' ' VAL . 15.0 tm-20 -154.92 138.42 15.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 153.95 -173.52 32.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.427 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 58.7 m-85 -66.03 149.98 49.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.82 156.06 39.77 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.554 0.692 . . . . 0.0 111.077 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.52 -27.16 24.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.718 2.279 . . . . 0.0 112.308 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -56.08 -20.8 18.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -58.8 -20.26 48.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.818 HD13 ' HD3' ' A' ' 144' ' ' PRO . 41.4 mt -59.19 -26.63 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.08 -17.17 56.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.07 -50.87 52.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -108.52 -51.48 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.834 -159.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 p -120.0 -15.09 8.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -166.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . 75.4 5.14 76.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 139.58 173.04 12.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.818 ' HD3' HD13 ' A' ' 137' ' ' LEU . 64.5 Cg_endo -71.44 -48.21 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.615 2.21 . . . . 0.0 112.296 171.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.45 -19.64 3.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.769 151.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -169.07 142.61 2.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.947 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 142' ' ' GLY . 94.8 mt -56.21 -26.08 49.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.39 -19.86 63.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.801 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.98 -8.21 59.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.413 HD21 ' HD3' ' A' ' 144' ' ' PRO . 77.2 mt -83.99 141.07 40.31 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 0.0 110.883 -166.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.36 136.04 17.3 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.729 2.286 . . . . 0.0 112.303 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.06 155.76 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 168.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 153' ' ' LEU . 4.0 tt -57.26 -41.27 79.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.963 169.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.21 -34.18 75.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.2 m -63.23 -41.75 99.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.75 -49.62 72.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.37 -24.59 62.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.9 p -81.66 -24.67 36.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.869 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -82.76 -17.06 45.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tt -113.89 102.71 55.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.635 0.731 . . . . 0.0 110.869 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.28 -20.23 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.736 2.291 . . . . 0.0 112.356 -170.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 87.4 p -65.86 -23.81 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 -156.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 163' ' ' LEU . 2.8 pp -134.02 167.96 19.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.008 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -93.33 136.99 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 172.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -92.05 126.31 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.1 mt -91.39 -31.51 16.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.665 ' CG2' ' HB3' ' A' ' 191' ' ' LEU . 15.8 tt -143.41 137.38 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -166.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.05 116.66 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -140.06 144.27 36.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -98.65 125.54 43.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 42.7 mt -110.67 149.92 29.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.97 126.6 53.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.832 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -156.9 147.47 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.66 134.78 56.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 185' ' ' ALA . 45.8 tp -68.44 126.53 29.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.31 150.03 42.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 59.81 35.8 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -104.09 -151.92 22.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.521 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.87 163.12 28.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.679 0.276 . . . . 0.0 111.136 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -54.62 -46.14 73.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -64.4 141.92 58.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.817 177.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -60.01 171.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.06 114.99 0.41 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.28 153.04 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 175' ' ' LEU . . . -150.8 150.91 31.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.07 34.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.129 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 132' ' ' PHE . 5.7 mp -120.09 146.65 45.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 92.3 mt -109.52 132.14 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -132.99 129.07 37.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 168.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.542 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -153.47 146.94 24.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.934 171.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -143.64 131.06 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -170.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.92 170.62 36.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.526 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -102.85 126.34 49.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 124' ' ' GLY . 85.9 tttt -89.62 115.18 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 169.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.7 137.37 33.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.886 165.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -46.61 125.15 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 197' ' ' HIS . 86.1 t60 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -164.83 142.2 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.97 169.94 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.922 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -156.98 139.24 14.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -136.34 175.09 9.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.907 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.92 165.03 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.5 p -155.65 169.97 23.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -155.03 159.95 40.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -164.56 131.76 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.01 149.97 47.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -151.97 129.67 11.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.8 t -119.27 125.41 74.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -159.43 134.52 8.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.947 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.76 176.69 29.12 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.521 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.619 HG22 ' HD3' ' A' ' 17' ' ' PRO . 89.9 m -126.0 137.63 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.153 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -122.47 78.08 45.81 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.694 0.759 . . . . 0.0 110.943 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD3' HG22 ' A' ' 15' ' ' THR . 65.1 Cg_endo -76.77 155.58 34.93 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.712 2.274 . . . . 0.0 112.401 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -130.07 68.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -95.9 -160.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -48.92 145.59 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 30.1 tp -69.18 -60.35 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -173.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.79 -83.53 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.162 -168.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -127.85 -47.22 1.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.809 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.765 HG23 HD13 ' A' ' 191' ' ' LEU . 28.6 m -122.92 21.03 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.064 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -57.54 -19.11 22.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -69.4 -4.21 17.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -90.31 -2.79 58.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.8 mt -77.24 129.25 78.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.565 0.697 . . . . 0.0 111.173 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.44 137.28 25.41 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.83 3.12 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -169.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.44 -151.99 8.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.08 148.95 41.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.15 135.07 64.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.6 tp -105.96 121.24 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -109.17 126.89 53.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.91 138.32 42.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.45 53.3 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.34 99.74 11.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.858 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.36 88.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.518 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.1 7.46 6.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.8 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 74.63 25.08 70.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -67.35 -42.21 83.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.784 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.78 -28.39 55.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.937 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' HG11 ' A' ' 54' ' ' VAL . . . -63.2 -43.97 96.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 176.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.8 m -68.28 -35.81 78.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -65.35 -45.57 83.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 54' ' ' VAL . 80.2 mt -64.85 -38.84 92.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.01 76.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -68.45 -22.05 64.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.02 -4.42 59.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.37 56.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.454 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -80.55 140.34 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -89.79 109.52 20.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 167.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 47' ' ' LEU . 62.7 t -112.96 134.16 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -167.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.8 m -107.71 125.07 50.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.168 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.74 130.95 55.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.88 136.04 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.171 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -157.46 159.35 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -78.6 -25.07 45.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -102.93 128.38 49.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.931 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.6 p -69.82 -30.44 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.45 -33.95 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.9 95.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.521 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 -34.83 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.07 86.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.94 -35.46 81.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.8 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.65 -42.01 98.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.092 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.63 -42.35 98.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.83 -41.5 97.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.6 -40.8 98.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.67 94.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.033 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.16 -39.1 93.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -33.97 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.93 -11.97 34.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.01 35.3 57.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.38 160.55 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 0.0 111.14 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -103.38 131.1 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -134.65 163.28 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.4 m -115.74 135.88 53.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.2 p -121.56 134.97 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.9 t -132.01 123.94 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.73 120.04 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 t -173.66 144.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -62.16 127.44 31.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 170.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.67 -33.52 68.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.5 77.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -99.41 -7.0 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -63.26 130.96 46.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -94.07 113.11 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.576 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.3 mt -91.81 115.41 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.9 t -86.58 137.93 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.03 52.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.102 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.76 -27.18 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.817 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.77 86.18 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.107 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -76.55 100.09 5.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.22 109.88 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.58 127.96 35.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.483 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -100.6 125.1 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.397 . . . . 0.0 111.104 -161.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.6 129.01 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.3 m -101.95 117.98 35.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.54 114.75 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 -172.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.582 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 53.6 m-85 50.2 56.19 8.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.2 m -107.92 88.77 2.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.848 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -86.62 111.72 20.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.2 pp -145.49 153.02 51.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.924 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.46 152.32 70.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.647 2.231 . . . . 0.0 112.295 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.0 p -58.69 -29.81 66.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.919 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.8 m -57.89 -36.11 71.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 105' ' ' LEU . 47.0 tp -71.65 -36.03 70.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -54.02 -44.02 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -62.92 -28.65 70.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 -37.16 28.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.76 -39.19 73.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.5 m-85 -52.01 -52.49 61.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.722 0.772 . . . . 0.0 110.961 -165.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.1 Cg_endo -68.37 -32.1 26.67 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.637 2.225 . . . . 0.0 112.329 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -71.72 -44.12 64.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.0 -34.33 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -71.16 -52.77 17.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.53 -31.57 71.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.576 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -63.35 -31.04 79.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.64 135.42 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.19 157.55 78.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.561 0.696 . . . . 0.0 110.887 165.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.41 125.1 11.67 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.77 2.313 . . . . 0.0 112.332 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.78 2.17 67.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.496 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.14 176.91 46.38 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.386 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.32 139.05 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 0.0 111.155 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -120.64 128.92 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 191' ' ' LEU . 86.9 mt -124.67 136.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 39.3 tp -123.99 125.66 44.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -153.04 136.13 15.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.847 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 148.62 -164.54 29.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.541 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.538 ' HB3' ' HG2' ' A' ' 136' ' ' GLN . 68.8 m-85 -65.09 140.25 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -173.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -97.09 163.7 19.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 0.0 111.104 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 133' ' ' ALA . 84.5 Cg_exo -47.23 -34.44 18.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 147' ' ' LEU . 98.4 mt-10 -58.2 -29.55 65.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 -174.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.538 ' HG2' ' HB3' ' A' ' 132' ' ' PHE . 3.7 pp0? -64.86 -24.99 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -168.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 137' ' ' LEU . 3.8 pp -68.55 -23.84 64.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -165.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.518 ' HG3' ' HA3' ' A' ' 142' ' ' GLY . 36.2 tt0 -60.17 -28.71 68.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.49 ' C ' ' O ' ' A' ' 138' ' ' GLN . 86.8 t80 -25.06 -65.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 171.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -116.5 -24.01 8.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 73.7 p -117.93 17.02 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.05 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.518 ' HA3' ' HG3' ' A' ' 138' ' ' GLN . . . -64.81 126.04 31.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.52 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.0 -115.05 0.36 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.428 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.1 -25.96 31.15 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.393 170.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.63 32.99 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -61.26 161.97 8.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 147' ' ' LEU . 2.8 pp -65.86 -15.07 62.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.885 -160.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -79.74 -18.72 50.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.17 -1.5 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.959 -171.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 147' ' ' LEU . 82.9 mt -99.49 159.62 29.56 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 110.95 -160.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.67 142.2 82.8 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.324 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.6 167.78 10.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.874 ' O ' HD23 ' A' ' 153' ' ' LEU . 5.3 tt -49.76 -37.16 28.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 170.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.21 -27.23 68.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 92.2 m -63.34 -59.75 4.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.045 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.09 -15.07 61.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.801 ' N ' HD22 ' A' ' 156' ' ' LEU . 62.9 tt0 -68.98 -40.07 79.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 171.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.2 p -79.68 -20.78 45.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.01 -19.5 58.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.52 103.07 55.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.719 . . . . 0.0 110.842 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.83 -21.85 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.0 p -73.14 -23.35 60.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -158.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.485 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.6 pp -135.59 158.33 44.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.935 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.64 143.07 28.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.519 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 99.2 m95 -98.91 128.74 45.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.9 mt -94.3 -30.21 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.937 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.55 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.0 pt -135.31 147.55 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 115.71 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.068 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -133.7 140.13 46.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.877 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -110.04 129.77 55.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.2 mt -107.99 132.55 53.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -116.26 128.75 55.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -130.38 144.52 51.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -67.59 119.61 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 127.81 32.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.925 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.598 ' OD2' ' HB3' ' A' ' 179' ' ' ALA . 59.5 t0 -77.85 132.2 37.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -117.06 -27.57 6.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.25 -55.05 2.56 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.411 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.598 ' HB3' ' OD2' ' A' ' 176' ' ' ASP . . . -87.65 168.14 13.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.138 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.21 13.47 14.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -125.98 62.67 1.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.8 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.92 162.44 35.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.939 169.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.81 22.98 5.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.66 144.56 32.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.817 0.341 . . . . 0.0 110.924 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -155.36 157.05 36.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.14 130.93 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.74 151.8 44.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 133' ' ' ALA . 39.6 pt -125.46 143.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.71 129.55 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -153.01 149.7 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.765 HD13 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -140.08 132.23 28.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -173.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.26 173.24 54.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.549 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -91.34 108.25 19.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.651 ' HD2' ' C ' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -95.24 108.03 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 169.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.93 131.41 37.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 173.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -109.41 115.66 30.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' A' ' 197' ' ' HIS . 65.7 t-80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 ttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.758 0.313 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.1 m0 59.12 44.87 15.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -114.92 159.98 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -126.87 150.0 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.75 145.03 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.845 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.09 165.07 37.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.4 p -154.33 169.98 22.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.64 170.03 8.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.2 t -159.92 139.95 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.91 129.9 14.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.99 172.52 12.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -143.5 140.04 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -149.74 164.95 33.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.93 124.6 3.89 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.569 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.731 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 84.9 m -131.17 130.13 42.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.652 0.263 . . . . 0.0 111.258 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -134.61 115.97 12.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.688 0.756 . . . . 0.0 110.813 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.27 146.3 50.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.596 2.197 . . . . 0.0 112.328 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -127.63 156.75 41.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -117.62 152.44 35.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 62.72 35.38 14.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.6 tt -61.0 -36.29 79.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.95 -82.6 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.127 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m -127.06 -35.24 2.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 152.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 24' ' ' VAL . 8.3 p -128.64 16.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 28' ' ' ILE . . . -60.55 -10.37 4.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -64.49 -4.51 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -95.51 -11.56 27.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.933 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.498 ' CD1' HD11 ' A' ' 128' ' ' ILE . 81.7 mt -79.99 132.99 58.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 111.132 -172.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.23 111.46 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -79.44 16.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -168.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.22 -99.94 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -101.44 133.22 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.65 127.78 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.85 125.95 50.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 170.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -106.2 122.85 47.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.69 43.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 178.67 105.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 8.4 tm-20 -60.36 -59.85 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.15 33.22 82.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 65.49 15.88 10.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.49 16.87 70.07 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.43 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -64.43 -46.68 82.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -79.33 -28.24 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.77 63.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -69.19 -30.02 68.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.13 -48.94 74.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -65.54 -37.13 85.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.09 85.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -67.86 -19.95 65.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 mt -89.21 0.83 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 93.35 4.21 64.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -85.19 142.12 29.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.946 0.403 . . . . 0.0 110.819 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -89.73 104.43 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.92 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' A' ' 47' ' ' LEU . 96.1 t -107.35 125.76 63.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.054 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.6 m -112.53 125.04 53.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 167.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.06 55.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.13 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.78 134.07 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.9 t70 -155.17 158.85 39.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.7 -26.58 37.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.9 p -97.01 144.96 26.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.874 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.2 m -76.99 -37.78 54.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.869 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.68 -35.03 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 -170.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.6 -44.87 94.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.66 -36.17 80.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.56 -39.12 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.063 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.09 -36.67 83.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -60.6 -42.85 97.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.112 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.03 -43.69 98.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -63.72 -45.41 90.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mp -61.85 -41.51 97.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.98 92.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.45 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.01 -29.95 70.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.53 -5.56 55.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 31.87 60.94 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.05 161.39 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.159 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.23 131.34 54.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -132.37 169.45 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.093 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -122.88 131.95 53.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.6 p -120.8 133.95 55.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.7 123.34 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.174 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -86.65 113.37 22.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.981 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -172.19 141.6 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.75 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.31 133.79 55.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.82 -31.54 70.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -72.3 -27.12 62.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -101.87 -13.75 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -69.44 134.62 49.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.27 109.91 20.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.684 HG22 ' HA3' ' A' ' 120' ' ' GLY . 94.9 mt -87.64 124.63 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.66 138.19 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.97 -53.45 12.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.111 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.4 -27.81 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.18 86.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.109 -164.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -132.6 161.88 32.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -105.35 -44.17 4.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.06 157.55 15.99 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.4 mt -129.37 129.7 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.137 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.71 128.89 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -171.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 t -112.35 118.59 35.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.02 113.87 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.4 t80 42.72 52.2 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -105.53 96.42 6.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -82.16 121.0 26.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HD23 ' A' ' 109' ' ' LEU . 1.7 pt? -134.64 150.76 74.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.582 0.706 . . . . 0.0 110.905 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.61 151.68 69.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.8 p -53.94 -34.93 61.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.6 p -62.68 -35.98 81.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 105' ' ' LEU . 16.5 tp -75.45 -34.05 60.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -58.5 -43.82 89.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -61.18 -28.19 68.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -87.6 -42.99 12.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.942 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.85 -43.58 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -170.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.7 m-30 -54.05 -53.45 58.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.896 -170.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 38.0 Cg_endo -65.61 -29.8 51.83 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.59 -39.7 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.12 -43.41 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -63.87 -51.1 66.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.66 -31.45 72.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.684 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -81.15 -16.97 73.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.478 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -83.34 138.29 33.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.931 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.85 152.58 93.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.831 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.28 125.94 16.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.23 -2.7 88.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.562 -167.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.82 49.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.487 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.416 HG11 HG12 ' A' ' 28' ' ' ILE . 80.8 t -131.19 146.87 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 0.0 111.107 -174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -121.72 137.41 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 174.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' CD1' ' A' ' 28' ' ' ILE . 60.9 mt -116.92 135.89 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.5 124.57 40.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.958 162.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 189' ' ' GLN . 23.5 pt-20 -154.11 145.63 23.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.928 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.68 -172.64 33.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -61.75 148.26 43.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.749 0.309 . . . . 0.0 110.903 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.15 34.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.52 0.676 . . . . 0.0 111.139 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.34 -31.07 45.58 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.659 2.239 . . . . 0.0 112.416 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' A' ' 147' ' ' LEU . 67.1 mt-10 -61.51 -33.12 73.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.806 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.675 ' HG3' ' HB1' ' A' ' 185' ' ' ALA . 24.8 tm0? -67.3 -21.96 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.002 ' O ' HD23 ' A' ' 137' ' ' LEU . 5.8 tt -56.9 -25.36 57.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -174.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 139' ' ' TYR . 15.2 pt20 -59.92 -21.84 61.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.848 -171.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.1 t80 -28.32 -65.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -96.18 -36.62 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.833 -156.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.1 p -130.73 -7.7 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.087 -169.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.43 0.29 71.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.79 155.77 6.67 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.447 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.594 ' HD3' HD13 ' A' ' 137' ' ' LEU . 51.8 Cg_endo -72.34 -42.19 1.49 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 0.0 112.378 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 97.6 mttt -127.53 -20.99 3.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.893 153.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.554 ' HB3' HD13 ' A' ' 149' ' ' LEU . 67.8 t0 179.55 129.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.401 HD11 ' HA ' ' A' ' 135' ' ' GLU . 18.3 tp -56.33 -24.85 46.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -76.62 -21.76 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -170.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 146' ' ' ASP . 6.4 mp -84.58 -2.76 57.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -169.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.09 154.03 38.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.611 0.719 . . . . 0.0 110.916 -160.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -58.12 107.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -68.3 149.95 48.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 166.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -65.82 -36.61 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 81.6 m -63.97 -40.8 97.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.64 -37.69 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -64.12 -36.07 82.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.4 p -83.76 -28.18 28.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.903 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -80.5 -13.93 58.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 160' ' ' LEU . 3.3 tt -115.49 97.89 49.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.739 . . . . 0.0 110.981 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -91.08 -25.13 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 -170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 82.7 p -66.09 -20.47 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -161.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 163' ' ' LEU . 1.8 pp -128.18 154.21 46.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -94.83 140.58 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.67 121.49 31.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -171.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.08 -32.7 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.4 pt -139.93 147.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.165 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.04 117.11 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.62 137.1 46.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -112.09 123.04 49.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.456 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.4 pp -124.1 143.59 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -125.61 136.16 52.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -128.97 151.54 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -56.82 114.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -165.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.3 tp -108.71 130.32 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.05 146.57 49.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -93.32 -19.69 21.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.62 54.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.489 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.85 166.38 33.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 111.023 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -50.52 124.43 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -55.34 126.97 27.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.858 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.3 -3.32 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.36 -10.46 50.4 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.511 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.08 138.63 31.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 0.0 110.863 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.675 ' HB1' ' HG3' ' A' ' 136' ' ' GLN . . . -148.89 157.01 43.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.65 130.99 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.121 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.4 152.6 40.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.952 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.76 143.18 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' A' ' 130' ' ' GLU . 67.8 mt-30 -139.72 132.81 29.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.82 150.12 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.683 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.9 tt -139.92 127.5 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.609 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -108.49 140.28 15.48 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -106.0 130.48 53.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.402 . . . . 0.0 110.91 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -90.23 129.56 36.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.72 140.88 34.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 24.2 pm0 -77.96 -10.02 59.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 178.51 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.793 0.33 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.4 m0 58.96 44.98 15.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.51 159.93 17.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.16 149.95 49.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.96 145.02 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.98 164.94 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -154.94 169.99 22.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.67 170.0 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.96 139.98 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.04 129.56 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -161.57 163.81 29.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -121.78 131.03 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.114 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -143.76 163.09 34.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.14 155.13 8.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.53 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 17' ' ' PRO . 87.6 m -135.39 130.09 34.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 111.274 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -139.96 83.67 15.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.694 0.759 . . . . 0.0 110.829 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD3' HG22 ' A' ' 15' ' ' THR . 25.2 Cg_endo -69.3 136.47 34.31 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.702 2.268 . . . . 0.0 112.305 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -122.7 172.12 8.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -144.86 -179.96 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 56.32 50.36 13.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 66.4 tp -60.84 -49.71 76.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.65 -81.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -126.81 -47.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 158.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 191' ' ' LEU . 34.2 m -119.49 15.22 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.165 -171.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -60.38 -12.32 9.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -173.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -57.31 -13.12 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.36 -7.8 56.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 25' ' ' ALA . 12.3 tt -71.52 137.14 83.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.654 0.74 . . . . 0.0 111.034 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.55 112.43 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.314 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -78.68 3.27 16.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.939 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.38 -87.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.463 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 99.3 mttt -119.13 133.02 56.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.54 136.86 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 30.1 tp -94.74 121.01 35.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -103.11 110.5 22.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 90.5 mt -85.19 51.62 2.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.88 104.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.118 -171.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.5 tm-20 -56.18 -59.78 4.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.93 33.72 86.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.53 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 61.72 18.92 10.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.829 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.48 17.69 68.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -64.74 -51.74 60.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.325 . . . . 0.0 110.814 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -80.39 -29.27 37.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.74 82.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.039 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.21 -35.52 76.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.85 -51.13 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.509 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -66.88 -35.17 79.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.01 76.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.183 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -70.67 -15.97 62.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -86.46 -5.26 59.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.25 2.46 59.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.442 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -82.82 142.56 31.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.892 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -91.11 108.66 20.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.892 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 47' ' ' LEU . 90.9 t -108.76 131.0 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -109.66 124.12 50.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.95 130.88 55.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.53 134.43 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.2 t70 -154.3 159.45 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -80.77 -21.83 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -108.78 127.84 54.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.819 -173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.7 p -69.62 -29.81 67.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.77 -33.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.054 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.68 90.81 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.494 173.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.01 -34.83 78.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.32 94.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.17 -36.84 85.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.75 95.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.88 -41.13 97.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.929 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.29 -45.69 93.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.9 -40.44 95.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.36 97.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.98 -38.29 90.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.943 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.65 -31.81 71.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.32 -6.98 49.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.87 33.07 60.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.462 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.15 160.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 111.193 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -104.31 131.96 51.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.23 161.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.5 m -114.2 133.62 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.3 p -123.15 133.93 54.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.189 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.34 124.96 58.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -87.2 116.5 25.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 173.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 t -174.99 143.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.8 t30 -60.47 131.02 49.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.06 -36.96 73.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.46 -30.32 65.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.1 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -100.7 -7.06 24.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 84' ' ' ASN . 4.8 t80 -57.69 129.0 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -94.69 108.05 20.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.75 143.58 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.145 -166.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.82 131.81 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.28 -48.99 60.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.139 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -66.82 -22.62 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -173.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.45 -22.26 66.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.041 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 34' ' ' LEU . 30.7 p90 -147.95 167.08 25.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -118.58 -31.35 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.45 154.74 16.75 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.465 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.67 128.08 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 111.121 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.84 132.59 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.9 m -111.02 120.45 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -110.4 115.18 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.185 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.686 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 68.0 m-85 46.37 43.01 11.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -104.02 68.94 0.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.924 -172.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -74.34 117.49 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.5 mt -132.41 153.16 81.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.629 0.728 . . . . 0.0 110.905 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -63.52 148.86 92.23 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.643 2.229 . . . . 0.0 112.369 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -54.15 -30.38 48.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 72.4 m -60.07 -42.75 95.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -73.02 -32.58 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -57.34 -45.08 84.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -32.3 73.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -43.06 20.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 mt -70.44 -30.41 67.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.518 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 0.9 OUTLIER -50.07 -57.99 10.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.67 0.747 . . . . 0.0 110.917 -172.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 33.8 Cg_endo -63.43 -29.57 71.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.664 2.243 . . . . 0.0 112.309 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -68.52 -40.08 80.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.69 -42.97 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -63.18 -53.03 59.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.62 -33.34 74.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.54 -31.76 53.19 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.427 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.3 tp -75.9 134.42 40.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.998 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.67 139.84 80.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.668 0.747 . . . . 0.0 110.86 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.94 126.69 17.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.776 2.317 . . . . 0.0 112.304 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.82 1.5 87.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.514 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.15 173.31 54.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.45 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.79 139.49 50.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.143 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -115.42 131.39 56.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.51 131.28 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.078 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -124.61 126.38 45.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -152.12 131.75 13.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 147.7 -155.76 26.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.446 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -64.02 140.54 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -110.14 159.15 33.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.52 0.676 . . . . 0.0 111.165 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -52.12 -26.61 26.64 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.336 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.17 -28.59 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -57.63 -37.24 72.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.004 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.935 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.88 -15.16 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 178.055 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' A' ' 139' ' ' TYR . 66.4 tt0 -67.11 -2.77 6.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.618 ' C ' ' O ' ' A' ' 138' ' ' GLN . 74.6 m-85 -17.63 -77.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -175.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -129.7 -41.41 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.866 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.9 p -91.84 -0.34 57.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.498 ' HA2' ' HG3' ' A' ' 138' ' ' GLN . . . 65.47 20.94 68.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.437 171.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.68 173.26 12.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.803 ' HD3' HD13 ' A' ' 137' ' ' LEU . 70.3 Cg_endo -71.5 -35.03 8.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.699 2.266 . . . . 0.0 112.315 173.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.11 -29.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 158.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -172.27 155.78 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.818 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 142' ' ' GLY . 35.5 tp -60.78 -18.48 55.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -73.54 -30.27 62.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -161.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.713 HD13 ' H ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -105.12 11.76 32.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.894 -173.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.46 148.74 39.55 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.66 0.743 . . . . 0.0 110.901 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.69 129.47 34.11 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.736 2.291 . . . . 0.0 112.337 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 155' ' ' THR . 98.7 mttt -100.23 159.55 15.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.919 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.724 ' O ' HD23 ' A' ' 153' ' ' LEU . 5.7 tt -53.66 -41.77 67.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.22 -33.95 76.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 152' ' ' LYS . 87.4 m -61.49 -43.22 99.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.36 -39.12 92.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.35 -36.27 83.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.1 p -83.29 -29.71 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.787 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -83.3 -19.56 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.4 tp -107.44 106.41 58.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.625 0.726 . . . . 0.0 110.868 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -88.53 -22.98 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.421 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 89.2 p -69.18 -23.65 63.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 -159.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.662 HD13 ' HA3' ' A' ' 192' ' ' GLY . 4.3 pp -139.22 160.42 39.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -105.56 136.12 45.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.17 127.77 35.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -170.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.03 -33.83 12.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.694 HG12 ' HB3' ' A' ' 191' ' ' LEU . 49.8 pt -139.12 145.77 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.09 120.6 2.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -132.12 140.96 48.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.761 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -110.84 132.01 54.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.8 pp -128.87 146.73 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -118.11 139.85 50.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -133.07 154.87 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 171.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -57.81 119.68 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -167.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.6 mt -93.75 139.84 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -73.55 147.03 44.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.59 -29.42 12.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.99 55.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.62 166.14 34.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -54.47 129.29 35.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.839 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -54.01 120.93 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -86.56 -11.03 52.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.28 -26.83 9.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -70.53 137.84 50.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -155.29 154.72 32.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -79.82 127.48 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 172.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.1 mt -126.17 153.63 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.977 -168.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 133' ' ' ALA . 30.9 pt -122.27 147.52 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 170.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.56 122.72 15.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.684 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -151.13 149.31 29.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.4 tt -140.04 128.39 22.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.662 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -116.41 148.72 18.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.453 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -112.74 130.9 55.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.835 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -96.89 134.33 40.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.928 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.03 138.21 38.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.12 -41.11 74.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.505 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.745 0.307 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.95 44.94 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -111.4 159.94 17.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.64 150.02 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.6 145.0 46.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.97 164.94 38.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.922 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -153.51 169.94 21.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.58 169.98 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.94 140.01 11.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -145.36 121.98 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -159.52 165.04 33.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -101.16 131.11 49.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.108 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -149.73 166.09 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 154.52 21.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.547 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.2 m -126.18 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.75 0.309 . . . . 0.0 111.159 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -140.0 89.96 10.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 0.0 110.855 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.62 125.16 18.19 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.658 2.239 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -121.24 169.99 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -140.38 -177.89 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 55.16 58.9 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.604 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 64.2 tp -61.58 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.61 -84.19 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.176 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.1 m -126.52 -35.22 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 160.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.428 ' CG1' HD13 ' A' ' 191' ' ' LEU . 3.9 p -129.42 8.71 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.173 -168.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -63.2 -6.82 4.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.181 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -7.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -91.68 -8.4 47.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' HB ' ' A' ' 126' ' ' VAL . 11.4 tt -74.94 137.49 73.02 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.722 . . . . 0.0 111.151 -174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.09 112.26 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.339 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -77.65 10.99 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 -170.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.26 -96.79 0.35 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -109.63 131.39 55.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.25 130.04 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.7 tp -101.48 122.66 44.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -114.8 114.97 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.923 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 85.0 mt -91.91 58.9 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.991 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -54.31 -60.07 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.78 35.58 92.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 60.11 19.54 8.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.832 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.81 16.07 63.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.557 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -65.09 -48.9 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -81.17 -30.15 34.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.868 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.97 -51.14 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -65.28 -35.77 82.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.53 -51.65 68.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.66 -37.11 86.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.4 -37.82 78.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.2 p -68.11 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.7 mt -86.13 -3.28 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.97 3.64 61.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.519 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.3 m-30 -80.13 146.34 31.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -89.99 103.43 16.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.941 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.6 t -104.57 126.19 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 -170.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 m -112.78 128.93 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.163 166.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.2 126.67 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.155 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.27 129.97 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -157.89 163.43 37.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -78.19 -26.38 47.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -99.12 111.67 24.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.9 p -68.84 -27.99 66.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.91 -47.48 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -41.87 99.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.543 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.75 -36.48 84.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.4 89.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.26 -35.05 77.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.09 98.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.064 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.47 -40.87 98.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -66.17 -40.79 90.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.06 -40.59 96.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.66 92.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.83 -38.61 91.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.53 -32.74 73.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.43 -9.32 45.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.69 33.05 58.57 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.448 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.63 161.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 111.131 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -104.87 131.6 52.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.833 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.1 pt -135.03 165.99 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -123.21 131.87 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -120.72 134.71 55.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.125 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.41 124.86 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.106 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -85.09 119.54 25.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.1 t -172.06 140.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -57.34 130.6 46.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.78 -32.69 67.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -71.93 -29.74 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.042 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.04 -13.32 19.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.29 135.87 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.35 110.01 21.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.664 HG22 ' HA3' ' A' ' 120' ' ' GLY . 93.6 mt -84.07 125.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.2 t -100.76 139.17 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.96 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 99.1 m-20 -65.27 -28.3 69.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.61 68.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.074 -163.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -130.05 162.38 28.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.547 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 48.0 mp0 -114.66 -37.86 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.47 151.51 18.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.532 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.5 mt -129.19 127.99 66.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.345 . . . . 0.0 111.138 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.86 131.86 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -115.66 116.17 27.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.01 118.77 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.176 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 41.05 48.26 2.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.79 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.2 t -113.73 85.03 2.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -73.48 119.61 17.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.97 148.42 69.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.941 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.33 146.63 75.94 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.3 p -56.51 -35.33 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.3 m -60.48 -40.24 90.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 86' ' ' ALA . 45.3 tp -70.88 -39.94 72.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.932 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -55.46 -42.83 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.17 -28.56 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -82.19 -37.01 26.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.3 mt -71.79 -37.31 70.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.3 m-30 -50.07 -54.4 33.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.604 0.716 . . . . 0.0 110.92 -169.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 31.8 Cg_endo -62.73 -32.53 78.32 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.765 2.31 . . . . 0.0 112.357 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -71.66 -39.7 70.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.51 -42.7 90.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -64.68 -53.85 40.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.74 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.977 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.84 -22.43 63.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.59 135.89 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.931 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.547 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.5 mttt -78.25 152.68 79.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.617 0.723 . . . . 0.0 110.815 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.14 125.64 19.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.43 3.58 86.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.65 171.18 50.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 28' ' ' ILE . 76.9 t -131.1 142.09 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 111.117 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -119.64 136.0 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.6 mt -120.15 132.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 50.5 tp -125.6 129.11 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 168.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.53 129.42 13.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.0 -171.25 37.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -76.49 158.78 30.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 110.904 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.05 149.97 44.29 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.496 0.665 . . . . 0.0 111.169 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.29 -34.3 98.49 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.187 . . . . 0.0 112.349 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.96 -34.77 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.799 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.435 ' HG3' ' HB1' ' A' ' 185' ' ' ALA . 23.2 tm0? -66.36 -30.69 71.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.809 ' O ' HD23 ' A' ' 137' ' ' LEU . 4.9 tt -59.9 -29.46 68.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -174.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 139' ' ' TYR . 19.8 pt20 -61.03 -23.54 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -169.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 138' ' ' GLN . 83.3 t80 -28.23 -65.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -103.03 -33.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.846 -159.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.9 p -118.29 -20.65 8.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -170.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.08 -14.38 27.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.437 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 142.74 143.3 4.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.06 -43.16 1.71 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.624 2.216 . . . . 0.0 112.346 -175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -121.28 -27.89 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 157.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.548 ' HB3' HD13 ' A' ' 149' ' ' LEU . 5.4 t70 -170.7 150.62 3.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 HD12 ' A' ' 150' ' ' LEU . 17.7 tp -60.73 -25.95 66.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -80.03 -28.7 39.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.792 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.548 HD13 ' HB3' ' A' ' 146' ' ' ASP . 4.4 mp -78.64 -4.93 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -170.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 93.4 mt -85.46 143.83 39.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.662 0.744 . . . . 0.0 110.903 -164.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 71.9 Cg_exo -56.32 107.44 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.718 2.278 . . . . 0.0 112.345 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -71.08 152.38 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 174.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 54.4 tp -55.4 -39.87 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.09 -30.12 71.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 64.1 m -62.27 -59.66 4.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.008 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.27 -16.08 62.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -173.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.671 ' N ' HD22 ' A' ' 156' ' ' LEU . 88.0 mt-30 -69.35 -42.65 74.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.958 172.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 95.0 p -77.58 -21.84 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.18 -11.53 59.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 tp -114.13 100.99 53.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.599 0.714 . . . . 0.0 110.935 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.78 -23.53 1.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.715 2.276 . . . . 0.0 112.425 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 74.6 m -76.12 -25.33 55.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -165.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.899 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -96.84 136.32 37.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.826 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -88.42 123.55 33.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -167.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.05 -32.23 16.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.643 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.2 pt -138.13 145.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.63 113.46 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 167.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -133.25 141.87 48.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.13 130.48 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 167.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.1 pp -123.48 150.6 43.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.82 142.2 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.924 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -128.66 150.27 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 167.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -63.32 118.85 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -165.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.0 mt -93.44 138.34 31.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -72.0 146.32 47.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.16 -25.23 20.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.67 55.12 0.18 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -151.95 166.34 31.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 111.09 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -53.2 124.91 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -55.38 127.55 30.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -84.67 -4.77 59.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.66 13.33 57.0 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.5 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.7 147.98 22.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.799 0.333 . . . . 0.0 110.888 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.435 ' HB1' ' HG3' ' A' ' 136' ' ' GLN . . . -152.26 146.1 25.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.9 130.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.73 152.42 40.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 -168.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 46.3 pt -120.23 143.47 31.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -144.54 127.1 16.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.85 149.44 28.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.4 tt -139.98 128.28 22.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.91 140.05 15.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -111.04 134.59 52.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.896 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -97.89 136.28 38.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.01 142.95 39.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.17 -22.78 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 58.8 m170 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.825 178.278 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.8 44.98 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.69 158.56 18.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.18 149.95 49.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.62 144.97 46.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -157.37 165.06 36.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.4 p -152.89 169.01 23.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.65 169.87 8.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.884 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.6 t -159.97 140.02 11.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.21 126.64 11.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -160.06 165.02 32.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.57 133.34 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -150.05 166.83 28.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.75 147.83 9.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -134.89 135.49 41.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.6 84.4 22.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.746 0.784 . . . . 0.0 110.87 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -59.91 129.89 32.41 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 0.0 112.296 -174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -133.53 158.95 41.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 172.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.6 p30 -123.32 -170.13 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 59.17 53.67 5.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.662 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 94.8 mt -64.62 -34.26 77.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.49 -83.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.215 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.6 m -126.12 -39.6 2.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 157.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 191' ' ' LEU . 34.7 m -126.02 14.48 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 -170.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.662 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -59.97 -10.85 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.114 -173.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -7.2 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 171.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -90.37 -11.06 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 126' ' ' VAL . 9.7 tt -74.27 137.68 75.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 111.106 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.97 108.15 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.73 2.287 . . . . 0.0 112.298 168.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -80.03 18.35 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -166.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.23 -94.94 0.67 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.497 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.17 133.38 52.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.823 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.95 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.4 tp -101.3 122.38 43.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.7 t -106.07 112.6 25.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.45 52.04 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.06 105.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.042 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -63.2 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.05 35.49 92.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 60.0 20.02 9.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.817 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.3 68.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -64.87 -46.06 83.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.925 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.92 -33.0 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.26 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.1 m -69.18 -34.9 75.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.62 -49.43 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 3.1 mp -64.39 -38.19 90.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.68 79.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -68.96 -19.71 64.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 65.1 mt -93.3 2.99 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.933 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.29 6.03 64.98 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 73.1 m-85 -82.32 136.23 35.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.938 0.399 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -89.29 104.4 16.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.904 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -104.57 127.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.6 m -108.61 125.17 51.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.151 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.85 129.08 55.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.61 133.32 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.132 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.61 157.6 37.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -77.99 -22.38 49.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.0 p -114.53 132.19 56.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.1 p -67.07 -25.19 66.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.89 167.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.19 -44.63 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.028 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.43 93.61 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.08 -30.8 71.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.918 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.88 -34.97 72.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.068 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.39 -38.42 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.72 95.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.22 -47.57 76.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.969 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.34 -42.95 78.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.24 -39.48 82.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.941 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.98 94.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.06 -37.89 89.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.25 -33.1 74.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.47 -7.34 47.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.46 30.62 62.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.04 165.03 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.63 131.88 54.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.1 165.5 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.0 m -123.3 131.28 53.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.15 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 46.5 p -119.62 132.98 55.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.0 t -126.51 123.63 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -86.36 114.15 22.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.9 t -173.26 140.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -51.69 125.95 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.7 tp -58.33 -35.93 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.01 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.25 -7.71 31.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -64.44 135.16 55.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.6 111.02 22.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.702 HG22 ' HA3' ' A' ' 120' ' ' GLY . 90.6 mt -84.68 121.05 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.19 140.62 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.16 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.027 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.86 -29.19 66.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.93 79.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.062 -164.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -129.91 158.72 38.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.72 -42.37 5.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.96 157.06 15.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.8 mt -129.18 126.53 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.13 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.82 132.34 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.162 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -112.83 118.17 34.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -111.4 114.11 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.194 -175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 42.89 46.43 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.413 ' SG ' HD23 ' A' ' 105' ' ' LEU . 32.4 t -103.25 91.75 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -80.98 121.06 25.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.4 pp -152.75 153.1 29.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.563 0.697 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.48 154.81 55.53 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.671 2.247 . . . . 0.0 112.371 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.0 p -57.32 -32.97 67.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.821 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -60.01 -39.34 85.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 105' ' ' LEU . 38.2 tp -71.68 -35.41 70.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.415 ' HG3' HD12 ' A' ' 105' ' ' LEU . 27.7 mtt180 -56.76 -40.2 75.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.998 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -62.36 -27.73 69.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.896 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.37 -39.81 16.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.14 -39.03 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 4.6 m-30 -52.23 -54.67 39.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.658 0.742 . . . . 0.0 110.873 -171.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.6 Cg_endo -61.93 -30.1 83.16 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.708 2.272 . . . . 0.0 112.341 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -72.5 -39.66 67.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.44 -40.93 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -64.21 -54.65 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.33 -30.2 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.989 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.702 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -78.59 -24.35 62.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.455 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.2 tp -82.16 136.81 35.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 110.911 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.1 154.67 86.52 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 0.0 110.847 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.91 125.78 16.67 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.705 2.27 . . . . 0.0 112.353 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.11 -2.47 88.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.49 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.27 169.95 45.78 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 28' ' ' ILE . 79.7 t -129.02 142.58 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -119.27 136.52 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.893 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.1 mt -120.11 131.45 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.442 HD22 HD21 ' A' ' 190' ' ' LEU . 4.1 tt -127.93 130.5 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 167.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -150.15 140.87 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -164.47 -168.3 26.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.18 165.85 19.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.21 156.05 39.97 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 173.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -52.52 -36.34 70.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.624 2.216 . . . . 0.0 112.418 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 97.8 mt-10 -60.56 -34.85 74.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.809 -169.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.7 tm0? -64.33 -29.99 71.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 144' ' ' PRO . 31.9 mt -66.55 -20.85 66.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.625 ' O ' ' C ' ' A' ' 139' ' ' TYR . 16.8 pt20 -66.89 -13.74 62.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.906 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.625 ' C ' ' O ' ' A' ' 138' ' ' GLN . 33.9 t80 -18.57 -78.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -132.18 0.25 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 -167.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.2 p -124.52 -14.13 6.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.87 -14.42 31.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.436 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.53 171.43 18.09 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.438 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.519 ' HD3' HD13 ' A' ' 137' ' ' LEU . 49.4 Cg_endo -70.47 -50.19 0.41 Allowed 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.679 2.253 . . . . 0.0 112.378 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 99.6 mttt -131.99 -28.4 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.967 161.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.506 ' HB3' HD11 ' A' ' 149' ' ' LEU . 49.1 t0 171.24 124.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.822 -177.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 137' ' ' LEU . 53.6 mt -68.37 -20.07 64.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.965 -167.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -75.49 -36.65 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 -161.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.867 HD13 ' H ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -103.53 25.95 9.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.837 -171.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.12 162.33 46.72 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.643 0.735 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.97 116.83 2.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -79.16 137.9 37.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.995 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.45 -45.19 80.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.879 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.05 -35.04 78.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 m -62.43 -41.19 98.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.2 mt -60.61 -42.14 96.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.81 -37.11 81.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.8 p -81.46 -28.12 34.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.03 -11.32 55.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.13 98.87 52.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.736 0.779 . . . . 0.0 110.962 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.99 -22.26 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.4 p -68.53 -21.48 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.0 pp -130.17 153.98 47.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.78 138.99 35.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -88.13 121.79 30.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.78 -30.43 19.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.6 pt -138.46 147.09 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.058 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.01 111.91 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 164.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -136.62 143.08 43.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.51 119.81 39.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 165.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 mt -102.68 140.3 37.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -120.01 133.88 55.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -172.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -128.41 153.3 47.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 165.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -58.48 116.18 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.836 -166.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.2 mt -97.1 138.25 34.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -77.34 143.42 38.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -101.23 -22.44 14.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.72 55.08 0.19 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.441 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.68 166.25 34.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -54.87 130.01 39.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.892 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -55.07 119.24 5.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.82 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.25 -10.95 48.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -173.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 112.59 3.78 25.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -91.29 142.38 27.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -145.54 145.1 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.15 130.62 35.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 170.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 47.7 mt -124.0 157.12 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.004 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.1 pt -121.46 141.59 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -138.47 137.49 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.613 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.1 pt? -155.64 147.69 23.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.833 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.654 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.1 tt -140.1 128.37 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.84 139.42 15.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -107.14 133.04 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -98.13 132.66 43.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.68 144.84 30.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.42 -32.91 68.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.835 179.326 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.87 44.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.63 160.0 17.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.69 150.01 49.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -135.48 145.04 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.97 164.98 37.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.848 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.8 p -154.96 169.97 22.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -169.64 169.97 8.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -156.2 133.78 10.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -154.26 135.07 13.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.7 p90 -155.95 157.31 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.987 176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -122.26 132.97 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.091 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -137.13 126.69 25.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.52 166.81 23.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.631 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 86.9 m -119.85 132.31 55.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.727 0.298 . . . . 0.0 111.206 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -127.36 114.51 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.641 0.734 . . . . 0.0 110.817 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.32 144.97 42.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.35 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -130.05 168.06 17.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 26' ' ' ASN . 52.4 p30 -130.65 169.1 16.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.825 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 51.25 41.49 27.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.877 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 62.5 tp -66.38 -43.1 86.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.96 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.1 t -124.95 -51.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 152.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 HD13 ' A' ' 191' ' ' LEU . 35.9 m -118.05 13.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . . . -59.32 -12.19 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.159 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 19' ' ' ASP . 53.1 p30 -62.01 -5.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.869 173.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -90.57 -12.15 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.983 174.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 126' ' ' VAL . 8.7 tt -75.47 138.46 71.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.665 0.745 . . . . 0.0 111.059 -176.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.3 114.35 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 0.0 112.324 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -74.93 -0.58 19.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.61 -96.13 0.45 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 -170.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -99.05 125.6 44.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.4 127.68 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.11 121.54 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.868 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -108.09 112.67 25.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt -87.73 58.13 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.993 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.97 105.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.65 -60.0 4.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.863 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.64 32.24 83.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 62.08 18.52 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.9 16.16 72.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.539 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -63.54 -45.52 90.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.906 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -79.46 -29.97 41.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.77 -51.98 59.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 p -70.9 -29.62 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -65.03 -52.06 58.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.5 mt -67.41 -35.45 79.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.24 82.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.173 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.5 p -68.98 -17.39 63.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.26 0.61 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.937 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.71 2.68 61.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -87.1 144.86 26.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -90.17 109.02 20.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 47' ' ' LEU . 94.6 t -109.27 126.56 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.8 m -110.54 124.9 52.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 167.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.52 130.54 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.69 132.62 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -154.62 163.91 39.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -83.41 -21.22 33.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -104.52 117.88 35.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 91.0 p -67.12 -27.8 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.84 -46.1 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.77 -40.64 98.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.607 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.09 -35.62 81.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.33 . . . . 0.0 110.889 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.44 -38.54 84.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -65.42 -36.86 85.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.34 99.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.128 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.35 -42.21 93.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -62.24 -46.98 86.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 mp -61.49 -37.22 82.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.03 -45.98 83.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.69 -37.68 87.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -65.44 -29.82 70.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -92.88 -4.4 52.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.81 32.82 58.61 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.428 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.14 161.8 26.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.398 . . . . 0.0 111.104 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.58 131.13 54.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -133.54 163.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.7 m -119.56 135.48 54.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.0 p -120.23 134.58 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.195 -177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.8 t -128.56 123.5 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.177 170.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.88 114.88 23.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.8 t -173.49 141.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.834 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -54.99 130.79 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.96 -35.03 74.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.36 69.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -98.73 -9.51 24.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.05 136.74 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -92.89 108.76 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.698 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.3 mt -83.32 119.45 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.78 140.32 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.188 -172.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.49 -54.69 7.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -71.21 -29.4 65.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.51 81.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -129.36 164.45 23.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.7 -40.62 4.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.56 155.59 16.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.76 127.0 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 0.0 111.19 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.78 130.44 72.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.8 m -114.96 115.95 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.801 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mm -114.42 115.95 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.172 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 49.8 43.75 24.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -101.0 73.12 1.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -80.49 124.03 28.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -144.83 150.98 48.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.658 0.742 . . . . 0.0 110.878 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.37 154.86 71.7 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.762 2.308 . . . . 0.0 112.339 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.2 p -54.26 -30.82 51.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.1 m -58.17 -40.7 82.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.38 -34.22 65.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.888 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -55.87 -44.73 78.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.25 -30.38 71.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -85.85 -46.4 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.19 -42.16 80.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.854 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 6.5 m-30 -53.02 -54.98 38.24 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -168.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 28.5 Cg_endo -62.0 -28.74 80.87 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.349 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.46 -36.85 65.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.97 -41.13 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.151 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.55 -53.55 50.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.65 -31.49 72.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.937 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -76.56 -26.98 62.03 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.476 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.93 136.6 36.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.918 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -75.45 154.55 85.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 126.98 19.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.39 88.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.475 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.26 169.98 50.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.532 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 28' ' ' ILE . 60.4 t -129.56 143.82 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -119.77 136.93 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.88 128.71 75.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 190' ' ' LEU . 51.8 tp -123.41 129.77 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -153.46 134.72 14.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.952 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.01 -178.1 40.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -72.28 150.1 43.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.321 . . . . 0.0 110.963 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -94.84 154.77 39.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.504 0.668 . . . . 0.0 111.174 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.74 -25.1 78.13 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 174.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 138' ' ' GLN . 59.4 mt-10 -58.84 -23.37 60.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -54.3 -27.7 37.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.968 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.08 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.6 tt -57.88 -16.28 11.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 139' ' ' TYR . 20.1 pt20 -67.19 -4.89 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.611 ' C ' ' O ' ' A' ' 138' ' ' GLN . 77.6 m-85 -18.73 -77.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.96 -51.24 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.0 p -85.63 -1.95 57.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.24 35.13 87.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.35 170.59 13.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.826 ' HD3' HD13 ' A' ' 137' ' ' LEU . 93.7 Cg_endo -79.48 -31.94 1.86 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.762 2.308 . . . . 0.0 112.308 173.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 -26.6 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 161.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -171.46 154.6 3.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.48 -9.78 37.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 168.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.7 -25.02 26.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mp -89.96 -7.56 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -171.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.99 154.7 91.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.634 0.731 . . . . 0.0 110.88 -158.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.62 150.3 22.09 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.641 2.227 . . . . 0.0 112.367 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -104.94 137.49 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.417 HD11 HD22 ' A' ' 190' ' ' LEU . 64.2 tp -55.03 -38.12 67.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.878 161.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.78 -33.76 72.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 73.8 m -63.22 -41.89 99.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.98 -40.75 94.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.972 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.08 -36.53 84.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -83.98 -27.64 28.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -169.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -80.31 -13.28 59.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -111.75 100.55 48.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.938 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.35 -21.66 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 96.4 p -68.53 -20.81 64.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -163.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.2 pp -132.55 155.35 48.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -99.43 137.53 37.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.08 125.08 32.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -93.0 -30.75 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.633 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.6 pt -139.73 146.16 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.09 116.41 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -131.47 144.44 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -123.24 129.98 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 171.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.1 pp -130.49 152.9 49.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -119.49 138.05 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -130.77 154.9 47.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 173.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -69.1 133.74 48.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -166.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.419 HD12 ' HG3' ' A' ' 138' ' ' GLN . 85.2 mt -98.1 154.6 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.09 137.58 55.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 170.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.4 -38.68 78.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.822 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.18 55.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -164.38 -178.67 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 111.066 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -43.5 127.11 4.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -55.11 127.71 30.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.858 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -74.78 -23.0 58.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.89 -24.72 9.31 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.55 140.58 41.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.895 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -162.31 158.03 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.142 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.62 132.44 44.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 mt -122.16 149.97 42.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.042 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 133' ' ' ALA . 20.7 pt -124.27 142.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -145.0 129.15 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.67 150.84 28.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.867 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.688 ' C ' HD23 ' A' ' 191' ' ' LEU . 2.7 tt -139.95 129.93 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -175.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.03 140.19 15.92 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.545 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -106.65 131.46 53.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.935 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -96.63 133.01 41.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.79 145.0 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.05 -33.92 70.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.506 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.703 0.287 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.3 m95 59.22 43.0 17.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.65 160.0 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.29 149.99 48.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.42 145.03 46.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.99 165.01 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.5 p -151.15 169.85 20.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.51 170.08 8.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -159.66 140.0 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.35 134.94 16.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.97 167.59 29.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.13 128.23 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.191 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.06 164.87 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.97 147.77 22.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.74 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 85.3 m -113.04 124.78 53.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.745 0.307 . . . . 0.0 111.167 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.98 129.81 24.84 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.0 110.793 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.05 131.17 23.13 Favored 'Trans proline' 0 C--N 1.34 0.091 0 C-N-CA 122.676 2.251 . . . . 0.0 112.343 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -135.01 167.12 21.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 26' ' ' ASN . 56.1 p30 -141.98 179.33 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 56.56 37.86 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.724 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.9 tt -64.49 -40.46 95.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 170.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.25 -83.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.213 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -128.72 -37.0 1.79 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 154.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.54 HG23 HD13 ' A' ' 191' ' ' LEU . 27.3 m -121.86 17.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 -167.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.622 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -56.99 -11.03 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 46.9 t30 -52.57 -17.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.816 171.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -86.99 -20.0 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 126' ' ' VAL . 84.6 mt -79.47 129.84 70.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 0.0 111.097 -171.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.51 119.22 5.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 0.0 112.31 166.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -74.38 5.53 4.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.41 -96.11 0.51 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -167.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -100.81 125.08 47.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -120.43 129.34 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.6 tp -101.42 125.75 48.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.4 t -115.92 114.84 25.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.59 57.68 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.93 104.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.065 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 9.9 tm-20 -59.64 -60.05 4.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -176.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.83 35.93 92.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 173.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 60.41 19.75 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.25 20.53 60.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.476 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -65.29 -48.47 73.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.07 -31.1 50.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.79 -50.96 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.987 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.09 -35.71 81.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.28 -51.23 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.0 mt -67.73 -35.34 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.8 81.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.128 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -67.28 -17.58 64.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.73 -1.81 58.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.74 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.28 4.16 61.21 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.534 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.9 m-30 -85.43 142.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.861 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -89.97 105.86 18.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.926 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.3 t -106.76 127.68 62.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.6 m -109.64 125.24 52.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.174 168.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.44 128.55 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 133.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.082 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 6.7 t70 -154.15 161.31 41.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -82.3 -21.13 36.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.9 p -108.54 131.32 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.6 p -71.73 -26.2 62.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.96 -47.69 89.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.01 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.34 98.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.56 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.34 -36.48 84.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.12 -36.22 81.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.17 -35.57 79.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -62.36 -43.39 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.58 -41.25 96.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -62.19 -46.82 87.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.7 tp -60.07 -41.04 91.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.33 -43.73 96.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.53 -36.5 83.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -69.45 -31.17 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.42 -7.5 50.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 32.1 58.1 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.427 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.31 163.59 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.867 0.365 . . . . 0.0 111.194 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.97 131.33 53.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 pp -135.39 166.41 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -122.88 134.17 54.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.159 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 p -120.01 134.04 55.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.113 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -127.55 123.97 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 170.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 63.8 tt0 -88.46 117.24 27.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.947 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.1 t -174.61 142.58 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -61.29 132.14 52.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.85 -25.02 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.92 60.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -104.42 -13.74 15.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.23 132.73 46.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.96 112.32 24.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' HA3' ' A' ' 120' ' ' GLY . 82.1 mt -81.39 122.11 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.85 139.92 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.134 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -59.41 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -69.18 -28.27 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.07 78.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -132.89 161.07 35.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -105.34 -44.99 4.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.97 153.87 17.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.466 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.1 mt -124.09 125.44 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 111.107 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.1 131.88 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.7 m -111.92 117.08 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mm -106.58 111.29 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 43.87 45.08 6.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 43.4 t -106.26 94.89 5.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -94.01 120.68 34.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt -128.29 150.16 73.37 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 39.2 Cg_endo -63.83 145.64 90.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.358 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.2 p -54.98 -34.35 63.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.1 p -62.34 -35.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 109' ' ' LEU . 1.3 tt -76.27 -34.46 59.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.912 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -57.16 -42.62 81.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.97 -27.35 68.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.82 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -86.27 -36.01 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.27 -41.2 66.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -52.25 -55.06 34.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.69 0.757 . . . . 0.0 110.905 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 20.0 Cg_endo -59.74 -29.74 90.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.735 2.29 . . . . 0.0 112.333 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.05 -41.02 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.99 -43.98 92.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -63.69 -55.23 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.44 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.614 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -79.97 -23.93 60.76 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.62 137.52 34.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.78 154.1 87.14 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.1 126.93 18.96 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.778 2.318 . . . . 0.0 112.261 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.54 -0.85 89.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.526 -167.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.13 173.82 47.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 28' ' ' ILE . 56.5 t -132.9 146.55 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.17 -173.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -122.43 138.78 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' ILE . 69.2 mt -118.66 132.18 69.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.432 HD22 HD21 ' A' ' 190' ' ' LEU . 5.0 tt -126.28 130.1 50.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 167.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -147.64 135.58 21.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.914 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.81 -167.86 23.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.418 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -99.78 149.29 35.8 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.499 0.666 . . . . 0.0 111.213 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 150' ' ' LEU . 71.7 Cg_exo -50.13 -36.7 46.43 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.671 2.248 . . . . 0.0 112.44 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -58.01 -30.64 66.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -64.24 -25.45 68.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 -173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.475 ' CD1' ' HD3' ' A' ' 144' ' ' PRO . 1.6 mm? -62.73 -15.69 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.892 -168.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.625 ' O ' ' C ' ' A' ' 139' ' ' TYR . 64.7 tt0 -63.4 -17.71 62.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.899 -174.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.625 ' C ' ' O ' ' A' ' 138' ' ' GLN . 60.5 m-85 -19.19 -81.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -169.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -144.19 0.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.3 p -125.12 -13.43 6.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 -173.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 147' ' ' LEU . . . 84.64 -18.5 24.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.432 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 137' ' ' LEU . . . 138.7 -172.88 22.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.53 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.475 ' HD3' ' CD1' ' A' ' 137' ' ' LEU . 57.8 Cg_endo -73.03 -43.35 0.77 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.718 2.279 . . . . 0.0 112.336 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.87 -32.28 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 160.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.737 ' HB3' HD12 ' A' ' 149' ' ' LEU . 16.7 t0 -176.03 153.86 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 142' ' ' GLY . 26.5 tp -59.0 -35.38 73.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -79.84 -35.07 38.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -155.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.005 HD22 ' C ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -98.95 9.89 42.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -158.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 134' ' ' PRO . 75.8 mt -79.98 159.55 70.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 110.964 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -55.17 137.79 77.58 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.664 2.242 . . . . 0.0 112.407 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -92.81 139.21 30.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.5 -40.11 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.951 172.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.85 -30.97 68.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 90.7 m -60.6 -44.86 95.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.23 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.58 -39.35 94.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.36 -36.59 84.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -85.99 -26.35 25.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -84.05 -8.67 59.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.34 99.34 49.03 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 0.0 110.902 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -89.24 -20.74 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.699 2.266 . . . . 0.0 112.412 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.5 p -68.08 -22.12 64.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.4 pp -131.76 154.8 48.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -98.57 140.86 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -86.98 123.09 31.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 92.5 mt -89.63 -33.4 16.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 191' ' ' LEU . 44.8 pt -141.57 148.41 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.067 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.99 114.21 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.036 167.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -131.39 140.58 49.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -117.6 129.03 55.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 168.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.1 pp -122.95 151.69 41.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.83 142.59 48.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -175.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.62 154.11 47.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 168.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -58.93 123.11 15.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 64.1 mt -87.54 134.94 33.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -77.4 140.43 39.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.56 -22.48 8.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.875 -175.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.0 55.01 0.19 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -160.1 168.38 25.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.103 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -52.36 122.68 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.825 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -55.06 121.53 8.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -83.92 -17.23 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.97 -0.0 41.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.5 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -82.09 140.36 33.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.736 0.303 . . . . 0.0 110.899 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -152.99 152.93 31.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.081 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.38 129.76 34.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 167.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.11 151.55 43.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.961 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' A' ' 133' ' ' ALA . 29.9 pt -124.08 141.42 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 174.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -139.05 138.39 37.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.2 pt? -156.25 152.51 27.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 176.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 191' ' ' LEU . 6.8 tt -139.9 129.79 24.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.505 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -109.13 138.59 14.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.511 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -107.07 131.84 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.93 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -97.52 133.27 42.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 139.5 42.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.21 -42.5 93.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.461 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 45.02 16.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -110.56 159.34 17.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.78 149.94 49.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.16 145.01 47.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -156.84 165.03 37.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.839 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.5 p -152.52 169.87 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.74 170.05 8.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -159.36 139.93 12.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.83 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -149.35 130.03 14.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -164.01 168.72 18.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -145.85 139.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.156 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.39 165.01 32.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.65 167.53 14.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.553 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.674 HG22 ' HD3' ' A' ' 17' ' ' PRO . 96.6 m -93.8 120.04 33.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.281 . . . . 0.0 111.229 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.66 80.32 22.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.771 0.795 . . . . 0.0 110.863 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HD3' HG22 ' A' ' 15' ' ' THR . 55.9 Cg_endo -74.18 146.16 35.91 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.753 2.302 . . . . 0.0 112.288 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -137.9 157.73 45.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -150.64 -171.2 3.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 54.99 46.27 24.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.58 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 59.1 tp -65.0 -43.01 93.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.19 -86.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.144 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.5 t -125.74 -48.79 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 158.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 HD13 ' A' ' 191' ' ' LEU . 33.4 m -115.35 17.73 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.177 -170.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -60.18 -9.24 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -61.57 -3.1 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 171.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.72 -12.31 25.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' HB ' ' A' ' 126' ' ' VAL . 10.7 tt -74.27 137.52 75.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.654 0.74 . . . . 0.0 111.049 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.08 112.79 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.616 2.211 . . . . 0.0 112.311 167.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -75.03 10.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.59 -100.4 0.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.98 133.36 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.808 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 88.9 mt -123.72 136.05 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.4 tp -95.19 121.77 37.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.899 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.42 113.97 25.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 83.0 mt -94.66 57.12 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 174.96 104.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -67.08 -63.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 38.19 94.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 61.87 18.91 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.918 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.97 10.73 81.09 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.531 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -63.48 -45.58 90.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.945 0.402 . . . . 0.0 110.944 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.26 -33.6 37.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.09 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 88.3 m -66.23 -36.57 83.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.6 -49.29 75.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 54' ' ' VAL . 96.3 mt -60.83 -39.09 87.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.26 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.5 p -69.04 -18.32 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -83.34 0.24 46.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.77 64.58 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.512 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -80.11 143.68 33.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.884 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -86.97 103.57 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 47' ' ' LEU . 67.5 t -105.38 127.77 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 -168.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.8 m -112.49 125.17 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.6 129.26 56.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.63 133.91 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -154.63 163.62 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -83.79 -20.77 32.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.974 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.7 t -101.75 117.26 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.808 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.9 p -65.0 -28.15 69.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.53 -47.97 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.01 99.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.52 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.28 -35.55 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.945 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.0 99.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.36 -42.84 99.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -66.64 -41.16 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.3 -39.78 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.9 -40.99 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.43 -38.19 90.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.5 -33.72 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.38 -8.23 45.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.84 33.06 60.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.32 160.97 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.38 . . . . 0.0 111.113 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.57 131.01 53.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.814 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -134.73 166.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.102 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -124.85 131.2 53.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 p -120.32 135.17 55.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.132 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.7 t -130.26 125.44 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -84.89 116.6 23.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 t -173.76 142.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.501 HD21 ' HB3' ' A' ' 86' ' ' ALA . 26.8 t30 -58.73 130.06 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.38 -30.58 65.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 84' ' ' ASN . . . -76.12 -23.53 54.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -104.92 -13.45 15.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.884 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 84' ' ' ASN . 72.1 t80 -70.38 137.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -94.01 107.42 19.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.2 mt -88.2 125.24 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.34 138.88 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.74 -44.58 61.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.17 -26.62 66.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.84 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.69 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -164.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -130.1 156.73 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.796 -172.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.95 -40.04 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.76 159.92 15.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 88.3 mt -129.99 125.65 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.107 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.64 130.78 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -129.02 118.27 22.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.835 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.62 128.91 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.132 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.1 t80 43.73 52.64 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 51.0 t -115.53 88.32 2.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -80.84 117.55 21.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.8 mt -121.17 145.3 41.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.585 0.707 . . . . 0.0 110.899 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.9 Cg_endo -67.78 148.81 77.93 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.757 2.305 . . . . 0.0 112.303 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.7 m -54.17 -42.97 70.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.0 m -60.38 -39.77 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.54 -38.97 74.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 178.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -59.32 -41.65 89.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -29.32 70.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -83.56 -42.88 16.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -74.26 -42.22 60.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.831 -172.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.2 m-30 -54.51 -52.32 70.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.722 0.772 . . . . 0.0 110.923 -169.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 86.8 Cg_exo -45.1 -37.6 13.13 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 0.0 112.379 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -76.34 -37.07 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.51 -45.02 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.179 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 118' ' ' TYR . 2.7 m-30 -66.29 -54.45 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -176.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -65.07 -30.2 71.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.87 -29.56 67.04 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.512 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.18 133.6 38.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.344 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.48 153.12 78.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.701 0.762 . . . . 0.0 110.863 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.08 124.81 16.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.766 2.311 . . . . 0.0 112.31 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.56 87.51 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.524 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -71.54 170.91 47.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.441 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HB ' HG13 ' A' ' 28' ' ' ILE . 77.5 t -129.18 140.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.116 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -114.97 132.54 56.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.8 129.88 74.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.069 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 190' ' ' LEU . 56.7 tp -126.01 123.54 38.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 168.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -148.98 132.85 17.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.71 -169.35 35.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -68.13 157.32 35.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 136' ' ' GLN . . . -86.09 129.41 54.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.221 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.79 -36.28 72.89 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.624 2.216 . . . . 0.0 112.427 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -47.95 -35.13 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.814 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 133' ' ' ALA . 8.1 pt20 -58.63 -33.1 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.235 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.8 tt -59.73 -19.23 48.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -164.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 139' ' ' TYR . 22.4 pt20 -63.25 -13.26 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.945 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.588 ' C ' ' O ' ' A' ' 138' ' ' GLN . 33.2 m-85 -20.37 -74.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -120.74 -19.85 7.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -161.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.0 p -123.51 -16.81 6.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -164.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.62 -19.98 13.25 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.44 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.57 178.36 36.36 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.443 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.722 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.0 Cg_endo -73.51 -42.5 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.388 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.02 -28.04 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 155.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -165.69 159.78 16.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.455 HD23 HD12 ' A' ' 150' ' ' LEU . 90.2 mt -51.17 -26.31 6.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 170.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.84 -30.25 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.4 mp -78.8 -18.2 54.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.88 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.518 HD21 ' HD3' ' A' ' 144' ' ' PRO . 93.0 mt -87.84 113.67 55.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 0.0 110.914 -172.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 23.9 Cg_exo -70.66 124.11 10.42 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.66 2.24 . . . . 0.0 112.366 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.01 154.09 42.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.15 -42.64 91.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.903 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.49 -31.77 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.4 m -68.48 -56.17 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 -170.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.111 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.31 -17.87 62.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -173.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 156' ' ' LEU . 66.5 mt-30 -73.84 -42.35 60.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 170.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -74.44 -20.71 59.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -83.59 -11.94 56.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.961 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -118.03 93.84 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 0.0 110.905 -174.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -89.2 -22.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.721 2.281 . . . . 0.0 112.397 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.2 p -69.9 -20.49 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -161.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 163' ' ' LEU . 2.6 pp -131.49 154.96 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.09 142.14 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -89.35 119.35 29.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -169.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.6 mt -86.64 -31.47 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 191' ' ' LEU . 47.8 pt -139.99 145.58 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.57 114.49 2.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -128.6 138.82 52.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -122.86 132.67 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.589 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.5 pp -124.68 141.92 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 175.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -118.79 135.01 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.856 -165.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -131.46 158.19 41.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -51.89 119.02 3.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -166.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.79 139.77 34.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.978 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -79.38 143.86 34.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -98.45 -21.68 16.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.62 54.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.456 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -158.35 169.09 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.058 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -61.72 135.02 57.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 183' ' ' GLY . 18.7 t-160 -57.64 121.01 9.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -90.15 -5.02 56.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 181' ' ' HIS . . . 116.19 -27.73 7.98 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.453 175.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.23 141.14 40.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' HB1' ' OE1' ' A' ' 136' ' ' GLN . . . -149.56 148.58 29.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.088 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.53 137.05 39.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.74 146.03 49.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 133' ' ' ALA . 43.9 pt -126.05 148.46 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -147.93 132.81 18.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -154.86 149.84 26.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.677 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.2 tt -140.85 127.7 20.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 -176.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -111.89 142.09 16.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.42 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -111.27 129.93 55.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -90.17 133.66 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.01 140.57 40.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.76 -22.63 63.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 59.3 m170 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.81 178.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.73 44.97 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.62 157.97 19.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.61 149.79 49.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -135.5 145.03 46.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -157.89 165.07 36.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.787 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.3 p -155.38 169.96 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.62 170.02 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.918 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.5 t -159.99 139.84 11.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.18 128.54 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.672 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 54.2 p90 -156.96 159.04 37.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.947 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.6 t -122.95 132.98 70.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -138.13 125.15 21.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.57 158.73 15.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.69 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 94.2 m -112.66 131.78 55.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.49 105.12 21.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.727 0.775 . . . . 0.0 110.813 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -71.9 142.78 39.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.599 2.199 . . . . 0.0 112.323 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -127.25 170.34 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -126.88 149.29 49.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 60.25 49.5 7.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 66.4 tp -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.96 -79.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -126.55 -37.31 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 154.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 24' ' ' VAL . 5.4 p -130.07 16.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 -169.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -64.7 -2.12 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -174.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -54.74 -13.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -88.97 -16.4 31.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 25' ' ' ALA . 9.4 tt -76.53 138.26 67.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.706 0.765 . . . . 0.0 111.074 -173.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 52.8 Cg_exo -53.7 119.26 5.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.274 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -78.93 2.29 20.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.26 -90.32 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.478 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.74 134.02 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 0.0 110.858 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -124.31 132.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 55.9 tp -101.62 122.66 44.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.82 117.36 33.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 85' ' ' LEU . 47.8 mt -88.01 54.88 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.95 105.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -168.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -60.12 -60.34 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.86 78.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.45 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 63.2 16.12 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.89 22.08 71.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.67 -51.59 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.76 -28.8 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -69.5 -34.6 74.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.901 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 97.9 mt -69.6 -35.05 74.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.76 85.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.4 p -68.72 -18.38 64.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.853 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.83 -0.87 57.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 96.27 4.81 59.58 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.408 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.18 145.23 26.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -91.53 108.06 19.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 93.9 t -108.65 131.24 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -110.4 128.9 55.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.21 132.51 56.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.3 137.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.122 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -155.01 162.46 41.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.821 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.45 -24.18 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.8 t -102.87 119.63 39.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.9 p -68.03 -26.67 65.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 170.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.19 -46.22 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.035 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -41.96 99.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.41 -35.94 82.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.95 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.87 92.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.136 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.94 -37.54 88.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.867 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.98 96.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.068 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.11 -42.64 99.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -64.72 -41.32 96.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.94 -40.18 92.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.85 95.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.103 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.11 -37.84 88.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.03 -33.09 75.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.21 -9.68 41.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 72.02 34.68 61.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.419 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.02 161.31 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.887 0.375 . . . . 0.0 111.116 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -104.41 130.15 52.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -133.06 162.01 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -115.37 132.0 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.9 p -123.77 134.74 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.84 125.14 60.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -85.24 117.7 24.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.926 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -175.17 145.1 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.79 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 88' ' ' PHE . 55.3 t30 -55.25 128.24 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 170.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.421 HD11 HD22 ' A' ' 36' ' ' LEU . 43.8 tp -57.93 -36.36 72.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.14 70.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -100.0 -6.12 27.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 84' ' ' ASN . 53.7 t80 -62.07 133.23 55.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -84.94 103.35 13.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.4 mt -87.49 123.14 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.133 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.2 t -102.02 134.21 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.54 -59.45 2.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -171.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.53 -22.76 64.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.97 68.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.078 -172.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.474 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 64.6 p-90 -147.46 160.77 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.44 -36.9 4.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.19 16.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.488 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 98' ' ' ILE . 3.1 tp -132.83 123.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 111.199 -177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.83 129.7 71.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 t -113.21 116.37 29.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.59 113.75 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.143 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.0 t80 40.22 50.48 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.1 t -98.99 90.02 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -76.32 119.46 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 105' ' ' LEU . 2.3 pp -145.51 149.28 40.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.39 155.22 71.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.691 2.26 . . . . 0.0 112.331 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.6 p -54.16 -29.37 45.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -58.73 -40.43 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.798 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.9 -34.02 64.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -55.3 -44.42 75.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.08 -31.28 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -87.29 -50.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.86 -43.17 84.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.909 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 10.0 m-30 -55.82 -54.26 53.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.698 0.761 . . . . 0.0 110.964 -167.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 44.0 Cg_endo -66.75 -29.33 42.79 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.348 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -67.51 -40.24 85.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -39.77 85.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.57 -49.7 75.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -64.74 -32.02 73.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.957 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.46 -31.3 54.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.3 tp -73.59 132.04 42.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -75.49 155.06 85.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -54.29 127.46 25.95 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.688 2.258 . . . . 0.0 112.294 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.58 4.1 87.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.457 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.0 168.83 51.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 28' ' ' ILE . 98.0 t -127.0 139.18 52.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -111.8 132.66 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -117.94 131.23 71.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.21 123.94 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 168.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -150.28 128.98 12.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.04 -175.24 43.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.475 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -70.06 159.38 33.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.59 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -105.58 150.53 39.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.523 0.678 . . . . 0.0 111.146 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.35 -21.43 72.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.313 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -57.63 -29.05 64.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.768 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.81 -26.63 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.003 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.089 ' O ' HD23 ' A' ' 137' ' ' LEU . 5.2 tt -58.29 -22.05 51.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -165.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.578 ' O ' ' C ' ' A' ' 139' ' ' TYR . 21.5 pt20 -61.37 -13.84 22.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -170.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.578 ' C ' ' O ' ' A' ' 138' ' ' GLN . 48.1 m-85 -20.54 -78.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -119.97 -19.26 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 -157.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 p -121.25 -13.3 8.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -166.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . 65.81 16.88 64.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.49 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.18 165.85 10.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.859 ' HD3' HD13 ' A' ' 137' ' ' LEU . 87.7 Cg_endo -76.69 -42.56 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.64 -25.36 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 151.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -169.23 145.9 3.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 142' ' ' GLY . 90.4 mt -61.0 -21.0 63.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 172.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -77.89 -21.81 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.35 -7.74 59.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.06 142.94 39.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.686 0.755 . . . . 0.0 110.879 -170.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 142.11 27.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.785 2.323 . . . . 0.0 112.308 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -98.55 156.59 16.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.754 ' O ' HD23 ' A' ' 153' ' ' LEU . 5.4 tt -53.59 -44.0 69.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.99 -35.38 80.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.5 m -64.62 -41.74 95.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.24 -35.53 80.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.93 -33.77 70.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.0 p -78.27 -21.53 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -175.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.62 -22.4 56.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.887 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.444 HD12 ' CZ2' ' A' ' 165' ' ' TRP . 18.4 mt -105.36 102.85 39.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.679 0.752 . . . . 0.0 110.912 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.58 -27.76 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.788 2.325 . . . . 0.0 112.343 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.6 m -78.77 -17.07 56.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -165.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.639 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.9 pp -130.82 154.76 47.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.13 140.4 38.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.444 ' CZ2' HD12 ' A' ' 160' ' ' LEU . 99.1 m95 -85.08 126.24 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -172.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.86 -32.65 13.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.682 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.6 pt -140.1 146.73 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 153' ' ' LEU . . . -159.18 119.24 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 168.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -132.3 140.26 48.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.809 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -113.9 120.42 40.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.94 145.68 36.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -119.2 136.72 54.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -132.06 154.75 49.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 168.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -59.26 120.07 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.1 141.86 28.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -73.73 145.38 45.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -93.56 -39.05 11.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.26 54.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.461 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -153.37 174.73 13.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.773 0.32 . . . . 0.0 111.103 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.88 130.18 24.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -59.69 119.54 7.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -85.29 -12.92 51.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -172.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 118.82 -21.32 9.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.541 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.19 139.47 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 0.0 110.925 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -154.9 155.26 33.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.056 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.59 129.11 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 167.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.0 mt -120.15 149.51 42.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.93 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.59 HG23 ' HB2' ' A' ' 133' ' ' ALA . 31.7 pt -124.82 142.52 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 172.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -145.36 124.45 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -153.82 148.55 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -174.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.754 ' C ' HD23 ' A' ' 191' ' ' LEU . 3.3 tt -140.03 129.73 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.9 -172.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -119.98 152.36 17.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.515 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -118.75 135.84 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.921 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -92.49 130.1 38.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.94 144.55 30.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.84 -32.91 70.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 179.221 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.2 m0 59.1 45.04 15.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -115.01 160.05 20.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -127.47 149.96 49.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.09 144.98 45.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.776 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -157.02 165.06 37.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -155.04 169.93 22.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -169.52 169.95 8.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -159.94 140.06 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -149.85 128.7 12.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 52.9 p90 -163.64 162.67 24.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -130.22 136.76 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -138.34 149.25 45.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.98 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.93 172.41 42.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.64 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 88.7 m -124.3 129.56 50.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -119.76 96.23 49.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.702 0.763 . . . . 0.0 110.823 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.02 139.6 70.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.658 2.238 . . . . 0.0 112.355 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.414 ' H ' ' HH ' ' A' ' 52' ' ' TYR . 71.4 m-80 -129.5 170.22 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 56.0 p30 -129.96 165.15 22.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 52.55 39.44 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 63.3 tp -65.7 -40.51 92.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.59 -80.85 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -130.95 -36.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 152.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.85 14.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.166 -168.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -58.64 -13.84 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 10.3 p-10 -62.69 -8.47 6.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.9 -14.83 27.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.978 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.479 ' CD1' HD11 ' A' ' 128' ' ' ILE . 79.1 mt -80.43 132.62 58.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.69 0.757 . . . . 0.0 111.13 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.66 117.54 3.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.296 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -77.87 9.18 3.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.29 -101.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -99.95 133.6 44.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.703 0.287 . . . . 0.0 110.87 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.5 131.7 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.2 tp -105.19 125.89 51.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.958 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.4 t -114.94 115.28 26.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 74.7 mt -88.37 58.11 4.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.05 105.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.088 -172.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 67' ' ' ALA . 10.1 tm-20 -57.77 -59.74 4.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.09 34.85 90.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.469 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 62.06 18.34 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.946 0.403 . . . . 0.0 110.889 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.38 15.16 67.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.477 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -64.66 -49.63 70.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -79.36 -29.91 42.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.29 67.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.88 -33.97 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -61.15 -50.89 71.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 54' ' ' VAL . 95.4 mt -67.6 -36.82 81.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.47 82.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.159 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -70.59 -16.72 62.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.1 mt -91.3 0.15 57.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.969 172.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 95.95 4.65 60.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.584 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.414 ' HH ' ' H ' ' A' ' 18' ' ' ASN . 20.6 m-85 -89.85 145.91 24.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.83 -175.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -90.23 109.15 20.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.953 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 47' ' ' LEU . 99.2 t -109.21 128.75 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -110.05 125.71 53.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.127 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.26 129.79 55.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 -172.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 134.68 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.83 160.55 41.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.836 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -80.6 -24.0 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -106.07 140.74 38.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -77.19 -28.01 53.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.88 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.04 -46.76 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.031 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.82 99.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.519 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.13 -37.08 84.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.0 110.882 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.57 90.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.39 -37.48 87.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.893 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' HB2' ' OE2' ' A' ' 38' ' ' GLU . . . -61.16 -43.2 99.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.085 175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -61.36 -46.45 90.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.59 -40.67 92.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.47 94.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.3 -38.17 90.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.84 -31.89 72.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.44 -8.22 45.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.923 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 11' ' ' TYR . . . 73.8 34.18 56.66 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.437 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.8 160.22 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -104.38 130.81 52.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.3 pt -133.86 165.33 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.053 175.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.3 m -119.43 133.82 55.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.201 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.4 p -120.73 132.75 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.12 122.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -88.51 116.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.3 t -173.35 141.49 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 88' ' ' PHE . 49.1 t30 -57.45 129.41 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.05 -35.08 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.916 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.32 68.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.079 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -99.83 -8.31 24.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ASN . 79.4 t80 -66.45 134.55 52.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.819 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -92.45 108.9 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.779 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.9 mt -81.4 122.16 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.7 t -94.31 138.74 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.15 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' GLY . . . -72.7 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -24.39 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.05 70.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -165.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.484 ' CZ3' ' HB ' ' A' ' 98' ' ' ILE . 67.7 p-90 -149.55 161.28 42.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 122' ' ' LYS . 45.8 mp0 -116.42 -35.46 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.73 147.89 16.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 173.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.484 ' HB ' ' CZ3' ' A' ' 95' ' ' TRP . 15.9 tt -133.0 129.73 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.873 0.368 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.8 134.88 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -169.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -109.55 117.67 34.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.51 113.05 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.096 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 48.3 44.48 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.1 t -114.46 72.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -73.03 122.38 21.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.814 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.0 mt -131.59 151.76 79.24 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.565 0.698 . . . . 0.0 110.962 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.76 146.25 91.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.374 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -57.91 -33.33 68.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.0 m -61.28 -40.9 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.0 tp -72.31 -36.47 68.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -54.15 -46.61 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -65.86 -26.09 67.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.915 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -80.11 -38.2 32.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.19 -31.87 66.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 7.4 m-30 -53.09 -53.6 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.671 0.748 . . . . 0.0 110.956 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.7 Cg_endo -65.55 -31.28 50.94 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 122.698 2.265 . . . . 0.0 112.378 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -67.49 -42.67 82.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.94 -39.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.105 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.84 -53.66 52.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.54 -30.02 70.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' ALA . . . -80.16 -28.15 50.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.407 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.9 tp -78.84 131.75 36.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 97.2 mttt -78.92 153.08 77.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.634 0.73 . . . . 0.0 110.839 172.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.45 128.14 28.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.335 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.12 -3.59 86.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.457 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.407 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -71.62 171.89 46.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.431 -176.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.23 142.52 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 163' ' ' LEU . 68.1 t80 -115.74 135.21 54.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.479 HD11 ' CD1' ' A' ' 28' ' ' ILE . 84.5 mt -120.04 131.86 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.407 HD23 HD21 ' A' ' 190' ' ' LEU . 54.4 tp -128.82 126.59 40.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.961 169.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -151.91 142.65 22.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.955 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.33 -166.9 34.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -64.73 153.33 40.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -93.35 156.56 39.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.54 0.686 . . . . 0.0 111.153 174.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -56.53 -23.81 49.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.642 2.228 . . . . 0.0 112.397 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -54.94 -27.58 44.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.766 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -58.52 -29.68 66.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.52 -10.73 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -162.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.615 ' O ' ' C ' ' A' ' 139' ' ' TYR . 65.3 tt0 -67.44 -8.48 33.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -176.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 138' ' ' GLN . 75.7 m-85 -20.0 -79.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.011 -170.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -134.65 -1.32 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.866 -166.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.3 p -131.67 -6.77 3.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.35 60.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.42 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.79 170.83 11.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.448 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.78 -39.63 19.64 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.659 2.239 . . . . 0.0 112.32 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 146' ' ' ASP . 98.4 mttt -129.34 -29.53 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 154.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.451 ' HB3' HD13 ' A' ' 149' ' ' LEU . 68.2 t0 179.24 126.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.493 ' C ' HD12 ' A' ' 147' ' ' LEU . 1.2 pp -56.3 -20.08 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -77.74 -20.17 53.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.907 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.8 mp -82.97 -6.52 59.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -163.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.19 154.96 40.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 110.918 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -52.98 114.4 1.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.784 2.322 . . . . 0.0 112.307 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.45 152.59 45.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.681 ' O ' HD23 ' A' ' 153' ' ' LEU . 4.8 tt -55.26 -46.78 76.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.58 -37.12 85.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.5 m -62.56 -42.02 99.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.84 -39.56 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.958 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -62.99 -37.75 88.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.2 p -82.98 -28.13 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -81.74 -14.36 56.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 160' ' ' LEU . 4.9 tt -107.71 102.19 43.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.636 0.732 . . . . 0.0 110.899 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -89.12 -24.2 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.386 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.2 m -68.96 -25.28 64.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -164.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 127' ' ' PHE . 4.2 mp -123.06 145.89 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.951 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -95.31 136.75 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.73 124.88 35.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -165.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.1 mt -92.01 -35.93 13.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.5 pt -141.78 146.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.05 119.38 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -135.05 141.05 46.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.835 -176.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -116.17 130.91 57.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 166.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.596 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.8 pp -127.01 149.96 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -114.14 136.8 52.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -133.55 155.86 48.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -55.16 117.06 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -170.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.79 133.0 36.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.49 140.78 55.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -100.01 -29.92 12.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.55 54.96 0.18 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -156.53 167.33 30.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 111.135 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -51.74 130.54 28.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.909 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -53.02 115.41 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -85.18 -12.72 52.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 120.9 -35.54 3.65 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.511 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.91 135.07 49.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.9 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -170.58 162.08 7.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.82 44.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.9 mt -118.58 149.85 40.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 133' ' ' ALA . 42.4 pt -120.81 142.73 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -142.21 126.96 18.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -146.72 148.57 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.721 ' C ' HD23 ' A' ' 191' ' ' LEU . 4.8 tt -143.07 128.16 18.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.934 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.459 ' N ' HD23 ' A' ' 191' ' ' LEU . . . -122.2 154.7 16.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -125.32 144.36 50.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -95.59 136.39 36.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.5 mt -72.7 141.5 48.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.832 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.11 -23.16 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 178.485 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.722 0.296 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.7 m0 58.05 44.99 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.86 140.23 37.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -125.11 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -133.93 145.02 49.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.1 165.06 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.0 p -150.9 169.79 20.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -169.65 170.02 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -159.42 140.04 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.81 134.94 18.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -153.71 169.29 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.929 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.74 132.73 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -145.19 165.04 29.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 147.25 21.27 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.777 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 92.0 m -116.48 129.02 55.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.633 0.254 . . . . 0.0 111.173 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -139.14 125.05 12.19 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.666 0.746 . . . . 0.0 110.902 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.56 149.18 49.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -125.27 149.88 47.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.92 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -113.5 149.51 34.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 62.57 25.21 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.941 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.9 tt -64.52 -39.94 94.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.97 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.02 -82.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.3 m -128.15 -37.56 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 143.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' CG2' HD13 ' A' ' 191' ' ' LEU . 27.0 m -124.96 29.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.202 -176.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -53.05 -15.08 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.121 -174.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -64.99 -2.01 2.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -100.59 -17.78 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 128' ' ' ILE . 89.7 mt -75.82 134.36 72.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.637 0.732 . . . . 0.0 111.177 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.96 108.37 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.315 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -78.27 18.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -167.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' HA3' ' OE1' ' A' ' 96' ' ' GLU . . . -84.59 -97.7 0.66 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -102.94 128.69 49.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.811 -171.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.2 127.99 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.089 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . 63.8 tp -106.66 123.36 48.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.8 t -111.44 116.79 31.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.808 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.16 60.21 5.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 174.99 105.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -67.07 -60.52 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -170.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.65 35.0 91.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 173.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 59.03 20.73 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.74 61.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.521 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -65.68 -46.4 79.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -77.57 -27.89 51.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -52.59 59.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.3 p -69.43 -29.18 66.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -64.83 -50.76 65.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' A' ' 54' ' ' VAL . 98.2 mt -65.27 -37.84 88.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.79 85.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -66.87 -20.17 65.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 mt -89.63 0.44 56.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 94.92 5.0 61.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.474 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.88 143.88 27.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -90.02 106.85 18.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.896 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 47' ' ' LEU . 77.5 t -107.21 125.66 63.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.4 m -112.08 128.59 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 167.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.49 130.57 56.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.128 -174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 133.19 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -155.79 156.62 35.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -77.93 -27.78 49.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.039 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.0 p -96.03 149.62 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -168.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -80.11 -31.29 39.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.949 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.74 -48.19 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.51 98.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.574 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.62 -36.71 81.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.14 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.09 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.88 -37.3 81.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.72 99.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.166 174.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.18 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -68.41 -41.21 80.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.36 -40.51 96.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.16 96.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.51 -37.72 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -32.7 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.98 -7.28 49.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.11 33.69 59.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.89 163.77 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 111.165 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -108.24 131.35 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.43 170.19 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -123.93 130.66 52.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.5 p -121.92 134.35 54.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.87 123.71 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -85.86 114.37 22.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -173.6 143.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -55.4 133.23 49.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -57.77 -35.61 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 109' ' ' LEU . . . -71.62 -27.22 62.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.078 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -99.92 -11.92 20.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.23 135.02 52.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -93.19 112.63 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.501 HG22 ' HA3' ' A' ' 120' ' ' GLY . 92.4 mt -87.66 125.12 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.094 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.9 t -102.95 138.05 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.192 -173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 -61.13 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -168.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.42 -35.04 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.05 -38.97 65.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 34' ' ' LEU . 17.8 m-90 -132.28 154.83 49.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 122' ' ' LYS . 53.7 mt-10 -107.38 -43.56 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.52 149.87 18.33 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mm -113.91 123.93 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.28 129.47 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.5 m -115.51 118.23 32.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.6 mm -113.67 116.69 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.176 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 47.42 42.97 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.2 t -108.06 96.44 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -89.9 120.39 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.5 150.04 74.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.637 0.732 . . . . 0.0 110.926 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.87 144.32 88.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.285 . . . . 0.0 112.324 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.4 p -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.877 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -60.12 -40.3 89.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 86' ' ' ALA . 37.1 tp -73.83 -33.38 64.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.937 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -56.38 -44.97 80.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -75.07 -30.23 60.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -69.98 -39.89 75.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.31 -34.83 68.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 115' ' ' PRO . 35.7 t80 -51.37 -48.92 84.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.917 -163.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 114' ' ' TYR . 98.0 Cg_exo -47.34 -46.09 20.78 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.386 176.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -76.81 -36.24 57.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.18 -47.13 85.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.23 -54.53 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.16 -30.45 71.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.928 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -84.91 -11.97 75.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.467 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.67 129.63 34.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 96' ' ' GLU . 83.8 tttt -67.91 139.9 93.52 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.857 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.5 127.61 18.71 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.722 2.282 . . . . 0.0 112.345 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.94 1.26 88.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.483 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -73.71 170.41 52.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.418 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.83 142.82 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.791 0.329 . . . . 0.0 111.206 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -109.59 128.27 55.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 28' ' ' ILE . 38.1 mm -118.5 131.67 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.139 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.526 HD23 HD21 ' A' ' 190' ' ' LEU . 58.4 tp -129.84 123.77 31.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 165.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -143.93 130.77 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 -177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.22 -167.38 30.13 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -59.7 158.74 9.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -86.57 131.22 46.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.511 0.672 . . . . 0.0 111.215 174.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.42 -38.42 63.38 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.564 2.176 . . . . 0.0 112.373 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -47.21 -35.41 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 133' ' ' ALA . 6.9 pt20 -56.71 -30.95 64.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.266 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.4 tt -59.04 -17.59 26.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 139' ' ' TYR . 15.8 pt20 -63.05 -16.45 59.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.566 ' C ' ' O ' ' A' ' 138' ' ' GLN . 37.9 m-85 -24.77 -66.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.951 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -120.13 -18.13 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.832 -161.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.6 p -126.37 -17.06 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -163.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.37 -22.88 7.88 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.424 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.63 175.76 37.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.544 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.77 ' HD3' HD13 ' A' ' 137' ' ' LEU . 73.8 Cg_endo -73.44 -41.1 1.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.754 2.303 . . . . 0.0 112.353 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -129.79 -27.96 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 156.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -161.92 155.87 21.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 169.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 HD12 ' A' ' 150' ' ' LEU . 53.5 tp -50.19 -23.86 2.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 169.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.15 -28.7 70.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 1.1 mp -78.49 -14.13 59.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.975 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.421 HD12 HD12 ' A' ' 147' ' ' LEU . 83.7 mt -95.81 112.13 58.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.931 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.76 132.27 6.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.379 -173.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -64.8 149.79 48.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 166.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 67.6 tp -55.45 -44.81 76.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.95 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.1 -38.39 90.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.0 m -60.4 -37.08 79.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.19 -42.58 93.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.949 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -65.91 -36.23 82.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.1 p -78.18 -25.89 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -84.58 -13.77 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 tt -119.36 92.95 46.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.663 0.744 . . . . 0.0 110.946 -175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -89.53 -24.65 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 0.0 112.347 -170.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.7 p -81.18 -15.36 55.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -162.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mp -114.51 140.03 49.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -86.35 132.85 33.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -92.29 114.48 27.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 191' ' ' LEU . 83.8 mt -89.63 -28.69 19.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 -175.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -138.61 145.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -161.37 113.73 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -129.11 139.19 52.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -118.41 128.76 54.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.8 mt -110.05 123.27 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -106.83 128.17 54.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -163.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -132.73 156.44 47.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 158.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -56.69 120.88 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -167.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.0 mt -97.1 142.09 29.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -76.81 150.92 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -98.3 -27.93 13.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.01 54.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.488 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -154.95 166.55 33.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -57.56 136.16 56.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 183' ' ' GLY . 20.1 t-160 -57.06 120.1 7.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -91.05 -5.55 55.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -173.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 181' ' ' HIS . . . 118.14 -31.47 5.64 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.531 175.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.45 139.74 46.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.917 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -150.09 148.21 28.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.109 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -104.19 137.69 41.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.027 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.99 145.44 49.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.434 HG23 ' HB2' ' A' ' 133' ' ' ALA . 44.2 pt -124.01 146.22 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.194 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -143.23 130.85 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.3 pt? -152.19 150.28 29.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.877 ' O ' HD23 ' A' ' 191' ' ' LEU . 0.2 OUTLIER -140.73 129.77 23.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.0 141.59 16.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.502 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -107.65 132.87 52.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -98.39 131.6 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.33 145.18 31.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -73.52 -18.0 61.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.746 177.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.756 0.312 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -164.79 142.75 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.05 159.99 40.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -123.89 119.42 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.83 148.11 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -126.39 154.93 42.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.7 p -153.52 169.96 21.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -154.98 160.07 40.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.8 p -156.79 164.42 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -126.06 146.86 49.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.61 164.98 23.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.0 134.96 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.059 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -149.29 164.96 33.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.46 163.09 11.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -121.06 102.13 8.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -139.95 69.88 35.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.655 0.74 . . . . 0.0 110.902 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.14 155.14 42.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.743 2.295 . . . . 0.0 112.314 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.2 155.02 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.46 170.14 22.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -60.02 133.38 56.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.83 -32.34 20.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.009 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.11 -93.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.2 t -124.97 -51.82 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 24' ' ' VAL . 40.1 t -126.82 26.11 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.092 173.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.72 -8.86 7.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -62.46 -7.69 4.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -89.27 -10.7 45.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.883 175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 126' ' ' VAL . 68.8 mt -79.24 130.76 68.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 111.207 173.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.88 153.06 79.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.741 2.294 . . . . 0.0 112.277 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.31 12.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 -173.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.58 -143.4 7.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.524 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.01 144.47 30.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.695 0.283 . . . . 0.0 110.948 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.49 135.05 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 55' ' ' THR . 51.0 tp -105.57 126.03 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -106.42 124.9 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.4 mt -95.57 133.24 39.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.06 53.76 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.059 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HG3' ' H ' ' A' ' 41' ' ' GLY . 54.0 tp10 -90.16 123.33 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.14 16.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.425 -166.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -129.99 10.02 5.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 38' ' ' GLU . . . 75.01 22.05 77.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -68.76 -42.11 77.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -75.12 -29.15 60.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.845 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -45.43 89.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.7 m -69.55 -37.27 76.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -63.06 -47.34 83.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 54' ' ' VAL . 70.0 mt -63.54 -38.82 92.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.28 79.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -70.64 -20.51 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.844 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.2 mt -87.58 0.12 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.74 7.66 58.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -83.96 145.0 28.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.17 112.61 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.826 165.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 47' ' ' LEU . 89.9 t -111.44 135.72 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 34' ' ' LEU . 97.5 m -107.75 125.34 51.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 165.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.98 133.92 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.079 -173.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.33 129.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 59' ' ' GLN . 49.5 t0 -154.5 153.24 31.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.424 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 92.4 mt-30 -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 174.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.3 t -95.67 115.45 27.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.83 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.0 p -69.07 -33.71 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.02 -31.37 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.78 -41.64 97.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.54 169.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.78 -35.04 79.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.29 88.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.074 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -64.29 -38.79 92.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.972 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.63 91.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.01 -43.16 99.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.15 -40.89 95.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.1 -40.14 92.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.17 96.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -33.91 77.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.9 -10.99 34.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.92 66.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.416 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.39 161.7 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.169 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -97.37 129.97 44.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 pt -137.08 163.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.143 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.0 m -121.65 134.08 54.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.5 p -119.17 133.05 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.91 122.38 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -85.12 118.79 24.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.4 t -174.53 143.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.29 128.16 35.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.31 -38.59 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.33 -32.56 74.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -97.78 -6.37 32.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.99 129.89 42.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -94.9 114.93 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.879 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -93.76 117.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.191 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -83.69 136.23 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.051 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.39 -49.51 54.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -56.92 -26.09 58.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.74 80.6 9.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -69.86 130.14 41.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -173.14 150.81 1.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.49 163.33 46.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.473 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.6 mm -114.84 117.89 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.7 t -123.45 124.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.7 m -112.6 115.03 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.46 123.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 102' ' ' PHE . 53.8 t80 43.19 49.83 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 83.1 m -97.27 79.02 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -75.46 114.8 14.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.8 pp -152.04 152.71 30.24 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.618 0.723 . . . . 0.0 110.821 -169.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.85 149.74 78.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.364 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -58.1 -29.77 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.0 m -59.2 -35.96 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 105' ' ' LEU . 49.7 tp -69.87 -36.9 75.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.947 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.85 -28.02 69.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -82.43 -39.93 21.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.55 -32.56 62.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 m-30 -54.73 -55.23 40.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.715 0.769 . . . . 0.0 110.94 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 29.4 Cg_endo -61.69 -34.01 84.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.314 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -68.63 -46.42 69.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.94 -31.61 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -69.2 -57.11 5.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -71.71 -34.04 69.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -68.26 -31.12 74.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.696 HD11 ' HA3' ' A' ' 125' ' ' GLY . 57.7 tp -86.2 128.84 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.947 0.403 . . . . 0.0 110.892 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.87 159.56 68.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.524 0.678 . . . . 0.0 110.911 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.04 133.53 46.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.44 48.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.696 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -75.54 168.3 54.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' A' ' 28' ' ' ILE . 96.1 t -131.95 140.16 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 111.124 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -106.46 131.88 53.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.7 134.4 66.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.19 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 190' ' ' LEU . 59.6 tp -127.19 127.18 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 172.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.84 139.74 15.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.08 30.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.539 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.435 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 72.9 m-85 -65.17 150.34 48.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.902 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -112.1 161.83 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 0.0 111.132 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -49.71 -30.02 21.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 0.0 112.309 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.1 -22.27 49.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 -175.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -59.78 -23.31 63.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.96 -20.03 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -172.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.469 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 58.7 tp60 -60.86 -24.5 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 -170.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.732 ' CZ ' ' HA3' ' A' ' 183' ' ' GLY . 43.3 t80 -47.42 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.012 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -117.61 -10.31 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 69.4 p -120.45 12.15 11.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -167.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 138' ' ' GLN . . . -82.38 81.65 1.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.464 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.41 -130.92 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.0 -31.67 35.49 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.706 2.271 . . . . 0.0 112.33 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -86.34 39.8 0.85 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.955 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.05 170.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.872 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.8 tp -53.96 -27.86 33.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -166.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -77.38 -22.48 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.8 mp -92.81 -9.6 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -170.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.92 150.48 42.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 0.0 110.926 -156.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.79 167.07 28.16 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.617 2.211 . . . . 0.0 112.393 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -129.94 154.33 47.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 168' ' ' ALA . 3.3 pp -48.2 -30.78 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 96.6 mt-10 -65.1 -36.51 84.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.1 p -75.15 -31.84 61.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 156' ' ' LEU . 10.1 tt -64.2 -45.17 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 171.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 154' ' ' GLU . 4.4 pt20 -66.46 -28.22 68.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.3 p -73.18 -16.09 61.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -78.97 -13.27 59.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.71 108.25 61.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.674 0.749 . . . . 0.0 110.947 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.4 -20.67 3.92 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.763 2.309 . . . . 0.0 112.309 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.5 p -71.66 -24.67 61.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -159.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 163' ' ' LEU . 3.7 pp -143.2 168.1 20.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.921 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -104.94 144.61 31.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -96.56 128.66 43.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 -171.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -88.72 -31.67 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.915 -172.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 190' ' ' LEU . 43.3 pt -138.27 147.83 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.087 -168.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -146.55 117.64 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 166.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -130.02 140.02 50.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -103.87 122.66 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 165.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 49.5 mt -111.08 143.22 42.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -170.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.98 124.29 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB2' HD11 ' A' ' 187' ' ' LEU . 88.5 mmt-85 -140.07 174.31 10.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -79.77 140.09 37.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.87 138.29 58.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.16 143.53 48.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.34 119.94 20.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.898 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.96 -88.17 0.12 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.517 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.58 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.25 170.17 9.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -84.65 -167.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.879 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -100.32 108.64 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.732 ' HA3' ' CZ ' ' A' ' 139' ' ' TYR . . . -179.31 -158.01 20.79 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.451 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -70.38 146.1 50.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 0.0 110.971 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.17 142.85 35.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.046 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -104.4 131.13 52.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 5.1 mp -126.94 153.02 46.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.928 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.54 HG23 ' HB2' ' A' ' 133' ' ' ALA . 44.7 pt -114.11 142.48 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -135.25 123.06 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.72 147.65 26.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 191' ' ' LEU . 9.9 tt -139.74 129.89 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.25 147.6 18.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.461 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.58 130.14 54.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.882 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 1.239 ' O ' ' HD2' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -80.06 115.33 19.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 175.381 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.83 140.25 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.72 34.83 5.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -176.553 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -155.03 166.8 32.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.937 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -162.0 160.07 27.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -129.9 149.97 51.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -159.22 129.01 5.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.99 168.11 28.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.3 t -151.66 139.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.1 160.0 38.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -165.79 137.26 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.884 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -161.7 164.61 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.75 163.45 39.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.63 80.51 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.17 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.35 172.38 7.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.32 176.48 22.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -153.8 154.95 34.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.694 0.283 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.92 149.16 62.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.79 154.39 48.71 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.33 156.13 43.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -152.65 105.61 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.39 110.82 22.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 48.0 tp -70.12 -51.18 33.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 189' ' ' GLN . 49.0 t -101.85 -82.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 -174.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.4 m -128.34 -39.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.821 158.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.63 15.65 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -63.89 -19.03 64.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.115 -166.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -57.3 -16.7 9.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.818 173.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.32 1.24 51.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.445 HD12 ' HB1' ' A' ' 25' ' ' ALA . 85.6 mt -67.48 133.84 92.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.716 . . . . 0.0 111.143 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.41 131.32 27.26 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 0.0 112.335 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . 84.4 mt-30 -75.91 13.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.947 -176.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.17 155.05 26.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 61.86 68.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 110.859 173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 52' ' ' TYR . 47.7 mm -115.01 126.51 72.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.42 120.71 43.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.5 t -108.49 125.94 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.6 mt -108.63 135.45 49.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 55.11 45.77 25.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CD ' ' HB1' ' A' ' 56' ' ' ALA . 19.8 pm0 -71.45 -18.33 62.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 -175.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.18 -66.95 3.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -130.33 11.61 5.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 82.98 5.24 89.51 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.507 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -64.86 -36.94 85.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.938 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.51 88.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -173.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.6 m -68.46 -38.38 81.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.845 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -58.47 -51.95 67.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.1 mt -59.71 -40.06 86.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.29 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.073 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.1 p -69.75 -17.83 63.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.87 1.06 41.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.77 4.61 65.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.498 ' HB3' HG13 ' A' ' 33' ' ' ILE . 10.1 m-30 -74.12 147.0 43.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 0.0 111.004 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -84.98 101.96 12.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.856 166.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.22 124.5 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -165.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.6 m -112.28 126.06 54.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 165.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HB1' ' CD ' ' A' ' 38' ' ' GLU . . . -110.05 126.61 54.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.078 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.24 128.33 74.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -176.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.23 155.92 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -78.99 -20.02 50.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 t -93.67 110.96 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 94.3 p -67.81 -34.85 77.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.85 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.43 -30.92 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.92 97.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.42 -36.53 81.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.871 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.74 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -64.25 -38.62 91.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 173.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.65 -43.33 93.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.86 -44.72 96.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -66.82 -41.13 87.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.35 -41.07 98.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.35 93.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.158 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.81 -39.21 93.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.92 -32.87 73.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.948 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -91.82 -10.1 41.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.57 32.98 58.92 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.499 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.79 160.1 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.23 137.68 45.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.972 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.1 pt -135.77 164.19 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -119.21 133.5 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.6 p -118.49 135.01 54.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.147 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 81.0 t -128.08 119.96 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 1.1 tm0? -84.09 113.63 21.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -173.04 143.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -54.86 124.06 15.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.29 -37.35 67.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.64 -32.08 72.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.75 -8.18 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.85 127.21 30.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.978 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.21 114.93 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 pt -126.58 141.82 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.089 168.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.91 -179.8 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.181 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.46 -34.11 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -173.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.64 -29.23 70.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.0 94.54 5.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.074 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 122' ' ' LYS . 41.7 m0 -89.89 104.84 17.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.945 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.92 126.08 15.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.86 158.7 36.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.546 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -112.12 118.7 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.129 -171.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.1 t -121.37 124.34 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 103' ' ' CYS . 58.8 m -130.1 108.44 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.9 mm -114.53 125.67 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.159 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 48.61 40.26 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -171.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 100' ' ' SER . 87.1 m -118.67 82.13 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.892 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.1 130.98 34.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.9 mt -121.1 146.96 45.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 109' ' ' LEU . 56.2 Cg_endo -67.67 147.6 76.26 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.604 2.203 . . . . 0.0 112.389 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -54.23 -40.25 67.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.913 -172.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.3 m -60.49 -38.91 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 109' ' ' LEU . 3.6 tt -71.91 -39.98 69.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.948 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -59.71 -40.24 87.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.848 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.59 -29.42 70.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -83.62 -39.82 19.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.9 tp -72.15 -41.62 66.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.576 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 3.2 m-30 -55.37 -49.51 92.07 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.667 0.746 . . . . 0.0 110.951 -165.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 96.4 Cg_exo -47.32 -39.36 27.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.98 -47.89 19.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.38 -25.21 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -64.95 -47.67 76.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 175.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.9 -24.91 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.1 -49.9 59.94 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.486 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' A' ' 194' ' ' LYS . 1.9 pt? -81.93 153.07 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 63.9 pttt -75.43 155.84 85.54 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.524 0.678 . . . . 0.0 110.895 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -56.22 122.7 12.25 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.64 -1.69 81.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.491 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.92 177.01 48.55 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.7 t -129.31 140.65 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.141 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -107.22 129.0 54.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.92 123.99 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 190' ' ' LEU . 63.2 tp -131.63 127.08 36.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.867 166.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -157.14 140.06 15.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 159.97 -178.59 35.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -58.35 160.86 4.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.96 142.03 98.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.562 0.696 . . . . 0.0 111.049 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . 80.9 Cg_exo -51.93 -48.78 19.83 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.338 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -45.72 -34.86 3.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.89 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.64 -22.72 66.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.775 HD23 ' N ' ' A' ' 138' ' ' GLN . 0.2 OUTLIER -78.76 -8.58 58.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -164.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.775 ' N ' HD23 ' A' ' 137' ' ' LEU . 77.4 mt-30 -72.54 -25.13 61.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -171.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.9 t80 -25.45 -65.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -110.84 -24.81 10.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.922 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.6 p -112.64 11.73 19.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.233 -167.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.02 104.21 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.608 ' H ' ' H ' ' A' ' 145' ' ' LYS . . . -174.98 -74.97 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -66.76 -3.27 9.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.645 2.23 . . . . 0.0 112.265 154.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.608 ' H ' ' H ' ' A' ' 143' ' ' GLY . 75.3 mmtt -114.29 38.22 3.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.908 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -69.76 147.85 49.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.802 -169.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 150' ' ' LEU . 19.2 tp -54.3 -26.25 28.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.21 -31.72 72.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 149' ' ' LEU . 5.4 mp -82.89 -13.53 55.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 147' ' ' LEU . 86.4 mt -93.33 123.19 61.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.692 0.758 . . . . 0.0 110.901 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 77.5 Cg_endo -84.57 135.05 5.81 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.363 -169.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.28 145.07 56.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 164.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.9 tp -52.89 -46.81 68.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.63 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.4 m -63.37 -40.47 97.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 175.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 54.8 mt -59.81 -39.95 86.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -64.0 -34.25 77.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.3 p -81.88 -25.01 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -77.58 -15.47 59.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.88 98.28 28.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.51 -28.33 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.278 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 92.0 p -73.55 -20.69 60.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.785 -163.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.552 HD13 ' HA3' ' A' ' 192' ' ' GLY . 3.4 pp -134.12 159.11 41.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -103.42 139.72 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -88.16 124.9 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.26 -31.74 14.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.665 HG12 ' HB3' ' A' ' 191' ' ' LEU . 45.7 pt -140.17 146.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.29 117.42 1.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -139.11 146.75 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.42 HD21 ' HB1' ' A' ' 186' ' ' ALA . 18.7 t-20 -113.72 129.98 56.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.5 pp -135.27 154.15 51.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -106.37 130.64 54.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -174.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -143.78 169.18 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.78 137.42 55.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.9 tp -67.45 129.09 38.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -69.72 131.37 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -169.85 157.04 6.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.93 -81.19 1.08 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.14 70.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 111.104 -175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.94 151.96 23.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -130.11 -34.93 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -74.79 129.99 38.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.62 125.74 1.21 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.557 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.856 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.16 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.098 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 170' ' ' ASN . . . -99.09 136.74 38.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.061 173.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.89 144.94 48.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.8 pt -120.71 142.68 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.43 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.6 pt20 -143.19 128.13 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.71 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.2 pt? -152.61 147.57 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.665 ' HB3' HG12 ' A' ' 167' ' ' ILE . 5.7 tt -139.75 127.19 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -174.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 163' ' ' LEU . . . -112.06 141.83 16.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.441 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -108.9 129.37 55.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.872 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.437 ' HD2' HD21 ' A' ' 121' ' ' LEU . 83.5 tttt -89.29 130.05 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.75 145.05 28.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.945 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -76.49 149.93 36.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.803 177.646 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mmm . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.05 165.02 38.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.989 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -160.93 160.01 30.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.954 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -158.78 128.42 5.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.974 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.96 168.73 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -149.69 139.08 21.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -157.0 160.0 38.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.922 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.9 t -161.95 139.96 8.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.827 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -160.86 160.88 31.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -153.71 129.97 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.921 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -120.5 125.05 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.137 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -159.99 134.95 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.19 -175.91 40.96 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 t -153.9 155.04 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.99 148.08 58.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.752 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 155.04 47.92 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.337 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -129.9 160.02 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.806 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -141.76 99.85 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.39 132.57 44.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 47.4 tp -68.56 -44.09 75.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 189' ' ' GLN . 67.9 t -111.35 -83.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 t -130.61 -37.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 163.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.17 2.96 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . . . -63.36 -24.24 67.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -162.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -63.3 -14.7 52.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -78.25 -4.09 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.32 139.69 96.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.579 0.705 . . . . 0.0 111.168 169.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -39.31 125.05 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.347 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -60.06 -5.67 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.903 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.28 -174.56 17.62 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' TRP . 72.0 mmtt 64.98 65.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.58 131.8 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 58.9 tp -104.35 119.85 39.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 174.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -105.89 122.5 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.04 127.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -171.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 62.73 50.09 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 20.0 pm0 -75.61 -19.19 59.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.29 -70.06 3.26 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.493 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.54 -4.03 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.4 12.77 64.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.455 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -61.71 -37.41 84.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -67.29 -41.06 86.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.14 90.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 93.4 m -72.37 -34.2 67.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.62 -51.73 68.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.952 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.01 -35.82 80.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.18 86.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -71.07 -20.67 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.02 2.77 51.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.81 4.86 61.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -82.92 137.84 34.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 111.006 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -87.81 110.11 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.99 130.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 -170.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.6 m -102.9 125.01 49.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 163.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.29 124.41 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 -170.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.85 126.79 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.111 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -157.17 154.68 29.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -79.26 -19.99 49.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.961 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -93.67 111.61 23.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.828 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.459 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 96.1 p -67.36 -33.95 76.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.1 -31.29 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.042 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.68 -39.73 97.83 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.535 170.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.8 mt -68.37 -34.64 76.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.14 82.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -62.5 -39.88 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.771 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -61.28 -41.66 97.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.061 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.93 -44.53 95.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -40.78 90.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 81.8 mt -61.71 -40.52 95.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.83 96.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.41 -38.26 90.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.26 -34.09 76.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.84 -9.5 43.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.44 33.97 63.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.412 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.23 160.72 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.158 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -105.37 132.31 51.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.965 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.6 pt -134.78 160.88 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.07 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -116.7 134.01 55.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.2 p -123.51 140.99 52.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 80.1 t -132.7 122.76 47.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 170.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.6 tm0? -83.37 116.91 22.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 t -174.83 145.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -55.18 123.17 12.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.901 172.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 113' ' ' LEU . 50.0 tp -55.78 -36.88 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.909 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -34.4 77.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -98.84 -7.22 27.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.29 134.8 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.948 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.37 111.29 22.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.8 mt -94.87 120.44 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.6 131.59 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 -176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.04 -43.59 33.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.12 -20.59 59.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.848 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.33 125.18 30.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 82.7 m95 -75.18 94.95 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.94 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 98.6 mt-10 -149.95 123.71 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.899 170.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.64 53.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.53 115.99 51.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 -172.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.96 129.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -135.04 112.67 10.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.424 HG22 ' CD2' ' A' ' 102' ' ' PHE . 25.6 mm -115.81 130.95 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.107 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.424 ' CD2' HG22 ' A' ' 101' ' ' ILE . 71.3 m-85 53.51 44.87 29.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -173.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -117.07 85.67 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -80.79 121.6 26.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.3 pp -142.92 153.58 60.95 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.588 0.709 . . . . 0.0 110.966 -174.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.15 153.95 46.58 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 0.0 112.333 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -59.52 -33.24 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -60.13 -32.32 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' A' ' 105' ' ' LEU . 52.8 tp -74.13 -39.31 63.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.0 mtm-85 -56.4 -42.68 78.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.02 -32.23 73.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.99 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -78.9 -40.49 32.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' HG ' ' A' ' 85' ' ' LEU . 63.4 mt -73.73 -40.1 63.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.894 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 2.8 m-30 -53.55 -51.17 78.51 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.691 0.758 . . . . 0.0 110.877 -164.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 89.9 Cg_exo -46.94 -43.39 24.42 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 174.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.88 -45.99 26.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.6 -30.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -170.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -63.88 -51.18 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -71.68 -25.99 62.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.947 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.31 -52.61 51.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.404 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.405 HD21 ' HD2' ' A' ' 194' ' ' LYS . 1.6 pt? -81.31 153.97 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.941 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -88.88 155.87 49.88 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 110.923 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.01 130.17 26.88 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.772 2.315 . . . . 0.0 112.334 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.08 77.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.451 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.68 175.46 47.0 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.518 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.64 139.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -109.69 127.87 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 170.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.9 mt -122.44 128.37 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.035 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tt -134.34 128.3 33.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -155.55 139.97 16.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.54 -174.48 34.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -56.01 160.8 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . . . -59.9 136.97 90.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.5 0.667 . . . . 0.0 111.107 171.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . 96.5 Cg_exo -52.04 -40.32 68.14 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -47.51 -30.34 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -57.6 -28.0 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -171.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 138' ' ' GLN . 0.2 OUTLIER -74.24 -16.63 60.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -165.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.627 ' N ' HD23 ' A' ' 137' ' ' LEU . 70.9 mt-30 -68.93 -21.3 64.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 -170.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.568 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.4 t80 -25.1 -65.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -114.12 -22.3 10.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.1 p -113.85 6.52 16.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.16 -166.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.6 114.66 7.0 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.456 ' H ' ' H ' ' A' ' 145' ' ' LYS . . . -175.04 -75.28 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.451 169.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.06 -11.07 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.625 2.217 . . . . 0.0 112.363 155.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 137' ' ' LEU . 73.8 mmtt -96.18 34.28 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB3' HD13 ' A' ' 149' ' ' LEU . 10.9 t70 -66.27 146.5 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -169.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.493 ' HA ' HD12 ' A' ' 150' ' ' LEU . 19.4 tp -56.45 -24.74 47.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.66 -31.03 71.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 149' ' ' LEU . 7.5 mp -85.78 -16.46 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 175.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 147' ' ' LEU . 89.5 mt -86.66 134.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.609 0.719 . . . . 0.0 110.982 -176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.35 135.72 6.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 -171.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.8 155.69 37.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.25 -45.39 87.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -34.98 79.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.8 m -64.84 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.158 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.8 mt -57.95 -51.11 71.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.999 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.13 -31.82 69.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 84.7 p -75.56 -24.2 56.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 161' ' ' PRO . 97.3 mt-10 -83.82 -2.08 55.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.9 mt -104.47 95.11 7.94 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.597 0.713 . . . . 0.0 110.986 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 66.2 Cg_endo -83.14 -31.52 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.655 2.237 . . . . 0.0 112.277 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 90.7 p -75.81 -17.05 59.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.786 -168.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 163' ' ' LEU . 4.5 pp -132.01 162.06 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 -176.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -107.63 130.56 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.862 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -87.27 134.8 33.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 -170.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.42 -30.09 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' HB3' ' A' ' 191' ' ' LEU . 59.8 mt -129.91 138.47 53.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -170.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.06 111.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.078 162.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -138.31 145.91 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -117.16 129.93 56.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 170.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 171' ' ' LEU . 4.5 pp -132.13 154.33 49.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.96 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.99 134.63 50.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.85 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -140.19 173.66 11.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.51 135.59 56.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 tp -74.78 127.2 32.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.985 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.55 139.54 45.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -169.94 156.29 6.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.98 -73.02 1.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.518 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.62 77.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 111.023 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.82 166.76 10.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.96 -34.96 1.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -88.29 156.09 19.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 136.45 148.43 5.52 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.56 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.96 151.87 25.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.16 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.11 133.92 43.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.71 145.54 49.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 47.2 pt -120.03 143.72 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.417 ' HB2' HG13 ' A' ' 22' ' ' VAL . 21.5 pt20 -138.16 134.36 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.918 174.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 190' ' ' LEU . 2.4 pt? -152.11 150.54 30.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.926 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.74 ' HB3' HD12 ' A' ' 167' ' ' ILE . 3.5 tt -139.93 129.68 24.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -112.75 146.64 18.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.497 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -114.18 128.97 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.836 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.405 ' HD2' HD21 ' A' ' 121' ' ' LEU . 82.5 tttt -83.3 125.23 31.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 145.1 26.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 -175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.83 154.5 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 178.038 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.752 0.31 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -154.94 165.03 37.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -144.97 -175.79 4.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.825 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -162.15 163.57 28.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -137.05 166.88 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -150.59 126.0 10.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -107.79 168.14 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -125.03 154.94 40.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.6 p -159.94 170.0 22.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -160.79 160.48 31.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.822 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.0 168.59 26.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.22 160.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.547 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 53.4 p90 -163.45 149.95 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.89 172.07 42.14 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.403 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -156.65 -174.93 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.77 151.49 42.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.674 0.749 . . . . 0.0 110.937 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.57 123.07 11.17 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.58 2.187 . . . . 0.0 112.309 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -143.03 -164.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -84.95 -170.07 2.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.72 142.93 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 58.1 tp -67.35 -49.33 64.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.61 -81.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.2 t -122.45 -54.38 1.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 165.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' CG2' HD22 ' A' ' 191' ' ' LEU . 34.6 m -125.87 20.53 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . . . -57.92 -19.99 34.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -160.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -65.38 -7.56 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.05 0.07 54.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 25' ' ' ALA . 23.2 pt -81.0 152.0 71.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.608 0.718 . . . . 0.0 111.115 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.8 133.13 55.99 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.613 2.209 . . . . 0.0 112.375 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.16 -2.65 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -78.06 -145.81 2.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.407 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.03 141.0 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.827 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.32 134.02 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 tp -102.38 121.89 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.33 113.99 25.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 64.3 mt -90.95 59.25 4.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . 175.02 105.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -172.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.01 -60.26 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.53 39.06 95.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 171.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 60.98 19.73 10.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.82 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.85 15.62 67.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.437 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.95 -46.1 82.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 0.0 110.849 -172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.23 -40.09 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.02 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.041 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.7 m -65.51 -38.38 89.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.58 -51.64 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.71 -35.07 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.23 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.062 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 p -63.13 -13.99 43.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.24 -5.91 55.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 97.38 -6.39 63.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -102.41 148.19 25.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 0.0 110.923 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.04 117.71 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.37 147.5 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -114.39 130.56 56.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.91 129.95 56.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.1 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 81' ' ' VAL . 49.3 t -117.29 132.47 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -159.74 162.52 34.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.864 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.07 -28.8 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -86.52 109.56 19.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -171.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.491 ' HB3' ' HG3' ' A' ' 82' ' ' GLN . 91.3 p -69.2 -36.25 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.85 -33.37 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.77 96.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.4 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.07 -34.89 79.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.55 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.95 -36.18 82.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.17 96.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.17 -42.48 98.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -65.0 -40.76 95.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.9 -41.35 97.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.73 95.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.009 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -64.2 -38.54 91.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.8 -33.55 75.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -92.4 -9.08 42.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.75 59.38 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.438 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.98 159.99 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.125 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -101.74 130.72 48.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.43 159.95 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.1 m -117.99 133.3 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -121.73 137.09 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 57' ' ' VAL . 96.1 t -127.84 119.88 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.13 173.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' A' ' 61' ' ' SER . 24.0 tm0? -85.09 114.42 22.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.866 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 t -173.41 145.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -58.41 125.22 22.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.93 -33.29 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.04 77.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -97.14 -8.54 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -64.49 132.4 49.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -91.75 111.91 23.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.5 HG22 ' HA3' ' A' ' 120' ' ' GLY . 89.9 mt -85.12 114.76 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.3 134.34 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 -170.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.6 40.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.57 -22.56 56.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.835 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.37 92.54 7.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CZ3' ' HA3' ' A' ' 31' ' ' GLY . 87.9 t90 -69.8 117.64 11.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -172.96 159.74 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.25 167.86 49.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.414 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.22 125.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.118 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.49 125.81 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.2 t -116.52 113.63 23.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.68 117.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 45.1 54.97 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 74.3 m -105.03 92.07 4.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -82.71 120.09 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.0 pp -156.14 150.88 20.46 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.991 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.1 149.48 89.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.76 2.307 . . . . 0.0 112.43 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.4 m -57.7 -29.71 64.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 -38.11 71.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 105' ' ' LEU . 25.7 tp -77.19 -35.96 55.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.4 mtm-85 -54.59 -43.66 72.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.97 -24.64 67.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -85.09 -37.61 20.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.4 mt -72.49 -35.84 68.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.931 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 5.0 m-85 -55.02 -52.66 69.19 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 0.0 110.926 -171.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 37.2 Cg_endo -65.23 -27.74 56.07 Favored 'Trans proline' 0 N--CA 1.466 -0.129 0 C-N-CA 122.739 2.293 . . . . 0.0 112.361 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -70.43 -39.11 74.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.791 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.7 -40.65 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.05 174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -63.67 -57.25 10.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -68.47 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.5 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -72.18 -40.7 55.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.528 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' HA3' ' A' ' 125' ' ' GLY . 41.3 tp -79.78 121.06 24.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.394 . . . . 0.0 110.876 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -80.01 153.76 74.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 110.888 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.91 129.9 35.16 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.342 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.32 -1.4 64.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.416 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.554 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -81.75 170.28 51.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 164.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.5 t -125.16 141.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -106.65 129.36 54.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 169.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.7 mt -120.43 129.61 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt -126.8 130.07 49.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.99 132.58 20.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.49 -168.6 32.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.453 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -91.52 159.4 15.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.975 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.08 145.89 35.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 0.0 111.112 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.434 ' HB2' HD23 ' A' ' 147' ' ' LEU . 33.4 Cg_endo -62.52 -33.25 79.11 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.265 . . . . 0.0 112.279 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.82 -29.96 70.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -63.0 -41.06 99.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.757 HD23 HD22 ' A' ' 150' ' ' LEU . 2.5 mm? -93.67 -5.02 49.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.842 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -69.16 -3.1 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -169.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -74.74 -165.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -74.39 -6.76 50.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -162.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.3 p -94.95 -2.37 50.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.23 34.48 90.04 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.712 ' CA ' ' HB3' ' A' ' 137' ' ' LEU . . . 56.17 -160.56 7.29 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.573 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.486 ' HD3' ' HG ' ' A' ' 137' ' ' LEU . 43.3 Cg_endo -69.96 -47.99 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.347 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.68 -41.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 162.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -164.36 119.76 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.829 HD22 ' C ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.77 -10.12 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.933 -177.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.7 ' N ' HD22 ' A' ' 147' ' ' LEU . 95.4 m-20 -64.29 -23.92 67.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 176.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.6 mp -70.7 -12.09 61.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.757 HD22 HD23 ' A' ' 137' ' ' LEU . 7.9 mp -103.58 128.03 28.28 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.887 -176.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 156' ' ' LEU . 87.0 Cg_endo -80.3 143.03 15.36 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.698 2.265 . . . . 0.0 112.416 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -76.98 139.98 40.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.53 -49.48 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.912 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.56 -33.11 74.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 53.5 m -71.57 -56.99 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.08 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.57 -20.65 61.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.601 ' N ' HD13 ' A' ' 156' ' ' LEU . 10.4 pt20 -75.72 -33.34 60.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.812 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -78.53 -19.26 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -84.43 -14.57 48.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.5 tp -104.25 109.87 63.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -88.81 -20.28 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.628 2.219 . . . . 0.0 112.356 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 84.3 p -61.63 -29.04 69.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -158.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.705 HD11 ' HA3' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -148.14 164.14 34.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -174.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 193' ' ' GLN . 96.6 m-20 -92.58 148.02 22.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -89.65 128.43 36.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 77.5 mt -88.55 -33.8 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 191' ' ' LEU . 43.9 pt -139.3 146.99 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.06 116.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -145.01 148.53 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -109.91 133.11 53.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.872 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.4 pp -120.9 152.76 38.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -111.69 137.68 49.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.9 mmt-85 -142.92 165.55 27.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.866 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -78.95 130.84 36.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 172.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.683 ' HB2' ' HB2' ' A' ' 185' ' ' ALA . 59.4 tp -90.15 126.45 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -77.91 122.84 26.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 171.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' O ' ' OE1' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -175.78 160.03 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -104.11 4.99 45.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.509 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -75.57 168.84 19.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.726 0.298 . . . . 0.0 111.085 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -106.6 1.18 25.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.917 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -77.68 170.04 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -50.64 125.02 12.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.39 21.01 40.32 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.47 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.53 143.78 55.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 110.883 171.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 175' ' ' LEU . . . -129.31 152.03 49.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.09 128.19 23.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.22 147.48 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.58 143.45 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -149.01 136.2 20.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.653 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.8 pt? -155.72 150.02 25.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 167' ' ' ILE . 6.4 tt -140.66 131.37 25.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.934 -169.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 163' ' ' LEU . . . -84.96 173.77 49.09 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 -172.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 164' ' ' ASN . 66.5 tt0 -105.92 129.33 54.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.854 0.359 . . . . 0.0 110.877 -174.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.895 ' O ' ' HD2' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -92.42 99.99 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 170.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.0 mt -99.1 133.63 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 157.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -87.66 -35.85 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -177.575 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -124.9 -74.99 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -162.0 160.82 28.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -126.01 154.67 42.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -151.76 130.07 12.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -160.47 165.04 31.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -157.42 169.94 23.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -159.94 132.77 6.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.4 p -156.9 168.02 28.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.81 134.96 15.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.866 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -155.86 167.26 30.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.0 160.71 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -162.27 165.24 26.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.06 176.75 24.24 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.579 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 17' ' ' PRO . 85.7 m -125.08 119.51 28.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -125.42 77.76 68.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.654 0.74 . . . . 0.0 110.932 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.665 ' HD3' HG22 ' A' ' 15' ' ' THR . 73.5 Cg_endo -76.62 153.54 34.34 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.651 2.234 . . . . 0.0 112.429 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -77.35 157.19 30.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.12 -35.98 70.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -113.81 152.51 30.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.802 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 49.1 tp -76.82 -55.2 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.79 -81.69 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 -169.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -125.08 -46.05 1.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 163.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.799 ' O ' HG12 ' A' ' 24' ' ' VAL . 94.7 t -124.84 17.27 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -170.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.802 ' HB3' ' H ' ' A' ' 21' ' ' LEU . . . -65.41 -11.21 40.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -65.9 -6.19 11.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -90.66 0.25 57.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.533 HD12 ' HB1' ' A' ' 25' ' ' ALA . 96.8 mt -70.05 132.7 88.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.64 0.733 . . . . 0.0 111.124 174.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.18 144.77 82.51 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -75.51 11.22 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -170.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.18 -130.37 3.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.53 139.31 32.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -174.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 81.8 mt -124.22 131.79 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 173.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 tp -106.91 120.28 41.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.898 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -105.63 127.04 52.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.7 120.8 40.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . . . 55.48 54.61 8.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.07 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 pm0 -70.23 -17.71 63.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.914 -172.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.51 -111.54 4.26 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.66 -41.5 70.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 110.904 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . 88.59 13.88 62.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.447 176.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -65.83 -35.06 79.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.81 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.51 -33.07 72.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.92 97.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.8 m -65.82 -35.89 81.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -62.61 -44.51 96.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.56 -43.0 99.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.906 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.81 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.5 p -71.02 -20.26 62.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.878 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.2 mt -85.68 -1.59 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.41 8.59 59.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.51 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.78 147.69 35.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.33 105.05 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 170.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.82 120.73 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -165.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.8 m -117.44 124.95 50.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 165.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.26 131.87 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.157 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.02 134.83 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -155.31 157.21 36.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.28 -20.09 41.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.0 t -93.13 111.38 23.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.7 p -67.8 -34.41 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.29 -31.35 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.105 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -40.26 98.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 170.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.92 -38.09 89.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.74 86.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.132 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.81 -39.98 94.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -63.16 -41.88 99.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.33 -43.28 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.7 -45.5 93.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.06 -41.3 98.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.6 -44.87 93.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -64.56 -38.92 92.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.79 -31.79 69.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.21 -8.3 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.19 56.05 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.469 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.66 160.94 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.348 . . . . 0.0 111.195 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -106.85 135.5 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.866 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.4 pt -137.32 160.82 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.6 m -108.55 135.4 49.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.3 p -117.65 135.62 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -125.97 122.78 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -87.45 111.44 21.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.954 172.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 t -172.93 143.4 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -59.51 125.67 24.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 171.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.46 -36.38 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.5 -31.48 68.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -100.06 -9.23 22.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -63.77 134.48 55.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -89.79 112.22 23.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 120' ' ' GLY . 87.8 mt -98.59 115.75 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.29 139.36 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.25 4.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.146 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.76 -23.79 65.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.922 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -52.38 10.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -96.79 139.82 32.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -164.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -126.72 166.47 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 42.73 71.05 0.43 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.482 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -92.73 130.47 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.08 130.39 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -173.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.4 t -103.71 118.09 35.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.8 mm -110.01 115.03 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -169.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 61.6 m-85 47.38 48.81 16.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 88.8 m -99.61 74.04 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.874 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -76.7 114.96 16.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -153.48 153.38 29.08 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.517 0.675 . . . . 0.0 110.952 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.03 149.56 89.14 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.648 2.232 . . . . 0.0 112.389 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 99.7 p -57.79 -30.57 65.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.812 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.6 p -62.77 -31.28 72.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.3 tp -73.1 -35.53 66.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -55.16 -39.93 70.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.764 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -63.18 -30.86 71.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -82.77 -35.68 26.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -73.51 -41.55 62.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.595 ' HB2' ' HD3' ' A' ' 115' ' ' PRO . 8.3 m-30 -55.01 -48.06 96.96 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.71 0.767 . . . . 0.0 110.907 -164.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 114' ' ' TYR . 84.8 Cg_exo -49.82 -41.75 45.99 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.68 2.254 . . . . 0.0 112.353 176.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -78.67 -46.03 20.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 77.9 t -73.31 -54.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.035 -165.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -80.04 -38.66 31.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 -168.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -69.15 -30.13 68.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 90' ' ' ILE . . . -70.92 -14.85 73.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.45 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.27 124.33 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.07 139.78 97.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 0.0 110.9 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.27 130.37 32.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.92 -1.52 85.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.425 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.82 178.65 51.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.462 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.06 147.04 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -112.98 133.45 54.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mp -121.97 135.52 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 190' ' ' LEU . 47.3 tp -121.17 129.35 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 171.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -157.54 134.18 9.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 102' ' ' PHE . . . 172.81 -171.67 44.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.513 -177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -65.51 140.89 58.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.55 ' HB2' HG23 ' A' ' 188' ' ' ILE . . . -90.94 144.9 30.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.582 0.706 . . . . 0.0 111.077 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.38 -26.49 21.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' HD11 ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.3 -25.05 31.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -57.17 -24.8 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.42 HD12 ' HG ' ' A' ' 150' ' ' LEU . 92.5 mt -62.64 -13.03 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.002 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 139' ' ' TYR . 21.5 tm0? -56.73 -12.16 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.588 ' C ' ' O ' ' A' ' 138' ' ' GLN . 63.2 m-85 -21.16 -69.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.96 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -135.11 -57.05 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.944 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.1 p -102.32 0.9 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 138' ' ' GLN . . . 84.88 -5.69 81.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.48 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 142.59 -171.45 24.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.01 -32.8 16.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.569 2.179 . . . . 0.0 112.367 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.63 -45.03 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.484 ' HB3' HD13 ' A' ' 149' ' ' LEU . 22.3 t0 -173.56 151.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.898 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 135' ' ' GLU . 16.3 tp -62.97 -22.97 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 170.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -74.67 -20.59 59.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 -168.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 146' ' ' ASP . 1.4 mp -81.07 -9.58 59.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -174.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 150' ' ' LEU . 3.2 mm? -89.02 142.29 30.1 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.546 0.689 . . . . 0.0 110.978 -165.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.48 145.75 38.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -94.77 165.82 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 156' ' ' LEU . 45.6 tp -49.48 -40.45 37.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 171.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.95 -30.74 71.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.7 m -66.5 -60.24 2.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -171.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.076 ' C ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.43 -16.5 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 -177.032 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.603 ' N ' HD22 ' A' ' 156' ' ' LEU . 65.0 tt0 -66.18 -40.91 90.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 170.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.9 p -79.25 -17.81 54.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.792 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -74.84 -13.3 60.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 163' ' ' LEU . 65.9 tp -104.58 107.46 58.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.624 0.726 . . . . 0.0 110.946 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.13 -29.64 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.705 2.27 . . . . 0.0 112.293 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -80.45 -22.53 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -160.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 160' ' ' LEU . 98.4 mt -123.43 150.73 43.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -174.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -94.54 139.61 30.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 157' ' ' GLN . 98.5 m95 -93.49 126.94 38.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 91.3 mt -93.47 -31.05 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.653 HG12 ' HB3' ' A' ' 191' ' ' LEU . 46.7 pt -138.06 148.47 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.19 122.59 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -128.92 134.88 48.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -117.08 119.95 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 171' ' ' LEU . 3.7 pp -127.57 147.91 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -172.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -118.58 138.09 52.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -132.47 152.39 51.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -56.43 119.83 6.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.74 125.73 27.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.988 -166.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -123.46 28.99 6.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -94.3 -143.92 14.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.509 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.63 -178.39 5.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 111.057 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -73.24 75.0 1.32 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -144.95 -178.47 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.8 151.54 31.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.57 -168.37 35.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.521 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -76.84 142.2 40.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -164.13 159.51 20.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.26 130.66 41.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.9 mt -124.43 150.83 45.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.973 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 133' ' ' ALA . 33.2 pt -125.65 144.66 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.94 134.19 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 190' ' ' LEU . 1.1 pt? -154.51 152.55 30.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.653 ' HB3' HG12 ' A' ' 167' ' ' ILE . 1.5 tt -138.17 130.59 29.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.6 171.21 52.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.538 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -84.92 123.36 30.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -115.33 109.96 18.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.26 134.16 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.906 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.34 -40.14 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.842 -179.775 . . . . . . . . 0 0 . 1 stop_ save_